<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF
   xmlns:ao="http://www.w3.org/ns/oa#"
   xmlns:dailymed="http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/"
   xmlns:dct="http://purl.org/dc/terms/"
   xmlns:dikbD2R="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/"
   xmlns:domeo="http://www.w3.org/ns/domeo#"
   xmlns:foafx="http://xmlns.com/foaf/0.1/"
   xmlns:ns1="ncit:"
   xmlns:pav="http://purl.org/pav/"
   xmlns:permissions="http://vocab.deri.ie/cpo#"
   xmlns:poc="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#"
   xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
   xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
   xmlns:sio="http://semanticscience.org/resource/"
>
  <rdf:Description rdf:about="urn:domeoclient:uuid:83C1E0C2-65AC-4358-9C01-F765A5E20B1B">
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:876859AD-C7C7-49EB-9C33-302237E827B8"/>
    <pav:lastSavedOn>2015-06-19 11:02:27 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:EC837692-C376-409C-9797-06D056AF0AC8</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:861d7355-bd05-4520-a9bc-7cbebbde07d6</pav:lineageUri>
    <pav:createdOn>2015-06-19 11:00:45 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6B12D9AC-F09A-4157-8E26-ACDF40ECBB03">
    <domeo:deleted>false</domeo:deleted>
    <permissions:permissions rdf:nodeID="N4185661995254120894c47b64a642bfb"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.0alpha-040"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:2DDE57E8-8DE6-4ED1-ADB7-2F109930DB5D"/>
    <pav:createdOn>2014-02-09 21:22:24 -0500</pav:createdOn>
    <domeo:agents rdf:resource="urn:person:uuid:080e143043ef9cf90143f8ea240c0005"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:97462094-EB47-4D8E-A3F1-3B41A3ABEFF5</pav:lineageUri>
    <pav:lastSavedOn>2014-02-09 21:22:48 -0500</pav:lastSavedOn>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/Clopidogrel-1086a7b4-b89b-4bee-8120-5f752626c046.html</ao:annotatesResource>
    <rdfs:label>Default Set</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:13EC47DA-B354-4A9B-AFAE-04FE1A0CAF73">
    <ao:exact>Norgestrel</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>        90 once daily        N</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 14:05:57 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:13EC47DA-B354-4A9B-AFAE-04FE1A0CAF73"/>
    <ao:prefix>(0.92, 1.21)  1.07 (0.89, 1.28)    </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0F92F586-5DB5-4479-9955-AD6B17AD2096">
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>0F92F586-5DB5-4479-9955-AD6B17AD2096</domeo:uuid>
    <ao:prefix>is extensively metabolized in the liver by CYP2C19 and CYP3A4.   </ao:prefix>
    <ao:exact>In vitro and in vivo studies have shown that esomeprazole is not likely to inhibit CYPs 1A2, 2A6, 2C9, 2D6, 2E1 and 3A4. No clinically relevant interactions with drugs metabolized by these CYP enzymes would be expected. Drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin, warfarin, quinidine, clarithromycin or amoxicillin. Postmarketing reports of changes in prothrombin measures have been received among patients on concomitant warfarin and esomeprazole therapy. Increases in INR and prothrombin time may lead to abnormal bleeding and even death. Patients treated with proton pump inhibitors and warfarin concomitantly may need to be monitored for increases in INR and prothrombin time</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0F92F586-5DB5-4479-9955-AD6B17AD2096"/>
    <pav:createdOn>2015-06-26 14:42:39 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D09B9624-D2E1-4E6F-B917-1E5FDA3F555B">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:30:12 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:FCF24CB4-A151-42ED-A71D-5C251DD4ED3F"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:05889969-8C7C-44F9-8962-6661FD64EB05">
    <ao:prefix> In a crossover study in 76 pediatric patients, intravenous </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <domeo:uuid>05889969-8C7C-44F9-8962-6661FD64EB05</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:05889969-8C7C-44F9-8962-6661FD64EB05"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>did not increase blood levels of high-dose methotrexate. </ao:suffix>
    <ao:exact>ondansetron </ao:exact>
    <pav:createdOn>2015-06-24 14:51:07 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:E9F13BFE-1A17-4FDF-99A7-13B89F697635">
    <permissions:permissions rdf:nodeID="N8e5c5521fd5c46d3a2dca054f7a800a4"/>
    <pav:createdOn>2014-02-19 12:23:10 -0500</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:B26CD913-F144-4BFF-8967-7F740FF37133"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:66FF0DF3-C777-4A3D-971F-8E83B304FDCC"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.0alpha-040"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143043ef9cf90143f8ea240c0005"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:18CB9938-6266-493E-A282-DB819CD3E51A"/>
    <pav:previousVersion>urn:domeoserver:annotationset:47A2106C-5354-420D-9E05-D9E4F945B6D0</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:37DDEDB4-2423-46DF-880E-A2D411563078"/>
    <pav:lineageUri>urn:domeoserver:annotationset:357321A7-5793-4DE5-BB38-BF5FA7A5D72C</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/Clopidogrel-1086a7b4-b89b-4bee-8120-5f752626c046.html</ao:annotatesResource>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:8B9CE845-DC5C-4C1A-B610-A49E5EABC515"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:633CA52C-A1B8-4DA1-936D-70D2F0106564"/>
    <pav:lastSavedOn>2014-02-19 12:41:40 -0500</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD50317C-F9EF-46BC-827B-B24D2D22C267">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AD50317C-F9EF-46BC-827B-B24D2D22C267"/>
    <pav:createdOn>2015-06-24 14:54:31 -0400</pav:createdOn>
    <domeo:uuid>AD50317C-F9EF-46BC-827B-B24D2D22C267</domeo:uuid>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:exact>ondansetron </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> Pharmacokinetic samples were collected from 74 cancer patients 6 to 48 months of age, who received a dose of 0.15 mg/kg of intravenous </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>every 4 hours for 3 doses during a safety and efficacy trial. These data were combined with sequential pharmacokinetics data from 41 surgery patients 1 month to 24 months of age, who received a single dose of 0.1 mg/kg of intravenous ondansetron prior to</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:59DF4D10-049A-4D60-9FB6-CC8F0710DB5A">
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:87EF0115-C8CB-4EEA-8E06-EC31B768F498"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:31:05 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB">
    <ao:item rdf:resource="urn:domeoclient:uuid:A28BABF2-B3F1-457B-BF34-0EC97508FA98"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9ED99674-EA90-4B88-B587-A3EFF7675F31"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:BA7CEFC5-C16D-45AB-90AE-2F8C30FC9D3B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F6711DFF-CFA2-4B07-A265-C2C5AC30B690"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0104F79C-E976-4414-ABA3-4E5849840F3B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:527C0121-16D7-400E-B847-FFAC78B04935"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:828E63F7-E817-4FAF-B199-C1D9B5E70427"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:90855586-8753-47DB-A6F4-E00CCFF3B2A5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9F92D7DC-DEA3-44EF-A836-411B21BAF560"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F5C523FE-31D5-4AAB-AB87-E7F27C6D6985"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:C3C51332-1F4B-428E-8EBA-57EC2E79E7B7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:640B26C4-E159-4852-BDFA-CBE889756A4C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:43DA552C-84B0-4E1A-8B1A-94AC040776EF"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/73852acd-fee5-4e4d-bed5-d1c42d6b6cf4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:45A3A8BE-7E8A-4BE3-BE31-40A89606427B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F35A08B5-4C26-4012-B4DA-DA9BF994C2F7"/>
    <rdfs:label>NER Sets</rdfs:label>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:DFED9A23-523F-47EA-B795-5F98D263A8DF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:45A22364-35E0-4139-A898-0ADF64EFD6E0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:86F21B0D-4E53-4259-9F6B-2D629026A512"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143043ef9cf90143f8ea240c0005"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.0alpha-040"/>
    <pav:createdOn>2015-06-12 16:57:58 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:398200FE-FFD1-4612-A307-9920E6117728"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6D1DE281-6653-4634-9592-C6F6CF291354"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:979A2048-B848-4C06-B910-9ED52FDE4CEA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CDE2F1A4-BC4C-4325-A9D0-F4A22851876B"/>
    <pav:previousVersion>urn:domeoserver:annotationset:38B84CE5-4B40-42FA-98A3-2F535BBC6FF8</pav:previousVersion>
    <permissions:permissions rdf:nodeID="Ne1f3f4a6200942eb81cdc748c0fc2f9a"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:55379DA0-98D9-4F93-B6CD-36F967DF0107"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:annotatesResource>
    <pav:lineageUri>urn:domeoserver:annotationset:2284e984-435c-475d-8023-97355b70469b</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:D0684FBC-AA59-4E77-8084-24E821D53ACD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A7B76179-9CF7-4A07-A0D3-E83B14BC7676"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:20BB7686-88A0-4E91-BD4D-B473C525AD83"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:445F16EB-3F7F-4228-86FA-3BD5D2FEE5DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F4321EE8-ACB3-46D1-AA21-E9DABC675E50"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8ED0921C-1671-4D6F-863A-50860535426C"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:D909DA64-14F1-4718-9FA6-CC479090962F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:66C68254-44C6-4638-BFDC-2477A1CC1740"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D8F9EC0A-92FE-4D04-83D2-B6BC458830E1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:04AB3EB2-077F-4618-8DA5-BF7A70F1BD9F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BD03B2D0-4DE0-4E44-9EDC-2E2F30367528"/>
    <pav:lastSavedOn>2015-06-26 14:32:43 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:5AA27CFC-7040-496C-9F00-98667F4A2C18"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9A93244B-B29F-4731-81CE-6A5BB7531ED2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8573FC78-CE49-4C4A-9B2A-ED62F9279AAA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C7732FF4-4B1E-4EED-82DB-ECD7D976EF7A"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3CC5D732-22E8-4066-B85C-4076AC71BC65">
    <pav:createdOn>2015-06-24 13:30:01 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:7CE6CB8C-CA5F-4917-9556-C8C508345887"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/75177B0E-1BCD-4296-B6BC-BE16B82420B0">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>atazanavir</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/343047</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6423F89C-E4EF-45EF-8E29-DAEBCE732B19">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:08D97455-3C15-4FFB-95D9-78ACEFCD76C1"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:8E542C03-CF21-45D1-8083-4B09FC33A436</pav:lineageUri>
    <pav:createdOn>2015-06-24 13:57:37 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 13:57:41 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F0F94768-ECF7-4184-A096-FC386CDC34D2">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 14:51:56 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:48BB5DA3-A213-4558-B6B9-422872085E5C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E763C2B0-180E-4A13-B051-EBB9EADF4094">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:FAC8D76C-FDE5-4357-9D84-3FDE7C406C81"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:41:57 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:90661E65-B3C5-411B-9C21-BEE9207964C0">
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 14:06:09 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:2A4594E0-CEA6-4598-A1C5-6BAFA46A0B1F"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:76214DD5-F739-4F31-B3BE-FE0AADBFD1AE">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:15CCD238-A976-4247-92FE-21E992A68365"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:15FC7B0D-9403-48C6-9C44-CD528D89C1A4">
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:30:11 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:3BB005FD-87C8-46E4-AF8C-25F6F76F9A00"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:18BE6837-88C8-4534-A4B5-C66D6354DFBC">
    <ao:exact>GS-331007</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:18BE6837-88C8-4534-A4B5-C66D6354DFBC"/>
    <ao:suffix> (N=2113) were 7290, 1320, and 12,000 ng∙hr/mL, respectively. Steady-state C</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix> (N=1542), and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:40:46 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:23D15EB5-40FE-4A88-B11A-3005C07F44C0">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/790F7DD9-B082-43CE-85AF-0A3C94CCEAD9"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/56CCB2C2-AE6B-4544-B067-2F765388E339"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1BBB8113-6883-416B-9571-B23DE13477F4">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:30A56BFA-B511-451F-8A9C-CF11FEA38C24"/>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:createdOn>2015-06-24 14:51:13 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AE545A8F-061B-4405-8427-ECD67DA5C602">
    <pav:createdOn>2015-06-26 14:06:49 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AE545A8F-061B-4405-8427-ECD67DA5C602"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Concomitant treatment with rabeprazole (20 mg daily) and ketoconazole in healthy subjects decreased the bioavailability of ketoconazole by 30% and increased the AUC and Cmax for digoxin by 19% and 29%, respectively. Therefore, patients may need to be monitored when such drugs are taken concomitantly with rabeprazole. Co-administration of rabeprazole and antacids produced no clinically relevant changes in plasma rabeprazole concentrations</ao:exact>
    <ao:prefix>can increase during treatment with ACIPHEX .   </ao:prefix>
    <domeo:uuid>AE545A8F-061B-4405-8427-ECD67DA5C602</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C3D5761B-F1E9-43C2-9D22-5854F1ED38ED">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/Clopidogrel-1086a7b4-b89b-4bee-8120-5f752626c046.html</ao:hasSource>
    <ao:suffix>. (</ao:suffix>
    <ao:exact>Reduced effectiveness in impaired CYP2C19 function: Avoid concomitant use with drugs that inhibit CYP2C19 (e.g., omeprazole)</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid>C3D5761B-F1E9-43C2-9D22-5854F1ED38ED</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2014-02-19 12:41:17 -0500</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C3D5761B-F1E9-43C2-9D22-5854F1ED38ED"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/091B1535-5762-4976-86BA-97D3F802A0CA">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>ondansetron</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3CB42E72-909A-4A4C-8382-77CB52A35E53">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:exact>Ledipasvir</ao:exact>
    <ao:suffix> and sofosbuvir are substrates of drug transporters P-gp and BCRP while GS-331007 is not. P-gp inducers (e.g., rifampin or St. John's wort) may decrease ledipasvir and sofosbuvir plasma concentrations, leading to reduced therapeutic effect of HARVONI, an</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:56:12 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3CB42E72-909A-4A4C-8382-77CB52A35E53"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70">
    <ao:item rdf:resource="urn:domeoclient:uuid:5B26F4D0-1B51-4F1D-AA58-5347E37B448A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FCD85EC4-04DD-4DF3-9155-E01E66AFFFA4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F073C031-4850-414C-9AAF-7A7CB6619988"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D8D191F0-3CC9-4933-BF6B-AFBF98015E37"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9BD634E5-955A-4F3C-8635-B79E4BC1A6E1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:40978775-9652-4684-9A51-66A2E6B91DA9"/>
    <pav:previousVersion>urn:domeoserver:annotationset:426730AE-AE82-4632-B5A4-DF46E99E0A84</pav:previousVersion>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:FBAAF687-0459-419E-B287-28E543B0ED45"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AD29D9A4-991E-47B0-A162-6A4CA0DC4913"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:10D5167F-417B-40B4-B521-BFD09A986C23"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:95C09FC9-FB7F-430B-B5D4-5E406DA01647"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:14481787-9288-4199-8F75-34841FB9BB99"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:B121266A-9A5A-4B75-A84C-7B045C86BC38"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BC515F1F-2E1D-4905-AF8F-69465C44F3A8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4914B47D-3FD3-4346-B260-E22283815ADE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:47A174B6-BABC-4A2C-B120-EBDA4D8ABB00"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:221375F9-ED01-447F-B3A6-99118DB3E4B2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B9A9B58E-E7D3-4A0E-B34C-D1B901EA610D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1432258A-6DD0-4204-87CF-66BCD8D2CDF9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0AD4752B-43D4-4ECB-8451-81D75648598C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0FD9D5BA-6BF5-4F2B-871B-EF75AAA3BCE4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5138346F-A55F-4B2A-A312-64E0EED62520"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:59DF4D10-049A-4D60-9FB6-CC8F0710DB5A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B957B653-5D89-4E8E-8AEB-AEEAF3467FF0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DBF1748F-4743-43A5-802F-7F6A5BAA2817"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:61EADC2F-22F5-4BA6-B4A0-D09436ADA0BE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:51EED05F-756F-476C-995C-B9BDEA114786"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8D09FC70-23D9-438F-8C23-CD68634F22E6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3B42C83D-8558-408E-B626-5FE2649E0072"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:38CB78BF-DC15-48C6-A716-48D1CD385058"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:276F7993-E726-4D0F-910D-8E3FA0149DB8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8606EDAE-0D8A-4F24-A833-57F889B0C46C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EC9F9772-617D-4868-8EE5-981BCCF92C0B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6423F89C-E4EF-45EF-8E29-DAEBCE732B19"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D46F101B-4C98-4800-9880-79FDFE696471"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A51198BF-BEDE-4B2B-8C62-25AB9952B609"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F9739C64-1B7F-440E-835B-AE64A8E649E6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B465E423-580F-444F-9FFF-69B9F7775DA0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:94591B37-EB7A-4F95-88DF-65B185289495"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.0alpha-040"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:806E8B10-9AED-4C6C-81FD-52625884D3E8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3B1D9D8E-76F9-4581-98E6-770ED398A577"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9277D06A-A729-4CEB-BF63-CFD9BAD12ACC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5F70EB41-EE4A-4F09-AE14-83FC1AE2218C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A2998F38-F39F-4AAA-B348-72D4A0318E4D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7833DD49-3AB2-4409-A76F-70220219D8F8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A9DF38FE-4E34-4990-9A79-C1B7044B92FC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2B069448-3F9D-4546-A20E-26BAA41CA533"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1DC72C25-E026-40E5-AB15-7CB214A5F36F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3D12BC91-A93A-43B5-B34E-367C05C52347"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:EDB8A04B-DB76-4A61-A993-FB81D9B0782F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B6032D11-CD5A-4065-89D5-7180CA4B12CD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CC9EC46D-CF77-4BC8-BB24-5A947D1757A5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:49AFD22C-676B-48FD-9510-4BA5F6241FA1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:320B5BA1-675E-41DD-97E9-41B3E57A54B7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:328D816D-0675-422A-B70A-ABD4886386EE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1D3D992D-A6FC-49F3-8570-E367501F67A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0CD65CF4-142D-4489-828C-EEF820C878C7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A8C8D2A7-F1AB-40A8-9545-B062022DBDAD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:132F2712-A4FF-4342-8E9F-780474C8B7B1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BF1A3598-40A0-466D-9DA1-A732F864DD97"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0DD1525B-D8D7-4BEF-9410-82B5E9E6BD2A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9D993CCE-022C-44AE-A2DB-ECB5EE7558C0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:721BB3EC-1BBC-4BAA-B56A-E4E587A7F8F8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F456F601-9F57-457A-A860-C7F87C1C991A"/>
    <pav:createdOn>2015-06-12 16:57:42 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:DD4CB317-8E03-4E29-80A2-2F0EDF2B3094"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DEBBBD3A-01FE-4EE4-8B50-2D97B85F3709"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:704BEB52-B906-45A1-843E-924D08C8BBA8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8067DDF0-007F-40E9-8EF8-B0E19A0DD6B0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:254CD313-2561-4B27-A846-A69362660545"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5057A643-C8F2-47DF-BDD6-F3F926418451"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:838B50E6-EDCF-47E3-9187-AE8F1C8A6A3E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D01BFFD2-4A08-4388-A548-51F665C77BAB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:66913E9E-0DF8-49CE-A39A-7690572C8F8B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6C4459A9-4287-4821-9260-E2A70BF5144B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A8977D20-5445-4FBC-B099-8E9A69117CAC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7154222A-60C0-4D07-ADE0-7458FABF470A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E763C2B0-180E-4A13-B051-EBB9EADF4094"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:872F18C8-D0AF-44B7-A6E2-9D12FD618A39"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:898A4586-1608-4536-A415-FCF1D19C9F5C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4DAE57F1-104B-4C53-8A4D-449DFAD11010"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C7690AF3-956C-4483-9809-E636B620F534"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:175760DD-A1C9-4DC4-8A7D-E091D1F96F93"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:47BA2497-2B76-4257-A45E-E6AB7172F13E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:887A63A6-BF10-4C0E-A8EF-00E85489CE86"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8FE4CE20-53DF-4EB7-A588-F2A4BA003CFB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:921BE2CF-21DB-4B19-AF5C-F7728291FB1D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E95AA727-C0C5-4FC4-BFD9-0E9952A7A862"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3B68D5B8-B7B3-4BCB-808F-FC1E13D6D1A5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:296A68C0-31B7-4AE3-825A-55E6B5A44A72"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:360E2C81-7800-4E2C-9719-E9AE317B4450"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:72ECF928-359A-46C4-BB2F-2A43129326FF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:929B1C40-721A-407F-8A09-CD90300E71A2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8737A8AA-3C3D-4143-8FEE-54CF3A7E0DF3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:191E1785-D944-4F5F-9555-F97370D2505B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7E4ED115-6EE5-4897-A3A3-220E1AF94609"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:775D9945-9E10-4698-A841-B976A09926DC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA1C7292-40CB-4591-A038-11AC440913EF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:72E8E163-BD77-48F7-9D93-24D38363FE15"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:932C7A99-78B6-423A-A3D3-67B955F4C7FD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0FF171AB-0C4B-4203-813B-81D849C85D49"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D8CDB679-A337-47FC-972C-0280F177E864"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:48FA3E8B-B0D1-422E-954E-23990194A1A0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F8402414-A1AF-4167-BA6F-F7DBC881BEE7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6B55AE26-A9AD-40A6-BD0A-CCAC2DB73A0A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C39D166C-7605-45CE-912C-C831CA3D0D1B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:297D4D19-C8D2-47AB-8014-689C9CC2EFD2"/>
    <pav:lastSavedOn>2015-06-26 14:55:50 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:6DCAA33E-68AA-494D-96A8-08D4E60008F9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:62F37051-6F0A-47E6-9E62-BBAFD5D1E4B6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CCEB07C9-29EC-476F-890C-12D1F4979398"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EE904256-1070-40E4-8465-AC43FCC5803B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FABC06FA-48C2-4637-960B-562CF975FD1A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:03F76D6A-5714-49BA-9119-24799884A860"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1E970E8-6572-4958-B3BF-0998635FC327"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6550BB9A-B58D-4EFE-9290-8325F58F3970"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F987AFF0-7540-4CD1-83C3-D0919E11FB32"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CB3EA0D4-97D9-43CD-BBBD-999525A30044"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:997B55C2-F1DB-42AE-BFBF-4446E8BF178B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1CE0A04-057F-444A-8277-8AD756B5202A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E65106E9-0A6F-489A-8B88-59AE401F3D47"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7204AB9D-53EC-4C4F-85E1-ED8026C359FA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:90235EBE-A4E7-450D-AB7E-F2CC75A71763"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D89022AD-A7CA-4475-9E65-5CFA53D36AAE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:856ACBEC-5155-41D8-B53D-DABAC70AC167"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FBD4780A-2CF1-4338-A5D2-BBD2641E11D1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F7728C11-5BE6-4414-9375-258032F11909"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8B058E25-B7EC-47FE-81CB-8CC0DF8D945D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8E07AED9-E09F-4EBE-B0E7-527787B7E452"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9582E934-3102-46B7-8EC9-E19DAD318BC3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5127D1F2-886B-4124-96C2-EEB595CD3FA6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A3FF34AF-F90E-4B5A-BB1E-AB587EF033FE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A0F251E9-D6A8-42CF-9E01-8B1B1C86018C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:24FA0132-8CE7-4641-87A0-338B6EDEA58C"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:D2C3BEBE-0D09-40CF-AFB6-35D254C5F6EA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:60AD93C8-63BE-418E-A152-E7951F93A783"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DE308562-87E4-4226-981C-B0A1540E340F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B4D1AEB6-8792-4EA0-8BC4-87E834A0C675"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2B611FD4-29B6-482E-8F02-37DD5BB8AD10"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5335704A-8A43-4545-A959-225A196391F9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D1BB31CA-FDCD-4DCB-90C3-3E5E6C9CFB85"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E33A20DC-279D-4DFF-BF26-43D80614D9D5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9E8C9B9D-1EED-41BE-AB65-1E8F01BD3389"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:18B76D8B-4ECB-4303-9C35-5AF8C70112F2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DA07967E-A7A2-42C4-83D2-9D077D96A8F3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3869AEDF-FA01-4F26-8A72-F2BEADD14C83"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:153034D2-E6F5-42BB-8FFF-4B317A29CCA0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:21AB03A1-CEBA-4572-B4E2-A29701AF19BF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:27AC35ED-4323-4666-B982-577354082CF8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AA6BF2C5-504B-46F6-96A1-FBBB5D7C5F0C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D44E648D-6F19-4752-B129-5167C12573D0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:19D106F6-2C8F-4467-AB6E-C9707F5147AC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:69E429CB-59F3-4584-B221-1B4D961B0075"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FCFDA02-3B40-49EA-9B7D-6FDF08A81FFB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D09B9624-D2E1-4E6F-B917-1E5FDA3F555B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D3B52782-ED05-4DF4-9B04-3D8052C961A4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:14771221-FA3D-4F83-BB45-2CBFC3CA534D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:01F197A1-0E6A-4F94-89D5-715ABF597EA5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:291F6D7C-ABE8-491B-B67D-2AFCF06AAE5B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7DB8F817-3420-470E-8853-514D3846C981"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6F48D51C-42AA-44FC-8710-1CC751A82C55"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AB4D4B49-F805-4F28-9A50-106803553A96"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:58921AB8-8C62-43FC-904F-53953B30F2BD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:326F2A29-ECA8-43D2-B721-3C4922DF4737"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1A47AA61-3232-4F08-90A4-16CB8032E16D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CDF75166-895C-4707-A0EB-313BA1C31796"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:21B60E76-0F18-4B18-B47E-ACA1EC93052F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:73DA8AFB-B49E-415B-A4A1-B0D98E62B5A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A2CF82A9-9110-4448-9271-1B7A43E3ACD8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7D82FCEC-AAAF-4B8A-B346-9956969C4AB0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:768AA3B2-059A-4D55-B231-7FF9C658DA10"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EC583886-AB43-4BC8-A738-544C0BE4E997"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EB2C9B82-E225-474E-80E2-C58CA140779B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3580DAFC-9D65-45D8-A93C-CECDA56A1F4E"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143043ef9cf90143f8ea240c0005"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5BC79418-F91B-4E6B-8CEA-A6DDDA54890B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B68CB993-FF06-42DC-9683-F32CB86AA560"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F686B890-17C0-434A-874B-02D3264C918F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:14F8DFF3-9177-4E32-989C-4A6EA43D0F2C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B4CA3F17-4678-437D-8937-D6CB6D7EEEE0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:46037266-2275-4C32-A459-43B403557EDC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D5F927C9-ECA9-483D-A35F-1B66DCBCE0EC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:676501EF-BB84-42F5-B053-0ADD1C44902B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:32677D71-846D-40CC-8CAC-12B59D98ED75"/>
    <permissions:permissions rdf:nodeID="N2269999d380440b28c98a943133622d2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:90661E65-B3C5-411B-9C21-BEE9207964C0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2F10298C-2A81-494E-9AD1-ABD580483D6C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B3004F71-517D-410F-931B-075CEBE20FEC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:041CB31E-39FF-4196-8054-0061A7E53B52"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:840E5563-001E-4EA3-8BDD-CEE5F9C00E29"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:37D7C804-E2E1-411E-8C44-541340FF6194"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4E683CE2-B58E-49B0-9F1D-8B6F624B352D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E377260C-DF7B-4F2A-B579-C17581893FBE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BE7F5A33-2C73-4027-AFC9-9BCBDFA6CCE0"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">10</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:5277F21C-DBA3-4147-8BAC-6BC4ADF34904"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CFE49BB4-1C31-4623-B66D-293C72A00AD5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:86A39B51-D81F-4367-83A6-DF8308535A1B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FF6B4FA3-376E-447C-B793-E2F0C1BDE4F9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9AE8B2D3-50AF-402B-B7FD-66B6981C8CF2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:59E8DF4A-0191-4071-9D86-F81300BDE4F6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:84CEECAF-BEBB-4E25-A4F8-A4AA7FE7ACEC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D9042A2D-981F-4997-948A-20F4BE1530DC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C30C9775-7EF4-4325-B024-AEBE40B1D413"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C1A5D662-E57A-4E03-80F0-C41670441C51"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:35A346FE-E487-4516-B765-6DD3E191493E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:29C4967C-71D4-491E-A325-E3F4FD902F7D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8E0338DD-3BE9-4C9D-9ED2-6B382BB74502"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA1A4382-FD7A-47B4-9FCA-44A5E1809C8D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:774060B3-CB97-4D04-9CE8-9506CC7620CF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:70496807-BB43-4B36-9CC1-9575C1468289"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3FAB46DB-F556-4C97-BE13-D6AAAA55A85B"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:8EBE2B3C-4283-4C3A-9494-4CFD773885DE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AE55FAC3-E060-4B9A-862A-496E91503E4C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B42A7D30-E3E7-4E9F-BD94-C056EC00AC4F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E731AF4B-8676-4D97-AF10-EB79D94D351D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BAB3BDD1-716C-46B3-BC7E-A177DB6D8F6C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2266C4AF-AC87-4B18-8A9C-67EAAC8C0856"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CFCDFC28-C534-49F2-A00F-6757FD6C75CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D729373A-12B2-411D-9445-5A2D8046EDED"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E3720D1D-2FEA-42A6-9B73-97DE66DF6E73"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:856728B4-6530-4C32-ACA5-0F42C7F38501"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EE1140D2-DC5C-49F8-95C0-F8D8552A6D90"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D897FF57-D178-4757-9FA0-05A94E551C7B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D96B9193-90EA-479B-8529-B73A8562CA49"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:717C5C37-5CB6-4CB6-937C-9396EE48C261"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5A56CA68-6D95-4468-BC91-84B504A5B1A5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BCBFA9C2-F83E-46B5-A2FD-C39229FEDD28"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:76DE5DB3-7CBD-4B97-B770-62941C1542C4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B1199E58-911B-4A5F-B16D-A0E8581AB13E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:09D3548C-32D4-4234-BF5B-9866B40F61CD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:032C5193-FA11-4ED7-B116-DFBA6D3BAF56"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D4582CD5-9B22-4B2E-9020-9F4EF253FB14"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:43E026DA-1EEF-46B0-B29F-35C3E6F4276C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:01AB475B-AF5C-4A7D-B3FB-67173CC8B083"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EC90CBEB-019D-4684-B03B-87F6A39205D8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4E05A927-F710-4834-81AA-9BD904D8879B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CF2D9502-6AD5-470B-B888-7C219EC8E56D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:15FC7B0D-9403-48C6-9C44-CD528D89C1A4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E78E7094-4859-4D69-B493-A0B08D316619"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:46F00088-7B53-4146-8FA2-8AEB1ADAA740"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FEA089DE-8539-4732-A990-3E7AC8FFCDCC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2DAC2694-87BD-4C21-B9CE-D9C208FD380A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E311870E-9D37-4C98-A213-27DD0EFE6E65"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:CAF87BB4-B786-4B62-8518-22A98C36B09B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9CE9354C-6CC5-437B-B94B-A83F19F0C710"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3C039EA8-5898-4FFB-BB5E-D3B0E3240A2C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C432C1C1-E088-4A61-83C6-4571E01F0EFB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FBE7772F-72AA-4A63-9326-802E5A02C137"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7242AC02-960A-4EE7-89A3-77DCD1C96663"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1177FD1D-7161-46FA-BEAB-3C134CC80E41"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3488106F-0AD7-4BCB-B176-B61B07C5BCEF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7BF8D3A5-E762-4F01-86A9-72A859C4B8B9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ECDEE416-7EF2-45F3-A3F1-8C857D50513E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:02DD69E3-5EAA-493C-915F-E0671CEC31DB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C3E2CD62-A6B6-4B24-8C10-E4A3A21DF40C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:16E51B1F-400D-4728-B53D-EC2A21D3CFCF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EE7C05BE-A3B5-4103-A74A-323F541A21B2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3CC5D732-22E8-4066-B85C-4076AC71BC65"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:923E24EB-91E8-424F-8A54-97D52B3754C8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A7DA1A3C-BAF8-4192-A8FC-39BC84099791"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B13E37DB-BFFF-4DDA-BEC2-1A6A60F8983D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F297EA3F-5638-4271-8938-A5E2955FF012"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7D17F70D-6306-4DB0-A068-76281697AE12"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BBCB7C63-3BB0-4000-B005-682E4802DB33"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:38043ECB-FFD5-4629-B586-139608987E8B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FE605D80-CA16-4116-938D-D77262ABAEFB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:42D71B8E-4653-4335-B84B-1BA76AB9C069"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:89E76100-C580-46F2-8779-FE3F00E8420C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BD325990-1CFF-4A8D-8D26-076EA13383D0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D01558B5-53CE-4A1A-8C99-228B68DBDC5A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:75A84D48-D6B8-434E-86C6-DE82AD308CAB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:76EEA2CA-8D8D-41E5-A0D1-7DFA980ACE2D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EBB488F9-80C3-4A62-BE29-8305244FFAAE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B26C0B2C-46CB-4C3A-BF6A-3EBFDA216EE3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:16B39690-B40C-40A7-8FB0-3593FD490671"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:23F9047B-9114-4927-8995-5A762616FD2A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6A7C209F-568B-4721-A490-0683B78E50BD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C3B2A21D-018D-4862-BAEA-4F4598B163C5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:978C71D1-95E1-424C-8CE6-FAE68DAF9ABD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5CCB173C-1015-412A-8DF4-427B72CBD1FE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:33B59D1E-DB5A-430A-B2E5-F5205FB70DB4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:04F40ACE-7040-494A-85FB-7A97935F68C4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:EFD5A0D1-93E4-4554-A914-C1D52BCF6D28"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D80D5542-0075-4893-AA55-E4B43A7A1D36"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B1F68B40-A89C-48BB-9E9F-C3BBB1768BAC"/>
    <rdfs:label>NER Sets</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:55784FE3-4246-4640-895D-3282AAE4E905"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BD3E754F-F8E5-4CCE-9416-05CAF65FF1BD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C7768CBA-676A-4543-96D9-FED2595B1ED8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2503CDD0-CA5D-4DA5-9861-E84209E700CC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D8537446-0624-489A-96CD-0579E45720A7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:90ABDB8F-0F66-4691-A9B2-14DD1C26D6D1"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:690341A1-629C-4B14-8A55-7723055B4F58"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2B92BC1A-A5E4-428D-8761-C3F03DE9884F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:519D02CA-EC41-4DF9-9397-9A0FEF701C7C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:55F8CEE3-B65B-4554-A674-FA9C98EAA3FC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D8CDB679-A337-47FC-972C-0280F177E864">
    <pav:createdOn>2015-06-24 14:05:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:213CED45-C627-4F20-82C8-D940623C4FA6"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1317357D-54DA-4F8F-91DE-1604061BC8FD">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
    <rdfs:label>rifampin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D1E970E8-6572-4958-B3BF-0998635FC327">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:35:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:6DD3BADF-D580-4C1F-AB70-0A72CE43EDFB"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:978C71D1-95E1-424C-8CE6-FAE68DAF9ABD">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:52F31ADE-9DD3-471A-AF38-89E722BB13BE"/>
    <pav:createdOn>2015-06-24 14:03:36 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:368BC474-49D4-43C7-8063-96E85874F3FA">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> and </ao:prefix>
    <pav:createdOn>2015-06-24 13:42:29 -0400</pav:createdOn>
    <ao:suffix> following administration of HARVONI were 0.5 and 27 hours, respectively.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:368BC474-49D4-43C7-8063-96E85874F3FA"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>GS-331007</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F686B890-17C0-434A-874B-02D3264C918F">
    <pav:lineageUri>urn:domeoserver:annotation:8BD69287-F317-4CA7-82B8-EA8DD8FE5F7A</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:5B185B3E-4902-4438-85F1-43A683ADE7AD"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:50:54 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 13:57:41 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7E818858-3C28-40B0-ADD8-5058D941A327">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>rabeprazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:286B60B9-65FD-463C-AE85-68A498160D42">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:28:46 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:286B60B9-65FD-463C-AE85-68A498160D42"/>
    <ao:exact>HARVONI</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> </ao:suffix>
    <ao:prefix>) as individual agents, or are predicted drug interactions that may occur with </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C3C51332-1F4B-428E-8EBA-57EC2E79E7B7">
    <pav:previousVersion>urn:domeoserver:annotationset:D645D2F4-4D34-4A9F-B51F-F0E2A0F9826D</pav:previousVersion>
    <dikbD2R:assertionType>increase-auc</dikbD2R:assertionType>
    <pav:lineageUri>urn:domeoserver:annotationset:2284e984-435c-475d-8023-97355b70469b</pav:lineageUri>
    <pav:lastSavedOn>2015-06-26 14:10:58 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N291820426f55420393d6f9759707134c"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:createdOn>2015-06-18 15:54:14 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:77FFD867-74BC-4F12-B8CB-7F7F3B36D02C"/>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21B60E76-0F18-4B18-B47E-ACA1EC93052F">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:3826C72E-AC80-447B-B666-54C904FF490A"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:35:25 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F9DC5F39-5E01-4813-9D0A-15DD2D3F918B">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
    <rdfs:label>digoxin</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dikbD2R:dose>Unk</dikbD2R:dose>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/12BCBC47-19C9-4E77-86C9-396A81D17AE2">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>esomeprazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:155D5814-EE0C-4F34-86F4-62DEB2A907A1">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <pav:createdOn>2015-06-26 14:32:35 -0400</pav:createdOn>
    <domeo:uuid>155D5814-EE0C-4F34-86F4-62DEB2A907A1</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>and 14-hydroxyclarithromycin is not expected to produce safety concerns   </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:155D5814-EE0C-4F34-86F4-62DEB2A907A1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Concomitant Use with Clopidogrel: Clopidogrel is metabolized to its active metabolite in part by CYP2C19. A study of healthy subjects, including CYP2C19 extensive and intermediate metabolizers receiving once daily administration of clopidogrel 75 mg concomitantly with placebo or with ACIPHEX 20 mg (n=36), for 7 days was conducted. The mean AUC of the active metabolite of clopidogrel was reduced by approximately 12% (mean AUC ratio was 88%, with 90% CI of 81.7 to 95.5%) when ACIPHEX was coadministered compared to administration of clopidogrel with placebo.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:62E87CAF-6E90-4144-8628-1A9974F7FE34">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:62E87CAF-6E90-4144-8628-1A9974F7FE34"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>7.6 Combined Administration with Clarithromycin\nCombined administration consisting of rabeprazole, amoxicillin, and clarithromycin resulted in increases in plasma concentrations of rabeprazole and 14-hydroxyclarithromycin [see Clinical Pharmacology (12.3)].</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>62E87CAF-6E90-4144-8628-1A9974F7FE34</domeo:uuid>
    <ao:prefix> </ao:prefix>
    <pav:createdOn>2015-06-26 14:13:08 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A2998F38-F39F-4AAA-B348-72D4A0318E4D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:48:28 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:E7E2AADF-1CA9-44FC-B1F4-9DD4FBFA1E4B</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:586857BF-8459-41FC-903B-00B9617F6CA4"/>
    <pav:lastSavedOn>2015-06-24 13:57:41 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA">
    <ao:item rdf:resource="urn:domeoclient:uuid:EE4C46FB-BA4B-4B64-A98A-CC94C90D600B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:264A1A8A-20F8-455F-894C-66B10DDDD770"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DE89DB10-B27A-4098-AA8D-85A540932FB9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5CEF478D-5683-496D-AFF1-24043480AD95"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143043ef9cf90143f8ea240c0005"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7F8C8555-4324-48EE-B5F9-0A604F2434B8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:89E147C9-6A2A-417F-BDAC-0639C2DBEDB7"/>
    <rdfs:label>NER Sets</rdfs:label>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:BDBF440D-6632-4AFB-B15C-575526524672"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:ADABFCE1-7DA7-4F72-85A4-6FAB377530D4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:422409A3-4CF4-48DF-89AC-8EB0DB45F077"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:0F1220E5-7287-4DFB-9D3B-63657827D948"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F83ED8E2-DBDD-4836-89C2-04B14261DF4F"/>
    <dct:description>The NER set is created automatically by NER annotation loading program.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:AE080DAC-07A7-407D-8DE8-3B723EE6AC78"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2AB0C859-63AF-42B9-90FA-D18484D317B0"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AB6DBC9C-8744-4E60-91FA-B7E89E17B3D8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1611A71F-C755-4B14-86F2-F0AF1FBA1C4D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4F608AE8-73E3-45A3-91FF-C711F5986F79"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C3D19AA2-CA54-465B-9900-48FAB77D377A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E51B8030-30B8-4D0E-81C6-06ED2DB88A82"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:83C1E0C2-65AC-4358-9C01-F765A5E20B1B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5DBC4FFF-CF59-4271-9232-F1AF092163B8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:758904B8-504D-450A-B6A3-6CF8B5796E67"/>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.1alpha-050"/>
    <pav:previousVersion>urn:domeoserver:annotationset:32105ED1-1117-4040-B381-9F8732D6435B</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:EDC97344-95CC-41C6-9D02-B413ECCEF2DA"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <pav:lastSavedOn>2015-06-26 14:52:05 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:E7AC5B35-8CF6-4D77-AB8B-38C121499BC7"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B55F4B0E-9FE1-4AD3-90C2-B9641F3D979E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7D8DBD95-E7EC-41A5-8EB2-6248BF6AC764"/>
    <pav:lineageUri>urn:domeoserver:annotationset:861d7355-bd05-4520-a9bc-7cbebbde07d6</pav:lineageUri>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.0alpha-040"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">10</pav:versionNumber>
    <ao:item rdf:resource="urn:domeoclient:uuid:75546D73-270F-49E1-8CEC-3974DDE6192E"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:25B8FA4D-6405-4996-A4EC-13493B4E5D77"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6E9D94E2-E221-47BE-91E9-50195D6774EB"/>
    <pav:createdOn>2015-06-12 16:57:51 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:747EEA37-1BAD-420C-B886-395117292C86"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D340B61F-D0A0-4F8D-A948-DBB014DBAAC5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:BA89B1CB-1FE1-4065-A319-517551CE67F8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:394336AA-03A7-4380-9E12-67719DDAF4EA"/>
    <ao:item rdf:resource="file:///home/yin2/python-SPL-connector/abda6a7c-98eb-42dd-8fbc-9971d2cc96b9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:087D3D4C-B1B5-4AE5-B7E4-EA2272CFC096"/>
    <permissions:permissions rdf:nodeID="N3114b77eb06f407a8488e5f296114654"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:082B75C9-42FD-4AEE-B0DD-3266529AEC2C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:823D0C85-027B-4821-B556-F07B100A7A26"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:421F78EB-FB4D-475B-818E-4D14E8E205D6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:38043ECB-FFD5-4629-B586-139608987E8B">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:33:42 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8733187C-8E2D-4009-BE51-FA10C6D34EE6"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2B94B81B-FC46-481A-989A-76F7B49B6A77">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:30:53 -0400</pav:createdOn>
    <ao:prefix> is expected to decrease the concentration of ledipasvir and sofosbuvi</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <ao:exact>r</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2B94B81B-FC46-481A-989A-76F7B49B6A77"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:491545AF-9030-4770-8AE0-3D585F8366DC">
    <pav:createdOn>2015-06-19 11:57:27 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:491545AF-9030-4770-8AE0-3D585F8366DC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability. Like with other drugs that decrease the intragastric acidity, the absorption of drugs such as ketoconazole , atazanavir ,</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact> iron salts</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <ao:suffix>, and </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B086BDA4-2393-42B8-B02A-2F49DBDA0C9B">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>erlotinib</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1124C607-B87A-429F-8D2D-319ABC684871">
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 15:02:21 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:979E3ED3-A4C6-4415-A196-6A5233342007</pav:lineageUri>
    <ao:body rdf:nodeID="N7188691895a347388a725e864dfda9ff"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:E905A9AF-EFAA-459D-A284-BC1FD9D65AA7"/>
    <pav:createdOn>2015-06-24 15:00:41 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:01AB475B-AF5C-4A7D-B3FB-67173CC8B083">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:31:52 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:6CFED0AD-DD71-4CD3-B14C-CC00281B4B90"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F987AFF0-7540-4CD1-83C3-D0919E11FB32">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:F8FA26AA-7340-4AC1-982F-718D93D1430D"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:33:13 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5FFE2D87-0403-4804-BD39-8E6495C11B91">
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 14:51:24 -0400</pav:createdOn>
    <ao:suffix>is a selective 5-HT</ao:suffix>
    <domeo:uuid>5FFE2D87-0403-4804-BD39-8E6495C11B91</domeo:uuid>
    <ao:exact>Ondansetron </ao:exact>
    <ao:prefix>   12.1 Mechanism of Action   </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5FFE2D87-0403-4804-BD39-8E6495C11B91"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:33F29679-E217-4D93-9174-2D69A0E1B032">
    <poc:PharmacodynamicImpact>http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#none</poc:PharmacodynamicImpact>
    <dct:description>none.</dct:description>
    <sio:SIO_000563>poc:PharmacodynamicImpact</sio:SIO_000563>
    <rdfs:label>None</rdfs:label>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:25A68AA5-98AC-4A23-B7C6-DEB28A57DD21">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 14:05:40 -0400</pav:createdOn>
    <ao:exact>cobicistat</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>        elvitegravir 150 once </ao:suffix>
    <ao:prefix>1.56 (1.42, 1.71)    Elvitegravir / </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:25A68AA5-98AC-4A23-B7C6-DEB28A57DD21"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A7B76179-9CF7-4A07-A0D3-E83B14BC7676">
    <pav:createdOn>2015-06-18 16:05:14 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N6804b33265de4ac8900dcb08abc8be01"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>ddi Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:4E2A068C-A8BD-4FF9-AEAB-B1A3F1E56AEE"/>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:lineageUri>urn:domeoserver:annotation:8A7917DE-B18A-42F2-B6F9-2DCDF9B49989</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E583813B-AE66-4A9C-8F8C-E6C434EB1F49">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>E583813B-AE66-4A9C-8F8C-E6C434EB1F49</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 14:45:38 -0400</pav:createdOn>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:suffix> and serotonin and noradrenaline reuptake inhibitors (SNRIs) </ao:suffix>
    <ao:exact>selective serotonin reuptake inhibitors (SSRIs)</ao:exact>
    <ao:prefix>, including </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E583813B-AE66-4A9C-8F8C-E6C434EB1F49"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E905A9AF-EFAA-459D-A284-BC1FD9D65AA7">
    <domeo:uuid>E905A9AF-EFAA-459D-A284-BC1FD9D65AA7</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E905A9AF-EFAA-459D-A284-BC1FD9D65AA7"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:prefix>   7.6 Chemotherapy   </ao:prefix>
    <ao:exact>In humans, carmustine, etoposide, and cisplatin do not affect the pharmacokinetics of ondansetron</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 15:00:41 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:704BEB52-B906-45A1-843E-924D08C8BBA8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:30:14 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:8C63E9B3-E04C-46EE-AB89-8CC3A39FA392"/>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6DA12934-7F28-40D2-8E34-66DB73709449">
    <pav:createdOn>2015-06-24 14:51:18 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:CA3D580A-8791-4762-90AE-296899E7C4E3"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D909DA64-14F1-4718-9FA6-CC479090962F">
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:7B0F453E-377A-4CDF-A707-C3D2CEA15823"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <ao:body rdf:nodeID="N6bdc0f784b5843609a0786b69cadc84b"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2015-06-18 15:52:36 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:9741C451-AA45-475F-A3D6-AFD0683E6A71</pav:lineageUri>
    <rdfs:label>ddi Annotation</rdfs:label>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BD3E754F-F8E5-4CCE-9416-05CAF65FF1BD">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:31:47 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:6C06A06D-0631-4573-9C9A-36B220F7161A"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0F6282BB-A6BD-48A3-847F-C776B00D9013">
    <ao:suffix>        0.86 (0.76, 0.96)     </ao:suffix>
    <pav:createdOn>2015-06-24 14:01:57 -0400</pav:createdOn>
    <ao:prefix>(0.87, 1.23)  0.94 (0.81, 1.10)  NA    </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0F6282BB-A6BD-48A3-847F-C776B00D9013"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>GS-331007</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ED6C210C-E64A-48DD-967A-88DE1659D6D0">
    <ao:exact>simeprevir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix> and </ao:prefix>
    <ao:suffix> are increased when simeprevir is coadministered with ledipasvir. Coadministration of HARVONI with simeprevir is not recommended.</ao:suffix>
    <pav:createdOn>2015-06-24 13:34:48 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ED6C210C-E64A-48DD-967A-88DE1659D6D0"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CAF87BB4-B786-4B62-8518-22A98C36B09B">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:0742663E-EC80-4267-AB12-D53243023255"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdOn>2015-06-24 14:05:38 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:33B59D1E-DB5A-430A-B2E5-F5205FB70DB4">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:DB93AC8A-17E3-46EA-97C3-D3FFDF302CAC"/>
    <pav:createdOn>2015-06-24 13:28:11 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoclient:uuid:b8f2cc8a-d0ef-4f41-b982-9f169e468ba8</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:28:47 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4D1CAE97-5AE6-470B-B5CB-AD33D4969966">
    <ao:suffix>), which can be incorporated into HCV RNA by the NS5B polymerase and acts as a chain terminator. In a biochemical assay, GS-461203 inhibited the polymerase activity of the recombinant NS5B from HCV genotypes 1b, 2a, 3a and 4a with IC</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <ao:prefix> is a nucleotide prodrug that undergoes intracellular metabolism to form the pharmacologically active uridine analog triphosphate (</ao:prefix>
    <pav:createdOn>2015-06-24 14:06:26 -0400</pav:createdOn>
    <ao:exact>GS-461203</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4D1CAE97-5AE6-470B-B5CB-AD33D4969966"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4A8FAD25-0915-4322-A329-45E7E6992788">
    <ao:suffix> concentrations unknown</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4A8FAD25-0915-4322-A329-45E7E6992788"/>
    <ao:exact>sofosbuvir </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:29:33 -0400</pav:createdOn>
    <ao:prefix>Effect on amiodarone , ledipasvir , and </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1D0B64D0-8634-4062-8229-4E9274E2CD53">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-26 14:46:27 -0400</pav:createdOn>
    <domeo:uuid>1D0B64D0-8634-4062-8229-4E9274E2CD53</domeo:uuid>
    <ao:suffix> is expected to substantially decrease </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <ao:exact>proton pump inhibitors</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> with </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1D0B64D0-8634-4062-8229-4E9274E2CD53"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2442E9F2-FA58-4294-984C-C5198DDEFBB2">
    <ao:prefix>   </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <pav:createdOn>2015-06-26 14:05:09 -0400</pav:createdOn>
    <domeo:uuid>2442E9F2-FA58-4294-984C-C5198DDEFBB2</domeo:uuid>
    <ao:exact>7.4 Compounds Dependent on Gastric pH for Absorption\nDue to its effects on gastric acid secretion, rabeprazole can reduce the absorption of drugs where gastric pH is an important determinant of their bioavailability. Like with other drugs that decrease the intragastric acidity, the absorption of drugs such as ketoconazole, atazanavir, iron salts, erlotinib, and mycophenolate mofetil (MMF) can decrease, while the absorption of drugs such as digoxin can increase during treatment with ACIPHEX.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2442E9F2-FA58-4294-984C-C5198DDEFBB2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4914B47D-3FD3-4346-B260-E22283815ADE">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:30:03 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:98507E4C-CA05-433D-B45E-C807E12C205F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2B611FD4-29B6-482E-8F02-37DD5BB8AD10">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:createdOn>2015-06-24 13:30:04 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:CEC886CD-92EB-4AEE-9C71-0BF30DD25F3B"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4A9F7E84-D0E0-4A4B-885E-D6D058427789">
    <ao:exact>GS-331007</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4A9F7E84-D0E0-4A4B-885E-D6D058427789"/>
    <ao:prefix> was absorbed quickly and the peak median plasma concentration was observed ~0.8 to 1 hour post-dose. Median peak plasma concentration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix> was observed between 3.5 to 4 hours post-dose.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:40:34 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3488106F-0AD7-4BCB-B176-B61B07C5BCEF">
    <ao:context rdf:resource="urn:domeoclient:uuid:65393C4E-5067-4819-A359-9FA44838F2C5"/>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:33:31 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:person:uuid:080e143043ef9cf90143f8ea240c0005">
    <foafx:email>kak59@pitt.edu</foafx:email>
    <foafx:homepage></foafx:homepage>
    <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
    <foafx:picture>http://www.hcklab.org/images/me/paolo%20ciccarese-boston.jpg</foafx:picture>
    <foafx:middlename></foafx:middlename>
    <foafx:name>Katrina</foafx:name>
    <rdfs:label>Katrina</rdfs:label>
    <foafx:firstname>Katrina</foafx:firstname>
    <foafx:title></foafx:title>
    <foafx:lastname>Romagnoli</foafx:lastname>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:61048C6C-BCA5-4E14-80F1-8C49CC2E17D9">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7E818858-3C28-40B0-ADD8-5058D941A327"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6A1E76EE-73F5-422C-9E87-1FC12D00DE25"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:823D0C85-027B-4821-B556-F07B100A7A26">
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <rdfs:label>ddi Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <pav:lineageUri>urn:domeoserver:annotation:4AE224B8-8EAC-4B02-A24F-B4FA0F2683F8</pav:lineageUri>
    <pav:createdOn>2015-06-19 11:58:46 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:104B7FF8-A012-4E11-A279-807735473525"/>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:lastSavedOn>2015-06-19 12:02:00 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="Na00921bbbeaf41409ad6144a274966ac"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B90DC881-F0CB-4888-A60A-935ADE5609DD">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B90DC881-F0CB-4888-A60A-935ADE5609DD"/>
    <pav:createdOn>2015-06-24 13:30:26 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>:</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>. Coadministration is not recommended.    </ao:prefix>
    <ao:exact>Antimycobacterials</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C7690AF3-956C-4483-9809-E636B620F534">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:33:56 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:951E4E4B-3347-4714-A3A2-291B3535B8A5"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8D869AC5-11A1-47C6-B72D-5D0285ABE2A1">
    <ao:body rdf:resource="urn:linkedspls:uuid:0768CA5A-42B5-4AEE-898D-336AADC10B13"/>
    <pav:createdBy>urn:person:uuid:080e1430434f70e501434f711b6e0000</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/>
    <pav:createdOn>2014-02-20 13:49:37 -0500</pav:createdOn>
    <ao:body rdf:resource="urn:linkedspls:uuid:8EBC3A86-CAF7-4AEB-8718-D2C34C496981"/>
    <ao:body rdf:resource="urn:linkedspls:uuid:CBE2B329-4E6C-4915-91A7-775A43D4D87E"/>
    <ao:body rdf:resource="urn:linkedspls:uuid:BFDA94B6-C3E3-4254-B29F-1D8EE09A501D"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:23530D0B-F4A5-407A-AED0-EE99C0B30E6D"/>
    <ao:body rdf:resource="urn:linkedspls:uuid:7F46AEEA-D7F6-4F1F-A426-9F20EDEB76A3"/>
    <ao:body rdf:resource="urn:linkedspls:uuid:AA18BF65-3F61-4179-8A1D-B73034A9E587"/>
    <ao:body rdf:resource="urn:linkedspls:uuid:82327B05-8BB1-401E-ACB4-42C3E0930D57"/>
    <rdfs:label>SPL Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:resource="urn:linkedspls:uuid:56EA7F48-3179-452B-BB6A-F74C96533A0D"/>
    <ao:body rdf:resource="urn:linkedspls:uuid:94611C47-47D7-4D38-8EEF-17379EF5BB78"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:E07CBE6D-93C5-4C75-8C1F-2BADEA50F654</pav:lineageUri>
    <ao:body rdf:resource="urn:linkedspls:uuid:2615D048-46FA-4557-B691-24297A4787D9"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:8AD21D6C-B585-4986-9335-FAD5A45407B9</domeo:belongsToSet>
    <pav:lastSavedOn>2014-02-20 13:49:40 -0500</pav:lastSavedOn>
    <ao:body rdf:resource="urn:linkedspls:uuid:3D046132-84C4-4ABF-8B1C-EC07A0D07CA1"/>
    <ao:body rdf:resource="urn:linkedspls:uuid:BF13ABBA-974C-4D13-B3D9-09EF5A6BB2FA"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:resource="urn:linkedspls:uuid:CAB63AF9-D23A-4109-A615-275C9421E6CB"/>
    <ao:body rdf:resource="urn:linkedspls:uuid:16FDB844-0908-4D9D-9647-601A4C547C45"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:175760DD-A1C9-4DC4-8A7D-E091D1F96F93">
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:42D44ED6-AB36-4399-850F-9C7FFCFA845C"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:28:51 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E6B970A0-A5AC-46A9-B86C-69DFD8FDF319">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7AA0718E-EF1F-4DCA-B4A9-1EA6CAC03112"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:14771221-FA3D-4F83-BB45-2CBFC3CA534D">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:b8f2cc8a-d0ef-4f41-b982-9f169e468ba8</pav:previousVersion>
    <pav:createdOn>2015-06-24 13:28:42 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:133AF071-ACC0-4749-BDDA-D13BDC2BD1E3"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 13:28:47 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CACDAFFB-6701-43E6-8CAE-010F32912A6C">
    <ao:exact>ondansetron</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>. The metabolites are observed in the urine. </ao:suffix>
    <domeo:uuid>CACDAFFB-6701-43E6-8CAE-010F32912A6C</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CACDAFFB-6701-43E6-8CAE-010F32912A6C"/>
    <pav:createdOn>2015-06-24 14:52:33 -0400</pav:createdOn>
    <ao:prefix> Although some nonconjugated metabolites have pharmacologic activity, these are not found in plasma at concentrations likely to significantly contribute to the biological activity of </ao:prefix>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6DCE9DA8-029F-4DC9-B028-FAC63C916DEB">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6DCE9DA8-029F-4DC9-B028-FAC63C916DEB"/>
    <pav:createdOn>2015-06-24 14:02:56 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>600 once daily  90 single dose  ND  31  </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ledipasvir</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6D0E5332-9579-42E1-9D35-67887E5B604E">
    <rdfs:label>esomeprazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:1135EFA3-67D9-4B8E-B010-CD51438236F7">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
    <dct:description>none.</dct:description>
    <poc:PharmacodynamicImpact>http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#none</poc:PharmacodynamicImpact>
    <sio:SIO_000563>poc:PharmacodynamicImpact</sio:SIO_000563>
    <rdfs:label>None</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FEA089DE-8539-4732-A990-3E7AC8FFCDCC">
    <pav:createdOn>2015-06-24 14:06:54 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:C95A383C-FC63-4F86-A721-CE43075556A9"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B121266A-9A5A-4B75-A84C-7B045C86BC38">
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:32:11 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:9DA85141-45C3-472D-AFA0-84EB262D7C2A"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F297EA3F-5638-4271-8938-A5E2955FF012">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:E5124444-903A-4C0E-8153-BA96BDDA79DB"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2015-06-24 14:01:09 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FA0D1ACA-EFEE-46B1-B441-6883866047B3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:0454F7F9-AFB1-4B93-BC80-4CCEDCCC9BFE"/>
    <pav:createdOn>2015-06-24 14:56:08 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:12DA0EA2-5E66-4ADF-BC75-D3295E49A087">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:059ABD62-3344-4DC9-A8C4-8FA60469962D"/>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2015-06-24 14:51:25 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C7732FF4-4B1E-4EED-82DB-ECD7D976EF7A">
    <pav:previousVersion>urn:domeoserver:annotationset:D645D2F4-4D34-4A9F-B51F-F0E2A0F9826D</pav:previousVersion>
    <rdfs:label>ddi Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:createdOn>2015-06-18 15:55:53 -0400</pav:createdOn>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lastSavedOn>2015-06-26 14:10:58 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:2284e984-435c-475d-8023-97355b70469b</pav:lineageUri>
    <ao:body rdf:nodeID="Nf15e95ecbdfe43b8ac1a42180d2faa12"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:45139020-BB82-463D-979A-03233083EE3E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7D8DBD95-E7EC-41A5-8EB2-6248BF6AC764">
    <pav:createdOn>2015-06-19 10:54:38 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:previousVersion>urn:domeoclient:uuid:7e333e71-de31-4d19-9e13-65096f431517</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lastSavedOn>2015-06-26 14:52:05 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:0F92F586-5DB5-4479-9955-AD6B17AD2096"/>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:861d7355-bd05-4520-a9bc-7cbebbde07d6</pav:lineageUri>
    <ao:body rdf:nodeID="Nc5836aa368d04301bef855f2d0f5c430"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <rdfs:label>ddi Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:640B26C4-E159-4852-BDFA-CBE889756A4C">
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:489469CB-15ED-45FA-8421-4ED668E7EC08</pav:lineageUri>
    <pav:createdOn>2015-06-18 16:01:07 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:20922FAD-22F1-45F4-A045-98184A1D2AC0"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8BB81D03-111D-46E8-89AC-A3029079CBBB">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Tenofovir DF</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 14:06:14 -0400</pav:createdOn>
    <ao:prefix>(0.59, 0.90)  1.09 (0.84, 1.40)  NA    </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8BB81D03-111D-46E8-89AC-A3029079CBBB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F3C8FCA9-6823-425D-857B-1E02D798093C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Serotonin </ao:exact>
    <pav:createdOn>2015-06-24 14:45:25 -0400</pav:createdOn>
    <ao:prefix> </ao:prefix>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:suffix>syndrome (including altered mental status, autonomic instability, and neuromuscular symptoms) has been described following the concomitant use of 5-HT3 receptor antagonists and other serotonergic drugs, including selective serotonin reuptake inhibitors (</ao:suffix>
    <domeo:uuid>F3C8FCA9-6823-425D-857B-1E02D798093C</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F3C8FCA9-6823-425D-857B-1E02D798093C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:721BB3EC-1BBC-4BAA-B56A-E4E587A7F8F8">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:A15EB1EC-2E30-4C76-8394-8AF897717FD4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:31:45 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C0F4B61B-0C95-4C6B-BC2E-0DC5D987C6EB">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>voriconazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/121243</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:66C68254-44C6-4638-BFDC-2477A1CC1740">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2015-06-18 16:02:38 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:9619FB30-53D4-46D3-93D9-2E7198CE96C7"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:4FB210F8-54CE-4FD7-BE90-95916806BE6C</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8A460368-E52E-454E-80C8-AAEBEB805956">
    <rdfs:label>clopidogrel</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32968</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A638709D-ADC4-4F10-9766-A87EB2D9C172">
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <pav:createdOn>2015-06-24 14:57:44 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <ao:body rdf:nodeID="N927d1c04f9284410959f2300ca2f719e"/>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:37576AB1-ACF6-43D8-AAB3-0DA200371061</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 15:02:21 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:E65BD6D2-D214-4C43-A64B-77F16B0A7D01"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:83CB79EA-02B3-4785-8CCA-967E22F48392">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:83CB79EA-02B3-4785-8CCA-967E22F48392"/>
    <ao:prefix>were 323, 618, and 707 ng/mL, respectively. Sofosbuvir  and </ao:prefix>
    <ao:suffix> AUC</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:40:52 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>GS-331007</ao:exact>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:768AA3B2-059A-4D55-B231-7FF9C658DA10">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:33:51 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:FCAE70DF-F53B-4C16-9E8B-F9AEE35533CC"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2B6DE5B1-07D2-474A-80A6-363307A7D6D9">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>naproxen</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:38789AE9-C5B4-4066-9B3C-6FF0EE6D6A3D">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> and BCRP while GS-331007 is not. P-gp inducers (e.g., rifampin or St. John's wort) may decrease ledipasvir and sofosbuvir plasma concentrations, leading to reduced therapeutic effect of HARVONI, and the use with P-gp inducers is not recommended with HAR</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:38789AE9-C5B4-4066-9B3C-6FF0EE6D6A3D"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Ledipasvir and sofosbuvir are substrates of drug transporters </ao:prefix>
    <pav:createdOn>2015-06-24 13:59:26 -0400</pav:createdOn>
    <ao:exact>P-gp</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C48FAFD7-141B-4978-94AE-1C3B2EC12DC5">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>ondansetron</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6A1E76EE-73F5-422C-9E87-1FC12D00DE25">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>erlotinib</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B957B653-5D89-4E8E-8AEB-AEEAF3467FF0">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:30:37 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:E1066321-87F0-4153-9A1B-AFB06A11B448"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C15D4D58-873C-479E-9A2B-264652E742A2">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>atazanavir</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/343047</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:651CDE74-8C4C-4728-B528-64420A01F53B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:33:44 -0400</pav:createdOn>
    <ao:suffix> with tipranavir/ritonavir is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>Coadministration of </ao:prefix>
    <ao:exact>HARVONI </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:651CDE74-8C4C-4728-B528-64420A01F53B"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5F70EB41-EE4A-4F09-AE14-83FC1AE2218C">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:33:07 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:6635F1E6-97B3-4DBF-B7C3-E9909DA710D3"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F87733E0-3AEC-4210-9FC7-5C2E284B8D15">
    <ao:exact>ondansetron </ao:exact>
    <ao:suffix>had no effect on the pharmacokinetics and pharmacodynamics of temazepam. </ao:suffix>
    <ao:prefix> The coadministration of </ao:prefix>
    <pav:createdOn>2015-06-24 14:51:10 -0400</pav:createdOn>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <domeo:uuid>F87733E0-3AEC-4210-9FC7-5C2E284B8D15</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F87733E0-3AEC-4210-9FC7-5C2E284B8D15"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4AEDFF29-C0D9-48E2-AFD5-05D6FA926D6F">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B71C7900-E3D5-4F7D-894C-4F09C688C933"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AADC6F3B-AA13-40C0-89E4-4258AAE366BE">
    <pav:createdOn>2015-06-24 14:52:33 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:CACDAFFB-6701-43E6-8CAE-010F32912A6C"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FA14ACDB-7AE2-4FE0-83CF-762C340AF8F1">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FA14ACDB-7AE2-4FE0-83CF-762C340AF8F1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 13:30:44 -0400</pav:createdOn>
    <ao:suffix> with rifampin, a P-gp inducer, is not recommended </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>Coadministration of </ao:prefix>
    <ao:exact>HARVONI </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AD29D9A4-991E-47B0-A162-6A4CA0DC4913">
    <ao:context rdf:resource="urn:domeoclient:uuid:17768823-D380-40C1-87DF-2762B3B34989"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdOn>2015-06-24 14:05:30 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A365FF98-9741-4D3E-9E75-94ADEB053742">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>rabeprazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FA0D7B15-46CE-44A2-B9DB-888B18129207">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B089813C-4903-460C-BDC1-78023B87AE0D"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:679D73F6-155D-4BEC-AD0A-7BC483D07223">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/102BA6E5-B06A-41F3-B840-424D1230569E"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F0DF205F-F4F6-447A-8D96-652B0BAD0709"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:516DD69C-F5E2-44AE-906A-0E59B78F46FF">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 14:44:55 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:DBB8E22B-803A-4C54-9986-A71D449DDBFA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:55782C06-4587-4091-B11F-6C24A31C7FD6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>HMG-CoA Reductase Inhibitors</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:55782C06-4587-4091-B11F-6C24A31C7FD6"/>
    <pav:createdOn>2015-06-24 13:35:18 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>:</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:485E578F-BE41-481D-BBC1-AAB903F02449">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>esomeprazole or these NSAIDs .  </ao:prefix>
    <ao:exact>Esomeprazole inhibits gastric acid secretion. Therefore, esomeprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability. Like with other drugs that decrease the intragastric acidity, the absorption of drugs such as ketoconazole, atazanavir, iron salts, and erlotinib can decrease, while the absorption of drugs such as digoxin can increase during treatment with esomeprazole. Concomitant treatment with omeprazole (20 mg daily) and digoxin in healthy subjects increased the bioavailability of digoxin by 10% (30% in two subjects). Esomeprazole is an enantiomer of omeprazole. Coadministration of digoxin with esomeprazole is expected to increase the systemic exposure of digoxin. Therefore, patients may need to be monitored when digoxin is taken concomitantly with esomeprazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:485E578F-BE41-481D-BBC1-AAB903F02449"/>
    <pav:createdOn>2015-06-19 11:58:25 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C9AD6B6-A47F-4C79-9345-2A0246940089">
    <pav:createdOn>2015-06-24 14:01:33 -0400</pav:createdOn>
    <ao:suffix>        600 single dose       </ao:suffix>
    <ao:prefix>(1.18, 1.29)  1.28 (1.21, 1.36)    </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1C9AD6B6-A47F-4C79-9345-2A0246940089"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>Cyclosporine</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F9CD6C73-A3A2-43A1-858F-D3EBB8FFE437">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F9CD6C73-A3A2-43A1-858F-D3EBB8FFE437"/>
    <ao:exact>Clopidogrel \nClopidogrel is metabolized to its active metabolite in part by CYP2C19. Concomitant use of esomeprazole 40 mg results in reduced plasma concentrations of the active metabolite of clopidogrel and a reduction in platelet inhibition. Avoid concomitant administration of esomeprazole sodium with clopidogrel. When using esomeprazole sodium, consider use of alternative anti-platelet</ao:exact>
    <ao:suffix> </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>F9CD6C73-A3A2-43A1-858F-D3EBB8FFE437</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2015-06-26 14:44:05 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EE1140D2-DC5C-49F8-95C0-F8D8552A6D90">
    <pav:createdOn>2015-06-24 13:29:52 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:979CD2A9-4928-41B1-91F1-0CD2BEEE3158"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:48BDA0FE-0C55-4945-98E7-358610650E2D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>ledipasvir</ao:exact>
    <ao:prefix>, </ao:prefix>
    <ao:suffix>, and sofosbuvir concentrations unknown</ao:suffix>
    <pav:createdOn>2015-06-24 13:29:32 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:48BDA0FE-0C55-4945-98E7-358610650E2D"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7654F3A2-97C0-4586-BF74-8A9DF379FD3D">
    <domeo:uuid>7654F3A2-97C0-4586-BF74-8A9DF379FD3D</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 14:45:24 -0400</pav:createdOn>
    <ao:suffix>      Serotonin syndrome (inclu</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Serotonergic Drugs</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7654F3A2-97C0-4586-BF74-8A9DF379FD3D"/>
    <ao:prefix>   7.5 </ao:prefix>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6A7C209F-568B-4721-A490-0683B78E50BD">
    <ao:context rdf:resource="urn:domeoclient:uuid:E487941B-7ED0-472F-B3BC-5364DC4E761E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 13:34:34 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:69E070CA-F21A-4A8F-9BBE-E1F680F30089">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>, no clinically significant drug interactions have been either observed or are expected when </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:exact>HARVONI</ao:exact>
    <pav:createdOn>2015-06-24 13:35:39 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> is used with the following drugs individually </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:69E070CA-F21A-4A8F-9BBE-E1F680F30089"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nbf6199e5b63345dab67ba2502649f6ed">
    <domeo:sets rdf:resource="urn:pddi:uuid:45F6F5BF-1C1D-4543-A911-C2331BD4FE01"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:84541557-8858-4DFE-9A06-2D5E4353F6D9">
    <pav:lineageUri>urn:domeoserver:annotation:D974FD68-7A39-42CB-9DDC-09EC551A5E75</pav:lineageUri>
    <rdfs:label>ddi Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <ao:body rdf:nodeID="Ne38325e993d54b91b31032438f348794"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:F33E42A3-7BF0-49B9-ACFC-CB757B11FC28"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2015-06-24 15:02:21 -0400</pav:lastSavedOn>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <pav:createdOn>2015-06-24 14:59:26 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BC4D79C3-E386-4C3C-8810-13F849D3DE60">
    <ao:prefix> 7.3 Phenytoin , Carbamazepine , and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 14:44:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>      In patients treated with </ao:suffix>
    <domeo:uuid>BC4D79C3-E386-4C3C-8810-13F849D3DE60</domeo:uuid>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:exact>Rifampin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BC4D79C3-E386-4C3C-8810-13F849D3DE60"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DCC00389-BD30-4E81-8333-8687C61E4E08">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DCC00389-BD30-4E81-8333-8687C61E4E08"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:31:34 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, </ao:suffix>
    <ao:exact>efavirenz</ao:exact>
    <ao:prefix>Warnings and Precautions (5.2) ].    HIV Antiretrovirals:    </ao:prefix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DE19F1A4-DC95-41BF-80DF-509DDD2F3305">
    <domeo:uuid>DE19F1A4-DC95-41BF-80DF-509DDD2F3305</domeo:uuid>
    <ao:suffix> concentration and ΔΔQTcF. Using the established exposure-response relationship, 24 mg infused intravenously over 15 min had a mean predicted (95% upper prediction interval) ΔΔQTcF of 14.0 (16.3) ms. In contrast, 16 mg infused intravenously over 15 min u</ao:suffix>
    <pav:createdOn>2015-06-24 14:51:39 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ondansetron </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, respectively. A significant exposure-response relationship was identified between </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DE19F1A4-DC95-41BF-80DF-509DDD2F3305"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BE112022-3D37-4A7A-9E4A-2E059D9D097D">
    <ao:suffix>/tenofovir DF</ao:suffix>
    <ao:prefix>ritonavir   atazanavir / ritonavir  + </ao:prefix>
    <pav:createdOn>2015-06-24 13:32:16 -0400</pav:createdOn>
    <ao:exact>emtricitabine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BE112022-3D37-4A7A-9E4A-2E059D9D097D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F8FA26AA-7340-4AC1-982F-718D93D1430D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>-associated adverse reactions. Refer to VIREAD or TRUVADA prescribing information for recommendations on renal monitoring.</ao:suffix>
    <pav:createdOn>2015-06-24 13:33:13 -0400</pav:createdOn>
    <ao:exact>tenofovir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F8FA26AA-7340-4AC1-982F-718D93D1430D"/>
    <ao:prefix> exposures. If coadministration is necessary, monitor for </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/43046F06-FFBE-46C8-8730-6559194EEFEE">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32968</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>Clopidogrel</rdfs:label>
    <dikbD2R:dose>0.075</dikbD2R:dose>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:133AF071-ACC0-4749-BDDA-D13BDC2BD1E3">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:133AF071-ACC0-4749-BDDA-D13BDC2BD1E3"/>
    <ao:exact>ledipasvir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:28:42 -0400</pav:createdOn>
    <ao:suffix> and sofosbuvir) as individual agents, or are predicted drug interactions that may occur with HARVONI </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> (</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2752FB82-2172-43EF-871E-F589746748B4">
    <pav:createdOn>2015-06-19 10:54:20 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <ao:prefix>is extensively metabolized in the liver by CYP2C19 and CYP3A4.   </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>In vitro and in vivo studies have shown that esomeprazole is not likely to inhibit CYPs 1A2, 2A6, 2C9, 2D6, 2E1 and 3A4. No clinically relevant interactions with drugs metabolized by these CYP enzymes would be expected. Drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin, warfarin, quinidine, clarithromycin or amoxicillin. Postmarketing reports of changes in prothrombin measures have been received among patients on concomitant warfarin and esomeprazole therapy. Increases in INR and prothrombin time may lead to abnormal bleeding and even death. Patients treated with proton pump inhibitors and warfarin concomitantly may need to be monitored for increases in INR and prothrombin time</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2752FB82-2172-43EF-871E-F589746748B4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4D74B658-A9ED-40C0-8306-F72545868C5C">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4D74B658-A9ED-40C0-8306-F72545868C5C"/>
    <ao:prefix> is expected to decrease the concentration of </ao:prefix>
    <pav:createdOn>2015-06-24 13:31:31 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix> and sofosbuvir, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <ao:exact>ledipasvir</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:45A22364-35E0-4139-A898-0ADF64EFD6E0">
    <pav:previousVersion>urn:domeoserver:annotationset:D645D2F4-4D34-4A9F-B51F-F0E2A0F9826D</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:2284e984-435c-475d-8023-97355b70469b</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:571D76BE-9340-47A9-8695-42BF51BFD9BB"/>
    <ao:body rdf:nodeID="Naa5e0bf72cce44f3a3f8197a5323f3a8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-18 15:58:07 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-26 14:32:43 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8B0AEFF5-2554-4F77-9CA9-C9249C01DCFD">
    <ao:context rdf:resource="urn:domeoclient:uuid:7654F3A2-97C0-4586-BF74-8A9DF379FD3D"/>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 14:45:24 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1A47AA61-3232-4F08-90A4-16CB8032E16D">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:67FA2B78-8F02-4259-B96A-39AB67CEE1CD"/>
    <pav:createdOn>2015-06-24 13:32:35 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:53928634-1F9A-461D-A372-D6EE1895E856">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:53928634-1F9A-461D-A372-D6EE1895E856"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> is not recommended. Coadministration of </ao:suffix>
    <ao:exact>proton pump inhibitors</ao:exact>
    <ao:prefix> and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <domeo:uuid>53928634-1F9A-461D-A372-D6EE1895E856</domeo:uuid>
    <pav:createdOn>2015-06-26 14:46:23 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6804b33265de4ac8900dcb08abc8be01">
    <domeo:sets rdf:resource="urn:pddi:uuid:4AEDFF29-C0D9-48E2-AFD5-05D6FA926D6F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9619FB30-53D4-46D3-93D9-2E7198CE96C7">
    <ao:prefix> and</ao:prefix>
    <ao:suffix> [</ao:suffix>
    <ao:exact> 14-hydroxyclarithromycin</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <pav:createdOn>2015-06-18 16:02:38 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9619FB30-53D4-46D3-93D9-2E7198CE96C7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BED7A75E-0B44-4F8C-B125-BC24681388F7">
    <ao:exact>omeprazole</ao:exact>
    <pav:createdOn>2015-06-24 13:29:24 -0400</pav:createdOn>
    <ao:suffix> 20 mg or lower can be administered simultaneously with HARVONI under fasted conditions.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BED7A75E-0B44-4F8C-B125-BC24681388F7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix> doses comparable to </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0AD4752B-43D4-4ECB-8451-81D75648598C">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:A6DAC4AF-DA7F-484F-BBC7-DD7CA7AF9A61"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:32:06 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7B6CB219-DA8D-4658-B93B-767D60825587">
    <ao:suffix>, 2 mg (3 to 7 years) or 4 mg (8 to 12 years), was administered immediately prior to anesthesia induction. Mean weight-normalized clearance and volume of distribution values in these pediatric surgical patients were similar to those previously reported f</ao:suffix>
    <ao:exact>ondansetron</ao:exact>
    <domeo:uuid>7B6CB219-DA8D-4658-B93B-767D60825587</domeo:uuid>
    <ao:prefix> In a study of 21 pediatric patients (3 to 12 years of age) who were undergoing surgery requiring anesthesia for a duration of 45 minutes to 2 hours, a single intravenous dose of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <pav:createdOn>2015-06-24 14:55:12 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7B6CB219-DA8D-4658-B93B-767D60825587"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:57AF1988-D82C-46DC-8DBA-8137EE89BE19">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 14:55:12 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:7B6CB219-DA8D-4658-B93B-767D60825587"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:8AD21D6C-B585-4986-9335-FAD5A45407B9">
    <rdfs:label>Default Set</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:6B63AAA7-56D3-4CE3-85CF-8ADE045F53A7</pav:lineageUri>
    <permissions:permissions rdf:nodeID="N578a84f95d88403eaab8dec1f0c5170b"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:8D869AC5-11A1-47C6-B72D-5D0285ABE2A1"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:agents rdf:resource="urn:person:uuid:080e1430434f70e501434f711b6e0000"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <pav:previousVersion>urn:domeoclient:uuid:F9D4CB21-4899-4A2F-B0CD-7E645C1D09AE</pav:previousVersion>
    <domeo:agents rdf:resource="urn:person:uuid:080e143043ef9cf90143f8ea240c0005"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.0alpha-040"/>
    <ao:annotatesResource>http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/Warfarin-ab047628-67d0-4a64-8d77-36b054969b44.html </ao:annotatesResource>
    <pav:lastSavedOn>2014-02-20 13:49:40 -0500</pav:lastSavedOn>
    <pav:createdOn>2014-02-09 21:25:30 -0500</pav:createdOn>
    <domeo:deleted>false</domeo:deleted>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8E50581F-BECF-43A4-843D-DDE76ACB85F3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, data from two small studies indicate that concomitant use of ondansetron may result in reduced analgesic activity of tramadol. Patients on concomitant ondansetron self administered tramadol more frequently in these studies, leading to an increased cumu</ao:suffix>
    <ao:prefix>and </ao:prefix>
    <domeo:uuid>8E50581F-BECF-43A4-843D-DDE76ACB85F3</domeo:uuid>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:exact>tramadol</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 14:45:13 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8E50581F-BECF-43A4-843D-DDE76ACB85F3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BFFCFB55-82B7-40B7-B909-B08D883BE6F3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> </ao:prefix>
    <domeo:uuid>BFFCFB55-82B7-40B7-B909-B08D883BE6F3</domeo:uuid>
    <ao:suffix>does not appear to induce or inhibit the cytochrome P-450 drug-metabolizing enzyme system of the liver. Because ondansetron is metabolized by hepatic cytochrome P-450 drug-metabolizing enzymes (CYP3A4, CYP2D6, CYP1A2), inducers or inhibitors of these enz</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BFFCFB55-82B7-40B7-B909-B08D883BE6F3"/>
    <pav:createdOn>2015-06-24 14:44:44 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:exact>Ondansetron </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/880B6869-AE91-4174-979A-3393AD1D4AEA">
    <rdfs:label>quinidine</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A6DAC4AF-DA7F-484F-BBC7-DD7CA7AF9A61">
    <pav:createdOn>2015-06-24 13:32:06 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> and a HIV protease inhibitor/ritonavir         </ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>Regimens containing </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>tenofovir DF</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A6DAC4AF-DA7F-484F-BBC7-DD7CA7AF9A61"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CA3D580A-8791-4762-90AE-296899E7C4E3">
    <ao:exact>atracurium</ao:exact>
    <ao:suffix>. Interactions with general or local anesthetics have not been studied. </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CA3D580A-8791-4762-90AE-296899E7C4E3"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>CA3D580A-8791-4762-90AE-296899E7C4E3</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 14:51:18 -0400</pav:createdOn>
    <ao:prefix>or the degree of neuromuscular blockade produced by </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ADABFCE1-7DA7-4F72-85A4-6FAB377530D4">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-19 11:06:23 -0400</pav:createdOn>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2015-06-19 11:13:42 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="Ne9c56b5ba8474a9a9187322af8d4fde3"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:5D509668-1511-484F-B388-598435B3790B</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:265AAD7B-2FE8-4D89-A810-D1E17E6394B5"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <rdfs:label>ddi Annotation</rdfs:label>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E48EBB8B-130E-48C5-944B-379725C7CEEA">
    <ao:suffix>. However, no formal drug interaction studies of </ao:suffix>
    <ao:prefix>and/or its metabolite </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-18 16:04:14 -0400</pav:createdOn>
    <ao:exact>hydroxymethotrexate</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E48EBB8B-130E-48C5-944B-379725C7CEEA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EDB8A04B-DB76-4A61-A993-FB81D9B0782F">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:35:36 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F87AA69C-7D44-4450-833F-57AAA0D8BCD9"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8881BB6E-9E6F-4C2A-B2BE-B1897371D77C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>solubility decreases as pH increases. Drugs that increase gastric pH are expected to decrease concentration of ledipasvir .    </ao:prefix>
    <ao:suffix> (e.g., aluminum and magnesium hydroxide)</ao:suffix>
    <pav:createdOn>2015-06-24 13:28:56 -0400</pav:createdOn>
    <ao:exact>Antacids</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8881BB6E-9E6F-4C2A-B2BE-B1897371D77C"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9083FC28-34C3-43F1-ABFD-E19F7094B4A9">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>rabeprazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E78E7094-4859-4D69-B493-A0B08D316619">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:8832B53B-67B5-4528-8ADE-E4B3215A6C39"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:createdOn>2015-06-24 13:30:35 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DAD72EDB-846A-4F8D-8C4E-3B9EDFB98D6A">
    <ao:prefix>: Plasma protein binding of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>as measured in vitro was 70% to 76%, over the pharmacologic concentration range of 10 to 500 ng/mL. Circulating drug also distributes into erythrocytes. </ao:suffix>
    <pav:createdOn>2015-06-24 14:52:20 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DAD72EDB-846A-4F8D-8C4E-3B9EDFB98D6A"/>
    <domeo:uuid>DAD72EDB-846A-4F8D-8C4E-3B9EDFB98D6A</domeo:uuid>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:exact>ondansetron </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6B55AE26-A9AD-40A6-BD0A-CCAC2DB73A0A">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:BAF13C30-A14B-40D1-8DD9-BC8EF0B76A1C"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 14:03:23 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:455671EF-A282-4814-96C5-826043846A2F">
    <pav:createdOn>2015-06-24 13:35:05 -0400</pav:createdOn>
    <ao:prefix>Hypericum perforatum )  ↓ ledipasvir ↓ </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:455671EF-A282-4814-96C5-826043846A2F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sofosbuvir</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>↓ GS-331007       Coadministra</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5CB25C32-2C5D-44BE-AD76-70380F754D19">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B15F635C-A0DA-4A8D-8888-F179E283DF40"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A6624C63-DFE2-4582-94C2-037F69A7DBFE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A1DED679-4B9E-4C81-9450-8E9D1C121394">
    <pav:createdOn>2015-06-24 14:44:56 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:54FE181A-5351-4C93-84BE-B2AFA6411C35"/>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:20922FAD-22F1-45F4-A045-98184A1D2AC0">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:20922FAD-22F1-45F4-A045-98184A1D2AC0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> with caution in transplant patients receiving </ao:prefix>
    <ao:exact>MMF</ao:exact>
    <pav:createdOn>2015-06-18 16:01:07 -0400</pav:createdOn>
    <ao:suffix>.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:37DDEDB4-2423-46DF-880E-A2D411563078">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E9F13BFE-1A17-4FDF-99A7-13B89F697635</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:C3D5761B-F1E9-43C2-9D22-5854F1ED38ED"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/>
    <pav:lastSavedOn>2014-02-19 12:41:40 -0500</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>SPL Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:0B909215-7514-42AE-8D33-022CB8C17D3A</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2014-02-19 12:41:17 -0500</pav:createdOn>
    <ao:body rdf:resource="urn:linkedspls:uuid:A26A390E-AB65-462C-81C3-438BDBA41B70"/>
    <ao:body rdf:resource="urn:linkedspls:uuid:1ED20ED1-FB0C-422E-8105-1ED7D0D52049"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:29C4967C-71D4-491E-A325-E3F4FD902F7D">
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:47C4A7F7-5DCE-47D9-A794-A20CD0E2E20B"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:33:36 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:A26A390E-AB65-462C-81C3-438BDBA41B70">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
    <poc:PharmacodynamicImpact>http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#none</poc:PharmacodynamicImpact>
    <rdfs:label>None</rdfs:label>
    <sio:SIO_000563>poc:PharmacodynamicImpact</sio:SIO_000563>
    <dct:description>none.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:265AAD7B-2FE8-4D89-A810-D1E17E6394B5">
    <pav:createdOn>2015-06-19 11:06:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Coadministration of oral contraceptives, diazepam, phenytoin, or quinidine did not seem to change the pharmacokinetic profile of esomeprazole</ao:exact>
    <ao:prefix>rifampin with esomeprazole sodium .   </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:265AAD7B-2FE8-4D89-A810-D1E17E6394B5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B6C0AC51-BD1D-425B-A355-337B17F99721">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C37C664C-2740-4C3F-90C2-2343DA0C4901"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D96B9193-90EA-479B-8529-B73A8562CA49">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdOn>2015-06-24 14:00:41 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:38911A62-E66E-49F3-9B9F-3CEF91DB3332"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BF1A3598-40A0-466D-9DA1-A732F864DD97">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2015-06-24 13:29:14 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:E27AB217-E6E5-4F02-B31D-CE65D26C4EA1"/>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/942F6894-2A7C-41BD-8C67-92964FA36266">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>etoposide</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/CF31EF34-410C-4FEB-8776-DC4E017716E0">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>rabeprazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CC9EC46D-CF77-4BC8-BB24-5A947D1757A5">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdOn>2015-06-24 14:05:27 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:90DD7091-9FED-4616-BE31-6DF53BF54C6C"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BB01147D-4F92-4781-B5C0-AD48A3E85F20">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>rabeprazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C30C9775-7EF4-4325-B024-AEBE40B1D413">
    <pav:createdOn>2015-06-24 13:30:18 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:4AA0CA35-8312-45FC-83FD-9AAEE36DF2E5"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FABC06FA-48C2-4637-960B-562CF975FD1A">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:0B411E49-EB80-4ACD-9312-987A1CFD6EA0"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:32:21 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/37488F1E-49D5-4812-92A8-CC3B9ACCC747">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>ACIPHEX</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dikbD2R:dose>0.02</dikbD2R:dose>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:404C8183-3E9F-4FE4-ABAA-0C6D4A41C8E1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:404C8183-3E9F-4FE4-ABAA-0C6D4A41C8E1"/>
    <pav:createdOn>2015-06-24 14:51:06 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>. </ao:suffix>
    <domeo:uuid>404C8183-3E9F-4FE4-ABAA-0C6D4A41C8E1</domeo:uuid>
    <ao:exact>ondansetron</ao:exact>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:prefix>do not affect the pharmacokinetics of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DB93AC8A-17E3-46EA-97C3-D3FFDF302CAC">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DB93AC8A-17E3-46EA-97C3-D3FFDF302CAC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:28:11 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix> were monitored for purposes of pharmacokinetic analyses.</ao:suffix>
    <ao:exact>GS-331007</ao:exact>
    <ao:prefix> and the inactive metabolite </ao:prefix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E7AC5B35-8CF6-4D77-AB8B-38C121499BC7">
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <ao:context rdf:resource="urn:domeoclient:uuid:9F705C01-1A2E-45D6-BDB7-8FF75AD686E9"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <rdfs:label>ddi Annotation</rdfs:label>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <ao:body rdf:nodeID="Neec5e0b24e964414a38397d2ea5bede3"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:861d7355-bd05-4520-a9bc-7cbebbde07d6</pav:lineageUri>
    <pav:lastSavedOn>2015-06-26 14:52:05 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:7309B8E4-6AF7-4EB4-8538-D405A11D8CD4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:createdOn>2015-06-19 11:54:10 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1B3A21A2-252F-44DD-B7BB-323EBE75B53E">
    <domeo:uuid></domeo:uuid>
    <ao:prefix> is expected to decrease the concentration of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1B3A21A2-252F-44DD-B7BB-323EBE75B53E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 13:33:49 -0400</pav:createdOn>
    <ao:suffix> and sofosbuvir, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <ao:exact>ledipasvir</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E65106E9-0A6F-489A-8B88-59AE401F3D47">
    <pav:createdOn>2015-06-24 13:30:05 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:CB4B8EE2-739E-4BE1-B393-AF529B74CF4C"/>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:297B7B7F-B4EA-477C-9EEB-5361C7BAB04D">
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> may be administered simultaneously with or 12 hours apart from HARVONI at a dose that does not exceed doses comparable to famotidine 40 mg twice daily</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>H2-receptor antagonists</ao:exact>
    <pav:createdOn>2015-06-24 13:29:12 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:297B7B7F-B4EA-477C-9EEB-5361C7BAB04D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3E79B94A-C1D1-42A0-9BE4-E700237B5197">
    <ao:suffix>, respectively. A significant exposure-response relationship was identified between ondansetron concentration and ΔΔQTcF. Using the established exposure-response relationship, 24 mg infused intravenously over 15 min had a mean predicted (95% upper predic</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Ondansetron</ao:exact>
    <pav:createdOn>2015-06-24 14:51:37 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3E79B94A-C1D1-42A0-9BE4-E700237B5197"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>3E79B94A-C1D1-42A0-9BE4-E700237B5197</domeo:uuid>
    <ao:prefix>itive-controlled, crossover study in 58 healthy subjects. The maximum mean (95% upper confidence bound) difference in QTcF from placebo after baseline-correction was 19.5 (21.8) ms and 5.6 (7.4) ms after 15 minute intravenous infusions of 32 mg and 8 mg </ao:prefix>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B3004F71-517D-410F-931B-075CEBE20FEC">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:DCA4C9CB-4899-40D5-93CB-9C50F6CEBEBC"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdOn>2015-06-24 13:41:09 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:70496807-BB43-4B36-9CC1-9575C1468289">
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdOn>2015-06-24 13:33:11 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:ADB5A04D-32D0-402A-87A2-E4C2C656B227"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E3A0F170-A7B9-4E6A-BCBA-401A56CAE5D5">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>esomeprazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C7768CBA-676A-4543-96D9-FED2595B1ED8">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:7227C100-BBF1-415F-AC67-74E78FC1D161"/>
    <pav:lastSavedOn>2015-06-24 13:28:47 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:b8f2cc8a-d0ef-4f41-b982-9f169e468ba8</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:28:28 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB4B8EE2-739E-4BE1-B393-AF529B74CF4C">
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CB4B8EE2-739E-4BE1-B393-AF529B74CF4C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>↓ sofosbuvir↓ GS-331007       </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:30:05 -0400</pav:createdOn>
    <ao:prefix>phenobarbital   oxcarbazepine  ↓ </ao:prefix>
    <ao:exact>ledipasvir</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5DBC4FFF-CF59-4271-9232-F1AF092163B8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:lastSavedOn>2015-06-19 11:57:12 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:861d7355-bd05-4520-a9bc-7cbebbde07d6</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:7309B8E4-6AF7-4EB4-8538-D405A11D8CD4</pav:previousVersion>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:createdOn>2015-06-19 11:54:44 -0400</pav:createdOn>
    <ao:body rdf:nodeID="N506dcfd1e6da4b629b2e2dafd846ad9f"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:42FE9E48-9583-43ED-BA73-BFF3FE8CC8CA"/>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <rdfs:label>ddi Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DE1E2211-EFF9-4F24-8EF4-A576A4D1B5A4">
    <ao:exact>HARVONI</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> with a moderate fat (~600 kcal, 25% to 30% fat) or high fat (~1000 kcal, 50% fat) meal increased </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>Relative to fasting conditions, the administration of a single dose of </ao:prefix>
    <pav:createdOn>2015-06-24 13:40:59 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DE1E2211-EFF9-4F24-8EF4-A576A4D1B5A4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DCA4C9CB-4899-40D5-93CB-9C50F6CEBEBC">
    <pav:createdOn>2015-06-24 13:41:09 -0400</pav:createdOn>
    <ao:prefix> were not altered in the presence of either meal type. The response rates in Phase 3 trials were similar in HCV-infected subjects who received </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DCA4C9CB-4899-40D5-93CB-9C50F6CEBEBC"/>
    <ao:suffix> with food or without food. HARVONI can be administered without regard to food.</ao:suffix>
    <ao:exact>HARVONI</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:36CA16EF-2271-4DD6-B9B5-03F91B9C64B1">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> exposure on organ rejection has not been established in transplant patients receiving PPIs and MMF. Use </ao:suffix>
    <pav:createdOn>2015-06-18 16:01:01 -0400</pav:createdOn>
    <ao:prefix>solubility at an increased gastric pH. The clinical relevance of reduced </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:36CA16EF-2271-4DD6-B9B5-03F91B9C64B1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>MPA </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B4CA3F17-4678-437D-8937-D6CB6D7EEEE0">
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 14:02:30 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:251C6435-7AAA-4167-BD78-2438E725B90A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E872450C-D5BC-488E-982F-1E045C60EE53">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B05F2AFE-2205-46C6-B50F-43438DD2CADF"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/FB32D318-794D-4C21-98A3-C8C4F2989310">
    <rdfs:label>esomeprazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CBE4B8F7-5F5E-4F09-847A-693C228BD236">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CBE4B8F7-5F5E-4F09-847A-693C228BD236"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>5 single dose  ND  400 single dose  16  </ao:prefix>
    <pav:createdOn>2015-06-24 14:03:01 -0400</pav:createdOn>
    <ao:exact>sofosbuvir</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8D79383B-2A3E-4E36-9C5F-92DB228F0374">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>rabeprazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:42D71B8E-4653-4335-B84B-1BA76AB9C069">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdOn>2015-06-24 14:03:47 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:0B0868CC-DAF9-44BD-9DBA-5143D670B31F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:90ABDB8F-0F66-4691-A9B2-14DD1C26D6D1">
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 14:01:37 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:449383ED-07B9-477F-9444-6629432FE9F6"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:08E308D4-7D74-409C-99C8-6D994D3CD268">
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 14:51:07 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:05889969-8C7C-44F9-8962-6661FD64EB05"/>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:46037266-2275-4C32-A459-43B403557EDC">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdOn>2015-06-24 14:05:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:8FCA2599-BD79-40F4-8F97-F64C92FA23F1"/>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1C1B3D30-CA09-4A74-8D5C-001A06F42561">
    <dikbD2R:numOfParticipants>Unk</dikbD2R:numOfParticipants>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/43046F06-FFBE-46C8-8730-6559194EEFEE"/>
    <dikbD2R:auc>-12%</dikbD2R:auc>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/37488F1E-49D5-4812-92A8-CC3B9ACCC747"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EC583886-AB43-4BC8-A738-544C0BE4E997">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:04378783-BC15-4351-B8B6-4DC956673F57"/>
    <pav:createdOn>2015-06-24 13:40:50 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8B9CE845-DC5C-4C1A-B610-A49E5EABC515">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:05D1E91D-8E58-4E8E-995F-9FE6DBC6A3C3</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E9F13BFE-1A17-4FDF-99A7-13B89F697635</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2014-02-19 12:41:37 -0500</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2014-02-19 12:41:40 -0500</pav:lastSavedOn>
    <rdfs:label>SPL Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:5DDF6D10-A992-43D4-B1C2-B010E34F248F"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:041CB31E-39FF-4196-8054-0061A7E53B52">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:17468A3F-0A53-4772-8277-BAFA9C9CC04D"/>
    <pav:createdOn>2015-06-24 13:54:38 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 13:57:41 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:4A00BF04-4EC7-42F2-8B6D-815E00609DE8</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:45A3A8BE-7E8A-4BE3-BE31-40A89606427B">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-26 14:10:58 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2284e984-435c-475d-8023-97355b70469b</pav:lineageUri>
    <rdfs:label>ddi Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <pav:previousVersion>urn:domeoserver:annotationset:D645D2F4-4D34-4A9F-B51F-F0E2A0F9826D</pav:previousVersion>
    <ao:body rdf:nodeID="N4a6713573a7946aca88b87c6dd8b6426"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdOn>2015-06-18 15:56:35 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:5A454442-22BF-444D-8B34-E6B173A6006A"/>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:302ED0D4-6A0C-4919-AAA6-9119B0A2555F">
    <ao:suffix>/tenofovir DF</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:32:24 -0400</pav:createdOn>
    <ao:prefix>tenofovir DF ‡   darunavir / ritonavir  + </ao:prefix>
    <ao:exact>emtricitabine</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:302ED0D4-6A0C-4919-AAA6-9119B0A2555F"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/437D7C7A-92E0-462C-8348-6497FA63211F">
    <rdfs:label>esomeprazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DEDED152-7DA5-4390-94BF-3DC9A8BDD06E">
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <rdfs:label>ddi Annotation</rdfs:label>
    <ao:body rdf:nodeID="N2e12f51bd0b742bcacffb9f19469d3e3"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:852B2EEE-512F-4027-A62E-2A81E29AAE3D"/>
    <pav:lastSavedOn>2015-06-24 15:02:21 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:B9858811-8398-457A-A21F-EBD4AA865BCA</pav:lineageUri>
    <pav:createdOn>2015-06-24 14:57:58 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:05814CF8-0DC0-4445-8375-38A95B98775D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7AF14910-9FB0-403E-9F3E-EA164E20BCEC"/>
    <dikbD2R:auc>69%</dikbD2R:auc>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1363F954-5CB9-477C-BB63-F09C52880379"/>
    <dikbD2R:numOfParticipants>20</dikbD2R:numOfParticipants>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0044FFC5-65ED-4E6E-BAFE-A343C1206CD0">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0044FFC5-65ED-4E6E-BAFE-A343C1206CD0"/>
    <pav:createdOn>2015-06-18 15:56:01 -0400</pav:createdOn>
    <ao:exact>iron salts</ao:exact>
    <ao:suffix>, </ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <ao:prefix>can reduce the absorption of drugs where gastric pH is an important determinant of their bioavailability. Like with other drugs that decrease the intragastric acidity, the absorption of drugs such as ketoconazole , atazanavir , </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D01B1C2D-FBD5-4586-943B-15FDB7897397">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>tramadol</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Naa7bd7b6c51b46ec838c907984286ffd">
    <domeo:sets rdf:resource="urn:pddi:uuid:FEC35B13-A985-4957-BD41-64E3BC92E3FD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:27AC35ED-4323-4666-B982-577354082CF8">
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:89F41DCF-C3C4-439E-97EC-ACF92D0BE31F"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:33:28 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2AB0C859-63AF-42B9-90FA-D18484D317B0">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2015-06-19 12:02:00 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:491545AF-9030-4770-8AE0-3D585F8366DC"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2015-06-19 11:57:27 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:1E503691-7FE3-4DF9-9199-6446F5E28A27</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:89230FE5-2A1A-4801-90B4-D8B8748389DD">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:89230FE5-2A1A-4801-90B4-D8B8748389DD"/>
    <pav:createdOn>2015-06-24 14:44:59 -0400</pav:createdOn>
    <ao:prefix>   7.3 Phenytoin , </ao:prefix>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:suffix>, and Rifampin      In patients treated with </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Carbamazepine</ao:exact>
    <domeo:uuid>89230FE5-2A1A-4801-90B4-D8B8748389DD</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:86F21B0D-4E53-4259-9F6B-2D629026A512">
    <ao:context rdf:resource="urn:domeoclient:uuid:1B3DD780-4249-46E6-8BF2-E7194584147C"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2015-06-18 15:51:34 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:795D6636-705E-4545-A9D7-BE577A354293</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <ao:body rdf:nodeID="Nae7a93d397884f7299b4943404c70c03"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EBB488F9-80C3-4A62-BE29-8305244FFAAE">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:4A9F7E84-D0E0-4A4B-885E-D6D058427789"/>
    <pav:createdOn>2015-06-24 13:40:34 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9DA85141-45C3-472D-AFA0-84EB262D7C2A">
    <ao:exact>ritonavir</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>tenofovir DF and a HIV protease inhibitor /</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9DA85141-45C3-472D-AFA0-84EB262D7C2A"/>
    <ao:suffix>         </ao:suffix>
    <pav:createdOn>2015-06-24 13:32:11 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2F4B0F07-5E0C-47F2-8DB6-39B74E54718C">
    <pav:createdOn>2015-06-19 11:06:41 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2F4B0F07-5E0C-47F2-8DB6-39B74E54718C"/>
    <ao:exact>Coadministration of oral contraceptives, diazepam, phenytoin, or quinidine did not seem to change the pharmacokinetic profile of esomeprazole</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <ao:prefix>rifampin with esomeprazole sodium .   </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:3D046132-84C4-4ABF-8B1C-EC07A0D07CA1">
    <rdfs:label>Active ingredient</rdfs:label>
    <dct:description>the ingredient is active</dct:description>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
    <dailymed:ActiveMoiety>http://dbmi-icode-01.dbmi.pitt.edu/linkedSPLs/vocab/resource/ingredient-active</dailymed:ActiveMoiety>
    <sio:SIO_000628>dailymed:ActiveMoiety</sio:SIO_000628>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:416CBAFE-EAE8-453C-A706-B18F9FB4AE49">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>efavirenz</ao:exact>
    <ao:prefix>concomitantly with the combination of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:31:51 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, emtricitabine and tenofovir DF. Refer to VIREAD, TRUVADA, or ATRIPLA prescribing information for recommendations on renal monitoring.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:416CBAFE-EAE8-453C-A706-B18F9FB4AE49"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C1CE0A04-057F-444A-8277-8AD756B5202A">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:D028CAF9-AC5B-4B50-B1A7-2B6BCCF1820B"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 14:03:16 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:04AB3EB2-077F-4618-8DA5-BF7A70F1BD9F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <ao:body rdf:nodeID="Ndb790365576f485d930905e5ac6e1425"/>
    <rdfs:label>ddi Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:F9847FC9-DB99-4ED0-BEEB-198DA2808285</pav:lineageUri>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <ao:context rdf:resource="urn:domeoclient:uuid:BADB6CA6-59E1-4D0B-9033-7F41FCE21402"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-18 16:05:33 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E27AB217-E6E5-4F02-B31D-CE65D26C4EA1">
    <ao:suffix> at a dose that does not exceed doses comparable to famotidine 40 mg twice daily.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:29:14 -0400</pav:createdOn>
    <ao:exact>HARVONI </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix> may be administered simultaneously with or 12 hours apart from </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E27AB217-E6E5-4F02-B31D-CE65D26C4EA1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FCAE70DF-F53B-4C16-9E8B-F9AEE35533CC">
    <ao:suffix>, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <ao:prefix> is expected to decrease the concentration of ledipasvir and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FCAE70DF-F53B-4C16-9E8B-F9AEE35533CC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sofosbuvir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:33:51 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:31970159-BA37-4601-BC02-24599B428FF3">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 13:31:59 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix>, TRUVADA, or ATRIPLA prescribing information for recommendations on renal monitoring.</ao:suffix>
    <ao:exact>VIREAD</ao:exact>
    <ao:prefix>. Refer to </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:31970159-BA37-4601-BC02-24599B428FF3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BCBFA9C2-F83E-46B5-A2FD-C39229FEDD28">
    <ao:context rdf:resource="urn:domeoclient:uuid:F33B270C-BB52-4810-AF89-0A84E60ED71C"/>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:40:09 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:221375F9-ED01-447F-B3A6-99118DB3E4B2">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:40:02 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:BFA1EB0C-6694-4CEC-AB7F-7D2759706880"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB1600C8-C9AB-4A9A-90EA-E1C9D96DB30B">
    <pav:createdOn>2015-06-18 15:58:12 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>antacids </ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EB1600C8-C9AB-4A9A-90EA-E1C9D96DB30B"/>
    <ao:prefix> and </ao:prefix>
    <ao:suffix> produced no clinically relevant changes in plasma </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:C0D4F41F-0FCC-446B-A746-DAED97C65270">
    <poc:PharmacokineticImpact>http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#not-important</poc:PharmacokineticImpact>
    <dct:description>The pharmacogenomic biomarker is not associated any clinically relevant pharmacokinetic with respect to the drug.</dct:description>
    <rdfs:label>Not Important</rdfs:label>
    <sio:SIO_000563>poc:PharmacokineticImpact</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:10D5167F-417B-40B4-B521-BFD09A986C23">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 14:05:53 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:6C783FB5-B1DF-4953-A17C-D3351874DA5F"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1A8354E6-E47A-41FD-9A2C-5A0499783979">
    <domeo:uuid>1A8354E6-E47A-41FD-9A2C-5A0499783979</domeo:uuid>
    <ao:exact>ondansetron </ao:exact>
    <ao:prefix>ntestinal transit time. In another study in six normal male volunteers, a 16-mg dose infused over 5 minutes showed no effect of the drug on cardiac output, heart rate, stroke volume, blood pressure, or electrocardiogram (ECG). Multiday administration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 14:51:53 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>has been shown to slow colonic transit in normal volunteers. Ondansetron has no effect on plasma prolactin concentrations. In a gender-balanced pharmacodynamic study (n = 56), ondansetron 4 mg administered intravenously or intramuscularly was dynamically</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1A8354E6-E47A-41FD-9A2C-5A0499783979"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4D4C1776-9F2A-4B73-8821-F04F41554819">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:0F337F95-4751-4C6D-A90B-F434AE7F84BA"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3F9C3A7E-FFB6-4E8D-98FF-DF51A8E29BFC">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2015-06-24 14:54:01 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:3F21DF91-01B3-4304-8826-FA9B9746E104"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6B1FEF5E-56BF-4EF8-B66A-E506C74F57DF">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6B1FEF5E-56BF-4EF8-B66A-E506C74F57DF"/>
    <pav:createdOn>2015-06-24 13:35:23 -0400</pav:createdOn>
    <ao:exact>rosuvastatin</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> may significantly increase the concentration of rosuvastatin which is associated with increased risk of myopathy, including rhabdomyolysis. Coadministration of HARVONI with rosuvastatin is not recommended.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>with </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E2510036-D006-4144-A348-C7E9407DE956">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3322</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>diazepam</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1B56138D-6FEE-4D1E-9B56-E1A1CBFFCCBF">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DF138C38-68F4-4445-A554-7A4AA8A625C8"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7DB8F817-3420-470E-8853-514D3846C981">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdOn>2015-06-24 14:01:30 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:AFE55325-48CA-40F0-8B61-574BB1683EF4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D7DB3988-4246-4843-AB4F-A1B3DE9B586F">
    <ao:prefix> is expected to decrease the concentration of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D7DB3988-4246-4843-AB4F-A1B3DE9B586F"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:31:26 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ledipasvir</ao:exact>
    <ao:suffix> and sofosbuvir, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FB7A62C6-4E6E-4406-9717-458E36BF511D">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:comment>Decreased bioavailability of ketoconazole</dikbD2R:comment>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:0B86E822-3E0A-4D98-B1FD-D688CD5BD17B"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:612EDC34-81F0-4ABC-9877-93F8CB72B63C">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:4B61F64B-1C15-4E99-80D9-A5A7949357CB"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6A523E71-53C3-4CC6-8839-C9706F1A7B5A">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9CD19067-7F3D-4499-8B67-9459D04ACFBD"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A1ACC31E-A190-491A-A2E4-E08F4FBABBAC">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:33:22 -0400</pav:createdOn>
    <ao:exact>tenofovir DF</ao:exact>
    <ao:prefix>elvitegravir , cobicistat , emtricitabine , </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A1ACC31E-A190-491A-A2E4-E08F4FBABBAC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:264A1A8A-20F8-455F-894C-66B10DDDD770">
    <ao:body rdf:nodeID="N697827ff8fa846b78c1b9161f830168d"/>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:createdOn>2015-06-19 11:56:50 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:861d7355-bd05-4520-a9bc-7cbebbde07d6</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:D6ACE5D3-F7A0-445F-978A-8B43E1955827"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:lastSavedOn>2015-06-19 11:57:12 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:7309B8E4-6AF7-4EB4-8538-D405A11D8CD4</pav:previousVersion>
    <rdfs:label>ddi Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:39EB13F6-7078-4FF5-8DC3-182CD939DC1C">
    <ao:exact>rabeprazole</ao:exact>
    <ao:prefix> in healthy volunteers following 14 days of dosing with 20 mg of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-18 15:53:34 -0400</pav:createdOn>
    <ao:suffix>. This degree of inhibition is similar to that by </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:39EB13F6-7078-4FF5-8DC3-182CD939DC1C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DD4CB317-8E03-4E29-80A2-2F0EDF2B3094">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 13:29:29 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:163E445A-9B45-4FEB-8FAA-8BEC5E8EB605"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35A1B681-2EBE-45D7-A28D-EBB2B0C08AB5">
    <ao:exact>simeprevir</ao:exact>
    <ao:prefix>ledipasvir . Coadministration of HARVONI  with </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:34:54 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> is not recommended.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:35A1B681-2EBE-45D7-A28D-EBB2B0C08AB5"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:54709A02-DE7C-4CE2-9C5D-7AA7A2C15C51">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:54709A02-DE7C-4CE2-9C5D-7AA7A2C15C51"/>
    <ao:prefix>It is recommended to separate antacid  and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:29:04 -0400</pav:createdOn>
    <ao:suffix> administration by 4 hours.</ao:suffix>
    <ao:exact>HARVONI </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DED9357D-A5DF-4F91-BC4F-FF44361FD1A6">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>PPIs </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>and </ao:suffix>
    <pav:createdOn>2015-06-18 16:04:09 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DED9357D-A5DF-4F91-BC4F-FF44361FD1A6"/>
    <ao:prefix>Case reports, published population pharmacokinetic studies, and retrospective analyses suggest that concomitant administration of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CFE49BB4-1C31-4623-B66D-293C72A00AD5">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdOn>2015-06-24 13:30:29 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:55022387-B655-48CF-99B9-ED8A36941A09"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C2C63095-0AE6-41B3-9D2D-AD31D8C96FAF">
    <ao:context rdf:resource="urn:domeoclient:uuid:5C5FEB42-CB4C-43D4-AA70-1744475D7D12"/>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2015-06-24 14:44:51 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4528B99F-3151-4F9E-BF26-4F9318E8B1A2">
    <dikbD2R:comment>AUC was reduced</dikbD2R:comment>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:1C1B3D30-CA09-4A74-8D5C-001A06F42561"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D49B4E42-DEEB-418D-8861-72E69CEC8026">
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 14:44:44 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:BFFCFB55-82B7-40B7-B909-B08D883BE6F3"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/44DB02B7-1F3B-4AC3-BB10-DA71DD7AB2D6">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>warfarin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:09009F96-21F3-4835-99B4-D0AA49EE5ACA">
    <ao:exact>In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:09009F96-21F3-4835-99B4-D0AA49EE5ACA"/>
    <domeo:uuid>09009F96-21F3-4835-99B4-D0AA49EE5ACA</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2015-06-24 14:57:30 -0400</pav:createdOn>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:prefix> </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A6624C63-DFE2-4582-94C2-037F69A7DBFE">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>atazanavir</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/343047</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586">
    <ao:item rdf:resource="urn:domeoclient:uuid:D65449E7-A994-4E7D-AE8E-CE069C6AE64E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9A72589E-592B-448F-8E6C-D19E12F65B00"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C96971DC-25BC-4460-A152-64526835BF6F"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:54518493-720B-4E2C-8C32-9A835524BAF3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6CC2628A-116D-40B3-A220-5B0669FE8058"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <domeo:agents rdf:resource="urn:domeo:software:id:Domeo-2.0alpha-040"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:431A18F2-3700-410D-ADBE-483AAAD7C3FB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:84541557-8858-4DFE-9A06-2D5E4353F6D9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:52D6831A-BF03-4645-8325-C4B67C5D0EBB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:63491321-018F-40B5-86B2-D94CC4DD44EE"/>
    <ao:annotatesResource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:annotatesResource>
    <ao:item rdf:resource="urn:domeoclient:uuid:B101920A-211E-46C5-AEF4-647FEF133794"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1124C607-B87A-429F-8D2D-319ABC684871"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A638709D-ADC4-4F10-9766-A87EB2D9C172"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:76F0646B-C8BA-4437-8B3F-931B01C0B560"/>
    <dct:description>The default set is created automatically by Domeo when no other set is existing.</dct:description>
    <ao:item rdf:resource="urn:domeoclient:uuid:7440F6C5-57DA-470D-BEBF-8A01ECB3D27B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C83167C4-C89B-48D3-B42A-57F073AF5BCA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B598EBDB-E12D-4748-B9B0-54BB72F974DA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D0CBB383-05F9-40BD-8EB7-190662945E36"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA91C7E9-2B6A-4A0C-9FCB-2F69AEBD76AD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:731B388B-A97C-478E-8E32-2776BCD6B5BF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A951E730-9AB7-433C-9C4B-A9DAE5503B07"/>
    <domeo:agents rdf:resource="urn:person:uuid:080e143043ef9cf90143f8ea240c0005"/>
    <domeo:deleted>false</domeo:deleted>
    <ao:item rdf:resource="urn:domeoclient:uuid:CBED5ECA-89ED-41E1-A01B-549EE271FD96"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3F9C3A7E-FFB6-4E8D-98FF-DF51A8E29BFC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:686DDE4B-A971-4010-B144-E3C7F66C0AED"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8700ABFA-812B-4DB1-82DF-BF728BC57F9A"/>
    <pav:lastSavedOn>2015-06-24 15:02:21 -0400</pav:lastSavedOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:C02B0785-064D-41D8-B5C1-A51F4BC80C3E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FAB6C7B6-2CBF-4A78-9445-47CAE66AF9F4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:39DEC04B-F6BB-4835-A57D-572727F57C13"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:item rdf:resource="urn:domeoclient:uuid:ED252933-988E-4648-8406-1C148CD2E7F6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:C2C63095-0AE6-41B3-9D2D-AD31D8C96FAF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FFA150FB-9F96-4B31-891F-3974106B33C8"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:61D778EC-18C0-4E50-9522-578D2479CDE3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6DA12934-7F28-40D2-8E34-66DB73709449"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:AADC6F3B-AA13-40C0-89E4-4258AAE366BE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:03B0ACCD-FA83-445C-853C-C5627D41BEF5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4C1C9387-A144-40A6-AAF4-5EA57C6A4415"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DEDED152-7DA5-4390-94BF-3DC9A8BDD06E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:08E308D4-7D74-409C-99C8-6D994D3CD268"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3C9FC6EC-2A3D-460B-BBD3-B0501F806754"/>
    <permissions:permissions rdf:nodeID="N38cf1b61155a450390c5a07bde12e53e"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F6C68992-2159-4247-A9EA-1E43912A4BDE"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:57AF1988-D82C-46DC-8DBA-8137EE89BE19"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:8B0AEFF5-2554-4F77-9CA9-C9249C01DCFD"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:391C4659-99D4-4906-B78E-F1A98D71A0B6"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:6FD2ACA8-20DA-4149-BEE3-9DDF7C6D5402"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:4457E9A8-D9EA-47EC-AA1C-3AD9C77BFCC5"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:9693508D-9149-4E3B-8D12-4117BC7AE8CB"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:1BBB8113-6883-416B-9571-B23DE13477F4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:2E24D915-78B5-473F-BEDE-3B121D1096F3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:625E4868-FC86-4321-B1EE-0EF53FECAE8C"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:item rdf:resource="urn:domeoclient:uuid:4091FF72-B4BE-457A-9263-AB2E085C3B10"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:7D13EBA3-8D8C-4CE2-BC68-03D8C1564643"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DC11B470-143A-4770-8C76-995B4962D19D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:DFC99041-B832-4FA7-A9CB-57505F6A3A1B"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:360ABF8B-DE34-48F9-9214-477A4582C9DC"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12DA0EA2-5E66-4ADF-BC75-D3295E49A087"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F4919C6E-FE07-4CAC-A01C-6A5DC2CDB77A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:D49B4E42-DEEB-418D-8861-72E69CEC8026"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F0F94768-ECF7-4184-A096-FC386CDC34D2"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:81FC4FFB-555E-4BF4-B0D9-BC2A42D39E71"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:3CC5D1D9-F156-4D38-B107-48C8F269AEBE"/>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <ao:item rdf:resource="urn:domeoclient:uuid:1441CBB2-3BBA-413E-B33C-C3076022858E"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:79FD9C3E-88FE-4C78-BE5B-AD12C9639E1E"/>
    <pav:previousVersion>urn:domeoclient:uuid:056B280D-9897-4629-963C-6AE918E73CD5</pav:previousVersion>
    <ao:item rdf:resource="urn:domeoclient:uuid:4C57CE1F-184E-4374-B490-908F426964A9"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:61A977E5-A1A0-4D6B-ACF8-89AA4A6B6D67"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:5441A056-387F-4CDF-82F2-8F8CB4E5679A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:700E5CED-610C-4858-966A-85628552F3DC"/>
    <pav:createdOn>2015-06-24 14:44:44 -0400</pav:createdOn>
    <ao:item rdf:resource="urn:domeoclient:uuid:4AFA497F-59E5-4CA5-AAEE-C41F341E31D4"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0D376767-0310-471A-9277-1AB7DEDD4F16"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:12A9CD3E-42F3-422A-8C8E-7F5F8FA9E4ED"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:0DC3EB1B-A0BA-4869-AA2B-BEB0A45B1127"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:A1DED679-4B9E-4C81-9450-8E9D1C121394"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:F6821B13-8484-4F9C-9F71-E110A7D8E0DA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:B7204F8D-CC5D-4BB8-992F-408384543314"/>
    <rdfs:label>Default Set</rdfs:label>
    <ao:item rdf:resource="urn:domeoclient:uuid:1D895A9D-D7BD-448B-AF09-DC567CFCCF12"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#AnnotationSet"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:516DD69C-F5E2-44AE-906A-0E59B78F46FF"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:40FB143F-C905-4D97-A0F1-098EBD25BA66"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FE173B4B-54CC-4269-90E9-BB737524408A"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:643DBABA-8C4A-43E8-93E6-2320F0D96797"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:36FE7C2F-46D1-40AD-BFC9-44ABF32E537C"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:862083C5-A4AA-4901-B48C-17566539AACA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:43E9D40A-E856-4C5D-BE1B-31D1D720044D"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:67D435F1-479E-4E0E-912D-E4796C8C5793"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:23DDEB34-CF71-4590-A750-E0AC686514EA"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FA0D1ACA-EFEE-46B1-B441-6883866047B3"/>
    <ao:item rdf:resource="urn:domeoclient:uuid:FF092A73-4CB5-4EC5-B0F8-4864E9C6C0F1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BE7F5A33-2C73-4027-AFC9-9BCBDFA6CCE0">
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:30:06 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:B1325640-15DC-479E-9BAC-B339BCD48B43"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FEC35B13-A985-4957-BD41-64E3BC92E3FD">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:4757029F-D770-4D80-AB44-409225C8DDD4"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A5FB18E2-E185-4935-B0E4-7A2A91710841">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> and sofosbuvir, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A5FB18E2-E185-4935-B0E4-7A2A91710841"/>
    <pav:createdOn>2015-06-24 13:30:16 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>ledipasvir</ao:exact>
    <ao:prefix>is expected to decrease the concentration of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:530AEDAE-056F-43F2-8014-42BA17CFA1EC">
    <ao:suffix>:</ao:suffix>
    <ao:prefix>HARVONI under fasted conditions.    </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Antiarrhythmics</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:530AEDAE-056F-43F2-8014-42BA17CFA1EC"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:29:35 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3EF7E40C-8233-41C5-BCCC-904C620CD4F0">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>nelfinavir</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/134527</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F6821B13-8484-4F9C-9F71-E110A7D8E0DA">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:F305741B-F312-4BFA-9CAF-0B41AC00B214"/>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 14:45:19 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C1A5D662-E57A-4E03-80F0-C41670441C51">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:30:34 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:F280FCA0-4C1C-4FD3-9834-96920BC5B631"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D44E648D-6F19-4752-B129-5167C12573D0">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:35:19 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:C53F4ED6-1A3D-4FEB-A32F-3F85DD710897"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:01F197A1-0E6A-4F94-89D5-715ABF597EA5">
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdOn>2015-06-24 14:03:31 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:45BD7451-7DA5-47CA-B1E4-883417062A80"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1D4428CF-B747-41FC-AC59-E66228792F0A">
    <pav:createdOn>2015-06-18 15:55:17 -0400</pav:createdOn>
    <ao:exact>7.4 Compounds Dependent on Gastric pH for Absorption\nDue to its effects on gastric acid secretion, rabeprazole can reduce the absorption of drugs where gastric pH is an important determinant of their bioavailability. Like with other drugs that decrease the intragastric acidity, the absorption of drugs such as ketoconazole, atazanavir, iron salts, erlotinib, and mycophenolate mofetil (MMF) can decrease, while the absorption of drugs such as digoxin can increase during treatment with ACIPHEX. </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <ao:prefix>   </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1D4428CF-B747-41FC-AC59-E66228792F0A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:48174C77-8AA2-4177-A9C8-F0F6197B6446">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>T</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:48174C77-8AA2-4177-A9C8-F0F6197B6446"/>
    <ao:exact>ests are available to identify a patient's CYP2C19 genotype and can be used as an aid in determining therapeutic strategy</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>48174C77-8AA2-4177-A9C8-F0F6197B6446</domeo:uuid>
    <pav:createdOn>2014-02-19 12:37:38 -0500</pav:createdOn>
    <ao:suffix>. (</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/Clopidogrel-1086a7b4-b89b-4bee-8120-5f752626c046.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/00753894-8D97-4D2D-9F99-6FD1E55626B0">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>omeprazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7646</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dikbD2R:dose>0.04</dikbD2R:dose>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:37D7C804-E2E1-411E-8C44-541340FF6194">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:13C7E81C-632C-4FE6-A6F6-58A32F60C67C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 14:05:48 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:04378783-BC15-4351-B8B6-4DC956673F57">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:04378783-BC15-4351-B8B6-4DC956673F57"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:40:50 -0400</pav:createdOn>
    <ao:exact>GS-331007</ao:exact>
    <ao:suffix> were 323, 618, and 707 ng/mL, respectively. </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:56695EC5-8D30-41BF-9938-08A084E9F788">
    <pav:createdOn>2015-06-24 13:31:43 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>)</ao:exact>
    <ao:prefix>   efavirenz , emtricitabine , tenofovir disoproxil fumarate (DF</ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:56695EC5-8D30-41BF-9938-08A084E9F788"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:586857BF-8459-41FC-903B-00B9617F6CA4">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>GS-331007</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:586857BF-8459-41FC-903B-00B9617F6CA4"/>
    <pav:createdOn>2015-06-24 13:48:28 -0400</pav:createdOn>
    <ao:prefix>Population pharmacokinetic analysis in HCV-infected subjects showed that within the age range (18 to 80 years) analyzed, age did not have a clinically relevant effect on the exposure to ledipasvir , sofosbuvir , and </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:03B0ACCD-FA83-445C-853C-C5627D41BEF5">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:65869B99-385F-4379-91BF-4CC94D40E478"/>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2015-06-24 14:45:01 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DAEFE458-98DE-4894-8048-A533DF02D0C2">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>ACIPHEX</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/862732FE-CAB7-4B9E-9CC1-1C6CF978075D">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-group"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>serotonergic drugs</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ADEDE14D-56E2-47B4-9304-3812A20B3C8D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sofosbuvir</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix>) as individual agents, or are predicted drug interactions that may occur with HARVONI </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ADEDE14D-56E2-47B4-9304-3812A20B3C8D"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix> and </ao:prefix>
    <pav:createdOn>2015-06-24 13:28:43 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6CFED0AD-DD71-4CD3-B14C-CC00281B4B90">
    <ao:exact>emtricitabine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6CFED0AD-DD71-4CD3-B14C-CC00281B4B90"/>
    <ao:prefix>, </ao:prefix>
    <pav:createdOn>2015-06-24 13:31:52 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> and tenofovir DF. Refer to VIREAD, TRUVADA, or ATRIPLA prescribing information for recommendations on renal monitoring.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9CE9354C-6CC5-437B-B94B-A83F19F0C710">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 14:02:54 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:A1858A61-864E-4FDE-8460-041D4D2FDF8D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:775D9945-9E10-4698-A841-B976A09926DC">
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:1EFDE2A9-1CB1-4108-8A44-F8BDB1E408D2"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdOn>2015-06-24 14:02:50 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:66FF0DF3-C777-4A3D-971F-8E83B304FDCC">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:resource="urn:linkedspls:uuid:C0D4F41F-0FCC-446B-A746-DAED97C65270"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:E62C93E3-E9D2-4338-BF38-206615042C69"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:resource="urn:linkedspls:uuid:33F29679-E217-4D93-9174-2D69A0E1B032"/>
    <rdfs:label>SPL Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E9F13BFE-1A17-4FDF-99A7-13B89F697635</domeo:belongsToSet>
    <pav:lastSavedOn>2014-02-19 12:28:11 -0500</pav:lastSavedOn>
    <pav:createdOn>2014-02-19 12:27:56 -0500</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:357321A7-5793-4DE5-BB38-BF5FA7A5D72C</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C83167C4-C89B-48D3-B42A-57F073AF5BCA">
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:lastSavedOn>2015-06-24 15:02:21 -0400</pav:lastSavedOn>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 14:58:34 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:82D3A933-3A7A-44CD-AC5C-347B7F27053D</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:body rdf:nodeID="N9e51d194c96c4e0aae038833f624c5ba"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:0E7045CB-CAF9-4933-83D9-8169B0CE03D8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CCEB07C9-29EC-476F-890C-12D1F4979398">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:31:18 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:01C92373-EA9B-42D5-B735-F626BA94BFEC"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/037A67AC-284D-4F9D-8FF8-C97F5F12BC7F">
    <rdfs:label>5-HT3 receptor antagonists</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-group"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:23530D0B-F4A5-407A-AED0-EE99C0B30E6D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>% and 7% for CYP2C9*2 and CYP2C9*3, respectively. Other CYP2C9 alleles associated with reduced enzymatic activity occur at lower frequencies, including *5, *6, and *11 alleles in populations of African ancestry and *5, *9, and *11 alleles in Caucasians. </ao:prefix>
    <ao:exact>Warfarin reduces the regeneration of vitamin K from vitamin K epoxide in the vitamin K cycle through inhibition of VKOR, a multiprotein enzyme complex. Certain single nucleotide polymorphisms in the VKORC1 gene (e.g., –1639G&gt;A) have been associated with variable warfarin dose requirements. VKORC1 and CYP2C9 gene variants generally explain the largest proportion of known variability in warfarin dose requirements.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2014-02-20 13:49:37 -0500</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/Warfarin-ab047628-67d0-4a64-8d77-36b054969b44.html </ao:hasSource>
    <domeo:uuid>23530D0B-F4A5-407A-AED0-EE99C0B30E6D</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:23530D0B-F4A5-407A-AED0-EE99C0B30E6D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2B069448-3F9D-4546-A20E-26BAA41CA533">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:30:21 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:7B91D004-098F-4694-A45D-5FF96E095014"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:75546D73-270F-49E1-8CEC-3974DDE6192E">
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <pav:lineageUri>urn:domeoserver:annotation:672459D9-295D-4101-8E07-BF406A986B6B</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:lastSavedOn>2015-06-19 11:13:42 -0400</pav:lastSavedOn>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:2F4B0F07-5E0C-47F2-8DB6-39B74E54718C"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N16eb050157e1445b9199eb9dad8f1549"/>
    <pav:createdOn>2015-06-19 11:06:41 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F5C523FE-31D5-4AAB-AB87-E7F27C6D6985">
    <ao:context rdf:resource="urn:domeoclient:uuid:653BC8BE-F6D5-4135-848B-89867CA18491"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:createdOn>2015-06-18 16:04:16 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:35AEB0F0-993D-4E34-849A-8F7F88E2D635</pav:lineageUri>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9E8C9B9D-1EED-41BE-AB65-1E8F01BD3389">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:6F2E0904-8E5F-4BA2-9813-721AE400245B"/>
    <pav:createdOn>2015-06-24 13:35:07 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:519D02CA-EC41-4DF9-9397-9A0FEF701C7C">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:C683D19D-1255-4D18-97FC-F5859222DD17"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:31:50 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E683CE2-B58E-49B0-9F1D-8B6F624B352D">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:30:17 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:B4D9860A-18AF-4A67-ACAD-EC1D46218518"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D52FD7E6-44AA-4A62-BA9D-0EB7A8972D4C">
    <pav:createdOn>2015-06-24 15:01:32 -0400</pav:createdOn>
    <ao:prefix> </ao:prefix>
    <ao:exact>In a crossover study in 76 pediatric patients, intravenous ondansetron did not increase blood levels of high-dose methotrexate.</ao:exact>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D52FD7E6-44AA-4A62-BA9D-0EB7A8972D4C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>D52FD7E6-44AA-4A62-BA9D-0EB7A8972D4C</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:758904B8-504D-450A-B6A3-6CF8B5796E67">
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:FA367F4F-B76B-4ADA-A13D-371E1B62E022"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2015-06-19 11:59:05 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:BEAF57CB-B3D0-41DF-A50F-0A9C1D166941</pav:lineageUri>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:lastSavedOn>2015-06-26 14:52:05 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="Nf970759d097448d1b3ae1f328a6ae01c"/>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B1A1CCDF-8868-4A2A-AC49-F8C4A52C3257">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E6AF9E8F-6C4D-44B4-AC2B-394622D64DF4"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/752D768A-A123-4AEC-894F-A0345EF71DCA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E62C93E3-E9D2-4338-BF38-206615042C69">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/Clopidogrel-1086a7b4-b89b-4bee-8120-5f752626c046.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Effectiveness of Plavix depends on activation to an active metabolite by the cytochrome P450 (CYP) system, principally CYP2C19</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>. (</ao:suffix>
    <domeo:uuid>E62C93E3-E9D2-4338-BF38-206615042C69</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E62C93E3-E9D2-4338-BF38-206615042C69"/>
    <pav:createdOn>2014-02-19 12:27:56 -0500</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3C039EA8-5898-4FFB-BB5E-D3B0E3240A2C">
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:31:48 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8DD4AC30-CA18-47FC-B406-B6AB138A8391"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC281B20-559F-4546-9398-22CEB07AC412">
    <pav:createdOn>2015-06-24 13:28:04 -0400</pav:createdOn>
    <ao:prefix>, any interactions that have been identified with these agents individually may occur with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>HARVONI</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DC281B20-559F-4546-9398-22CEB07AC412"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B8A8356B-72A0-4CE0-9ADD-A8069FB45E7D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 14:01:05 -0400</pav:createdOn>
    <ao:prefix>This study was conducted in the presence of two other investigational HCV direct-acting agents.        Atazanavir/ </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B8A8356B-72A0-4CE0-9ADD-A8069FB45E7D"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>ritonavir</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:CBE2B329-4E6C-4915-91A7-775A43D4D87E">
    <rdfs:label>Absorption Increase</rdfs:label>
    <dct:description>The pharmacogenomic biomarker is associated with a increase in absorption of the drug.</dct:description>
    <poc:PharmacokineticImpact>http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#absorption-increase</poc:PharmacokineticImpact>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
    <sio:SIO_000563>poc:PharmacokineticImpact</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:350EE9E4-4411-4E2A-AA8E-CEB5C46D5088">
    <ao:exact>ledipasvir</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2015-06-24 13:33:38 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>has not been established. Coadministration is not recommended.    tipranavir / ritonavir  ↓ </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:350EE9E4-4411-4E2A-AA8E-CEB5C46D5088"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F280FCA0-4C1C-4FD3-9834-96920BC5B631">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>with </ao:prefix>
    <pav:createdOn>2015-06-24 13:30:34 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>rifabutin</ao:exact>
    <ao:suffix> or rifapentine is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F280FCA0-4C1C-4FD3-9834-96920BC5B631"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:50AE2A4D-DE93-4327-83DA-1CE8DA0DE6B0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>50AE2A4D-DE93-4327-83DA-1CE8DA0DE6B0</domeo:uuid>
    <ao:prefix>is not normally required for the recommended doses. However, in patients who may require higher doses, dose adjustment may be considered .  </ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <pav:createdOn>2015-06-26 14:45:53 -0400</pav:createdOn>
    <ao:exact>Drugs known to induce CYP2C19 or CYP3A4 (such as rifampin) may lead to decreased esomeprazole serum levels. Omeprazole, of which esomeprazole is an enantiomer, has been reported to interact with St. John’s wort, an inducer of CYP3A4. In a cross-over study in 12 healthy male subjects, St John’s wort (300 mg three times daily for 14 days) significantly decreased the systemic exposure of omeprazole in CYP2C19 poor metabolizers (Cmax and AUC decreased by 37.5% and 37.9%, respectively) and extensive metabolizers (Cmax and AUC decreased by 49.6% and 43.9%, respectively). Avoid concomitant use of St. John’s Wort or rifampin with esomeprazole sodium. \n Coadministration of oral contraceptives, diazepam, phenytoin, or quinidine did not seem to change the pharmacokinetic profile of esomeprazole.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:50AE2A4D-DE93-4327-83DA-1CE8DA0DE6B0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3869AEDF-FA01-4F26-8A72-F2BEADD14C83">
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:CF61D783-CD3B-4801-8433-0F92EADFA7C0"/>
    <pav:createdOn>2015-06-24 14:03:34 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EE904256-1070-40E4-8465-AC43FCC5803B">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:333D5DF9-CAE8-4AAC-A75B-7C07C526D13B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 14:06:35 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:865E5694-3D5A-4824-9C5D-CAF4FA88FC9E">
    <domeo:uuid>865E5694-3D5A-4824-9C5D-CAF4FA88FC9E</domeo:uuid>
    <pav:createdOn>2015-06-24 14:44:53 -0400</pav:createdOn>
    <ao:prefix> Based on reports of profound hypotension and loss of consciousness when </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>apomorphine </ao:exact>
    <ao:suffix>was administered with ondansetron, concomitant use of apomorphine with ondansetron is contraindicated </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:865E5694-3D5A-4824-9C5D-CAF4FA88FC9E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C3D19AA2-CA54-465B-9900-48FAB77D377A">
    <pav:createdOn>2015-06-19 10:57:51 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:861d7355-bd05-4520-a9bc-7cbebbde07d6</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:F9CD6C73-A3A2-43A1-858F-D3EBB8FFE437"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:EC837692-C376-409C-9797-06D056AF0AC8</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <ao:body rdf:nodeID="N5096a583f3124aedbfeb3949bb7b7aa3"/>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <pav:lastSavedOn>2015-06-26 14:52:05 -0400</pav:lastSavedOn>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7D82FCEC-AAAF-4B8A-B346-9956969C4AB0">
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 14:03:11 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:82CA4A6F-BCFF-40AC-8125-A7CB049FCC68"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F88B4270-3108-4EC5-90F7-AC5AE63F34C1">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:91C1CFA2-4D8A-4251-B376-95CE972C903B"/>
    <dikbD2R:comment>AUC decreased</dikbD2R:comment>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B598EBDB-E12D-4748-B9B0-54BB72F974DA">
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:DE0B112E-6E65-4E8C-9056-E608A16C8C28"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2015-06-24 14:55:27 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:747EEA37-1BAD-420C-B886-395117292C86">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:previousVersion>urn:domeoserver:annotationset:EC837692-C376-409C-9797-06D056AF0AC8</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <dikbD2R:assertionType>increase-auc</dikbD2R:assertionType>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:861d7355-bd05-4520-a9bc-7cbebbde07d6</pav:lineageUri>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <ao:context rdf:resource="urn:domeoclient:uuid:6E6D9A63-949B-4CD4-A63A-45C7041484A6"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-26 14:52:05 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="Nb9b3c01db8d245459fd2a995ee0bcfc4"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:createdOn>2015-06-19 11:01:40 -0400</pav:createdOn>
    <rdfs:label>ddi Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:625E4868-FC86-4321-B1EE-0EF53FECAE8C">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2015-06-24 14:45:12 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:9F214CD6-7D99-408B-8028-0B5916C39CC4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:46F00088-7B53-4146-8FA2-8AEB1ADAA740">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:CC4F35B7-329F-4B55-BFE4-481AA1B64A04"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 14:01:58 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D729373A-12B2-411D-9445-5A2D8046EDED">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:4A8FAD25-0915-4322-A329-45E7E6992788"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 13:29:33 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7204AB9D-53EC-4C4F-85E1-ED8026C359FA">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:35:34 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:2909785D-B623-43A3-B162-6A9D7463C7C3"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:856ACBEC-5155-41D8-B53D-DABAC70AC167">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2015-06-24 13:28:55 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:458FDCF9-BC4F-4EEC-9AB7-FB00991C94E3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:47A174B6-BABC-4A2C-B120-EBDA4D8ABB00">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:33:25 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:91425A2B-743A-42D7-953D-A9B4896A6A96"/>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D8D191F0-3CC9-4933-BF6B-AFBF98015E37">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:3A195713-ED3B-400E-A099-6915D973B78E"/>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:34:43 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:42D44ED6-AB36-4399-850F-9C7FFCFA845C">
    <ao:exact>ledipasvir</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:42D44ED6-AB36-4399-850F-9C7FFCFA845C"/>
    <ao:prefix>These interactions have been studied in healthy adults.        Acid Reducing Agents:  ↓ </ao:prefix>
    <pav:createdOn>2015-06-24 13:28:51 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:38BD703F-9BF2-4DA7-BAC7-793C948BE8D7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>        1.81 (1.69, 2.94)     </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:38BD703F-9BF2-4DA7-BAC7-793C948BE8D7"/>
    <ao:exact>ledipasvir</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 14:02:58 -0400</pav:createdOn>
    <ao:prefix>150 once daily  30 once daily  ND  22  </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1611A71F-C755-4B14-86F2-F0AF1FBA1C4D">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <ao:body rdf:nodeID="Ncdb3ef91d86c4c55a4a746f3661b0727"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotationset:861d7355-bd05-4520-a9bc-7cbebbde07d6</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:A2DE8B85-AD53-46D3-8EC0-315550708632"/>
    <dikbD2R:assertionType>increase-auc</dikbD2R:assertionType>
    <pav:createdOn>2015-06-19 11:56:17 -0400</pav:createdOn>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:lastSavedOn>2015-06-26 14:52:05 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:previousVersion>urn:domeoserver:annotationset:7309B8E4-6AF7-4EB4-8538-D405A11D8CD4</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4A99DB56-883A-47D0-84F3-25016B32EB4A">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/236D73FE-AC4C-4AA3-A50F-E1CCB676F197"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6CAF6CD3-C5FA-4966-8010-CE7B98A5DCD2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:43E9D40A-E856-4C5D-BE1B-31D1D720044D">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 14:44:59 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:BC4D79C3-E386-4C3C-8810-13F849D3DE60"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:94591B37-EB7A-4F95-88DF-65B185289495">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:6EA9EBAE-DDEF-4493-A525-C7EBD19B43A0"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:34:57 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:09D3548C-32D4-4234-BF5B-9866B40F61CD">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 14:03:03 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:5D93C36D-93A1-49FD-A18F-E6A961FFFB8F"/>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:207C3A96-FB55-4167-AFF7-F9AB89948A15">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>emtricitabine</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>tenofovir DF ‡   lopinavir / ritonavir  + </ao:prefix>
    <ao:suffix>/tenofovir DF</ao:suffix>
    <pav:createdOn>2015-06-24 13:32:30 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:207C3A96-FB55-4167-AFF7-F9AB89948A15"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B15F635C-A0DA-4A8D-8888-F179E283DF40">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>rabeprazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F4C99D39-C95C-49D8-9702-01E37B79229C">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:066CD9D3-41FE-4ED8-B075-86420D766482"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D89022AD-A7CA-4475-9E65-5CFA53D36AAE">
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:66CC1BA2-2CE7-4DE3-A256-30CB4D1B6E98"/>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:30:09 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:951E4E4B-3347-4714-A3A2-291B3535B8A5">
    <ao:suffix>, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <ao:prefix> is expected to decrease the concentration of ledipasvir and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:951E4E4B-3347-4714-A3A2-291B3535B8A5"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:33:56 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sofosbuvir</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:774060B3-CB97-4D04-9CE8-9506CC7620CF">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:31:51 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:416CBAFE-EAE8-453C-A706-B18F9FB4AE49"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7086E081-1D09-4FDB-8FF1-5E5EB3110488">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 13:28:03 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:exact>HARVONI</ao:exact>
    <ao:suffix> contains </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>7.1 Potential for Drug Interaction  As </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7086E081-1D09-4FDB-8FF1-5E5EB3110488"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FBAAF687-0459-419E-B287-28E543B0ED45">
    <ao:context rdf:resource="urn:domeoclient:uuid:31970159-BA37-4601-BC02-24599B428FF3"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:31:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B224EE88-5B44-4C33-935A-ED47191A441C">
    <ao:prefix> following administration of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B224EE88-5B44-4C33-935A-ED47191A441C"/>
    <ao:suffix> were 0.5 and 27 hours, respectively.</ao:suffix>
    <ao:exact>HARVONI</ao:exact>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:42:30 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8ED0921C-1671-4D6F-863A-50860535426C">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-18 15:58:12 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:D55A4FFF-ADDE-4FEA-A23E-852BB9A4A795</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:EB1600C8-C9AB-4A9A-90EA-E1C9D96DB30B"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7B0F453E-377A-4CDF-A707-C3D2CEA15823">
    <ao:prefix>   </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>7.1 Drugs Metabolized by CYP450\nRabeprazole is metabolized by the cytochrome P450 (CYP450) drug metabolizing enzyme system. Studies in healthy subjects have shown that rabeprazole does not have clinically significant interactions with other drugs metabolized by the CYP450 system, such as warfarin and theophylline given as single oral doses, diazepam as a single intravenous dose, and phenytoin given as a single intravenous dose (with supplemental oral dosing). Steady state interactions of rabeprazole and other drugs metabolized by this enzyme system have not been studied in patients</ao:exact>
    <pav:createdOn>2015-06-18 15:52:36 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7B0F453E-377A-4CDF-A707-C3D2CEA15823"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1967A102-179C-4E95-AFB2-07C7F77F9AB0">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1967A102-179C-4E95-AFB2-07C7F77F9AB0"/>
    <ao:suffix>, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix> is expected to decrease the concentration of ledipasvir and </ao:prefix>
    <ao:exact>sofosbuvir</ao:exact>
    <pav:createdOn>2015-06-24 13:30:48 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F5E517F5-6AFE-43B7-A1DF-4FBAFE854D5B">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>esomeprazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:67D435F1-479E-4E0E-912D-E4796C8C5793">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:AFAB5DE2-35E7-4530-A8F4-3893871BFFDD"/>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <ao:body rdf:nodeID="N10d0d32cdec74608a170db85d454db7a"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>ddi Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:4084E65C-EC9C-44D0-9073-61312D4A1D19</pav:lineageUri>
    <pav:createdOn>2015-06-24 15:02:09 -0400</pav:createdOn>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 15:02:21 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:228D2C67-AEF2-45E3-AD9D-6CAEA24FD4A0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:228D2C67-AEF2-45E3-AD9D-6CAEA24FD4A0"/>
    <ao:suffix>, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sofosbuvir</ao:exact>
    <ao:prefix> is expected to decrease the concentration of ledipasvir and </ao:prefix>
    <pav:createdOn>2015-06-24 13:30:38 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EE7C05BE-A3B5-4103-A74A-323F541A21B2">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:32:29 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:51D54F2C-070A-48EC-8B35-B7B39ECC65A2"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EC90CBEB-019D-4684-B03B-87F6A39205D8">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:F2AA53CF-62A0-4AC1-A905-90234DD019B3"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:33:18 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/836125FD-9114-4165-B3B7-6D009B850F81">
    <rdfs:label>esomeprazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9D993CCE-022C-44AE-A2DB-ECB5EE7558C0">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:9876EF6E-0576-4F83-86E4-057D7EA677EA"/>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 13:32:20 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:686DDE4B-A971-4010-B144-E3C7F66C0AED">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:0C1D6F13-6328-4087-B43F-88CB3A651419"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 14:45:15 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F09C6543-E7FD-4ACA-8D29-2DEBF6B87C0D">
    <ao:prefix>. Therapeutic concentration monitoring of </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:suffix> is recommended when coadministered with HARVONI.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>digoxin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F09C6543-E7FD-4ACA-8D29-2DEBF6B87C0D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:29:54 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CEC886CD-92EB-4AEE-9C71-0BF30DD25F3B">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CEC886CD-92EB-4AEE-9C71-0BF30DD25F3B"/>
    <ao:prefix>carbamazepine  phenytoin  phenobarbital   </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:30:04 -0400</pav:createdOn>
    <ao:exact>oxcarbazepine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4a6713573a7946aca88b87c6dd8b6426">
    <domeo:sets rdf:resource="urn:pddi:uuid:3CFA9199-52F0-48D6-9A94-5E728F3C76BF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:47BA2497-2B76-4257-A45E-E6AB7172F13E">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:ED6C210C-E64A-48DD-967A-88DE1659D6D0"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:34:48 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3CFA9199-52F0-48D6-9A94-5E728F3C76BF">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:60473C32-18E4-4261-BA70-0C982FB8F146"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E60C5C49-AA40-4899-81E3-A1D2FBC43DFF">
    <ao:prefix>Co-administration of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E60C5C49-AA40-4899-81E3-A1D2FBC43DFF"/>
    <ao:exact>PPIs </ao:exact>
    <ao:suffix>in healthy subjects and in transplant patients receiving MMF has been reported to reduce the exposure to the active metabolite, mycophenolic acid (MPA), possibly due to a decrease in MMF solubility at an increased gastric pH. The clinical relevance of re</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <pav:createdOn>2015-06-18 16:00:52 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:82327B05-8BB1-401E-ACB4-42C3E0930D57">
    <sio:SIO_000563>poc:PharmacodynamicImpact</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
    <dct:description>The pharmacogenomic biomarker is associated with an increased risk of toxicity.</dct:description>
    <rdfs:label>Increased Toxicity Risk</rdfs:label>
    <poc:PharmacodynamicImpact>http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#drug-toxicity-risk-increased</poc:PharmacodynamicImpact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:297D4D19-C8D2-47AB-8014-689C9CC2EFD2">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdOn>2015-06-24 14:01:52 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:461052D9-3BF8-462B-AABD-FA1AF2B48E62"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7B8F9645-3FCD-4A37-80A9-776EE9040394">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-group"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>proton pump inhibitors</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AB6DBC9C-8744-4E60-91FA-B7E89E17B3D8">
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:FD84B1C7-498A-4015-ABDC-E15BDE2E12CD</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:lastSavedOn>2015-06-26 14:52:05 -0400</pav:lastSavedOn>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2015-06-26 14:47:06 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <ao:body rdf:nodeID="N16b475a12c0e4f24b49b0657a1f316ae"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:1C3D4BA7-4E14-4C58-8F3B-324B69D575DE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ECDEE416-7EF2-45F3-A3F1-8C857D50513E">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:35:39 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:69E070CA-F21A-4A8F-9BBE-E1F680F30089"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8134FD05-7D3D-4B7E-84B5-1C353893691D">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>amoxicillin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/723</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9582E934-3102-46B7-8EC9-E19DAD318BC3">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 13:34:44 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:259E7A6A-4A9C-4B5D-9F0E-238A7799F5ED"/>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AEEB7E17-5EEE-4AE1-946C-DEFA401806CF">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>, </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:exact>TRUVADA</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:32:00 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AEEB7E17-5EEE-4AE1-946C-DEFA401806CF"/>
    <ao:suffix>, or ATRIPLA prescribing information for recommendations on renal monitoring.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0CD65CF4-142D-4489-828C-EEF820C878C7">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 13:30:31 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:E5DB0308-F107-462B-81BC-DE5F19729DF5"/>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:806E8B10-9AED-4C6C-81FD-52625884D3E8">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:BFC0CDB7-F6B6-46D4-9C3D-50F1FBE6F9A1"/>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdOn>2015-06-24 13:32:56 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:45139020-BB82-463D-979A-03233083EE3E">
    <ao:prefix>   </ao:prefix>
    <ao:exact>7.4 Compounds Dependent on Gastric pH for Absorption\nDue to its effects on gastric acid secretion, rabeprazole can reduce the absorption of drugs where gastric pH is an important determinant of their bioavailability. Like with other drugs that decrease the intragastric acidity, the absorption of drugs such as ketoconazole, atazanavir, iron salts, erlotinib, and mycophenolate mofetil (MMF) can decrease, while the absorption of drugs such as digoxin can increase during treatment with ACIPHEX.</ao:exact>
    <domeo:uuid>45139020-BB82-463D-979A-03233083EE3E</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:45139020-BB82-463D-979A-03233083EE3E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-26 14:05:21 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A2CF82A9-9110-4448-9271-1B7A43E3ACD8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:52EF7CCE-FA13-412F-9B75-99C7ECC2CF8C"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdOn>2015-06-24 13:34:51 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9A93244B-B29F-4731-81CE-6A5BB7531ED2">
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <ao:body rdf:nodeID="Nac12e3de40b2499698a501eab97baf26"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:62E87CAF-6E90-4144-8628-1A9974F7FE34"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:025EC374-CC1E-4F10-9F2E-7FC1FC2C6E39</pav:lineageUri>
    <pav:createdOn>2015-06-18 16:03:26 -0400</pav:createdOn>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:lastSavedOn>2015-06-26 14:32:43 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:491145C4-A045-430B-8632-0E99B7060139">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:491145C4-A045-430B-8632-0E99B7060139"/>
    <pav:createdOn>2015-06-24 14:44:49 -0400</pav:createdOn>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:prefix>is metabolized by hepatic cytochrome P-450 drug-metabolizing enzymes (CYP3A4, CYP2D6, CYP1A2), inducers or inhibitors of these enzymes may change the clearance and, hence, the half-life of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>491145C4-A045-430B-8632-0E99B7060139</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ondansetron </ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9F92D7DC-DEA3-44EF-A836-411B21BAF560">
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-18 16:01:03 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:213D19FC-A976-4916-A04A-C4C532B682F9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:C42BCBEC-7A53-435C-A8B6-A25482272F15"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7A10B286-E4F1-42EF-8775-8F323AAF85C8">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, the components of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:28:41 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> (ledipasvir and sofosbuvir) as individual agents, or are predicted drug interactions that may occur with HARVONI </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7A10B286-E4F1-42EF-8775-8F323AAF85C8"/>
    <ao:exact>HARVONI</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A0F251E9-D6A8-42CF-9E01-8B1B1C86018C">
    <ao:context rdf:resource="urn:domeoclient:uuid:EB2229EB-B9A4-426C-96DE-60BFE4F14AD6"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:29:39 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:391C4659-99D4-4906-B78E-F1A98D71A0B6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 14:51:10 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:F87733E0-3AEC-4210-9FC7-5C2E284B8D15"/>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0B0868CC-DAF9-44BD-9DBA-5143D670B31F">
    <pav:createdOn>2015-06-24 14:03:47 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0B0868CC-DAF9-44BD-9DBA-5143D670B31F"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix>mediated by CYP or UGT1A1 enzymes are not expected.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> is not a substrate for CYP and UGT1A1 enzymes. Clinically significant drug interactions with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>HARVONI </ao:exact>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7440F6C5-57DA-470D-BEBF-8A01ECB3D27B">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2015-06-24 14:55:33 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:83EA7D09-5E60-4EAE-BD46-C7BAA2F2ED7B"/>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F073C031-4850-414C-9AAF-7A7CB6619988">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:29:35 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:530AEDAE-056F-43F2-8014-42BA17CFA1EC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:13C7E81C-632C-4FE6-A6F6-58A32F60C67C">
    <pav:createdOn>2015-06-24 14:05:48 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>Norelgestromin</ao:exact>
    <ao:suffix>        norgestimate 0.180/0.2</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:13C7E81C-632C-4FE6-A6F6-58A32F60C67C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>(1.49, 1.70)  4.25 (3.47, 5.22)    </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:171282B3-7DE2-4824-B4DC-F62DC8D1DB32">
    <domeo:uuid>171282B3-7DE2-4824-B4DC-F62DC8D1DB32</domeo:uuid>
    <ao:prefix>see Pharmacokinetics (12.3) ].  </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-26 14:44:44 -0400</pav:createdOn>
    <ao:exact>Omeprazole acts as an inhibitor of CYP2C19. Omeprazole, given in doses of 40 mg daily for one week to 20 healthy subjects in cross-over study, increased Cmax and AUC of cilostazol by 18% and 26%, respectively. Cmax and AUC of one of its active metabolites, 3,4-dihydro-cilostazol, which has 4 to 7 times the activity of cilostazol, were increased by 29% and 69%, respectively. Coadministration of cilostazol with esomeprazole is expected to increase concentrations of cilostazol and its above mentioned active metabolite. Therefore, a dose reduction of cilostazol from 100 mg twice daily to 50 mg twice daily should be considered.</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:171282B3-7DE2-4824-B4DC-F62DC8D1DB32"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0FF171AB-0C4B-4203-813B-81D849C85D49">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 13:33:40 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:1CB361AE-28F4-4AA2-94E7-E8D3E69C9B7A"/>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BD325990-1CFF-4A8D-8D26-076EA13383D0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:32:14 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:761B7445-EC65-4123-AE80-12D835EEB212"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D5636884-A50A-4610-A80B-786AC9F28E7A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:32:43 -0400</pav:createdOn>
    <ao:exact>HIV protease inhibitor</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>/ritonavir has not been established</ao:suffix>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D5636884-A50A-4610-A80B-786AC9F28E7A"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B13E37DB-BFFF-4DDA-BEC2-1A6A60F8983D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:EB09A44A-6C89-4F1F-AA4D-B63D2123D037"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:33:29 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:59E8DF4A-0191-4071-9D86-F81300BDE4F6">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2015-06-24 13:29:03 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:B517A36E-A608-474F-A8E4-8B920D5D0F96"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DE89DB10-B27A-4098-AA8D-85A540932FB9">
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:2752FB82-2172-43EF-871E-F589746748B4"/>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-19 10:54:20 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:7e333e71-de31-4d19-9e13-65096f431517</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:861d7355-bd05-4520-a9bc-7cbebbde07d6</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <ao:body rdf:nodeID="N271687b568984fdead9a841d960fb785"/>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:lastSavedOn>2015-06-19 10:55:03 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0454F7F9-AFB1-4B93-BC80-4CCEDCCC9BFE">
    <ao:exact>Drugs Affecting Cytochrome P-450 Enzymes</ao:exact>
    <ao:prefix>7.1 </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 14:56:08 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0454F7F9-AFB1-4B93-BC80-4CCEDCCC9BFE"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <domeo:uuid>0454F7F9-AFB1-4B93-BC80-4CCEDCCC9BFE</domeo:uuid>
    <ao:suffix> </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B1325640-15DC-479E-9BAC-B339BCD48B43">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B1325640-15DC-479E-9BAC-B339BCD48B43"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sofosbuvir</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:30:06 -0400</pav:createdOn>
    <ao:prefix>phenobarbital   oxcarbazepine  ↓ ledipasvir ↓ </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4DAE57F1-104B-4C53-8A4D-449DFAD11010">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:35:44 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:C9483244-E13A-4C84-B971-0B0A1C6338E6"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A951E730-9AB7-433C-9C4B-A9DAE5503B07">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 14:44:56 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:DB642261-196B-4EBB-978D-BB2920D2E8B3"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7BE2C8F5-F7F5-4EA5-8A63-74744B527237">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7BE2C8F5-F7F5-4EA5-8A63-74744B527237"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> In a study of 51 pediatric patients (1 month to 24 months of age) who were undergoing surgery requiring general anesthesia, a single intravenous dose of </ao:prefix>
    <domeo:uuid>7BE2C8F5-F7F5-4EA5-8A63-74744B527237</domeo:uuid>
    <ao:exact>ondansetron</ao:exact>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:suffix>, 0.1 or 0.2 mg/kg, was administered prior to surgery. As shown in </ao:suffix>
    <pav:createdOn>2015-06-24 14:55:22 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5C5FEB42-CB4C-43D4-AA70-1744475D7D12">
    <domeo:uuid>5C5FEB42-CB4C-43D4-AA70-1744475D7D12</domeo:uuid>
    <ao:exact>Apomorphine</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5C5FEB42-CB4C-43D4-AA70-1744475D7D12"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:suffix>      Based on reports of profo</ao:suffix>
    <pav:createdOn>2015-06-24 14:44:51 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>   7.2 </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:55F8CEE3-B65B-4554-A674-FA9C98EAA3FC">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:29:56 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:03930415-4E35-4388-9115-172DE3D97ED4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D1BB31CA-FDCD-4DCB-90C3-3E5E6C9CFB85">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:33:38 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:350EE9E4-4411-4E2A-AA8E-CEB5C46D5088"/>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DE308562-87E4-4226-981C-B0A1540E340F">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:35:23 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:6B1FEF5E-56BF-4EF8-B66A-E506C74F57DF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:16FDB844-0908-4D9D-9647-601A4C547C45">
    <sio:SIO_000338>poc:TestResult</sio:SIO_000338>
    <poc:TestResult>http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#gene-haplotype-positive</poc:TestResult>
    <rdfs:label>gene-haplotype-positive</rdfs:label>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
    <dct:description>A test result that is somehow related to the biomarker.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E51B8030-30B8-4D0E-81C6-06ED2DB88A82">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-26 14:52:05 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-26 14:46:27 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:1D0B64D0-8634-4062-8229-4E9274E2CD53"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:F685A44D-7B8D-45DF-872D-6285BF538DC3</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:37CBA84D-2E84-40DE-81D4-3D69143B4E24">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-18 15:52:22 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>7.1 Drugs Metabolized by CYP450\nRabeprazole is metabolized by the cytochrome P450 (CYP450) drug metabolizing enzyme system. Studies in healthy subjects have shown that rabeprazole does not have clinically significant interactions with other drugs metabolized by the CYP450 system, such as warfarin and theophylline given as single oral doses, diazepam as a single intravenous dose, and phenytoin given as a single intravenous dose (with supplemental oral dosing). Steady state interactions of rabeprazole and other drugs metabolized by this enzyme system have not been studied in patients</ao:exact>
    <ao:prefix>   </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:37CBA84D-2E84-40DE-81D4-3D69143B4E24"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B6032D11-CD5A-4065-89D5-7180CA4B12CD">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 14:01:48 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:EB82BD1C-02C8-40B6-B140-530A078C78F5"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/90DCD95F-3E59-4340-8C27-DD75DD24089E">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>esomeprazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9EA27DBC-5210-464D-A02B-CEA5DABB9772">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9EA27DBC-5210-464D-A02B-CEA5DABB9772"/>
    <ao:suffix>and Atracurium      Ondansetron does not alte</ao:suffix>
    <domeo:uuid>9EA27DBC-5210-464D-A02B-CEA5DABB9772</domeo:uuid>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Alfentanil </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 14:51:13 -0400</pav:createdOn>
    <ao:prefix>   7.8 </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:24A8491C-58D3-465E-9751-C3866F42BE74">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:4A99DB56-883A-47D0-84F3-25016B32EB4A"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EC13AE2D-F2E9-4943-A374-C51EC1463038">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/037A67AC-284D-4F9D-8FF8-C97F5F12BC7F"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/65F6B9BE-71BA-4E9B-8D7A-C5546E665CDB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:42FE9E48-9583-43ED-BA73-BFF3FE8CC8CA">
    <domeo:uuid></domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2015-06-19 11:54:44 -0400</pav:createdOn>
    <ao:prefix>plasma concentrations and thereby reduce its therapeutic effect.  </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Omeprazole has been reported to interact with some antiretroviral drugs. The clinical importance and the mechanisms behind these interactions are not always known. Increased gastric pH during omeprazole treatment may change the absorption of the antiretroviral drug. Other possible interaction mechanisms are via CYP2C19. For some antiretroviral drugs, such as atazanavir and nelfinavir, decreased serum levels have been reported when given together with omeprazole. Following multiple doses of nelfinavir (1250 mg, twice daily) and omeprazole (40 mg daily), AUC was decreased by 36% and 92%, Cmax by 37% and 89% and Cmin by 39% and 75%, respectively, for nelfinavir and M8. Following multiple doses of atazanavir (400 mg daily) and omeprazole (40 mg daily, 2 hr before atazanavir), AUC was decreased by 94%, Cmax by 96%, and Cmin by 95%. Concomitant administration with omeprazole and drugs such as atazanavir and nelfinavir is therefore not recommended. For other antiretroviral drugs, such as saquinavir, elevated serum levels have been reported with an increase in AUC by 82%, in Cmax by 75% and in Cmin by 106% following multiple dosing of saquinavir/ritonavir (1,000 mg/100 mg) twice daily for 15 days with omeprazole 40 mg daily coadministered days 11 to 15. Dose reduction of saquinavir should be considered from the safety perspective for individual patients. There are also some antiretroviral drugs of which unchanged serum levels have been reported when given with omeprazole.</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:42FE9E48-9583-43ED-BA73-BFF3FE8CC8CA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B26CD913-F144-4BFF-8967-7F740FF37133">
    <rdfs:label>SPL Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:357321A7-5793-4DE5-BB38-BF5FA7A5D72C</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:97020E1A-6E28-45D5-A4DA-64A1B59C3BF9"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E9F13BFE-1A17-4FDF-99A7-13B89F697635</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoclient:uuid:8803D2BD-5758-4131-9F54-9AEAC91645F8</pav:previousVersion>
    <pav:lastSavedOn>2014-02-19 12:35:49 -0500</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">2</pav:versionNumber>
    <pav:createdOn>2014-02-19 12:35:40 -0500</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:58921AB8-8C62-43FC-904F-53953B30F2BD">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:29:07 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:8D37CF1F-26B9-43DB-9341-086783C35A25"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:63491321-018F-40B5-86B2-D94CC4DD44EE">
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:91924412-8016-42BC-AFD4-AE1D60A1EDD1"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 14:54:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:72ECF928-359A-46C4-BB2F-2A43129326FF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:3318F312-0989-4238-ADDF-0ACDE57D79BD"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdOn>2015-06-24 14:02:02 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4421F6B6-683E-4D48-ADB1-4230ACF03ADB">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:25CCB293-E889-4D0F-9905-15F8664832E3"/>
    <dikbD2R:comment>45% decrease in clearance</dikbD2R:comment>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:72AED27D-3AC6-4665-8190-9DF45F455F74">
    <pav:createdOn>2015-06-19 10:53:45 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>In vitro and in vivo studies have shown that esomeprazole is not likely to inhibit CYPs 1A2, 2A6, 2C9, 2D6, 2E1 and 3A4. No clinically relevant interactions with drugs metabolized by these CYP enzymes would be expected. Drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin, warfarin, quinidine, clarithromycin or amoxicillin. Postmarketing reports of changes in prothrombin measures have been received among patients on concomitant warfarin and esomeprazole therapy. Increases in INR and prothrombin time may lead to abnormal bleeding and even death. Patients treated with proton pump inhibitors and warfarin concomitantly may need to be monitored for increases in INR and prothrombin time</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <ao:prefix>is extensively metabolized in the liver by CYP2C19 and CYP3A4.   </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:72AED27D-3AC6-4665-8190-9DF45F455F74"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DFED9A23-523F-47EA-B795-5F98D263A8DF">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:6730B3E8-D331-46F1-AC0F-3DDF52BD3845</pav:lineageUri>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
    <rdfs:label>ddi Annotation</rdfs:label>
    <ao:body rdf:nodeID="N397076bf771a487eb931b4759df53da7"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:37CBA84D-2E84-40DE-81D4-3D69143B4E24"/>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:createdOn>2015-06-18 15:52:22 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2e12f51bd0b742bcacffb9f19469d3e3">
    <domeo:sets rdf:resource="urn:pddi:uuid:DA42911B-9367-4F51-AA87-CCB8B383A13F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6C4459A9-4287-4821-9260-E2A70BF5144B">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:34:47 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:110D9085-4AF7-4F68-9690-FC966420203C"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/34BE0F6E-ECD8-4595-8188-CAE7687ABC12">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>Ondansetron</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:16CFA610-71CA-474C-9ED3-4B66021509DF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Antimycobacterials:  rifabutin </ao:prefix>
    <ao:exact>rifampin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:16CFA610-71CA-474C-9ED3-4B66021509DF"/>
    <pav:createdOn>2015-06-24 13:30:22 -0400</pav:createdOn>
    <ao:suffix>‡  rifapentine       ↓ ledipas</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:52DBAE18-F40A-4F85-B837-DF62214B31C1">
    <ao:prefix>had no effect on the pharmacokinetics and pharmacodynamics of </ao:prefix>
    <ao:suffix>. </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:52DBAE18-F40A-4F85-B837-DF62214B31C1"/>
    <pav:createdOn>2015-06-24 14:51:12 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <domeo:uuid>52DBAE18-F40A-4F85-B837-DF62214B31C1</domeo:uuid>
    <ao:exact>temazepam</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:55784FE3-4246-4640-895D-3282AAE4E905">
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:33:15 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:842BEDF4-89A6-4BDC-9ECF-4B8F06EF0857"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB2229EB-B9A4-426C-96DE-60BFE4F14AD6">
    <ao:exact>HARVONI</ao:exact>
    <ao:suffix> may result in serious symptomatic bradycardia. The mechanism of this effect is unknown. Coadministration of amiodarone with HARVONI is not recommended; if coadministration is required, cardiac monitoring is recommended </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:29:39 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>with </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EB2229EB-B9A4-426C-96DE-60BFE4F14AD6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:83EA7D09-5E60-4EAE-BD46-C7BAA2F2ED7B">
    <ao:suffix>at 4-hour intervals, patients older than 15 years of age exhibited ondansetron pharmacokinetic parameters similar to those of adults. </ao:suffix>
    <ao:exact>ondansetron </ao:exact>
    <ao:prefix> In a study of 21 pediatric cancer patients (4 to 18 years of age) who received three intravenous doses of 0.15 mg/kg of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:83EA7D09-5E60-4EAE-BD46-C7BAA2F2ED7B"/>
    <domeo:uuid>83EA7D09-5E60-4EAE-BD46-C7BAA2F2ED7B</domeo:uuid>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <pav:createdOn>2015-06-24 14:55:33 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CBED5ECA-89ED-41E1-A01B-549EE271FD96">
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2015-06-24 14:45:25 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:F3C8FCA9-6823-425D-857B-1E02D798093C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:153034D2-E6F5-42BB-8FFF-4B317A29CCA0">
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:E16B7AA7-1DBB-401F-AC62-85A925E7A982"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:33:52 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E65BD6D2-D214-4C43-A64B-77F16B0A7D01">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>Carbamazepine , and Rifampin    </ao:prefix>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:exact>In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 14:57:44 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>E65BD6D2-D214-4C43-A64B-77F16B0A7D01</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E65BD6D2-D214-4C43-A64B-77F16B0A7D01"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:67FA2B78-8F02-4259-B96A-39AB67CEE1CD">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>tenofovir </ao:exact>
    <ao:suffix> concentrations in the setting of HARVONI and a HIV protease inhibitor/ritonavir has not been established.</ao:suffix>
    <ao:prefix>The safety of increased </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:67FA2B78-8F02-4259-B96A-39AB67CEE1CD"/>
    <pav:createdOn>2015-06-24 13:32:35 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F478CD2C-6BBA-465F-9947-A371C80B4218">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-group"/>
    <rdfs:label>selective serotonin reuptake inhibitors (SSRIs)</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6D981CCF-6090-44C8-997F-12B29F43906F">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6D981CCF-6090-44C8-997F-12B29F43906F"/>
    <domeo:uuid>6D981CCF-6090-44C8-997F-12B29F43906F</domeo:uuid>
    <ao:suffix>does not alter the respiratory depressant effects produced by alfentanil or the degree of neuromuscular blockade produced by atracurium. Interactions with general or local anesthetics have not been studied. </ao:suffix>
    <pav:createdOn>2015-06-24 14:51:15 -0400</pav:createdOn>
    <ao:prefix> </ao:prefix>
    <ao:exact>Ondansetron </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:862083C5-A4AA-4901-B48C-17566539AACA">
    <pav:createdOn>2015-06-24 14:55:07 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:49C82874-AEA7-4B90-A6CE-3C994049A0A3"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:360E2C81-7800-4E2C-9719-E9AE317B4450">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:228D2C67-AEF2-45E3-AD9D-6CAEA24FD4A0"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 13:30:38 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FBE7772F-72AA-4A63-9326-802E5A02C137">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:42:49 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:B84BA1A0-F1CB-4E17-A5BB-11BFB9A5551F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1CEE84E7-EE74-47C6-A2FB-414E306D92F4">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1CEE84E7-EE74-47C6-A2FB-414E306D92F4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>St. John’s wort</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>, an inducer of CYP3A4. In a cross-over study in 12 healthy male subjects, St John’s wort (300 mg three times daily for 14 days) significantly decreased the systemic exposure of </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <pav:createdOn>2015-06-19 11:04:15 -0400</pav:createdOn>
    <ao:prefix> is an enantiomer, has been reported to interact with </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/2285BD92-3B23-4FE5-8938-8019F6DC68FB">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>rabeprazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:c8323af4-0712-4f01-b016-b900d5763a0a">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> at baseline. The other 2  patients had baseline H.  pylori</ao:suffix>
    <pav:createdOn>2015-06-12 16:57:58 -0400</pav:createdOn>
    <ao:prefix> to </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>amoxicillin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:c8323af4-0712-4f01-b016-b900d5763a0a"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9277D06A-A729-4CEB-BF63-CFD9BAD12ACC">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:28:46 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:b8f2cc8a-d0ef-4f41-b982-9f169e468ba8</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:286B60B9-65FD-463C-AE85-68A498160D42"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 13:28:47 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:12A9CD3E-42F3-422A-8C8E-7F5F8FA9E4ED">
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 15:02:21 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 15:01:48 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:lineageUri>urn:domeoserver:annotation:34B3C81B-25D0-46F3-9908-1FC0F748EA7E</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:0F1D1060-98DF-4840-B7DB-AB4C63A9F1A9"/>
    <rdfs:label>ddi Annotation</rdfs:label>
    <ao:body rdf:nodeID="N31882d61fc0d44d499622d4548f6c5a5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5DDF6D10-A992-43D4-B1C2-B010E34F248F">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix> (</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-02-19 12:41:37 -0500</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/Clopidogrel-1086a7b4-b89b-4bee-8120-5f752626c046.html</ao:hasSource>
    <ao:exact>CYP2C19 inhibitors (e.g., omeprazole): Avoid concomitant use.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5DDF6D10-A992-43D4-B1C2-B010E34F248F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>5DDF6D10-A992-43D4-B1C2-B010E34F248F</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:26804EFE-5B88-4704-900D-F68434907A22">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:679D73F6-155D-4BEC-AD0A-7BC483D07223"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:49C82874-AEA7-4B90-A6CE-3C994049A0A3">
    <ao:exact>ondansetron </ao:exact>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:49C82874-AEA7-4B90-A6CE-3C994049A0A3"/>
    <ao:suffix>every 4 hours for 3 doses would be expected to achieve a systemic exposure (AUC) consistent with the exposure achieved in previous pediatric studies in cancer patients (4 to 18 years of age) at similar doses. </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>49C82874-AEA7-4B90-A6CE-3C994049A0A3</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 14:55:07 -0400</pav:createdOn>
    <ao:prefix> Based on the population pharmacokinetic analysis, cancer patients 6 to 48 months of age who receive a dose of 0.15 mg/kg of intravenous </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE71CE30-E236-45B1-93D1-02C027095AB9">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FE71CE30-E236-45B1-93D1-02C027095AB9"/>
    <ao:prefix> is expected to decrease the concentration of ledipasvir and </ao:prefix>
    <pav:createdOn>2015-06-24 13:31:32 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix>, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sofosbuvir</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:398200FE-FFD1-4612-A307-9920E6117728">
    <pav:createdOn>2015-06-18 16:01:04 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:552F773B-DBC7-4402-B706-13A887A45DFD</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:EC715926-FDC1-4250-8100-CB32DAA261A2"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D01BFFD2-4A08-4388-A548-51F665C77BAB">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdOn>2015-06-24 14:02:04 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:EC45F1DF-BA10-4E22-A1C2-164C3F6FA654"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5B26F4D0-1B51-4F1D-AA58-5347E37B448A">
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:33:14 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:9564C183-6165-4F38-B011-E09C63DA2E7E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B5F1AF2F-264E-4FD5-87DF-6A0D282D56DD">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:EC13AE2D-F2E9-4943-A374-C51EC1463038"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9F46DCE0-64D3-483D-A2AC-AC3D2F87C34E">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>rabeprazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1E4BFD4B-5E4C-4F29-B6E9-6D0736D12537">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>digoxin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:276F7993-E726-4D0F-910D-8E3FA0149DB8">
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 14:02:05 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:38A283CF-09C1-459B-8D77-5299CE7884AB"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8606EDAE-0D8A-4F24-A833-57F889B0C46C">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:FA9ED8FC-E4D6-4D36-A1BF-43F4F761F805"/>
    <pav:createdOn>2015-06-24 13:31:37 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21B8A27F-A390-498D-AA5E-16882B919D12">
    <ao:exact>HARVONI </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:21B8A27F-A390-498D-AA5E-16882B919D12"/>
    <pav:createdOn>2015-06-24 13:30:33 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix> with rifabutin or rifapentine is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <ao:prefix>Coadministration of </ao:prefix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:876859AD-C7C7-49EB-9C33-302237E827B8">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-19 11:00:45 -0400</pav:createdOn>
    <ao:prefix> and AUC of one of its active metabolites,</ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <ao:exact> 3,4-dihydro-cilostazol</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:876859AD-C7C7-49EB-9C33-302237E827B8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9978323E-6250-41F4-A8A5-53444DDEFFDC">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:6A6BA103-5110-46CD-9B53-DD183FB0D543"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D1131B8C-9A11-4A5D-82E0-CA2618A30815">
    <ao:exact>GS-331007 </ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>was 55%, 88%, and 451% higher, respectively. In subjects with ESRD, relative to subjects with normal renal function, sofosbuvir  and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D1131B8C-9A11-4A5D-82E0-CA2618A30815"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix> AUC</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:42:42 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2B92BC1A-A5E4-428D-8761-C3F03DE9884F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 14:03:19 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:8DD5D6B2-A585-46B9-8938-7C3EAE574C1E"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:449383ED-07B9-477F-9444-6629432FE9F6">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sofosbuvir</ao:exact>
    <pav:createdOn>2015-06-24 14:01:37 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:449383ED-07B9-477F-9444-6629432FE9F6"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>600 single dose  ND  400 single dose  19  </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:132F2712-A4FF-4342-8E9F-780474C8B7B1">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:29:45 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:48FCA91B-3EAD-4029-A1C9-B2768BA5CD0E"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:291F6D7C-ABE8-491B-B67D-2AFCF06AAE5B">
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:30:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:7B455C2D-9CAA-48C4-9FA8-3B263BE5013F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:24FA0132-8CE7-4641-87A0-338B6EDEA58C">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdOn>2015-06-24 14:01:27 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:3C5298FD-B107-4B4C-BAC1-F1D59FA3F69C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:40978775-9652-4684-9A51-66A2E6B91DA9">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 13:29:24 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:BED7A75E-0B44-4F8C-B125-BC24681388F7"/>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A51198BF-BEDE-4B2B-8C62-25AB9952B609">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:29:50 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:574E142D-73B4-493A-B29F-6747FC8C1C94"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7D17F70D-6306-4DB0-A068-76281697AE12">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:31:32 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:FE71CE30-E236-45B1-93D1-02C027095AB9"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:43DA552C-84B0-4E1A-8B1A-94AC040776EF">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:36CA16EF-2271-4DD6-B9B5-03F91B9C64B1"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2015-06-18 16:01:01 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:306BC45C-521E-4719-B4D8-AA5AA854BBD5</pav:lineageUri>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C4550821-95EA-4220-9F6C-17EA10026452">
    <ao:exact>GS-331007</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix>        1.06 (0.97, 1.14)     </ao:suffix>
    <ao:prefix>(0.88, 1.50)  1.11 (1.00, 1.24)  NA    </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C4550821-95EA-4220-9F6C-17EA10026452"/>
    <pav:createdOn>2015-06-24 14:02:29 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FAB6C7B6-2CBF-4A78-9445-47CAE66AF9F4">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 14:44:53 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:865E5694-3D5A-4824-9C5D-CAF4FA88FC9E"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:328D816D-0675-422A-B70A-ABD4886386EE">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:41:06 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:DD42BEDC-AF3C-440D-9432-F84B068335B9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E69B96D6-3155-4D15-B187-4125EB54FF53">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:exact>phenytoin</ao:exact>
    <domeo:uuid>E69B96D6-3155-4D15-B187-4125EB54FF53</domeo:uuid>
    <ao:prefix> In patients treated with potent inducers of CYP3A4 (i.e., </ao:prefix>
    <pav:createdOn>2015-06-24 14:45:01 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, carbamazepine, and rifampin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on the</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E69B96D6-3155-4D15-B187-4125EB54FF53"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7B91D004-098F-4694-A45D-5FF96E095014">
    <ao:prefix>Antimycobacterials:  rifabutin rifampin ‡   </ao:prefix>
    <pav:createdOn>2015-06-24 13:30:21 -0400</pav:createdOn>
    <ao:exact>rifapentine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7B91D004-098F-4694-A45D-5FF96E095014"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1EFDE2A9-1CB1-4108-8A44-F8BDB1E408D2">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>(0.61, 1.30)  0.96 (0.66, 1.39)  NA    </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1EFDE2A9-1CB1-4108-8A44-F8BDB1E408D2"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 14:02:50 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sofosbuvir</ao:exact>
    <ao:suffix>        1.12 (0.88, 1.42)     </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AB4D4B49-F805-4F28-9A50-106803553A96">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:F09C6543-E7FD-4ACA-8D29-2DEBF6B87C0D"/>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2015-06-24 13:29:54 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2C06E1A4-BE82-418D-9222-0CC8C48C2B8F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix>        0.73(0.65, 0.83)      </ao:suffix>
    <ao:prefix>(0.68, 1.33)  1.30 (1.00, 1.69)  NA    </ao:prefix>
    <pav:createdOn>2015-06-24 14:02:44 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>GS-331007</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2C06E1A4-BE82-418D-9222-0CC8C48C2B8F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:421F78EB-FB4D-475B-818E-4D14E8E205D6">
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <pav:createdOn>2015-06-19 10:53:30 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <ao:body rdf:nodeID="Na0b61b3337e74e67bc811e9d9babc295"/>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:7109E30A-AFD9-4F6E-9F03-147408458FA5"/>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:lastSavedOn>2015-06-19 10:55:03 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoclient:uuid:7e333e71-de31-4d19-9e13-65096f431517</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:861d7355-bd05-4520-a9bc-7cbebbde07d6</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nfbec3fe47bd545b5b4f03832c8257517">
    <domeo:sets rdf:resource="urn:pddi:uuid:20613D2E-4479-4E63-9CF4-13340FDAAFA7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D98C450A-3F5C-4BA5-B5CC-67EE9AAB44E5">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7EAE164B-1420-4BB1-A42C-654776CE394B"/>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/33F7F627-DA10-4C65-A133-59CC402FB66B">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>rabeprazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:254CD313-2561-4B27-A846-A69362660545">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:6DCE9DA8-029F-4DC9-B028-FAC63C916DEB"/>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 14:02:56 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:66913E9E-0DF8-49CE-A39A-7690572C8F8B">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:28:03 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:7086E081-1D09-4FDB-8FF1-5E5EB3110488"/>
    <pav:lastSavedOn>2015-06-24 13:28:47 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:b8f2cc8a-d0ef-4f41-b982-9f169e468ba8</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:066CD9D3-41FE-4ED8-B075-86420D766482">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/34BE0F6E-ECD8-4595-8188-CAE7687ABC12"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/35EAB02B-C746-4C61-926F-DF758E04038E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A2067AB5-ED8F-4CDA-8AAD-1EB9B6BF9D03">
    <pav:createdOn>2015-06-24 14:45:16 -0400</pav:createdOn>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:prefix>may result in reduced analgesic activity of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>A2067AB5-ED8F-4CDA-8AAD-1EB9B6BF9D03</domeo:uuid>
    <ao:exact>tramadol</ao:exact>
    <ao:suffix>. Patients on concomitant ondansetron self administered tramadol more frequently in these studies, leading to an increased cumulative dose in patient controlled administration (PCA) of tramadol. </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A2067AB5-ED8F-4CDA-8AAD-1EB9B6BF9D03"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8067DDF0-007F-40E9-8EF8-B0E19A0DD6B0">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:59B1E035-6A8C-4BF9-8F1D-2742EFDDA4FA"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdOn>2015-06-24 14:02:46 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C3B2A21D-018D-4862-BAEA-4F4598B163C5">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 14:01:39 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:844425B4-210F-4F94-96EC-2C9EDC2D5EF8"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/747FB15F-0E72-4257-9624-4B06694CEBDB">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>rabeprazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:91924412-8016-42BC-AFD4-AE1D60A1EDD1">
    <ao:exact>ondansetron </ao:exact>
    <domeo:uuid>91924412-8016-42BC-AFD4-AE1D60A1EDD1</domeo:uuid>
    <ao:prefix>every 4 hours for 3 doses during a safety and efficacy trial. These data were combined with sequential pharmacokinetics data from 41 surgery patients 1 month to 24 months of age, who received a single dose of 0.1 mg/kg of intravenous </ao:prefix>
    <ao:suffix>prior to surgery with general anesthesia, and a population pharmacokinetic analysis was performed on the combined data set. The results of this analysis are included in </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:91924412-8016-42BC-AFD4-AE1D60A1EDD1"/>
    <pav:createdOn>2015-06-24 14:54:35 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E487941B-7ED0-472F-B3BC-5364DC4E761E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>simeprevir</ao:exact>
    <ao:prefix>CV Products :  simeprevir ‡  ↑ ledipasvir ↑ </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E487941B-7ED0-472F-B3BC-5364DC4E761E"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2015-06-24 13:34:34 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3F21DF91-01B3-4304-8826-FA9B9746E104">
    <domeo:uuid>3F21DF91-01B3-4304-8826-FA9B9746E104</domeo:uuid>
    <ao:exact>ondansetron </ao:exact>
    <pav:createdOn>2015-06-24 14:54:01 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3F21DF91-01B3-4304-8826-FA9B9746E104"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> In vitro metabolism studies have shown that </ao:prefix>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:suffix>is a substrate for multiple human hepatic cytochrome P-450 enzymes, including CYP1A2, CYP2D6, and CYP3A4. In terms of overall ondansetron turnover, CYP3A4 plays a predominant role while formation of the major in vivo metabolites is apparently mediated by</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6DCAA33E-68AA-494D-96A8-08D4E60008F9">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:29:12 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:297B7B7F-B4EA-477C-9EEB-5361C7BAB04D"/>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:67387524-F14E-4388-8F57-ED887FDD8F90">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:67387524-F14E-4388-8F57-ED887FDD8F90"/>
    <ao:prefix>syndrome (including altered mental status, autonomic instability, and neuromuscular symptoms) has been described following the concomitant use of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>5-HT3 receptor antagonists</ao:exact>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <pav:createdOn>2015-06-24 14:45:36 -0400</pav:createdOn>
    <ao:suffix> and other </ao:suffix>
    <domeo:uuid>67387524-F14E-4388-8F57-ED887FDD8F90</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4D88B7A4-4442-4FEB-B336-A2F9D1C3E536">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> has not been established. Coadministration is not recommended.</ao:suffix>
    <ao:prefix> and </ao:prefix>
    <pav:createdOn>2015-06-24 13:33:34 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4D88B7A4-4442-4FEB-B336-A2F9D1C3E536"/>
    <ao:exact>tenofovir DF </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:61EADC2F-22F5-4BA6-B4A0-D09436ADA0BE">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2015-06-24 14:01:33 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:1C9AD6B6-A47F-4C79-9345-2A0246940089"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4D8CA78F-BEE5-4E1F-81B4-B77210EBE5C0">
    <ao:exact>simeprevir</ao:exact>
    <ao:suffix> is coadministered with ledipasvir. Coadministration of HARVONI with simeprevir is not recommended.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4D8CA78F-BEE5-4E1F-81B4-B77210EBE5C0"/>
    <pav:createdOn>2015-06-24 13:34:50 -0400</pav:createdOn>
    <ao:prefix> are increased when </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7E4ED115-6EE5-4897-A3A3-220E1AF94609">
    <ao:context rdf:resource="urn:domeoclient:uuid:D7EE8318-ED9C-4ED7-9F37-C173E6FECBC0"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 13:33:46 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0DE7A0DD-98FF-4992-880B-5633FB61CECC">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0DE7A0DD-98FF-4992-880B-5633FB61CECC"/>
    <domeo:uuid>0DE7A0DD-98FF-4992-880B-5633FB61CECC</domeo:uuid>
    <ao:prefix>   7.3 </ao:prefix>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Phenytoin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, Carbamazepine, and Rifampin      In patients treated with </ao:suffix>
    <pav:createdOn>2015-06-24 14:44:58 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0459C974-E74C-4CCB-897C-AB878755E3BC">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>ondansetron</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2269999d380440b28c98a943133622d2">
    <permissions:accessType>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:77FFD867-74BC-4F12-B8CB-7F7F3B36D02C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> </ao:prefix>
    <ao:exact>7.3 Cyclosporine\nIn vitro incubations employing human liver microsomes indicated that rabeprazole inhibited cyclosporine metabolism with an IC50 of 62 micromolar, a concentration that is over 50 times higher than the Cmax in healthy volunteers following 14 days of dosing with 20 mg of rabeprazole. This degree of inhibition is similar to that by omeprazole at equivalent concentrations.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:77FFD867-74BC-4F12-B8CB-7F7F3B36D02C"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-26 14:04:04 -0400</pav:createdOn>
    <domeo:uuid>77FFD867-74BC-4F12-B8CB-7F7F3B36D02C</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F6C68992-2159-4247-A9EA-1E43912A4BDE">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:72C61C7F-6C03-476B-98FE-E82B9C59A121"/>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:createdOn>2015-06-24 14:54:04 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7903C81D-5A98-4BDB-9DCF-0DB798FF5898">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Co-administration of PPIs in healthy subjects and in transplant patients receiving MMF has been reported to reduce the exposure to the active metabolite, mycophenolic acid (MPA), possibly due to a decrease in MMF solubility at an increased gastric pH. The clinical relevance of reduced MPA exposure on organ rejection has not been established in transplant patients receiving PPIs and MMF. Use ACIPHEX with caution in transplant patients receiving MMF.</ao:exact>
    <pav:createdOn>2015-06-26 14:12:15 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>plasma concentrations and thereby reduce its therapeutic effect.  </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>7903C81D-5A98-4BDB-9DCF-0DB798FF5898</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7903C81D-5A98-4BDB-9DCF-0DB798FF5898"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:898A4586-1608-4536-A415-FCF1D19C9F5C">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdOn>2015-06-24 14:03:26 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:57B82720-EBC0-42F5-B9CD-4816839A1915"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5BC79418-F91B-4E6B-8CEA-A6DDDA54890B">
    <pav:createdOn>2015-06-24 13:31:43 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:56695EC5-8D30-41BF-9938-08A084E9F788"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DC11B470-143A-4770-8C76-995B4962D19D">
    <ao:context rdf:resource="urn:domeoclient:uuid:D52FD7E6-44AA-4A62-BA9D-0EB7A8972D4C"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:lastSavedOn>2015-06-24 15:02:21 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N4ab0dff5ec51472995ea68a1fb2be3e6"/>
    <pav:lineageUri>urn:domeoserver:annotation:66915531-C6F9-4CE8-B0D5-F19AC06FA718</pav:lineageUri>
    <pav:createdOn>2015-06-24 15:01:32 -0400</pav:createdOn>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E16B7AA7-1DBB-401F-AC62-85A925E7A982">
    <ao:exact>HARVONI</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E16B7AA7-1DBB-401F-AC62-85A925E7A982"/>
    <ao:prefix> is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:33:52 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>. Coadministration is not recommended.</ao:suffix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:087D3D4C-B1B5-4AE5-B7E4-EA2272CFC096">
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">6</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:EC837692-C376-409C-9797-06D056AF0AC8</pav:previousVersion>
    <pav:lastSavedOn>2015-06-26 14:52:05 -0400</pav:lastSavedOn>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:createdOn>2015-06-19 11:00:25 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <dikbD2R:assertionType>increase-auc</dikbD2R:assertionType>
    <ao:context rdf:resource="urn:domeoclient:uuid:171282B3-7DE2-4824-B4DC-F62DC8D1DB32"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <ao:body rdf:nodeID="Naa7bd7b6c51b46ec838c907984286ffd"/>
    <pav:lineageUri>urn:domeoserver:annotationset:861d7355-bd05-4520-a9bc-7cbebbde07d6</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:488967DC-0C5B-48AA-96B2-305C27A92FA9">
    <domeo:uuid>488967DC-0C5B-48AA-96B2-305C27A92FA9</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-26 14:04:49 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>7.4 Compounds Dependent on Gastric pH for Absorption\nDue to its effects on gastric acid secretion, rabeprazole can reduce the absorption of drugs where gastric pH is an important determinant of their bioavailability. Like with other drugs that decrease the intragastric acidity, the absorption of drugs such as ketoconazole, atazanavir, iron salts, erlotinib, and mycophenolate mofetil (MMF) can decrease, while the absorption of drugs such as digoxin can increase during treatment with ACIPHEX</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:488967DC-0C5B-48AA-96B2-305C27A92FA9"/>
    <ao:prefix>   </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2E24D915-78B5-473F-BEDE-3B121D1096F3">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:BE0CD96E-FFB2-47FD-A0A8-B67A897320B6</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N30de5a9469fb49feb850732c755f9cd3"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:lastSavedOn>2015-06-24 15:02:21 -0400</pav:lastSavedOn>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <ao:context rdf:resource="urn:domeoclient:uuid:9D860AAC-6FE8-446B-B6E5-1DA9F863E2CE"/>
    <pav:createdOn>2015-06-24 15:00:25 -0400</pav:createdOn>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0B411E49-EB80-4ACD-9312-987A1CFD6EA0">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ritonavir</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0B411E49-EB80-4ACD-9312-987A1CFD6EA0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>emtricitabine / tenofovir DF ‡   darunavir /</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:32:21 -0400</pav:createdOn>
    <ao:suffix> + emtricitabine/tenofovir DF</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3CC5D1D9-F156-4D38-B107-48C8F269AEBE">
    <pav:createdOn>2015-06-24 14:44:46 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:28A29972-6C19-4F85-8076-AB4A68312A66"/>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CDE2F1A4-BC4C-4325-A9D0-F4A22851876B">
    <pav:lineageUri>urn:domeoserver:annotation:74E6C226-A7BE-4587-94F4-D5E53D84C0F9</pav:lineageUri>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N9d77b047ca53458f95625f0a0662a865"/>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:createdOn>2015-06-18 15:51:49 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:6153AE25-D14E-4946-94AD-27E5BC1246D0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9A72589E-592B-448F-8E6C-D19E12F65B00">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:E583813B-AE66-4A9C-8F8C-E6C434EB1F49"/>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:createdOn>2015-06-24 14:45:38 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/236D73FE-AC4C-4AA3-A50F-E1CCB676F197">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3322</dailymed:activeMoietyRxCUI>
    <rdfs:label>diazepam</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/328A9BFC-C9D1-4F27-A323-9988E3DE16D0">
    <rdfs:label>rofecoxib</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9F705C01-1A2E-45D6-BDB7-8FF75AD686E9">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>9F705C01-1A2E-45D6-BDB7-8FF75AD686E9</domeo:uuid>
    <ao:prefix>plasma concentrations and thereby reduce its therapeutic effect.  </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9F705C01-1A2E-45D6-BDB7-8FF75AD686E9"/>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <pav:createdOn>2015-06-26 14:48:27 -0400</pav:createdOn>
    <ao:exact>Omeprazole has been reported to interact with some antiretroviral drugs. The clinical importance and the mechanisms behind these interactions are not always known. Increased gastric pH during omeprazole treatment may change the absorption of the antiretroviral drug. Other possible interaction mechanisms are via CYP2C19. For some antiretroviral drugs, such as atazanavir and nelfinavir, decreased serum levels have been reported when given together with omeprazole. Following multiple doses of nelfinavir (1250 mg, twice daily) and omeprazole (40 mg daily), AUC was decreased by 36% and 92%, Cmax by 37% and 89% and Cmin by 39% and 75%, respectively, for nelfinavir and M8. Following multiple doses of atazanavir (400 mg daily) and omeprazole (40 mg daily, 2 hr before atazanavir), AUC was decreased by 94%, Cmax by 96%, and Cmin by 95%. Concomitant administration with omeprazole and drugs such as atazanavir and nelfinavir is therefore not recommended. For other antiretroviral drugs, such as saquinavir, elevated serum levels have been reported with an increase in AUC by 82%, in Cmax by 75% and in Cmin by 106% following multiple dosing of saquinavir/ritonavir (1,000 mg/100 mg) twice daily for 15 days with omeprazole 40 mg daily coadministered days 11 to 15. Dose reduction of saquinavir should be considered from the safety perspective for individual patients. There are also some antiretroviral drugs of which unchanged serum levels have been reported when given with omeprazole.</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:89E76100-C580-46F2-8779-FE3F00E8420C">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:7D9647BB-86DC-4B59-A6A2-5A3CF0BF05E6"/>
    <pav:createdOn>2015-06-24 14:02:37 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A7CB0F46-CABC-45A4-A9BE-26AF180B654F">
    <ao:prefix>Population pharmacokinetics analysis in HCV-infected subjects indicated that gender had no clinically relevant effect on the exposure of sofosbuvir  and </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>. AUC and C</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>GS-331007</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A7CB0F46-CABC-45A4-A9BE-26AF180B654F"/>
    <pav:createdOn>2015-06-24 13:48:18 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B0AF1CF2-C4AD-4ADB-B6B9-3948C3AC55ED">
    <domeo:uuid></domeo:uuid>
    <ao:exact>HARVONI</ao:exact>
    <ao:prefix> with food or without food. </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B0AF1CF2-C4AD-4ADB-B6B9-3948C3AC55ED"/>
    <pav:createdOn>2015-06-24 13:41:11 -0400</pav:createdOn>
    <ao:suffix> can be administered without regard to food.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D0F03E37-C848-4BC2-BF36-5753658B7A0F">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>clopidogrel</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32968</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1D895A9D-D7BD-448B-AF09-DC567CFCCF12">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:createdOn>2015-06-24 14:54:13 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:2E54069D-11F2-4A58-8DA3-C4E926572AC1"/>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/3D872C1C-75C7-42F6-99B8-A84DFD312013">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>Omeprazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7646</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dikbD2R:dose>Unk</dikbD2R:dose>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:23F9047B-9114-4927-8995-5A762616FD2A">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:62A81291-0969-4502-82CE-26840084303D"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdOn>2015-06-24 14:05:28 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DEC633A4-9532-4B17-B849-118DCD1C19D0">
    <ao:exact>HARVONI </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DEC633A4-9532-4B17-B849-118DCD1C19D0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> with St. John's wort, a P-gp inducer is not recommended </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:35:09 -0400</pav:createdOn>
    <ao:prefix>Coadministration of </ao:prefix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0104F79C-E976-4414-ABA3-4E5849840F3B">
    <pav:lastSavedOn>2015-06-26 14:10:58 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:D645D2F4-4D34-4A9F-B51F-F0E2A0F9826D</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:2284e984-435c-475d-8023-97355b70469b</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:B60B4D20-6D08-4BFF-A854-44D21AE1B689"/>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-18 15:55:36 -0400</pav:createdOn>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <ao:body rdf:nodeID="Nbb54013c0dec4f8cb020b0e61188aa22"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F899E8A3-98A6-438A-AFD4-9A8B21F4B3B7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>        0.66 (0.59, 0.75)     </ao:suffix>
    <ao:prefix>90 once daily  400 once daily  14  </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 14:01:49 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:exact>ledipasvir</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F899E8A3-98A6-438A-AFD4-9A8B21F4B3B7"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4FEF78F0-0C15-4B14-8FCE-6063371126AB">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4FEF78F0-0C15-4B14-8FCE-6063371126AB"/>
    <ao:exact>etoposide</ao:exact>
    <pav:createdOn>2015-06-24 14:51:04 -0400</pav:createdOn>
    <ao:suffix>, and cisplatin do not affect the pharmacokinetics of ondansetron. </ao:suffix>
    <ao:prefix>, </ao:prefix>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>4FEF78F0-0C15-4B14-8FCE-6063371126AB</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:49AFD22C-676B-48FD-9510-4BA5F6241FA1">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 13:42:22 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:236C9CAF-ECF0-46BA-81D0-4A5464159BEA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2E54069D-11F2-4A58-8DA3-C4E926572AC1">
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <pav:createdOn>2015-06-24 14:54:13 -0400</pav:createdOn>
    <domeo:uuid>2E54069D-11F2-4A58-8DA3-C4E926572AC1</domeo:uuid>
    <ao:suffix>elimination half-life was 4.0 hours, and there was no difference in the multidose pharmacokinetics over a 4-day period. In a dose proportionality study, systemic exposure to 32 mg of ondansetron was not proportional to dose as measured by comparing dose-</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ondansetron </ao:exact>
    <ao:prefix> In adult cancer patients, the mean </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2E54069D-11F2-4A58-8DA3-C4E926572AC1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:52D6831A-BF03-4645-8325-C4B67C5D0EBB">
    <ao:context rdf:resource="urn:domeoclient:uuid:1A8354E6-E47A-41FD-9A2C-5A0499783979"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2015-06-24 14:51:53 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/9D31BFDE-0644-4862-B478-EB4FCA7A2C83">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3008</dailymed:activeMoietyRxCUI>
    <rdfs:label>cyclosporine</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dikbD2R:dose>Unk</dikbD2R:dose>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:65869B99-385F-4379-91BF-4CC94D40E478">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:65869B99-385F-4379-91BF-4CC94D40E478"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>carbamazepine</ao:exact>
    <pav:createdOn>2015-06-24 14:45:01 -0400</pav:createdOn>
    <domeo:uuid>65869B99-385F-4379-91BF-4CC94D40E478</domeo:uuid>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:suffix>, and rifampin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs </ao:suffix>
    <ao:prefix>, </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:537E3F2F-9582-45CC-92C6-98726D02A4BC">
    <pav:createdOn>2015-06-24 14:51:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ondansetron </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>has no effect on plasma prolactin concentrations. In a gender-balanced pharmacodynamic study (n = 56), </ao:prefix>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <domeo:uuid>537E3F2F-9582-45CC-92C6-98726D02A4BC</domeo:uuid>
    <ao:suffix>4 mg administered intravenously or intramuscularly was dynamically similar in the prevention of nausea and vomiting using the ipecacuanha model of emesis. </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:537E3F2F-9582-45CC-92C6-98726D02A4BC"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E66ECD58-5893-4E7B-A359-CEDE3E62DF19">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>clopidogrel</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32968</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9693508D-9149-4E3B-8D12-4117BC7AE8CB">
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:327B329E-217E-4D89-A240-CB9D1600CFA6"/>
    <pav:createdOn>2015-06-24 14:51:04 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6153AE25-D14E-4946-94AD-27E5BC1246D0">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>   </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-18 15:51:49 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>7.1 Drugs Metabolized by CYP450\nRabeprazole is metabolized by the cytochrome P450 (CYP450) drug metabolizing enzyme system. Studies in healthy subjects have shown that rabeprazole does not have clinically significant interactions with other drugs metabolized by the CYP450 system, such as warfarin and theophylline given as single oral doses, diazepam as a single intravenous dose, and phenytoin given as a single intravenous dose (with supplemental oral dosing). Steady state interactions of rabeprazole and other drugs metabolized by this enzyme system have not been studied in patients.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6153AE25-D14E-4946-94AD-27E5BC1246D0"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D6ACE5D3-F7A0-445F-978A-8B43E1955827">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Studies evaluating concomitant administration of esomeprazole and either naproxen (non-selective NSAID) or rofecoxib (COX-2 selective NSAID) did not identify any clinically relevant changes in the pharmacokinetic profiles of esomeprazole or these NSAIDs.</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2015-06-19 11:56:50 -0400</pav:createdOn>
    <ao:prefix>should be considered from the safety perspective for individual patients. There are also some antiretroviral drugs of which unchanged serum levels have been reported when given with omeprazole .  </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D6ACE5D3-F7A0-445F-978A-8B43E1955827"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CAD8820F-09D9-4185-BBBE-FD44AD97DDEA">
    <ao:suffix>may be coadministered with P-gp and/or BCRP inhibitors. Neither </ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:prefix> plasma concentration; </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CAD8820F-09D9-4185-BBBE-FD44AD97DDEA"/>
    <pav:createdOn>2015-06-24 14:04:09 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>HARVONI </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EC45F1DF-BA10-4E22-A1C2-164C3F6FA654">
    <ao:suffix>        1.33 (1.22, 1.44)     </ao:suffix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EC45F1DF-BA10-4E22-A1C2-164C3F6FA654"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 14:02:04 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>GS-331007</ao:exact>
    <ao:prefix>(1.14, 1.56)  1.36 (1.21, 1.52)  NA    </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4295AC72-AD3A-49A8-92CF-26D7CB1F8CCD">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4295AC72-AD3A-49A8-92CF-26D7CB1F8CCD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> is not recommended.</ao:suffix>
    <ao:exact>rosuvastatin</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:35:30 -0400</pav:createdOn>
    <ao:prefix>which is associated with increased risk of myopathy, including rhabdomyolysis. Coadministration of HARVONI with </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5138346F-A55F-4B2A-A312-64E0EED62520">
    <pav:createdOn>2015-06-24 14:00:47 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:03DC413E-C1B2-4446-A628-D54A0E14FEF4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8F3F06D9-6619-4593-92A6-3C4ED3DEC76B">
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2015-06-24 14:05:51 -0400</pav:createdOn>
    <ao:suffix> 0.180/0.215/0.25/ethinyl estradiol 0.025 once daily</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8F3F06D9-6619-4593-92A6-3C4ED3DEC76B"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>norgestimate </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:296A68C0-31B7-4AE3-825A-55E6B5A44A72">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:87720AF2-FAB3-4F5A-8DD9-455898EF2F42"/>
    <pav:createdOn>2015-06-24 13:41:50 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B26C0B2C-46CB-4C3A-BF6A-3EBFDA216EE3">
    <ao:context rdf:resource="urn:domeoclient:uuid:1EECDDE4-94BD-40E7-922B-371C11D945F1"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdOn>2015-06-24 14:03:44 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9AA3C838-7784-4CDA-9081-08778679640E">
    <ao:prefix>lopinavir / ritonavir + emtricitabine /</ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:exact>tenofovir DF</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 13:32:33 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9AA3C838-7784-4CDA-9081-08778679640E"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N397076bf771a487eb931b4759df53da7">
    <domeo:sets rdf:resource="urn:pddi:uuid:F0D670FF-56BA-40ED-BD33-8DBCED1DE0E3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F3C80B6B-71B9-4E44-A582-11971B499E17">
    <ao:prefix>is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.    </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F3C80B6B-71B9-4E44-A582-11971B499E17"/>
    <ao:exact>HCV Products</ao:exact>
    <pav:createdOn>2015-06-24 13:34:08 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5BF3F3B5-5CDB-4F05-9DAF-D0D4DB92861B">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5BF3F3B5-5CDB-4F05-9DAF-D0D4DB92861B"/>
    <pav:createdOn>2015-06-24 13:29:38 -0400</pav:createdOn>
    <ao:suffix> with HARVONI may result in serious symptomatic bradycardia. The mechanism of this effect is unknown. Coadministration of amiodarone with HARVONI is not recommended; if coadministration is required, cardiac monitoring is recommended </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>Coadministration of </ao:prefix>
    <ao:exact>amiodarone </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6E6D9A63-949B-4CD4-A63A-45C7041484A6">
    <domeo:uuid>6E6D9A63-949B-4CD4-A63A-45C7041484A6</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <ao:prefix>see Pharmacokinetics (12.3) ].  </ao:prefix>
    <ao:exact>Omeprazole acts as an inhibitor of CYP2C19. Omeprazole, given in doses of 40 mg daily for one week to 20 healthy subjects in cross-over study, increased Cmax and AUC of cilostazol by 18% and 26%, respectively. Cmax and AUC of one of its active metabolites, 3,4-dihydro-cilostazol, which has 4 to 7 times the activity of cilostazol, were increased by 29% and 69%, respectively. Coadministration of cilostazol with esomeprazole is expected to increase concentrations of cilostazol and its above mentioned active metabolite. Therefore, a dose reduction of cilostazol from 100 mg twice daily to 50 mg twice daily should be considered</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2015-06-26 14:44:24 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6E6D9A63-949B-4CD4-A63A-45C7041484A6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:852B2EEE-512F-4027-A62E-2A81E29AAE3D">
    <pav:createdOn>2015-06-24 14:57:58 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>852B2EEE-512F-4027-A62E-2A81E29AAE3D</domeo:uuid>
    <ao:exact>In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:852B2EEE-512F-4027-A62E-2A81E29AAE3D"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:prefix>Carbamazepine , and Rifampin    </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:977DD211-40C5-4893-B901-2C439A221015">
    <domeo:uuid>977DD211-40C5-4893-B901-2C439A221015</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>esomeprazole or these NSAIDs .  </ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-26 14:50:30 -0400</pav:createdOn>
    <ao:exact>Esomeprazole inhibits gastric acid secretion. Therefore, esomeprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability. Like with other drugs that decrease the intragastric acidity, the absorption of drugs such as ketoconazole, atazanavir, iron salts, and erlotinib can decrease, while the absorption of drugs such as digoxin can increase during treatment with esomeprazole. Concomitant treatment with omeprazole (20 mg daily) and digoxin in healthy subjects increased the bioavailability of digoxin by 10% (30% in two subjects). Esomeprazole is an enantiomer of omeprazole. Coadministration of digoxin with esomeprazole is expected to increase the systemic exposure of digoxin. Therefore, patients may need to be monitored when digoxin is taken concomitantly with esomeprazole</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:977DD211-40C5-4893-B901-2C439A221015"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:633CA52C-A1B8-4DA1-936D-70D2F0106564">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-02-19 12:37:38 -0500</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:8A890B84-DFB5-4F1E-AA94-2BFCA03E6EF0</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2014-02-19 12:41:40 -0500</pav:lastSavedOn>
    <rdfs:label>SPL Annotation</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:E9F13BFE-1A17-4FDF-99A7-13B89F697635</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:48174C77-8AA2-4177-A9C8-F0F6197B6446"/>
    <ao:body rdf:resource="urn:linkedspls:uuid:2DCBAB84-202D-41C3-B8EB-9CD9D668C3DF"/>
    <ao:body rdf:resource="urn:linkedspls:uuid:1135EFA3-67D9-4B8E-B010-CD51438236F7"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A28BABF2-B3F1-457B-BF34-0EC97508FA98">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:E60C5C49-AA40-4899-81E3-A1D2FBC43DFF"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:B0676079-FB86-4ED2-A396-A5DF848713B2</pav:lineageUri>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-18 16:00:52 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6F2E0904-8E5F-4BA2-9813-721AE400245B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>GS-331007</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>Hypericum perforatum )  ↓ ledipasvir ↓ sofosbuvir ↓ </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 13:35:07 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6F2E0904-8E5F-4BA2-9813-721AE400245B"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F4919C6E-FE07-4CAC-A01C-6A5DC2CDB77A">
    <ao:context rdf:resource="urn:domeoclient:uuid:537E3F2F-9582-45CC-92C6-98726D02A4BC"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 14:51:59 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E731AF4B-8676-4D97-AF10-EB79D94D351D">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 14:02:34 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:652D1F96-E16B-46A9-BBD0-FEE114478B79"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D8537446-0624-489A-96CD-0579E45720A7">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 14:03:09 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:9A8CD8A8-7A92-455C-81E9-02924A3D6EDC"/>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0CB4E5E7-F725-4D85-868C-79CF71B4DEA8">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>ondansetron</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:360ABF8B-DE34-48F9-9214-477A4582C9DC">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:6D981CCF-6090-44C8-997F-12B29F43906F"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2015-06-24 14:51:15 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:527C0121-16D7-400E-B847-FFAC78B04935">
    <pav:lastSavedOn>2015-06-26 14:10:58 -0400</pav:lastSavedOn>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <dikbD2R:assertionType>increase-auc</dikbD2R:assertionType>
    <ao:body rdf:nodeID="Nae898502a0894d49b32a4ea3fd95d8a6"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:D645D2F4-4D34-4A9F-B51F-F0E2A0F9826D</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:AE545A8F-061B-4405-8427-ECD67DA5C602"/>
    <pav:lineageUri>urn:domeoserver:annotationset:2284e984-435c-475d-8023-97355b70469b</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:createdOn>2015-06-18 15:59:37 -0400</pav:createdOn>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DFC99041-B832-4FA7-A9CB-57505F6A3A1B">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 14:51:03 -0400</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:C719FE82-62AF-4A7F-B984-74920BB2BAA3"/>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:52F31ADE-9DD3-471A-AF38-89E722BB13BE">
    <ao:prefix>(0.90, 1.05)  1.24 (1.18, 1.30)  NA    </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:52F31ADE-9DD3-471A-AF38-89E722BB13BE"/>
    <ao:exact>Efavirenz</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 14:03:36 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>/ </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:79FD9C3E-88FE-4C78-BE5B-AD12C9639E1E">
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:5FFE2D87-0403-4804-BD39-8E6495C11B91"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 14:51:24 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9564C183-6165-4F38-B011-E09C63DA2E7E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>VIREAD</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:suffix> or TRUVADA prescribing information for recommendations on renal monitoring.</ao:suffix>
    <ao:prefix>-associated adverse reactions. Refer to </ao:prefix>
    <pav:createdOn>2015-06-24 13:33:14 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9564C183-6165-4F38-B011-E09C63DA2E7E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:08D97455-3C15-4FFB-95D9-78ACEFCD76C1">
    <ao:exact>rifampin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:08D97455-3C15-4FFB-95D9-78ACEFCD76C1"/>
    <ao:prefix>Ledipasvir and sofosbuvir are substrates of drug transporters P-gp and BCRP while GS-331007 is not. P-gp inducers (e.g., </ao:prefix>
    <pav:createdOn>2015-06-24 13:57:37 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> or St. John's wort) may decrease ledipasvir and sofosbuvir plasma concentrations, leading to reduced therapeutic effect of HARVONI, and the use with P-gp inducers is not recommended with HARVONI </ao:suffix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E5DB0308-F107-462B-81BC-DE5F19729DF5">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>rifapentine  ↓ ledipasvir ↓ sofosbuvir ↓ </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>GS-331007</ao:exact>
    <pav:createdOn>2015-06-24 13:30:31 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E5DB0308-F107-462B-81BC-DE5F19729DF5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3BB005FD-87C8-46E4-AF8C-25F6F76F9A00">
    <ao:suffix> with carbamazepine, phenytoin, phenobarbital, or oxcarbazepine is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>Coadministration of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3BB005FD-87C8-46E4-AF8C-25F6F76F9A00"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 13:30:11 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>HARVONI </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:394336AA-03A7-4380-9E12-67719DDAF4EA">
    <ao:body rdf:nodeID="N61aee1e0c3f04be5a27e597a895e1dc0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:createdOn>2015-06-19 11:57:05 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:861d7355-bd05-4520-a9bc-7cbebbde07d6</pav:lineageUri>
    <pav:lastSavedOn>2015-06-26 14:52:05 -0400</pav:lastSavedOn>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <ao:context rdf:resource="urn:domeoclient:uuid:FBB1FBAB-106B-49F3-BB29-88CAFB31D769"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:7309B8E4-6AF7-4EB4-8538-D405A11D8CD4</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>ddi Annotation</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DB642261-196B-4EBB-978D-BB2920D2E8B3">
    <ao:prefix>, concomitant use of </ao:prefix>
    <domeo:uuid>DB642261-196B-4EBB-978D-BB2920D2E8B3</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DB642261-196B-4EBB-978D-BB2920D2E8B3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:exact>apomorphine </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>with ondansetron is contraindicated </ao:suffix>
    <pav:createdOn>2015-06-24 14:44:56 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:574E142D-73B4-493A-B29F-6747FC8C1C94">
    <ao:exact>HARVONI </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> with digoxin may increase the concentration of digoxin. Therapeutic concentration monitoring of digoxin is recommended when coadministered with HARVONI.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>Coadministration of </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:29:50 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:574E142D-73B4-493A-B29F-6747FC8C1C94"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AF574CF3-6DB6-42A1-B426-582036AB23D3">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>HARVONI</ao:exact>
    <ao:prefix>, any interactions that have been identified with these agents individually may occur with HARVONI .  After oral administration of </ao:prefix>
    <ao:suffix>, </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:28:06 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AF574CF3-6DB6-42A1-B426-582036AB23D3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C207EF3B-85CF-42E7-8A7C-58F0E6A11DC8">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:BFAC1FB6-3FF4-4227-B759-92D5B86F82B1"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C53F4ED6-1A3D-4FEB-A32F-3F85DD710897">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>       ↑ rosuvastatin        C</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:35:19 -0400</pav:createdOn>
    <ao:exact>rosuvastatin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>HMG-CoA Reductase Inhibitors :  </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C53F4ED6-1A3D-4FEB-A32F-3F85DD710897"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F4321EE8-ACB3-46D1-AA21-E9DABC675E50">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2015-06-18 16:00:09 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:65A07B92-959A-466A-8D2C-1FB013BBEC44</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:96E13409-55AE-494A-88E1-6AB7B799BB69"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:43FAF245-8F3A-4BEB-A48C-377BB060E183">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sofosbuvir</ao:exact>
    <ao:prefix>(1.29, 1.51)    ND  400 single dose  18  </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 14:01:46 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:43FAF245-8F3A-4BEB-A48C-377BB060E183"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C39D166C-7605-45CE-912C-C831CA3D0D1B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2015-06-24 13:30:26 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:B90DC881-F0CB-4888-A60A-935ADE5609DD"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8573FC78-CE49-4C4A-9B2A-ED62F9279AAA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-18 16:04:11 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:E270A93B-A228-44D8-98DD-415E4A6D1405"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:6D2961B9-9917-42B4-A184-2EF91AC11297</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:19D106F6-2C8F-4467-AB6E-C9707F5147AC">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:A83C5216-E399-4F2F-ACF0-CDAD74981ADE"/>
    <pav:createdOn>2015-06-24 14:03:28 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9CD19067-7F3D-4499-8B67-9459D04ACFBD">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/22460253-6B38-4836-9B75-A5D0884CC9B9"/>
    <dikbD2R:numOfParticipants>Unk</dikbD2R:numOfParticipants>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9D31BFDE-0644-4862-B478-EB4FCA7A2C83"/>
    <dikbD2R:auc>Unk</dikbD2R:auc>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BC515F1F-2E1D-4905-AF8F-69465C44F3A8">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 14:03:01 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:CBE4B8F7-5F5E-4F09-847A-693C228BD236"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:48FA3E8B-B0D1-422E-954E-23990194A1A0">
    <ao:context rdf:resource="urn:domeoclient:uuid:E6197088-A79F-4571-B7CB-60F5FE717210"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:29:31 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F35A08B5-4C26-4012-B4DA-DA9BF994C2F7">
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:createdOn>2015-06-18 16:04:09 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:9DA4CBC7-6D03-4058-9B6D-89C9962FDDF0</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:DED9357D-A5DF-4F91-BC4F-FF44361FD1A6"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5AA27CFC-7040-496C-9F00-98667F4A2C18">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:6B63E92B-7EA8-4B19-8131-60E2FA794335</pav:lineageUri>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-18 16:00:58 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:004EC39E-8FB9-4046-9FB2-F59DE19FE12D"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0742663E-EC80-4267-AB12-D53243023255">
    <ao:prefix>(0.98, 1.11)  1.56 (1.42, 1.71)    </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0742663E-EC80-4267-AB12-D53243023255"/>
    <pav:createdOn>2015-06-24 14:05:38 -0400</pav:createdOn>
    <ao:exact>Elvitegravir</ao:exact>
    <ao:suffix>/ cobicistat</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A8977D20-5445-4FBC-B099-8E9A69117CAC">
    <ao:context rdf:resource="urn:domeoclient:uuid:1EB2A765-DE4F-4598-B61C-42358B32C268"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:31:56 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9BE9EA5A-DD39-4E54-AC29-2869AE954DDA">
    <ao:exact>ondansetron </ao:exact>
    <ao:suffix>in vivo metabolism is relatively minor. </ao:suffix>
    <domeo:uuid>9BE9EA5A-DD39-4E54-AC29-2869AE954DDA</domeo:uuid>
    <pav:createdOn>2015-06-24 14:54:06 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9BE9EA5A-DD39-4E54-AC29-2869AE954DDA"/>
    <ao:prefix>turnover, CYP3A4 plays a predominant role while formation of the major in vivo metabolites is apparently mediated by CYP1A2. The role of CYP2D6 in </ao:prefix>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DA42911B-9367-4F51-AA87-CCB8B383A13F">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:8CB47DFC-2DAE-40EA-8112-FE93B3D8E4E7"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:78311B59-EEDC-4B8C-924C-A722E8EB1F7E">
    <ao:exact>MMF </ao:exact>
    <pav:createdOn>2015-06-18 16:01:00 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:78311B59-EEDC-4B8C-924C-A722E8EB1F7E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>solubility at an increased gastric pH. The clinical relevance of reduced MPA exposure on organ rejection has not been established in transplant patients receiving PPIs and MMF. Use </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>, possibly due to a decrease in </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A5548B6A-953A-4EC7-85E8-F376D2AA9E78">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>serotonin and noradrenaline reuptake inhibitors (SNRIs)</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-group"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8EBE2B3C-4283-4C3A-9494-4CFD773885DE">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:EF1B5DB4-0BC9-426D-8E23-3D5A36EB5E86"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:30:28 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:61119CD0-5DFD-4743-8BA2-379DAED4B42E">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0459C974-E74C-4CCB-897C-AB878755E3BC"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DC6441A0-656A-4189-AF90-704C18989D5D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5CCB173C-1015-412A-8DF4-427B72CBD1FE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:43EAE9AD-E5D9-4929-A88B-FD6EFBB155D7"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 14:02:52 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7268B6C0-4F0B-49F7-BC4F-C7C7D5A332F2">
    <ao:prefix>800/100 once daily  90 once daily  ND  23  </ao:prefix>
    <pav:createdOn>2015-06-24 14:01:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>ledipasvir</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7268B6C0-4F0B-49F7-BC4F-C7C7D5A332F2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76EEA2CA-8D8D-41E5-A0D1-7DFA980ACE2D">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 14:04:09 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:CAD8820F-09D9-4185-BBBE-FD44AD97DDEA"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6CC2628A-116D-40B3-A220-5B0669FE8058">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:FCFF4854-36D6-46AA-B637-5C0211E1AFD6"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2015-06-24 14:45:43 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2B1C1004-DA2D-415A-AE15-37A6F60A0614">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>St. John's wort  ( Hypericum perforatum )  ↓ </ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:35:04 -0400</pav:createdOn>
    <ao:exact>ledipasvir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2B1C1004-DA2D-415A-AE15-37A6F60A0614"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:98507E4C-CA05-433D-B45E-C807E12C205F">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:98507E4C-CA05-433D-B45E-C807E12C205F"/>
    <ao:suffix> </ao:suffix>
    <pav:createdOn>2015-06-24 13:30:03 -0400</pav:createdOn>
    <ao:prefix>Anticonvulsants :  carbamazepine  phenytoin  </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>phenobarbital</ao:exact>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D4C6944D-2B65-47FC-A9A5-FFC53D3C0D3B">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:23D15EB5-40FE-4A88-B11A-3005C07F44C0"/>
    <dikbD2R:comment>AUC decreased, not increased</dikbD2R:comment>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B517A36E-A608-474F-A8E4-8B920D5D0F96">
    <ao:prefix>It is recommended to separate </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> and HARVONI administration by 4 hours.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:29:03 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>antacid</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B517A36E-A608-474F-A8E4-8B920D5D0F96"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DC6441A0-656A-4189-AF90-704C18989D5D">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6851</dailymed:activeMoietyRxCUI>
    <rdfs:label>methotrexate</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D83BA006-6847-4773-AF79-65DC01F2DCDB">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D83BA006-6847-4773-AF79-65DC01F2DCDB"/>
    <pav:createdOn>2015-06-24 13:41:38 -0400</pav:createdOn>
    <ao:prefix> is extensively metabolized in the liver to form the pharmacologically active nucleoside analog triphosphate </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix>. The metabolic activation pathway involves sequential hydrolysis of the carboxyl ester moiety catalyzed by human cathepsin A (CatA) or carboxylesterase 1 (CES1) and phosphoramidate cleavage by </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>GS-461203</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3C5298FD-B107-4B4C-BAC1-F1D59FA3F69C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>        1.13(1.08, 1.19)      </ao:suffix>
    <pav:createdOn>2015-06-24 14:01:27 -0400</pav:createdOn>
    <ao:exact>GS-331007</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>(0.88, 1.05)  1.08 (1.02, 1.15)  NA    </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3C5298FD-B107-4B4C-BAC1-F1D59FA3F69C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:73DA8AFB-B49E-415B-A4A1-B0D98E62B5A7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:31:20 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:C49AEBD7-A870-45F6-8505-0A041646E11D"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EE4C46FB-BA4B-4B64-A98A-CC94C90D600B">
    <pav:lastSavedOn>2015-06-19 12:02:00 -0400</pav:lastSavedOn>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:createdOn>2015-06-19 11:58:25 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:7CB29656-6FA1-46DF-983D-BC80B1206E17</pav:lineageUri>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:body rdf:nodeID="N2c773e08fe7546c7aa2fbc30cc9a3a7a"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:485E578F-BE41-481D-BBC1-AAB903F02449"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:25CCB293-E889-4D0F-9905-15F8664832E3">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F5E517F5-6AFE-43B7-A1DF-4FBAFE854D5B"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E2510036-D006-4144-A348-C7E9407DE956"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D5AC2F3F-3D92-4F8D-80EC-9B2DD0C3B902">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>MMF</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C3D4BA7-4E14-4C58-8F3B-324B69D575DE">
    <ao:exact>Concomitant use of atazanavir and proton pump inhibitors is not recommended. Coadministration of atazanavir with proton pump inhibitors is expected to substantially decrease atazanavir plasma concentrations and thereby reduce its therapeutic effect.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>did not seem to change the pharmacokinetic profile of esomeprazole .  </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1C3D4BA7-4E14-4C58-8F3B-324B69D575DE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>1C3D4BA7-4E14-4C58-8F3B-324B69D575DE</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <pav:createdOn>2015-06-26 14:47:06 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/371E5ECF-93A3-4876-886A-9E45EAA51509">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>esomeprazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E2A068C-A8BD-4FF9-AEAB-B1A3F1E56AEE">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> </ao:prefix>
    <pav:createdOn>2015-06-18 16:05:14 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>7.8 Clopidogrel\nConcomitant administration of rabeprazole and clopidogrel in healthy subjects had no clinically meaningful effect on exposure to the active metabolite of clopidogrel [see Clinical Pharmacology (12.3)]. No dose adjustment of clopidogrel is necessary when administered with an approved dose of ACIPHEX.</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4E2A068C-A8BD-4FF9-AEAB-B1A3F1E56AEE"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EC9F9772-617D-4868-8EE5-981BCCF92C0B">
    <ao:context rdf:resource="urn:domeoclient:uuid:0A70190C-DBEB-4A2B-87D8-7B5B7678460B"/>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 14:04:07 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A70E203A-CE36-4AEA-AF8A-60C1DC7BE942">
    <dikbD2R:auc>82%</dikbD2R:auc>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7C5FEE2C-A530-4224-9CD0-DAEBA0ABA98E"/>
    <dikbD2R:numOfParticipants>Unk</dikbD2R:numOfParticipants>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/00753894-8D97-4D2D-9F99-6FD1E55626B0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7C5FEE2C-A530-4224-9CD0-DAEBA0ABA98E">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/83395</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dikbD2R:dose>1</dikbD2R:dose>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>saquinavir</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C719FE82-62AF-4A7F-B984-74920BB2BAA3">
    <domeo:uuid>C719FE82-62AF-4A7F-B984-74920BB2BAA3</domeo:uuid>
    <ao:suffix>, etoposide, and cisplatin do not affect the pharmacokinetics of ondansetron. </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <pav:createdOn>2015-06-24 14:51:03 -0400</pav:createdOn>
    <ao:exact>carmustine</ao:exact>
    <ao:prefix> In humans, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C719FE82-62AF-4A7F-B984-74920BB2BAA3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BAB3BDD1-716C-46B3-BC7E-A177DB6D8F6C">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:b8f2cc8a-d0ef-4f41-b982-9f169e468ba8</pav:previousVersion>
    <pav:createdOn>2015-06-24 13:28:40 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:28:47 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:AB5FCEF5-653A-41F7-9D37-1D1D5FEE4915"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8141D30A-E77B-4E2A-9686-B3EC33620E7B">
    <pav:createdOn>2015-06-24 13:33:45 -0400</pav:createdOn>
    <ao:prefix>with </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8141D30A-E77B-4E2A-9686-B3EC33620E7B"/>
    <ao:suffix>/ritonavir is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>tipranavir</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ABA8BD5F-96FA-4E99-9D0A-55D1AF49196C">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ABA8BD5F-96FA-4E99-9D0A-55D1AF49196C"/>
    <ao:prefix>HIV Antiretrovirals :    efavirenz , </ao:prefix>
    <pav:createdOn>2015-06-24 13:31:39 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix>, </ao:suffix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>emtricitabine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F504E5D4-4551-411C-9E0F-6F72E9A95933">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix> solubility decreases as pH increases. Drugs that increase gastric pH are expected to decrease concentration of ledipasvir.</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F504E5D4-4551-411C-9E0F-6F72E9A95933"/>
    <ao:exact>Ledipasvir</ao:exact>
    <pav:createdOn>2015-06-24 13:28:53 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/86651D12-A534-403C-9392-73B8DD0A7979">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>atazanavir</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/343047</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:04F40ACE-7040-494A-85FB-7A97935F68C4">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:33:34 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:4D88B7A4-4442-4FEB-B336-A2F9D1C3E536"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/DEC759BC-5FA0-46B2-A7E1-2F0C417EE7F2">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>ondansetron</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ABBEC517-E5C1-4888-A497-EB1B76018514">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>is not normally required for the recommended doses. However, in patients who may require higher doses, dose adjustment may be considered .  </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ABBEC517-E5C1-4888-A497-EB1B76018514"/>
    <domeo:uuid>ABBEC517-E5C1-4888-A497-EB1B76018514</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>Drugs known to induce CYP2C19 or CYP3A4 (such as rifampin) may lead to decreased esomeprazole serum levels. Omeprazole, of which esomeprazole is an enantiomer, has been reported to interact with St. John’s wort, an inducer of CYP3A4. In a cross-over study in 12 healthy male subjects, St John’s wort (300 mg three times daily for 14 days) significantly decreased the systemic exposure of omeprazole in CYP2C19 poor metabolizers (Cmax and AUC decreased by 37.5% and 37.9%, respectively) and extensive metabolizers (Cmax and AUC decreased by 49.6% and 43.9%, respectively). Avoid concomitant use of St. John’s Wort or rifampin with esomeprazole sodium. \n Coadministration of oral contraceptives, diazepam, phenytoin, or quinidine did not seem to change the pharmacokinetic profile of esomeprazole</ao:exact>
    <pav:createdOn>2015-06-26 14:45:28 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F7728C11-5BE6-4414-9375-258032F11909">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:D94A7A6E-CE26-4BCB-B569-712A62F13096"/>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:30:13 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A5852EA4-83DD-4E71-A965-3EC8623A84CE">
    <rdfs:label>rifampin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9384</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6F48D51C-42AA-44FC-8710-1CC751A82C55">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2015-06-24 13:35:30 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:4295AC72-AD3A-49A8-92CF-26D7CB1F8CCD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DA1C7292-40CB-4591-A038-11AC440913EF">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:2401D819-850F-400F-B6F5-DC895B0EDDED"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 14:02:25 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FFA150FB-9F96-4B31-891F-3974106B33C8">
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:D55C8880-190E-42D0-8546-27C63EC5BE1D"/>
    <pav:createdOn>2015-06-24 14:45:03 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D46F101B-4C98-4800-9880-79FDFE696471">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:31:09 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:59DDF7E4-44F8-4DFA-9E72-31B3FBC0E165"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D8F9EC0A-92FE-4D04-83D2-B6BC458830E1">
    <ao:body rdf:nodeID="N40a1b92c0b8b415fb87e36a0388951ca"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-26 14:10:58 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-18 15:56:19 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:2284e984-435c-475d-8023-97355b70469b</pav:lineageUri>
    <rdfs:label>ddi Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <pav:previousVersion>urn:domeoserver:annotationset:D645D2F4-4D34-4A9F-B51F-F0E2A0F9826D</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:2442E9F2-FA58-4294-984C-C5198DDEFBB2"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:18CB9938-6266-493E-A282-DB819CD3E51A">
    <domeo:belongsToSet>urn:domeoserver:annotationset:E9F13BFE-1A17-4FDF-99A7-13B89F697635</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/>
    <pav:lastSavedOn>2014-02-19 12:41:40 -0500</pav:lastSavedOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:E73D6B7D-A3A8-4817-A2C4-32DE510299C5"/>
    <ao:body rdf:resource="urn:linkedspls:uuid:80427841-8733-4D31-B75E-C7B5AC762B29"/>
    <rdfs:label>SPL Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:E28A51D7-37BE-4BCB-B3E3-5F03A528E03B</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:body rdf:resource="urn:linkedspls:uuid:CBC29E8F-3018-4FB3-9D06-66D1FC3641AB"/>
    <pav:createdOn>2014-02-19 12:38:23 -0500</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4320BBEC-6B55-4B9E-BCB8-E615576F99D3">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:878B20AD-EEB7-41E0-9875-74CA796015C4"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:47446137-0611-4F86-B7CA-8FB252835300">
    <domeo:uuid></domeo:uuid>
    <ao:prefix> and </ao:prefix>
    <ao:exact>GS-331007</ao:exact>
    <ao:suffix> are not inhibitors of drug transporters P-gp, BCRP, MRP2, BSEP, OATP1B1, OATP1B3, and OCT1, and GS-331007 is not an inhibitor of OAT1, OCT2, and MATE1.</ao:suffix>
    <pav:createdOn>2015-06-24 14:05:20 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:47446137-0611-4F86-B7CA-8FB252835300"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4AA0CA35-8312-45FC-83FD-9AAEE36DF2E5">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:30:18 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4AA0CA35-8312-45FC-83FD-9AAEE36DF2E5"/>
    <ao:suffix>. Coadministration is not recommended.</ao:suffix>
    <ao:exact>HARVONI</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>, leading to reduced therapeutic effect of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D88C186B-C28A-4695-A32D-74DDF023D1ED">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-19 12:01:02 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>is approximately 1.1 to 1.4 hours and is prolonged with increasing dose of intravenous esomeprazole .   </ao:prefix>
    <ao:exact>Concomitant Use with Clopidogrel \nResults from a crossover study in healthy subjects have shown a pharmacokinetic interaction between clopidogrel (300 mg loading dose/75 mg daily maintenance dose) and esomeprazole (40 mg p.o. once daily) when co-administered for 30 days. Exposure to the active metabolite of clopidogrel was reduced by 35% to 40% over this time period. Pharmacodynamic parameters were also measured and demonstrated that the change in inhibition of platelet aggregation was related to the change in the exposure to clopidogrel active metabolite</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D88C186B-C28A-4695-A32D-74DDF023D1ED"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:69E429CB-59F3-4584-B221-1B4D961B0075">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:5167B743-CB16-42C5-8D5A-B5DF4B34F33A"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 14:05:08 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DD42BEDC-AF3C-440D-9432-F84B068335B9">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:41:06 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DD42BEDC-AF3C-440D-9432-F84B068335B9"/>
    <ao:suffix> and </ao:suffix>
    <ao:prefix>by approximately 2-fold, but did not significantly affect sofosbuvir C max . The exposures of </ao:prefix>
    <ao:exact>GS-331007</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:838B50E6-EDCF-47E3-9187-AE8F1C8A6A3E">
    <ao:context rdf:resource="urn:domeoclient:uuid:DC281B20-559F-4546-9398-22CEB07AC412"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:b8f2cc8a-d0ef-4f41-b982-9f169e468ba8</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:28:04 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lastSavedOn>2015-06-24 13:28:47 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E33A20DC-279D-4DFF-BF26-43D80614D9D5">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 14:05:44 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:A5D03263-5B70-4D1E-B36D-EBEDBBF48CB4"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:923E24EB-91E8-424F-8A54-97D52B3754C8">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:D5636884-A50A-4610-A80B-786AC9F28E7A"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:32:43 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:320B5BA1-675E-41DD-97E9-41B3E57A54B7">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:81D5EC28-5A3A-49D6-83CE-AE3965A981FA"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdOn>2015-06-24 13:33:30 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/446A7DF7-86D2-4703-9911-6B970482C118">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>ketoconazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE605D80-CA16-4116-938D-D77262ABAEFB">
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:207C3A96-FB55-4167-AFF7-F9AB89948A15"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdOn>2015-06-24 13:32:30 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F456F601-9F57-457A-A860-C7F87C1C991A">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:FA14ACDB-7AE2-4FE0-83CF-762C340AF8F1"/>
    <pav:createdOn>2015-06-24 13:30:44 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E95AA727-C0C5-4FC4-BFD9-0E9952A7A862">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2015-06-24 13:32:10 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:71018C66-E9EE-4190-B182-AD0A3C834C07"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:7F46AEEA-D7F6-4F1F-A426-9F20EDEB76A3">
    <rdfs:label>Abacivir</rdfs:label>
    <dailymed:pharmgxDrug>http://fakeuri.org/Aripiprazole</dailymed:pharmgxDrug>
    <dct:description>The drug of interest.</dct:description>
    <sio:SIO_000628>dailymed:pharmgxDrug</sio:SIO_000628>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:03F76D6A-5714-49BA-9119-24799884A860">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:31:23 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:6F08DE9F-3541-4E03-8D30-0133E039919D"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E377260C-DF7B-4F2A-B579-C17581893FBE">
    <pav:createdOn>2015-06-24 13:31:26 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:D7DB3988-4246-4843-AB4F-A1B3DE9B586F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B7204F8D-CC5D-4BB8-992F-408384543314">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:4FEF78F0-0C15-4B14-8FCE-6063371126AB"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2015-06-24 14:51:04 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:676501EF-BB84-42F5-B053-0ADD1C44902B">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:2D52C44D-3A12-410B-AB64-5FBB527FFEF7"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:29:17 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ABBBB1E6-F3E6-415D-912F-310F984B5361">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>self administered tramadol more frequently in these studies, leading to an increased cumulative dose in patient controlled administration (PCA) of tramadol. </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>ABBBB1E6-F3E6-415D-912F-310F984B5361</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ABBBB1E6-F3E6-415D-912F-310F984B5361"/>
    <ao:prefix>. Patients on concomitant </ao:prefix>
    <ao:exact>ondansetron </ao:exact>
    <pav:createdOn>2015-06-24 14:45:18 -0400</pav:createdOn>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DF138C38-68F4-4445-A554-7A4AA8A625C8">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/008C8AF1-C81E-48A5-A569-1D3204C5E440"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/07A78060-72FF-4E1D-9B24-10A33CFDE12E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FF6B4FA3-376E-447C-B793-E2F0C1BDE4F9">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:31:39 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:ABA8BD5F-96FA-4E99-9D0A-55D1AF49196C"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FBD4780A-2CF1-4338-A5D2-BBD2641E11D1">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:33:22 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:A1ACC31E-A190-491A-A2E4-E08F4FBABBAC"/>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A83C5216-E399-4F2F-ACF0-CDAD74981ADE">
    <ao:suffix>/ cobicistat        150/150 once</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A83C5216-E399-4F2F-ACF0-CDAD74981ADE"/>
    <ao:prefix>(0.83, 0.97)  1.07 (1.02, 1.13)    </ao:prefix>
    <ao:exact>Elvitegravir</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 14:03:28 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:90DD7091-9FED-4616-BE31-6DF53BF54C6C">
    <domeo:uuid></domeo:uuid>
    <ao:prefix>(emtricitabine, rilpivirine, tenofovir DF).        </ao:prefix>
    <ao:suffix>/ ritonavir</ao:suffix>
    <ao:exact>Atazanavir</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 14:05:27 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:90DD7091-9FED-4616-BE31-6DF53BF54C6C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1E0246FC-6B80-4241-96CC-6BAA51732F3B">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix>    </ao:prefix>
    <ao:exact>7.6 Combined Administration with Clarithromycin\nCombined administration consisting of rabeprazole, amoxicillin, and clarithromycin resulted in increases in plasma concentrations of rabeprazole and 14-hydroxyclarithromycin [see Clinical Pharmacology (12.3)].</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <domeo:uuid>1E0246FC-6B80-4241-96CC-6BAA51732F3B</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-26 14:12:59 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1E0246FC-6B80-4241-96CC-6BAA51732F3B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:921BE2CF-21DB-4B19-AF5C-F7728291FB1D">
    <pav:createdOn>2015-06-24 14:01:46 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:43FAF245-8F3A-4BEB-A48C-377BB060E183"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BD03B2D0-4DE0-4E44-9EDC-2E2F30367528">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:CD8134A6-351A-48F5-975E-C21BBCA682D0</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <ao:body rdf:nodeID="N1ad4492e28ff43b69fda229d122263bd"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <pav:createdOn>2015-06-18 16:03:40 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:1E0246FC-6B80-4241-96CC-6BAA51732F3B"/>
    <pav:lastSavedOn>2015-06-26 14:32:43 -0400</pav:lastSavedOn>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2DDE57E8-8DE6-4ED1-ADB7-2F109930DB5D">
    <pav:lineageUri>urn:domeoserver:annotation:C50E7F1C-48E9-4F98-A9E5-68CC7E0BFB32</pav:lineageUri>
    <ao:body rdf:resource="urn:linkedspls:uuid:A0F0B55C-92C3-42AC-BA8B-D25B34B24813"/>
    <domeo:belongsToSet>urn:domeoclient:uuid:6B12D9AC-F09A-4157-8E26-ACDF40ECBB03</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SPLAnnotation"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2014-02-09 21:23:27 -0500</pav:createdOn>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>SPL Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:929BF940-1099-4796-BBA3-341FACCD0F42"/>
    <pav:lastSavedOn>2014-02-09 21:22:48 -0500</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1363F954-5CB9-477C-BB63-F09C52880379">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7646</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>Omeprazole</rdfs:label>
    <dikbD2R:dose>Unk</dikbD2R:dose>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7EAE164B-1420-4BB1-A42C-654776CE394B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A5548B6A-953A-4EC7-85E8-F376D2AA9E78"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/862732FE-CAB7-4B9E-9CC1-1C6CF978075D"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:51D54F2C-070A-48EC-8B35-B7B39ECC65A2">
    <ao:suffix> + emtricitabine/tenofovir DF</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:51D54F2C-070A-48EC-8B35-B7B39ECC65A2"/>
    <ao:exact>ritonavir</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>emtricitabine / tenofovir DF ‡   lopinavir /</ao:prefix>
    <pav:createdOn>2015-06-24 13:32:29 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:89E147C9-6A2A-417F-BDAC-0639C2DBEDB7">
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <ao:context rdf:resource="urn:domeoclient:uuid:115725FD-18A3-4BCE-A414-AA229DAA8A5E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:lastSavedOn>2015-06-19 11:13:42 -0400</pav:lastSavedOn>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:7D0E1CFA-52D6-4486-974F-4DD14F154871</pav:lineageUri>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:body rdf:nodeID="N97fde83a367f48f49826abd9686eaaad"/>
    <pav:createdOn>2015-06-19 11:06:02 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:60AD93C8-63BE-418E-A152-E7951F93A783">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2015-06-24 13:32:36 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:342424E7-8453-4746-BF8B-BD4F0051DE01"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EFD5A0D1-93E4-4554-A914-C1D52BCF6D28">
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:32:26 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:D257DA17-D0FB-4233-8104-FBACAC0A0C11"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A547A908-91EA-4679-AAC9-A0288F769F21">
    <rdfs:label>esomeprazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3F781073-CE54-47DB-9B1F-44AFDAF561D7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Temazepam</ao:exact>
    <domeo:uuid>3F781073-CE54-47DB-9B1F-44AFDAF561D7</domeo:uuid>
    <ao:prefix>   7.7 </ao:prefix>
    <ao:suffix>      The coadministration of o</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 14:51:09 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3F781073-CE54-47DB-9B1F-44AFDAF561D7"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:032F234F-9670-4104-81F1-5B1E0045E1AA">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E69C97F3-DD42-4274-BD9F-553DE3648279"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4AFA1DB8-57A9-46BF-9D4E-4AD1937D9C5F">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>iron salts</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/008C8AF1-C81E-48A5-A569-1D3204C5E440">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>temazepam</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:326F2A29-ECA8-43D2-B721-3C4922DF4737">
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:5BF3F3B5-5CDB-4F05-9DAF-D0D4DB92861B"/>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2015-06-24 13:29:38 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:72E8E163-BD77-48F7-9D93-24D38363FE15">
    <ao:context rdf:resource="urn:domeoclient:uuid:F504E5D4-4551-411C-9E0F-6F72E9A95933"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:28:53 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B2B5BB89-7E1A-42BF-893A-66324AE663FB">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/723</dailymed:activeMoietyRxCUI>
    <rdfs:label>amoxicillin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7B455C2D-9CAA-48C4-9FA8-3B263BE5013F">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7B455C2D-9CAA-48C4-9FA8-3B263BE5013F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>. Coadministration is not recommended.    Antimycobacterials:  </ao:prefix>
    <pav:createdOn>2015-06-24 13:30:23 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix> </ao:suffix>
    <ao:exact>rifabutin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B05F2AFE-2205-46C6-B50F-43438DD2CADF">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D5A21A1E-BF42-4ADF-B416-A80B7D1098CF"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B086BDA4-2393-42B8-B02A-2F49DBDA0C9B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E3A1E355-6379-422A-8750-D66F734250F8">
    <ao:prefix>solubility decreases as pH increases. Drugs that increase gastric pH are expected to decrease concentration of ledipasvir .    Antacids  (e.g., </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:suffix> and magnesium hydroxide)</ao:suffix>
    <pav:createdOn>2015-06-24 13:28:59 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>aluminum </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E3A1E355-6379-422A-8750-D66F734250F8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4C1C9387-A144-40A6-AAF4-5EA57C6A4415">
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:DE19F1A4-DC95-41BF-80DF-509DDD2F3305"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 14:51:39 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:110D9085-4AF7-4F68-9690-FC966420203C">
    <ao:prefix>Concentrations of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:110D9085-4AF7-4F68-9690-FC966420203C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 13:34:47 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:exact>ledipasvir</ao:exact>
    <ao:suffix> and simeprevir are increased when simeprevir is coadministered with ledipasvir. Coadministration of HARVONI with simeprevir is not recommended.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:97020E1A-6E28-45D5-A4DA-64A1B59C3BF9">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:97020E1A-6E28-45D5-A4DA-64A1B59C3BF9"/>
    <domeo:uuid>97020E1A-6E28-45D5-A4DA-64A1B59C3BF9</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>. (</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/Clopidogrel-1086a7b4-b89b-4bee-8120-5f752626c046.html</ao:hasSource>
    <ao:exact>Poor metabolizers treated with Plavix at recommended doses exhibit higher cardiovascular event rates following acute coronary syndrome (ACS) or percutaneous coronary intervention (PCI) than patients with normal CYP2C19 function</ao:exact>
    <pav:createdOn>2014-02-19 12:35:40 -0500</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CF2D9502-6AD5-470B-B888-7C219EC8E56D">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:F2138CBF-3156-4994-9973-B0FE596799DD"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:29:46 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CFCDFC28-C534-49F2-A00F-6757FD6C75CB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:2812183B-C211-4A2F-8C39-913F6559C7AE"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 14:01:42 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:5663414D-5202-44A3-8C33-DBBFB72B34C5">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2E9B5294-578E-49DB-9868-9FF3A8F509B0"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:35A346FE-E487-4516-B765-6DD3E191493E">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:30:22 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:16CFA610-71CA-474C-9ED3-4B66021509DF"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2503CDD0-CA5D-4DA5-9861-E84209E700CC">
    <ao:context rdf:resource="urn:domeoclient:uuid:25A68AA5-98AC-4A23-B7C6-DEB28A57DD21"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 14:05:40 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8ED694C0-1E0F-4D71-873D-D442F08A0001">
    <pav:createdOn>2015-06-24 14:45:06 -0400</pav:createdOn>
    <ao:suffix>blood concentrations were decreased. However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>8ED694C0-1E0F-4D71-873D-D442F08A0001</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8ED694C0-1E0F-4D71-873D-D442F08A0001"/>
    <ao:prefix>was significantly increased and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ondansetron </ao:exact>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6635F1E6-97B3-4DBF-B7C3-E9909DA710D3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:33:07 -0400</pav:createdOn>
    <ao:suffix> or antiretroviral therapy to avoid increases in tenofovir exposures. If coadministration is necessary, monitor for tenofovir-associated adverse reactions. Refer to VIREAD or TRUVADA prescribing information for recommendations on renal monitoring.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6635F1E6-97B3-4DBF-B7C3-E9909DA710D3"/>
    <ao:exact>HCV</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>Consider alternative </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:17468A3F-0A53-4772-8277-BAFA9C9CC04D">
    <ao:exact>GS-331007</ao:exact>
    <ao:prefix> were 126% and 143% higher in moderate and severe hepatic impairment, while the </ao:prefix>
    <pav:createdOn>2015-06-24 13:54:38 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix> AUC</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:17468A3F-0A53-4772-8277-BAFA9C9CC04D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D2C3BEBE-0D09-40CF-AFB6-35D254C5F6EA">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:F3C80B6B-71B9-4E44-A582-11971B499E17"/>
    <pav:createdOn>2015-06-24 13:34:08 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9b7b40b1-9baf-46b4-89da-5a91d22f25e7">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-12 16:57:51 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9b7b40b1-9baf-46b4-89da-5a91d22f25e7"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>methotrexate</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <ao:suffix> </ao:suffix>
    <ao:prefix>alyses suggest that concomitant administration of PPIs and </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:51EED05F-756F-476C-995C-B9BDEA114786">
    <pav:createdOn>2015-06-24 13:35:48 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:C41BE73D-8836-4CE0-AA2B-6424B08CAD71"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:578AFC15-167F-49CE-80DA-29BC4B5BD6B8">
    <pav:createdOn>2015-06-24 13:34:52 -0400</pav:createdOn>
    <ao:prefix>. Coadministration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> with simeprevir is not recommended.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:578AFC15-167F-49CE-80DA-29BC4B5BD6B8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>HARVONI</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A8C8D2A7-F1AB-40A8-9545-B062022DBDAD">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2015-06-24 13:30:33 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:21B8A27F-A390-498D-AA5E-16882B919D12"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A7DA1A3C-BAF8-4192-A8FC-39BC84099791">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:b8f2cc8a-d0ef-4f41-b982-9f169e468ba8</pav:previousVersion>
    <pav:createdOn>2015-06-24 13:28:41 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:7A10B286-E4F1-42EF-8775-8F323AAF85C8"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 13:28:47 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:BFDA94B6-C3E3-4254-B29F-1D8EE09A501D">
    <sio:SIO_000628>dailymed:pharmgxBiomarker</sio:SIO_000628>
    <dailymed:pharmgxBiomarker>http://fakeuri.org/CYP2C9</dailymed:pharmgxBiomarker>
    <rdfs:label>CYP2C19</rdfs:label>
    <dct:description>The selected biomarker.</dct:description>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76DE5DB3-7CBD-4B97-B770-62941C1542C4">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:AFD9AC8E-AD6D-4AB3-A56E-18DE5E2B01BC"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 14:03:13 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:37C14F63-F027-44F6-9356-AD6C13333122">
    <domeo:uuid></domeo:uuid>
    <ao:exact>GS-331007</ao:exact>
    <ao:prefix>Ledipasvir and sofosbuvir are substrates of drug transporters P-gp and BCRP while </ao:prefix>
    <ao:suffix> is not. P-gp inducers (e.g., rifampin or St. John's wort) may decrease ledipasvir and sofosbuvir plasma concentrations, leading to reduced therapeutic effect of HARVONI, and the use with P-gp inducers is not recommended with HARVONI </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:59:30 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:37C14F63-F027-44F6-9356-AD6C13333122"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B95DB431-068F-49FD-98D2-E14757BE4F1F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:33:24 -0400</pav:createdOn>
    <ao:exact>tenofovir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, emtricitabine , tenofovir DF  ↑ </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B95DB431-068F-49FD-98D2-E14757BE4F1F"/>
    <ao:suffix>       The safety of increased</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7AF14910-9FB0-403E-9F3E-EA164E20BCEC">
    <dikbD2R:dose>0.04</dikbD2R:dose>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/metabolite"/>
    <rdfs:label>3,4-dihydro-cilostazol</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D47865D2-09FA-4C16-A057-DDD0F8569AC9">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:BE46D5BB-4558-4167-AF51-2B679838F53F"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F8402414-A1AF-4167-BA6F-F7DBC881BEE7">
    <pav:createdOn>2015-06-24 13:29:51 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:902CE86B-6323-4EAB-9552-9BFBFF2F9199"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:CBC29E8F-3018-4FB3-9D06-66D1FC3641AB">
    <dct:description>none.</dct:description>
    <rdfs:label>None</rdfs:label>
    <poc:PharmacodynamicImpact>http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#none</poc:PharmacodynamicImpact>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
    <sio:SIO_000563>poc:PharmacodynamicImpact</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6CAF6CD3-C5FA-4966-8010-CE7B98A5DCD2">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>esomeprazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/73852acd-fee5-4e4d-bed5-d1c42d6b6cf4">
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:createdOn>2015-06-12 16:57:58 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:2284e984-435c-475d-8023-97355b70469b</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:c8323af4-0712-4f01-b016-b900d5763a0a"/>
    <pav:lastSavedOn>2015-06-12 16:57:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7A38085C-2B56-42D7-B6A0-F5E2197E2DF7">
    <ao:prefix>   7.5 Serotonergic Drugs    </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7A38085C-2B56-42D7-B6A0-F5E2197E2DF7"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2015-06-24 15:00:05 -0400</pav:createdOn>
    <ao:exact>Serotonin syndrome (including altered mental status, autonomic instability, and neuromuscular symptoms) has been described following the concomitant use of 5-HT3 receptor antagonists and other serotonergic drugs, including selective serotonin reuptake inhibitors (SSRIs) and serotonin and noradrenaline reuptake inhibitors (SNRIs)</ao:exact>
    <domeo:uuid>7A38085C-2B56-42D7-B6A0-F5E2197E2DF7</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D340B61F-D0A0-4F8D-A948-DBB014DBAAC5">
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <pav:createdOn>2015-06-19 12:01:02 -0400</pav:createdOn>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:body rdf:nodeID="Ndf1e8dd34684436baeb991b69807a9b0"/>
    <pav:lastSavedOn>2015-06-19 12:02:00 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:D88C186B-C28A-4695-A32D-74DDF023D1ED"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:DFF09E7A-31C1-4F4A-A24C-B631633E267A</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:81D5EC28-5A3A-49D6-83CE-AE3965A981FA">
    <ao:suffix>, emtricitabine and tenofovir DF has not been established. Coadministration is not recommended.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:81D5EC28-5A3A-49D6-83CE-AE3965A981FA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>cobicistat</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:33:30 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:25B8FA4D-6405-4996-A4EC-13493B4E5D77">
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-26 14:46:23 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:53928634-1F9A-461D-A372-D6EE1895E856"/>
    <pav:lineageUri>urn:domeoserver:annotation:44113BE4-E4ED-451F-962E-4494F9D9F5B7</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-26 14:52:05 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FA367F4F-B76B-4ADA-A13D-371E1B62E022">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Esomeprazole inhibits gastric acid secretion. Therefore, esomeprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability. Like with other drugs that decrease the intragastric acidity, the absorption of drugs such as ketoconazole, atazanavir, iron salts, and erlotinib can decrease, while the absorption of drugs such as digoxin can increase during treatment with esomeprazole. Concomitant treatment with omeprazole (20 mg daily) and digoxin in healthy subjects increased the bioavailability of digoxin by 10% (30% in two subjects). Esomeprazole is an enantiomer of omeprazole. Coadministration of digoxin with esomeprazole is expected to increase the systemic exposure of digoxin. Therefore, patients may need to be monitored when digoxin is taken concomitantly with esomeprazole</ao:exact>
    <ao:prefix>esomeprazole or these NSAIDs .  </ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FA367F4F-B76B-4ADA-A13D-371E1B62E022"/>
    <pav:createdOn>2015-06-26 14:50:51 -0400</pav:createdOn>
    <domeo:uuid>FA367F4F-B76B-4ADA-A13D-371E1B62E022</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4C631067-C1A2-4565-8127-6687AC6EC996">
    <ao:prefix>has not been established. Coadministration is not recommended.    tipranavir /</ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>ritonavir</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:4C631067-C1A2-4565-8127-6687AC6EC996"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 13:33:37 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5441A056-387F-4CDF-82F2-8F8CB4E5679A">
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2015-06-24 14:45:22 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:5599E97B-3837-40D4-B11D-DF18381B7149"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D0684FBC-AA59-4E77-8084-24E821D53ACD">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N22fc3e8b79134219bad4f1e679e5554a"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:155D5814-EE0C-4F34-86F4-62DEB2A907A1"/>
    <pav:lineageUri>urn:domeoserver:annotation:DEDD8FC1-572C-4642-8B4F-437B46F1DA55</pav:lineageUri>
    <pav:lastSavedOn>2015-06-26 14:32:43 -0400</pav:lastSavedOn>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <dikbD2R:assertionType>increase-auc</dikbD2R:assertionType>
    <pav:createdOn>2015-06-26 14:32:35 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C6BD587-9087-4AD2-B848-2D0DE3BD872D">
    <domeo:uuid></domeo:uuid>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix> is &gt;99.8% bound to human plasma proteins. After a single 90 mg dose of [</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0C6BD587-9087-4AD2-B848-2D0DE3BD872D"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>Ledipasvir</ao:exact>
    <pav:createdOn>2015-06-24 13:41:14 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5599E97B-3837-40D4-B11D-DF18381B7149">
    <ao:suffix>. </ao:suffix>
    <pav:createdOn>2015-06-24 14:45:22 -0400</pav:createdOn>
    <ao:exact>tramadol</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5599E97B-3837-40D4-B11D-DF18381B7149"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>more frequently in these studies, leading to an increased cumulative dose in patient controlled administration (PCA) of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <domeo:uuid>5599E97B-3837-40D4-B11D-DF18381B7149</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B8CFEE24-A7C8-4774-A2E2-0C154B0FD8F5">
    <ao:exact>Ethinyl estradio</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B8CFEE24-A7C8-4774-A2E2-0C154B0FD8F5"/>
    <ao:suffix>l</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>(0.98, 1.45)  1.23 (1.00, 1.51)    </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 14:06:00 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeo:software:id:Domeo-2.0alpha-040">
    <foafx:name>Domeo Annotation Toolkit</foafx:name>
    <foafx:version>2.0alpha</foafx:version>
    <foafx:build>040</foafx:build>
    <rdfs:label>Domeo Annotation Toolkit</rdfs:label>
    <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Software"/>
    <foafx:homepage></foafx:homepage>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6FD2ACA8-20DA-4149-BEE3-9DDF7C6D5402">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:14E27C56-973F-4122-97E2-0DEB66E2B193"/>
    <pav:createdOn>2015-06-24 14:45:04 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:54D54E55-63DC-4D98-B3F4-72030A66E9F3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>rifampin</ao:exact>
    <pav:createdOn>2015-06-24 13:31:13 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, a P-gp inducer, is not recommended </ao:suffix>
    <ao:prefix>with </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:54D54E55-63DC-4D98-B3F4-72030A66E9F3"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21AB03A1-CEBA-4572-B4E2-A29701AF19BF">
    <pav:createdOn>2015-06-24 13:32:33 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:9AA3C838-7784-4CDA-9081-08778679640E"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0DD1525B-D8D7-4BEF-9410-82B5E9E6BD2A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:83CB79EA-02B3-4785-8CCA-967E22F48392"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdOn>2015-06-24 13:40:52 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:38A283CF-09C1-459B-8D77-5299CE7884AB">
    <ao:exact>ledipasvir</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 14:02:05 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>90 single dose  400 single dose  12  </ao:prefix>
    <ao:suffix>        0.80 (0.69, 0.93)     </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:38A283CF-09C1-459B-8D77-5299CE7884AB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1EECDDE4-94BD-40E7-922B-371C11D945F1">
    <ao:prefix>The effects of coadministered drugs on the exposure of ledipasvir , sofosbuvir , and </ao:prefix>
    <ao:exact>GS-331007 </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix> are shown in Table 4 </ao:suffix>
    <pav:createdOn>2015-06-24 14:03:44 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1EECDDE4-94BD-40E7-922B-371C11D945F1"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf15e95ecbdfe43b8ac1a42180d2faa12">
    <domeo:sets rdf:resource="urn:pddi:uuid:26804EFE-5B88-4704-900D-F68434907A22"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6C06A06D-0631-4573-9C9A-36B220F7161A">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>       Monitor for tenofovir-a</ao:suffix>
    <ao:exact>tenofovir</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6C06A06D-0631-4573-9C9A-36B220F7161A"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>tenofovir disoproxil fumarate (DF )  ↑ </ao:prefix>
    <pav:createdOn>2015-06-24 13:31:47 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7BF8D3A5-E762-4F01-86A9-72A859C4B8B9">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotation:567C1760-28F1-4A9B-B4C1-A09733CF14C0</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:F228A337-0C25-4598-A6D7-3972632751E8"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 13:57:41 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:57:19 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4C57CE1F-184E-4374-B490-908F426964A9">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:EF32BFB0-65B9-42B9-8B8E-1C8D0E91A93E"/>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 14:51:31 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F83ED8E2-DBDD-4836-89C2-04B14261DF4F">
    <pav:createdOn>2015-06-19 12:00:00 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:977DD211-40C5-4893-B901-2C439A221015"/>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:FA9299CF-AA91-4F81-8AAC-88052A1148D4</pav:lineageUri>
    <pav:lastSavedOn>2015-06-26 14:52:05 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <dikbD2R:assertionType>increase-auc</dikbD2R:assertionType>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="Nfbec3fe47bd545b5b4f03832c8257517"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:28A29972-6C19-4F85-8076-AB4A68312A66">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:suffix>is metabolized by hepatic cytochrome P-450 drug-metabolizing enzymes (CYP3A4, CYP2D6, CYP1A2), inducers or inhibitors of these enzymes may change the clearance and, hence, the half-life of ondansetron </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>28A29972-6C19-4F85-8076-AB4A68312A66</domeo:uuid>
    <pav:createdOn>2015-06-24 14:44:46 -0400</pav:createdOn>
    <ao:prefix>does not appear to induce or inhibit the cytochrome P-450 drug-metabolizing enzyme system of the liver. Because </ao:prefix>
    <ao:exact>ondansetron </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:28A29972-6C19-4F85-8076-AB4A68312A66"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B1F68B40-A89C-48BB-9E9F-C3BBB1768BAC">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdOn>2015-06-24 14:02:29 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:C4550821-95EA-4220-9F6C-17EA10026452"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8B058E25-B7EC-47FE-81CB-8CC0DF8D945D">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2015-06-24 13:28:56 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:8881BB6E-9E6F-4C2A-B2BE-B1897371D77C"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EF32BFB0-65B9-42B9-8B8E-1C8D0E91A93E">
    <ao:suffix>. </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EF32BFB0-65B9-42B9-8B8E-1C8D0E91A93E"/>
    <ao:prefix>mechanism of action has not been fully characterized, it is not a </ao:prefix>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:exact>dopamine-receptor antagonist</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>EF32BFB0-65B9-42B9-8B8E-1C8D0E91A93E</domeo:uuid>
    <pav:createdOn>2015-06-24 14:51:31 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:62A81291-0969-4502-82CE-26840084303D">
    <ao:prefix>(emtricitabine, rilpivirine, tenofovir DF).        Atazanavir / </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:62A81291-0969-4502-82CE-26840084303D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 14:05:28 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>ritonavir</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:71018C66-E9EE-4190-B182-AD0A3C834C07">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> and a </ao:prefix>
    <pav:createdOn>2015-06-24 13:32:10 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>/ritonavir         </ao:suffix>
    <ao:exact>HIV protease inhibitor</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:71018C66-E9EE-4190-B182-AD0A3C834C07"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:45F6F5BF-1C1D-4543-A911-C2331BD4FE01">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:EFEEAF21-EECF-46EA-AA1F-EC8F6180E8C2"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9D860AAC-6FE8-446B-B6E5-1DA9F863E2CE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> </ao:prefix>
    <ao:exact>In humans, carmustine, etoposide, and cisplatin do not affect the pharmacokinetics of ondansetron</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9D860AAC-6FE8-446B-B6E5-1DA9F863E2CE"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2015-06-24 15:00:25 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <domeo:uuid>9D860AAC-6FE8-446B-B6E5-1DA9F863E2CE</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C96971DC-25BC-4460-A152-64526835BF6F">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:89230FE5-2A1A-4801-90B4-D8B8748389DD"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:createdOn>2015-06-24 14:44:59 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE173B4B-54CC-4269-90E9-BB737524408A">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:9BE9EA5A-DD39-4E54-AC29-2869AE954DDA"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2015-06-24 14:54:06 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:883B4A5D-B0CD-4F31-A00B-1D0931A05171">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:136B390C-8C34-4141-BBA6-5DFAFCED6DF2"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/abda6a7c-98eb-42dd-8fbc-9971d2cc96b9">
    <pav:lineageUri>urn:domeoserver:annotationset:861d7355-bd05-4520-a9bc-7cbebbde07d6</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-12 16:57:51 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-12 16:57:51 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.1alpha-050</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:9b7b40b1-9baf-46b4-89da-5a91d22f25e7"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:83208A7A-623B-43FE-A071-A131CAE04FC7">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:83208A7A-623B-43FE-A071-A131CAE04FC7"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>H CV Products :  simeprevir ‡  ↑ </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>ledipasvir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>↑ simeprevir        Concentrat</ao:suffix>
    <pav:createdOn>2015-06-24 13:34:38 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:90855586-8753-47DB-A6F4-E00CCFF3B2A5">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2015-06-18 15:56:01 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:7E191529-E228-475A-9337-529F354C7696</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:0044FFC5-65ED-4E6E-BAFE-A343C1206CD0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DC0955C1-EFC0-4995-A434-15EABB66AE36">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:2FD5B82E-A631-4EEE-AA57-F2AA5ACAB779"/>
    <dikbD2R:comment>AUC decreased</dikbD2R:comment>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DEBBBD3A-01FE-4EE4-8B50-2D97B85F3709">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:1B3A21A2-252F-44DD-B7BB-323EBE75B53E"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:33:49 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/07A78060-72FF-4E1D-9B24-10A33CFDE12E">
    <rdfs:label>ondansetron</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/10CF045C-6E22-4275-9107-769531063098">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-group"/>
    <rdfs:label>5-HT3 receptor antagonists</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1CB361AE-28F4-4AA2-94E7-E8D3E69C9B7A">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix>↓ GS-331007       Coadministra</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:33:40 -0400</pav:createdOn>
    <ao:prefix>tipranavir / ritonavir  ↓ ledipasvir ↓ </ao:prefix>
    <ao:exact>sofosbuvir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1CB361AE-28F4-4AA2-94E7-E8D3E69C9B7A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:59DDF7E4-44F8-4DFA-9E72-31B3FBC0E165">
    <pav:createdOn>2015-06-24 13:31:09 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:59DDF7E4-44F8-4DFA-9E72-31B3FBC0E165"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix>. Coadministration is not recommended.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of </ao:prefix>
    <ao:exact>HARVONI</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2DAC2694-87BD-4C21-B9CE-D9C208FD380A">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:33:37 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:4C631067-C1A2-4565-8127-6687AC6EC996"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9ED99674-EA90-4B88-B587-A3EFF7675F31">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2015-06-18 15:53:34 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotation:A1B65F81-012B-495A-9970-13BA6664DF15</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:39EB13F6-7078-4FF5-8DC3-182CD939DC1C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:86A39B51-D81F-4367-83A6-DF8308535A1B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:D47EC487-1A51-4EE1-BA01-FA2A373AF48F"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:30:14 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E5124444-903A-4C0E-8153-BA96BDDA79DB">
    <pav:createdOn>2015-06-24 14:01:09 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E5124444-903A-4C0E-8153-BA96BDDA79DB"/>
    <ao:suffix>/ </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>This study was conducted in the presence of two other investigational HCV direct-acting agents.        </ao:prefix>
    <ao:exact>Atazanavir</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AB71E1D5-CBAD-47DD-8283-198B63B85A9D">
    <pav:createdOn>2015-06-18 16:00:06 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix> and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>PPIs </ao:exact>
    <ao:suffix>is not recommended. Co-administration of </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AB71E1D5-CBAD-47DD-8283-198B63B85A9D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D4A0C663-49D4-404F-8671-097616E7C685">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2015-06-26 14:45:00 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D4A0C663-49D4-404F-8671-097616E7C685"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Concomitant administration of esomeprazole and a combined inhibitor of CYP2C19 and CYP3A4, such as voriconazole, may result in more than doubling of the esomeprazole exposure. Dose adjustment of esomeprazole is not normally required for the recommended doses. However, in patients who may require higher doses, dose adjustment may be considered</ao:exact>
    <ao:prefix>from 100 mg twice daily to 50 mg twice daily should be considered .  </ao:prefix>
    <domeo:uuid>D4A0C663-49D4-404F-8671-097616E7C685</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B6AA9417-B605-403B-8D84-F6601DB47883">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B4BA4022-38B6-42CE-939D-05E4D5C150BA"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D5AC2F3F-3D92-4F8D-80EC-9B2DD0C3B902"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:327B329E-217E-4D89-A240-CB9D1600CFA6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:suffix>do not affect the pharmacokinetics of ondansetron. </ao:suffix>
    <ao:prefix>, and </ao:prefix>
    <pav:createdOn>2015-06-24 14:51:04 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>327B329E-217E-4D89-A240-CB9D1600CFA6</domeo:uuid>
    <ao:exact>cisplatin </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:327B329E-217E-4D89-A240-CB9D1600CFA6"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:856728B4-6530-4C32-ACA5-0F42C7F38501">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:56:12 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:3CB42E72-909A-4A4C-8382-77CB52A35E53"/>
    <pav:lineageUri>urn:domeoserver:annotation:7DFD031F-B081-4FEA-9708-A2C290B08E24</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:57:41 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:84CEECAF-BEBB-4E25-A4F8-A4AA7FE7ACEC">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:83208A7A-623B-43FE-A071-A131CAE04FC7"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:34:38 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:997B55C2-F1DB-42AE-BFBF-4446E8BF178B">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:FDDD2139-7213-439B-A2F7-8C740C3ACF8E"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 13:30:42 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FE7E64CB-2E0C-43D0-9AFA-5EE8A9AD3FC4">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>prescribing information for recommendations on renal monitoring.    elvitegravir , cobicistat , </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FE7E64CB-2E0C-43D0-9AFA-5EE8A9AD3FC4"/>
    <ao:suffix>, tenofovir DF</ao:suffix>
    <pav:createdOn>2015-06-24 13:33:20 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>emtricitabine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:33E27E30-70E8-4B23-A205-68964E913421">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:3D946309-429B-4A19-9ECC-1176BCCF3CE8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2D52C44D-3A12-410B-AB64-5FBB527FFEF7">
    <ao:suffix>)</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>at a dose that does not exceed doses comparable to famotidine 40 mg twice daily.    Proton-pump inhibitors ‡  (e.g., </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:29:17 -0400</pav:createdOn>
    <ao:exact>omeprazole</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2D52C44D-3A12-410B-AB64-5FBB527FFEF7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:840E5563-001E-4EA3-8BDD-CEE5F9C00E29">
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:38BD703F-9BF2-4DA7-BAC7-793C948BE8D7"/>
    <pav:createdOn>2015-06-24 14:02:58 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E1066321-87F0-4153-9A1B-AFB06A11B448">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E1066321-87F0-4153-9A1B-AFB06A11B448"/>
    <ao:prefix> is expected to decrease the concentration of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>ledipasvir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:30:37 -0400</pav:createdOn>
    <ao:suffix> and sofosbuvir, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:16E51B1F-400D-4728-B53D-EC2A21D3CFCF">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 14:06:12 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:A428BCC0-4A63-443B-BB0D-4B09FAB918E8"/>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FDDD2139-7213-439B-A2F7-8C740C3ACF8E">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>HARVONI</ao:exact>
    <pav:createdOn>2015-06-24 13:30:42 -0400</pav:createdOn>
    <ao:prefix> is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>. Coadministration is not recommended.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FDDD2139-7213-439B-A2F7-8C740C3ACF8E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:259E7A6A-4A9C-4B5D-9F0E-238A7799F5ED">
    <ao:exact>ledipasvir</ao:exact>
    <pav:createdOn>2015-06-24 13:34:44 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> and sofosbuvir, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix> is expected to decrease the concentration of </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:259E7A6A-4A9C-4B5D-9F0E-238A7799F5ED"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3D12BC91-A93A-43B5-B34E-367C05C52347">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 13:32:16 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:BE112022-3D37-4A7A-9E4A-2E059D9D097D"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C41BE73D-8836-4CE0-AA2B-6424B08CAD71">
    <domeo:uuid></domeo:uuid>
    <ao:suffix> </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C41BE73D-8836-4CE0-AA2B-6424B08CAD71"/>
    <ao:prefix>with certain </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>HIV antiretroviral regimens</ao:exact>
    <pav:createdOn>2015-06-24 13:35:48 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9F214CD6-7D99-408B-8028-0B5916C39CC4">
    <ao:prefix> Although there are no data on pharmacokinetic drug interactions between </ao:prefix>
    <ao:exact>ondansetron </ao:exact>
    <ao:suffix>and tramadol, data from two small studies indicate that concomitant use of ondansetron may result in reduced analgesic activity of tramadol. Patients on concomitant ondansetron self administered tramadol more frequently in these studies, leading to an in</ao:suffix>
    <pav:createdOn>2015-06-24 14:45:12 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9F214CD6-7D99-408B-8028-0B5916C39CC4"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>9F214CD6-7D99-408B-8028-0B5916C39CC4</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0B86E822-3E0A-4D98-B1FD-D688CD5BD17B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/446A7DF7-86D2-4703-9911-6B970482C118"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9F46DCE0-64D3-483D-A2AC-AC3D2F87C34E"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D0897E0D-B76C-4AA1-9B30-0156A7C79883">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>rabeprazole</rdfs:label>
    <dikbD2R:dose>Unk</dikbD2R:dose>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:374263A0-89AD-4319-AFD7-9BB878C3A63D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:374263A0-89AD-4319-AFD7-9BB878C3A63D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-26 14:49:36 -0400</pav:createdOn>
    <ao:exact>Studies evaluating concomitant administration of esomeprazole and either naproxen (non-selective NSAID) or rofecoxib (COX-2 selective NSAID) did not identify any clinically relevant changes in the pharmacokinetic profiles of esomeprazole or these NSAIDs</ao:exact>
    <ao:prefix>should be considered from the safety perspective for individual patients. There are also some antiretroviral drugs of which unchanged serum levels have been reported when given with omeprazole .  </ao:prefix>
    <domeo:uuid>374263A0-89AD-4319-AFD7-9BB878C3A63D</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AFE55325-48CA-40F0-8B61-574BB1683EF4">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AFE55325-48CA-40F0-8B61-574BB1683EF4"/>
    <ao:suffix>        0.96(0.88, 1.05)      </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>(1.89, 2.40)  2.36 (2.08, 2.67)    </ao:prefix>
    <pav:createdOn>2015-06-24 14:01:30 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sofosbuvir</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F33E42A3-7BF0-49B9-ACFC-CB757B11FC28">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F33E42A3-7BF0-49B9-ACFC-CB757B11FC28"/>
    <domeo:uuid>F33E42A3-7BF0-49B9-ACFC-CB757B11FC28</domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>   7.5 </ao:prefix>
    <pav:createdOn>2015-06-24 14:59:26 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Serotonergic Drugs\nSerotonin syndrome (including altered mental status, autonomic instability, and neuromuscular symptoms) has been described following the concomitant use of 5-HT3 receptor antagonists and other serotonergic drugs, including selective serotonin reuptake inhibitors (SSRIs) and serotonin and noradrenaline reuptake inhibitors (SNRIs)</ao:exact>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:65393C4E-5067-4819-A359-9FA44838F2C5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:33:31 -0400</pav:createdOn>
    <ao:prefix>, </ao:prefix>
    <ao:exact>emtricitabine</ao:exact>
    <ao:suffix> and tenofovir DF has not been established. Coadministration is not recommended.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:65393C4E-5067-4819-A359-9FA44838F2C5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5D93C36D-93A1-49FD-A18F-E6A961FFFB8F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>GS-331007</ao:exact>
    <ao:suffix>        0.97(0.83, 1.14)      </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5D93C36D-93A1-49FD-A18F-E6A961FFFB8F"/>
    <pav:createdOn>2015-06-24 14:03:03 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>(0.65, 1.43)  1.13 (0.81, 1.57)  NA    </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7AF29A89-7F66-4B47-BA97-56F06C2BA4E0">
    <ao:exact>Esomeprazole may potentially interfere with CYP2C19, the major esomeprazole metabolizing enzyme. Coadministration of esomeprazole 30 mg and diazepam, a CYP2C19 substrate, resulted in a 45% decrease in clearance of diazepam. Increased plasma levels of diazepam were observed 12 hours after dosing and onwards. However, at that time, the plasma levels of diazepam were below the therapeutic interval, and thus this interaction is unlikely to be of clinical relevance.</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7AF29A89-7F66-4B47-BA97-56F06C2BA4E0"/>
    <ao:prefix>concomitantly may need to be monitored for increases in INR and prothrombin time .  </ao:prefix>
    <pav:createdOn>2015-06-26 14:43:57 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>7AF29A89-7F66-4B47-BA97-56F06C2BA4E0</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A3FF34AF-F90E-4B5A-BB1E-AB587EF033FE">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 14:05:57 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:13EC47DA-B354-4A9B-AFAE-04FE1A0CAF73"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D5F927C9-ECA9-483D-A35F-1B66DCBCE0EC">
    <pav:createdOn>2015-06-24 13:28:06 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoclient:uuid:b8f2cc8a-d0ef-4f41-b982-9f169e468ba8</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:AF574CF3-6DB6-42A1-B426-582036AB23D3"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:28:47 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8C63E9B3-E04C-46EE-AB89-8CC3A39FA392">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8C63E9B3-E04C-46EE-AB89-8CC3A39FA392"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix>, or oxcarbazepine is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:30:14 -0400</pav:createdOn>
    <ao:exact>phenobarbital</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7D9647BB-86DC-4B59-A6A2-5A3CF0BF05E6">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7D9647BB-86DC-4B59-A6A2-5A3CF0BF05E6"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 14:02:37 -0400</pav:createdOn>
    <ao:suffix>        1.13 (1.07, 1.20)     </ao:suffix>
    <ao:prefix>(0.76, 1.32)  0.95 (0.82, 1.10)  NA    </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>GS-331007</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6831B321-B7D8-4FD8-BC45-50EF2D7C558D">
    <ao:exact>alfentanil </ao:exact>
    <pav:createdOn>2015-06-24 14:51:16 -0400</pav:createdOn>
    <ao:suffix>or the degree of neuromuscular blockade produced by atracurium. Interactions with general or local anesthetics have not been studied. </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <domeo:uuid>6831B321-B7D8-4FD8-BC45-50EF2D7C558D</domeo:uuid>
    <ao:prefix>does not alter the respiratory depressant effects produced by </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6831B321-B7D8-4FD8-BC45-50EF2D7C558D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B5B14349-CBE2-4104-8D33-8D1547C5E602">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:5CB25C32-2C5D-44BE-AD76-70380F754D19"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F33B270C-BB52-4810-AF89-0A84E60ED71C">
    <pav:createdOn>2015-06-24 13:40:09 -0400</pav:createdOn>
    <ao:suffix> have been evaluated in healthy adult subjects and in subjects with chronic hepatitis C. Following oral administration of HARVONI, </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>, and the predominant circulating metabolite</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F33B270C-BB52-4810-AF89-0A84E60ED71C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact> GS-331007</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:48D88A72-F200-42C1-A797-BB3A83818893">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A365FF98-9741-4D3E-9E75-94ADEB053742"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A8303D27-0105-4BB0-B130-485B30A16D3D"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AD7B8ABD-B06E-40E2-B1BF-4DBAA0C2F3D8">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <rdfs:label>warfarin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AA78478C-E9A0-4224-98EE-C218B099E493">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>phenytoin</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:CAB63AF9-D23A-4109-A615-275C9421E6CB">
    <poc:DoseSelectionRecommendation>http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#increase-from-recommended-baseline</poc:DoseSelectionRecommendation>
    <rdfs:label>Increase from baseline</rdfs:label>
    <sio:SIO_000563>poc:DoseSelectionRecommendation</sio:SIO_000563>
    <dct:description>The pharmacogenomic biomarker is related to a recommendation to increase the dose of the drug from the recommended baseline.</dct:description>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F305741B-F312-4BFA-9CAF-0B41AC00B214">
    <pav:createdOn>2015-06-24 14:45:19 -0400</pav:createdOn>
    <domeo:uuid>F305741B-F312-4BFA-9CAF-0B41AC00B214</domeo:uuid>
    <ao:prefix>self administered </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F305741B-F312-4BFA-9CAF-0B41AC00B214"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:suffix>more frequently in these studies, leading to an increased cumulative dose in patient controlled administration (PCA) of tramadol. </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>tramadol </ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:606EE405-D693-4099-9B68-EEBAF0989AD8">
    <ao:exact>elvitegravir</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:606EE405-D693-4099-9B68-EEBAF0989AD8"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:33:17 -0400</pav:createdOn>
    <ao:prefix>xsd:String</ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>, cobicistat, emtricitabine, tenofovir DF</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7154222A-60C0-4D07-ADE0-7458FABF470A">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:40:59 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:DE1E2211-EFF9-4F24-8EF4-A576A4D1B5A4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:32677D71-846D-40CC-8CAC-12B59D98ED75">
    <ao:context rdf:resource="urn:domeoclient:uuid:DEDD7F05-B206-4D64-B6F0-5A91C8A8EEC4"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:30:56 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2F067E6D-130F-46E7-99E7-C36EB735262A">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:comment>Reduces atazanavir plasma concentration</dikbD2R:comment>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:34ED20FB-CA26-4D2E-AA1C-409B8D395CB9"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5096a583f3124aedbfeb3949bb7b7aa3">
    <domeo:sets rdf:resource="urn:pddi:uuid:85B7FC8D-6847-450F-87A2-A8DBB01431DE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FF092A73-4CB5-4EC5-B0F8-4864E9C6C0F1">
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:lastSavedOn>2015-06-24 15:02:21 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 14:57:30 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:09009F96-21F3-4835-99B4-D0AA49EE5ACA"/>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <ao:body rdf:nodeID="N6255314984e24015b5482e1701f69c4b"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:808045CD-C25E-46B2-AC0A-98F5CA51A016</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:89CB96C7-C2FE-4074-8ED8-CFAC554F7323">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:3E8B1646-11E2-415C-80B5-9F81F9937554"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C95A383C-FC63-4F86-A721-CE43075556A9">
    <ao:prefix>In treatment-experienced subjects whose virus had baseline NS5A polymorphisms at resistance-associated positions, relapse rates were 22% (5/23) after 12 weeks and 0% (0/19) after 24 weeks of treatment with </ao:prefix>
    <pav:createdOn>2015-06-24 14:06:54 -0400</pav:createdOn>
    <ao:suffix>.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>HARVONI</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C95A383C-FC63-4F86-A721-CE43075556A9"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/6A504DE8-967C-4520-87BF-D0CDE7EA102F">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/2002</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>carbamazepine</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FA9ED8FC-E4D6-4D36-A1BF-43F4F761F805">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FA9ED8FC-E4D6-4D36-A1BF-43F4F761F805"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>HIV Antiretrovirals</ao:exact>
    <pav:createdOn>2015-06-24 13:31:37 -0400</pav:createdOn>
    <ao:prefix>Warnings and Precautions (5.2) ].    </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>:</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:46A5402B-3A8E-4C2B-93DB-5583213BD0D1">
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:0F6E43FF-F96D-4E81-8097-B80CC7151AF2"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9d77b047ca53458f95625f0a0662a865">
    <domeo:sets rdf:resource="urn:pddi:uuid:3A1B602D-D416-4C4F-8F16-84F1EF4EFBD4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FAC8D76C-FDE5-4357-9D84-3FDE7C406C81">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>GS-331007 </ao:exact>
    <ao:suffix> accounted for approximately &gt;90% of total systemic exposure.</ao:suffix>
    <pav:createdOn>2015-06-24 13:41:57 -0400</pav:createdOn>
    <ao:prefix>, </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FAC8D76C-FDE5-4357-9D84-3FDE7C406C81"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:20035265-59C4-491F-97B3-DD8040080FCF">
    <pav:createdOn>2015-06-24 13:33:10 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:20035265-59C4-491F-97B3-DD8040080FCF"/>
    <ao:prefix> or </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>antiretroviral</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> therapy to avoid increases in tenofovir exposures. If coadministration is necessary, monitor for tenofovir-associated adverse reactions. Refer to VIREAD or TRUVADA prescribing information for recommendations on renal monitoring.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:929BF940-1099-4796-BBA3-341FACCD0F42">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>xsd:String</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2014-02-09 21:23:27 -0500</pav:createdOn>
    <ao:exact>CYP2C19 poor metabolizer status is associated with diminished antiplatelet response to clopidogrel. Although a higher dose regimen (600 mg loading dose followed by 150 mg once daily) in poor metabolizers increases antiplatelet response [see Clinical Pharmacology (12.5)], an appropriate dose regimen for this patient population has not been established in clinical outcome trials.</ao:exact>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:929BF940-1099-4796-BBA3-341FACCD0F42"/>
    <domeo:uuid>929BF940-1099-4796-BBA3-341FACCD0F42</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/Clopidogrel-1086a7b4-b89b-4bee-8120-5f752626c046.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C3E2CD62-A6B6-4B24-8C10-E4A3A21DF40C">
    <ao:context rdf:resource="urn:domeoclient:uuid:508F38A7-D0DF-47C2-9B5E-42A2DC1E5367"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 13:30:39 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F496E396-6A4F-467A-B135-656E9DD2E072">
    <pav:createdOn>2015-06-24 14:45:32 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>serotonergic drugs</ao:exact>
    <domeo:uuid>F496E396-6A4F-467A-B135-656E9DD2E072</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F496E396-6A4F-467A-B135-656E9DD2E072"/>
    <ao:prefix>syndrome (including altered mental status, autonomic instability, and neuromuscular symptoms) has been described following the concomitant use of 5-HT3 receptor antagonists and other </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, including selective serotonin reuptake inhibitors (SSRIs) and serotonin and noradrenaline reuptake inhibitors (SNRIs) </ao:suffix>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:21558B94-8A86-4139-B3BD-4F57FB4C76A6">
    <ao:prefix> The pharmacokinetics of intravenous </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:21558B94-8A86-4139-B3BD-4F57FB4C76A6"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>21558B94-8A86-4139-B3BD-4F57FB4C76A6</domeo:uuid>
    <ao:suffix>did not differ between subjects who were poor metabolisers of CYP2D6 and those who were extensive metabolisers of CYP2D6, further supporting the limited role of CYP2D6 in ondansetron disposition in vivo. </ao:suffix>
    <pav:createdOn>2015-06-24 14:54:07 -0400</pav:createdOn>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:exact>ondansetron </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1CE977D3-865D-4235-ACA8-8FA2ABD33B2A">
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:29:23 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1CE977D3-865D-4235-ACA8-8FA2ABD33B2A"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>Proton-pump inhibitor</ao:exact>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix> doses comparable to omeprazole 20 mg or lower can be administered simultaneously with HARVONI under fasted conditions.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2F10298C-2A81-494E-9AD1-ABD580483D6C">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:35:42 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:A9978477-7492-492E-9AD9-0709A5751B0E"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:86CB660B-55FF-4BB9-AD10-C6A9075D4832">
    <ao:exact>tenofovir DF</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:86CB660B-55FF-4BB9-AD10-C6A9075D4832"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>atazanavir / ritonavir + emtricitabine /</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:32:19 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FBB1FBAB-106B-49F3-BB29-88CAFB31D769">
    <ao:prefix>should be considered from the safety perspective for individual patients. There are also some antiretroviral drugs of which unchanged serum levels have been reported when given with omeprazole .  </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FBB1FBAB-106B-49F3-BB29-88CAFB31D769"/>
    <domeo:uuid>FBB1FBAB-106B-49F3-BB29-88CAFB31D769</domeo:uuid>
    <ao:exact>Studies evaluating concomitant administration of esomeprazole and either naproxen (non-selective NSAID) or rofecoxib (COX-2 selective NSAID) did not identify any clinically relevant changes in the pharmacokinetic profiles of esomeprazole or these NSAIDs</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-26 14:49:05 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A98985CB-522B-46BC-98AC-239D454225E9">
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>esomeprazole or these NSAIDs .  </ao:prefix>
    <ao:exact>Esomeprazole inhibits gastric acid secretion. Therefore, esomeprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability. Like with other drugs that decrease the intragastric acidity, the absorption of drugs such as ketoconazole, atazanavir, iron salts, and erlotinib can decrease, while the absorption of drugs such as digoxin can increase during treatment with esomeprazole. Concomitant treatment with omeprazole (20 mg daily) and digoxin in healthy subjects increased the bioavailability of digoxin by 10% (30% in two subjects). Esomeprazole is an enantiomer of omeprazole. Coadministration of digoxin with esomeprazole is expected to increase the systemic exposure of digoxin. Therefore, patients may need to be monitored when digoxin is taken concomitantly with esomeprazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A98985CB-522B-46BC-98AC-239D454225E9"/>
    <pav:createdOn>2015-06-19 11:58:06 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5CEF478D-5683-496D-AFF1-24043480AD95">
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:F0B4207B-A4C4-4444-88C8-4F03C2D212DC</pav:lineageUri>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <ao:body rdf:nodeID="N8eea819de9d943d893d6a431c29a2c88"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <ao:context rdf:resource="urn:domeoclient:uuid:141F8C41-36D9-4117-ABFB-E7837CC4D51F"/>
    <pav:createdOn>2015-06-26 14:49:51 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-26 14:52:05 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0C1D6F13-6328-4087-B43F-88CB3A651419">
    <pav:createdOn>2015-06-24 14:45:15 -0400</pav:createdOn>
    <ao:prefix>, data from two small studies indicate that concomitant use of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0C1D6F13-6328-4087-B43F-88CB3A651419"/>
    <ao:exact>ondansetron </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:suffix>may result in reduced analgesic activity of tramadol. Patients on concomitant ondansetron self administered tramadol more frequently in these studies, leading to an increased cumulative dose in patient controlled administration (PCA) of tramadol. </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>0C1D6F13-6328-4087-B43F-88CB3A651419</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0FD9D5BA-6BF5-4F2B-871B-EF75AAA3BCE4">
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:6180B9FF-F1D9-4400-BD2B-E9991DF5FBFC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:35:02 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8CB47DFC-2DAE-40EA-8112-FE93B3D8E4E7">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/97FE176E-F74A-4C89-8D9E-0D61BB262B54"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A5852EA4-83DD-4E71-A965-3EC8623A84CE"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AFAB5DE2-35E7-4530-A8F4-3893871BFFDD">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>xsd:String</ao:prefix>
    <pav:createdOn>2015-06-24 15:02:09 -0400</pav:createdOn>
    <ao:exact>Ondansetron does not alter the respiratory depressant effects produced by alfentanil or the degree of neuromuscular blockade produced by atracurium. Interactions with general or local anesthetics have not been studied</ao:exact>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AFAB5DE2-35E7-4530-A8F4-3893871BFFDD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>.</ao:suffix>
    <domeo:uuid>AFAB5DE2-35E7-4530-A8F4-3893871BFFDD</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4757029F-D770-4D80-AB44-409225C8DDD4">
    <dikbD2R:numOfParticipants>20</dikbD2R:numOfParticipants>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3D872C1C-75C7-42F6-99B8-A84DFD312013"/>
    <dikbD2R:auc>26%</dikbD2R:auc>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/60827E1F-0EDD-4A0B-9161-923256C51C60"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:18B76D8B-4ECB-4303-9C35-5AF8C70112F2">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:29:41 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:F19A3603-072E-4A60-80CD-CB7B769C3112"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6180B9FF-F1D9-4400-BD2B-E9991DF5FBFC">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6180B9FF-F1D9-4400-BD2B-E9991DF5FBFC"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>(</ao:prefix>
    <ao:suffix>)</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:35:02 -0400</pav:createdOn>
    <ao:exact>Hypericum perforatum</ao:exact>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DBB8E22B-803A-4C54-9986-A71D449DDBFA">
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ondansetron</ao:exact>
    <domeo:uuid>DBB8E22B-803A-4C54-9986-A71D449DDBFA</domeo:uuid>
    <ao:suffix>, concomitant use of apomorphine with ondansetron is contraindicated </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>was administered with </ao:prefix>
    <pav:createdOn>2015-06-24 14:44:55 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DBB8E22B-803A-4C54-9986-A71D449DDBFA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2909785D-B623-43A3-B162-6A9D7463C7C3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>7.3 Drugs without Clinically Significant Interactions with </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2909785D-B623-43A3-B162-6A9D7463C7C3"/>
    <pav:createdOn>2015-06-24 13:35:34 -0400</pav:createdOn>
    <ao:exact>HARVONI</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:23935A4D-B0D7-4232-A4D7-0167C734A4E3">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/32941B14-099C-454A-AE54-9C3CD71A33B2"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6A504DE8-967C-4520-87BF-D0CDE7EA102F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F0726269-B103-4C7D-8B6D-5CF480516C0F">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7D5761CB-DBD2-4B2F-9604-66E8FBEFC88B"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8036C253-34D4-4A2C-AE41-06A567DB009F"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B1199E58-911B-4A5F-B16D-A0E8581AB13E">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:29:23 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:1CE977D3-865D-4235-ACA8-8FA2ABD33B2A"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:14F8DFF3-9177-4E32-989C-4A6EA43D0F2C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:4D8CA78F-BEE5-4E1F-81B4-B77210EBE5C0"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:34:50 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D028CAF9-AC5B-4B50-B1A7-2B6BCCF1820B">
    <ao:prefix>(0.65, 0.83)  1.04 (0.89, 1.22)  NA    </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 14:03:16 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Omeprazole</ao:exact>
    <ao:suffix>        20 once daily simultan</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D028CAF9-AC5B-4B50-B1A7-2B6BCCF1820B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8E50503E-3FD9-479D-8F85-3CA3446466F4">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:E63287DF-F8A7-4604-9C55-697F2AD673D0"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D94A7A6E-CE26-4BCB-B569-712A62F13096">
    <ao:suffix>, phenobarbital, or oxcarbazepine is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D94A7A6E-CE26-4BCB-B569-712A62F13096"/>
    <pav:createdOn>2015-06-24 13:30:13 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>, </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>phenytoin</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:38911A62-E66E-49F3-9B9F-3CEF91DB3332">
    <domeo:uuid></domeo:uuid>
    <ao:prefix>Ledipasvir and </ao:prefix>
    <ao:exact>sofosbuvir</ao:exact>
    <pav:createdOn>2015-06-24 14:00:41 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:38911A62-E66E-49F3-9B9F-3CEF91DB3332"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> are substrates of drug transporters P-gp and BCRP while GS-331007 is not. P-gp inducers (e.g., rifampin or St. John's wort) may decrease ledipasvir and sofosbuvir plasma concentrations, leading to reduced therapeutic effect of HARVONI, and the use with </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BBCB7C63-3BB0-4000-B005-682E4802DB33">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:40:11 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:A8F3B4FF-7B64-4E32-B95C-C91881D911EC"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:717C5C37-5CB6-4CB6-937C-9396EE48C261">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:42:42 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:D1131B8C-9A11-4A5D-82E0-CA2618A30815"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D6B22657-DA20-408B-9AD8-2DF835B2782E">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D01B1C2D-FBD5-4586-943B-15FDB7897397"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C48FAFD7-141B-4978-94AE-1C3B2EC12DC5"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BAF13C30-A14B-40D1-8DD9-BC8EF0B76A1C">
    <pav:createdOn>2015-06-24 14:03:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BAF13C30-A14B-40D1-8DD9-BC8EF0B76A1C"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>        40 single dose simulta</ao:suffix>
    <ao:prefix>(1.41, 1.48)  1.53 (1.47, 1.59)    </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:exact>Famotidine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:39DEC04B-F6BB-4835-A57D-572727F57C13">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 14:51:47 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:E9DA2D16-D099-4E8B-B615-BDA0DDB0F4EB"/>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:41F591AC-C2DC-4399-BF35-8DA276BE377F">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2015-06-24 14:02:41 -0400</pav:createdOn>
    <ao:prefix>30 to 130 daily  ND  400 once daily  14  </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sofosbuvir</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:41F591AC-C2DC-4399-BF35-8DA276BE377F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EF1B5DB4-0BC9-426D-8E23-3D5A36EB5E86">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EF1B5DB4-0BC9-426D-8E23-3D5A36EB5E86"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>ledipasvir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix>↓ sofosbuvir↓ GS-331007       </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 13:30:28 -0400</pav:createdOn>
    <ao:prefix>rifabutin  rifampin ‡   rifapentine  ↓ </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:689F1ACF-7F51-4D73-9C1B-A1E74F0035AE">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:93A919B3-139D-437F-85D9-F478A8F945A5"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8e5c5521fd5c46d3a2dca054f7a800a4">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:431A18F2-3700-410D-ADBE-483AAAD7C3FB">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <ao:body rdf:nodeID="Nbf6199e5b63345dab67ba2502649f6ed"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>ddi Annotation</rdfs:label>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:createdOn>2015-06-24 14:59:49 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:ED04D26C-6166-4D8C-87C6-742E6B8242B7</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:30E100DC-0850-4108-A883-8C57C00E30D1"/>
    <pav:lastSavedOn>2015-06-24 15:02:21 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:54518493-720B-4E2C-8C32-9A835524BAF3">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:createdOn>2015-06-24 14:52:20 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:DAD72EDB-846A-4F8D-8C4E-3B9EDFB98D6A"/>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:23DDEB34-CF71-4590-A750-E0AC686514EA">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 14:52:23 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:204E82BC-F9BF-47E7-98D0-C9B42DA42B82"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:8EBC3A86-CAF7-4AEB-8718-D2C34C496981">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
    <rdfs:label>Required</rdfs:label>
    <sio:SIO_000563>poc:TestRecommendation</sio:SIO_000563>
    <poc:TestRecommendation>http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#required</poc:TestRecommendation>
    <dct:description>A required test is related to the biomarker.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C49AEBD7-A870-45F6-8505-0A041646E11D">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C49AEBD7-A870-45F6-8505-0A041646E11D"/>
    <pav:createdOn>2015-06-24 13:31:20 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <ao:prefix> is expected to decrease the concentration of ledipasvir and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sofosbuvir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/09536245-2892-4889-BEB4-BB9A3CB25145">
    <rdfs:label>quinidine</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/9068</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7833DD49-3AB2-4409-A76F-70220219D8F8">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2015-06-24 14:02:44 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:2C06E1A4-BE82-418D-9222-0CC8C48C2B8F"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:52EF7CCE-FA13-412F-9B75-99C7ECC2CF8C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>ledipasvir</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:52EF7CCE-FA13-412F-9B75-99C7ECC2CF8C"/>
    <ao:prefix> is coadministered with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:34:51 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix>. Coadministration of HARVONI with simeprevir is not recommended.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:00287984-BF88-4A6C-99E2-7A90C0941499">
    <pav:createdOn>2015-06-24 13:29:01 -0400</pav:createdOn>
    <ao:exact>magnesium hydroxide</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:00287984-BF88-4A6C-99E2-7A90C0941499"/>
    <ao:prefix>ledipasvir .    Antacids (e.g., aluminum and </ao:prefix>
    <ao:suffix>)</ao:suffix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C432C1C1-E088-4A61-83C6-4571E01F0EFB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:3928AF56-FCE2-42C8-BB7E-46DC7C39F7AA"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 13:42:14 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeo:software:id:Domeo-2.1alpha-050">
    <foafx:homepage></foafx:homepage>
    <rdfs:label>Domeo Annotation Toolkit</rdfs:label>
    <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Software"/>
    <foafx:name>Domeo Annotation Toolkit</foafx:name>
    <foafx:version>2.1alpha</foafx:version>
    <foafx:build>050</foafx:build>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8DD5D6B2-A585-46B9-8938-7C3EAE574C1E">
    <ao:exact>Methadone</ao:exact>
    <ao:prefix>(1.07, 1.20)  1.06 (1.01, 1.12)  NA    </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>        30 to 130 daily       </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 14:03:19 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8DD5D6B2-A585-46B9-8938-7C3EAE574C1E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BCF38BE6-95B6-4AB2-B90A-D9BE13FB20BF">
    <pav:createdOn>2015-06-24 13:30:02 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> phenobarbital  oxcarbazepine  </ao:suffix>
    <ao:prefix>Anticonvulsants :  carbamazepine  </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>phenytoin</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BCF38BE6-95B6-4AB2-B90A-D9BE13FB20BF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BFA1EB0C-6694-4CEC-AB7F-7D2759706880">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> 400 mg) four period crossover thorough QT trial in 59 healthy subjects. At a dose three times the maximum recommended dose, </ao:suffix>
    <pav:createdOn>2015-06-24 13:40:02 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>moxifloxacin</ao:exact>
    <ao:prefix> 400 mg (maximum recommended dosage) and 1200 mg (three times the maximum recommended dosage) on QTc interval was evaluated in a randomized, single-dose, placebo-, and active-controlled (</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BFA1EB0C-6694-4CEC-AB7F-7D2759706880"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:96E13409-55AE-494A-88E1-6AB7B799BB69">
    <ao:suffix>is expected to substantially decrease </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:96E13409-55AE-494A-88E1-6AB7B799BB69"/>
    <ao:exact>PPIs </ao:exact>
    <pav:createdOn>2015-06-18 16:00:09 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <ao:prefix>is not recommended. Co-administration of atazanavir  with </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7D5761CB-DBD2-4B2F-9604-66E8FBEFC88B">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>esomeprazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CF61D783-CD3B-4801-8433-0F92EADFA7C0">
    <ao:prefix>(0.90, 1.05)  1.24 (1.18, 1.30)  NA    Efavirenz/ </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>emtricitabine</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CF61D783-CD3B-4801-8433-0F92EADFA7C0"/>
    <ao:suffix>/ </ao:suffix>
    <pav:createdOn>2015-06-24 14:03:34 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6D1DE281-6653-4634-9592-C6F6CF291354">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:E48EBB8B-130E-48C5-944B-379725C7CEEA"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:939674CF-70F0-42A0-819A-0E47F66BCF05</pav:lineageUri>
    <pav:createdOn>2015-06-18 16:04:14 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N271687b568984fdead9a841d960fb785">
    <domeo:sets rdf:resource="urn:pddi:uuid:70FDCA3E-43B7-4C99-AD31-002FA0ED3E8A"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1EB2A765-DE4F-4598-B61C-42358B32C268">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1EB2A765-DE4F-4598-B61C-42358B32C268"/>
    <pav:createdOn>2015-06-24 13:31:56 -0400</pav:createdOn>
    <ao:prefix> and</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix>. Refer to VIREAD, TRUVADA, or ATRIPLA prescribing information for recommendations on renal monitoring.</ao:suffix>
    <ao:exact> tenofovir DF</ao:exact>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8D37CF1F-26B9-43DB-9341-086783C35A25">
    <pav:createdOn>2015-06-24 13:29:07 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>   H 2 -receptor antagonists ‡  (e.g., </ao:prefix>
    <ao:suffix>)</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8D37CF1F-26B9-43DB-9341-086783C35A25"/>
    <ao:exact>famotidine</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc5836aa368d04301bef855f2d0f5c430">
    <domeo:sets rdf:resource="urn:pddi:uuid:612EDC34-81F0-4ABC-9877-93F8CB72B63C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6DA5CB15-5144-4ACC-976F-D2A68AE4A1F1">
    <ao:prefix>did not differ between subjects who were poor metabolisers of CYP2D6 and those who were extensive metabolisers of CYP2D6, further supporting the limited role of CYP2D6 in </ao:prefix>
    <pav:createdOn>2015-06-24 14:54:11 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>6DA5CB15-5144-4ACC-976F-D2A68AE4A1F1</domeo:uuid>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:suffix>disposition in vivo. </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>ondansetron </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6DA5CB15-5144-4ACC-976F-D2A68AE4A1F1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E3720D1D-2FEA-42A6-9B73-97DE66DF6E73">
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 14:06:00 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:B8CFEE24-A7C8-4774-A2E2-0C154B0FD8F5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:653BC8BE-F6D5-4135-848B-89867CA18491">
    <ao:suffix>have been conducted [</ao:suffix>
    <ao:exact>PPIs </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>. However, no formal drug interaction studies of methotrexate  with </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:653BC8BE-F6D5-4135-848B-89867CA18491"/>
    <pav:createdOn>2015-06-18 16:04:16 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F0D670FF-56BA-40ED-BD33-8DBCED1DE0E3">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:48D88A72-F200-42C1-A797-BB3A83818893"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B13439A7-2217-4393-820A-4C2ED080B5C5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>B13439A7-2217-4393-820A-4C2ED080B5C5</domeo:uuid>
    <ao:prefix>at 4-hour intervals, patients older than 15 years of age exhibited </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B13439A7-2217-4393-820A-4C2ED080B5C5"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ondansetron </ao:exact>
    <pav:createdOn>2015-06-24 14:55:34 -0400</pav:createdOn>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:suffix>pharmacokinetic parameters similar to those of adults. </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:61D778EC-18C0-4E50-9522-578D2479CDE3">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:0DE7A0DD-98FF-4992-880B-5633FB61CECC"/>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2015-06-24 14:44:58 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:904E47B3-531B-456D-9138-357A2F3FB0D8">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>Coadministration of </ao:prefix>
    <ao:suffix> with rosuvastatin may significantly increase the concentration of rosuvastatin which is associated with increased risk of myopathy, including rhabdomyolysis. Coadministration of HARVONI with rosuvastatin is not recommended.</ao:suffix>
    <ao:exact>HARVONI </ao:exact>
    <pav:createdOn>2015-06-24 13:35:22 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:904E47B3-531B-456D-9138-357A2F3FB0D8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DE0B112E-6E65-4E8C-9056-E608A16C8C28">
    <ao:exact>ondansetron </ao:exact>
    <domeo:uuid>DE0B112E-6E65-4E8C-9056-E608A16C8C28</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DE0B112E-6E65-4E8C-9056-E608A16C8C28"/>
    <ao:suffix>clearance compared to adults leading to a shorter half-life in most pediatric patients. In patients 1 month to 4 months of age, a longer half-life was observed due to the higher volume of distribution in this age group. </ao:suffix>
    <ao:prefix> In general, surgical and cancer pediatric patients younger than 18 years tend to have a higher </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <pav:createdOn>2015-06-24 14:55:27 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B7AF6CD1-531B-4E74-9EE3-7175F1CC3A1B">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:40B75ED6-1906-4335-8A56-0406C85B9976"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3B1D9D8E-76F9-4581-98E6-770ED398A577">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2015-06-24 13:29:01 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:00287984-BF88-4A6C-99E2-7A90C0941499"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:004EC39E-8FB9-4046-9FB2-F59DE19FE12D">
    <ao:exact>mycophenolic acid (MPA)</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <ao:suffix>, possibly due to a decrease in MMF solubility at an increased gastric pH. The clinical relevance of reduced MPA exposure on organ rejection has not been established in transplant patients receiving PPIs and MMF. Use </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>has been reported to reduce the exposure to the active metabolite, </ao:prefix>
    <pav:createdOn>2015-06-18 16:00:58 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:004EC39E-8FB9-4046-9FB2-F59DE19FE12D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3928AF56-FCE2-42C8-BB7E-46DC7C39F7AA">
    <ao:suffix> was 47 hours.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>HARVONI</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3928AF56-FCE2-42C8-BB7E-46DC7C39F7AA"/>
    <pav:createdOn>2015-06-24 13:42:14 -0400</pav:createdOn>
    <ao:prefix> following administration of </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:FB0AF36D-DB3F-4654-8449-2B0F0BF58348">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/502D56E9-00C9-4713-AE9C-AA98AE07122D"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BB01147D-4F92-4781-B5C0-AD48A3E85F20"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EFFC915D-19FC-4BE0-991B-1A63021209C6">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EFFC915D-19FC-4BE0-991B-1A63021209C6"/>
    <ao:prefix>blood concentrations were decreased. However, on the basis of available data, no dosage adjustment for </ao:prefix>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:suffix> is recommended for patients on these drugs </ao:suffix>
    <ao:exact>ondansetron </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>EFFC915D-19FC-4BE0-991B-1A63021209C6</domeo:uuid>
    <pav:createdOn>2015-06-24 14:45:09 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D897FF57-D178-4757-9FA0-05A94E551C7B">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:A7CB0F46-CABC-45A4-A9BE-26AF180B654F"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:48:18 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 13:57:41 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotation:20BF9277-6252-45ED-9C93-5F672FCE1904</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C9483244-E13A-4C84-B971-0B0A1C6338E6">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> with certain HIV antiretroviral regimens </ao:suffix>
    <pav:createdOn>2015-06-24 13:35:44 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C9483244-E13A-4C84-B971-0B0A1C6338E6"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>HARVONI </ao:exact>
    <ao:prefix> for use of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/56CCB2C2-AE6B-4544-B067-2F765388E339">
    <rdfs:label>St. John’s wort</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:F49FA73C-A632-40A2-A984-8CEE9D40615B">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:comment>Auc decreased</dikbD2R:comment>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7C11BFDC-87F6-41F5-96F3-B0D89DA591EB"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BA89B1CB-1FE1-4065-A319-517551CE67F8">
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:createdOn>2015-06-19 11:07:23 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <ao:body rdf:nodeID="Nb3b1aed679e642a891d2c69dff4e4e0a"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:C8EF4B0D-28FB-4065-A76A-E7AE1896F999</pav:lineageUri>
    <pav:lastSavedOn>2015-06-19 11:13:42 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:9E55F473-6B03-4CBF-BA38-99ACBB369F36"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:191E1785-D944-4F5F-9555-F97370D2505B">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdOn>2015-06-24 13:32:19 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:86CB660B-55FF-4BB9-AD10-C6A9075D4832"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/845A128E-FD6A-44D2-9961-7E5BBB01CD15">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>ketoconazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D5A21A1E-BF42-4ADF-B416-A80B7D1098CF">
    <rdfs:label>esomeprazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F2F330FF-BB9F-4A83-9839-13942A2BED74">
    <rdfs:label>ACIPHEX</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:236C9CAF-ECF0-46BA-81D0-4A5464159BEA">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> dose recovered in urine was</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact> GS-331007 </ao:exact>
    <pav:createdOn>2015-06-24 13:42:22 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix> (78%) while 3.5% was recovered as </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:236C9CAF-ECF0-46BA-81D0-4A5464159BEA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3FAB46DB-F556-4C97-BE13-D6AAAA55A85B">
    <pav:createdOn>2015-06-24 13:41:11 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:B0AF1CF2-C4AD-4ADB-B6B9-3948C3AC55ED"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:571D76BE-9340-47A9-8695-42BF51BFD9BB">
    <pav:createdOn>2015-06-26 14:11:14 -0400</pav:createdOn>
    <ao:prefix>can increase during treatment with ACIPHEX .   </ao:prefix>
    <ao:exact>Concomitant treatment with rabeprazole (20 mg daily) and ketoconazole in healthy subjects decreased the bioavailability of ketoconazole by 30% and increased the AUC and Cmax for digoxin by 19% and 29%, respectively. Therefore, patients may need to be monitored when such drugs are taken concomitantly with rabeprazole. Co-administration of rabeprazole and antacids produced no clinically relevant changes in plasma rabeprazole concentrations</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>571D76BE-9340-47A9-8695-42BF51BFD9BB</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:571D76BE-9340-47A9-8695-42BF51BFD9BB"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5A56CA68-6D95-4468-BC91-84B504A5B1A5">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:6405CD3F-30AB-48B1-A167-9D2E4BD8D10D"/>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdOn>2015-06-24 14:01:11 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:40FB143F-C905-4D97-A0F1-098EBD25BA66">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:7A38085C-2B56-42D7-B6A0-F5E2197E2DF7"/>
    <pav:lineageUri>urn:domeoserver:annotation:BC2BA9A7-626A-489F-AA4D-7AF52DF0BC88</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lastSavedOn>2015-06-24 15:02:21 -0400</pav:lastSavedOn>
    <ao:body rdf:nodeID="N39780304147d47a1b3a9a45b43df7d3f"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 15:00:05 -0400</pav:createdOn>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7F8C8555-4324-48EE-B5F9-0A604F2434B8">
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <pav:createdOn>2015-06-19 11:03:03 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-26 14:52:05 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotation:D870B253-D6AE-4C0A-981A-AEA2C8C233E9</pav:lineageUri>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:D4A0C663-49D4-404F-8671-097616E7C685"/>
    <ao:body rdf:nodeID="Nf70afcce49bd4131a643ef83a37477da"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5335704A-8A43-4545-A959-225A196391F9">
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:55782C06-4587-4091-B11F-6C24A31C7FD6"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:35:18 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1441CBB2-3BBA-413E-B33C-C3076022858E">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:67387524-F14E-4388-8F57-ED887FDD8F90"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:createdOn>2015-06-24 14:45:36 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:48BB5DA3-A213-4558-B6B9-422872085E5C">
    <pav:createdOn>2015-06-24 14:51:56 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:48BB5DA3-A213-4558-B6B9-422872085E5C"/>
    <domeo:uuid>48BB5DA3-A213-4558-B6B9-422872085E5C</domeo:uuid>
    <ao:prefix>has been shown to slow colonic transit in normal volunteers. </ao:prefix>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:exact>Ondansetron </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>has no effect on plasma prolactin concentrations. In a gender-balanced pharmacodynamic study (n = 56), ondansetron 4 mg administered intravenously or intramuscularly was dynamically similar in the prevention of nausea and vomiting using the ipecacuanha m</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DA9F9ECD-BD26-442E-B926-8282B005FB81">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B1A1CCDF-8868-4A2A-AC49-F8C4A52C3257"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:059ABD62-3344-4DC9-A8C4-8FA60469962D">
    <domeo:uuid>059ABD62-3344-4DC9-A8C4-8FA60469962D</domeo:uuid>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:059ABD62-3344-4DC9-A8C4-8FA60469962D"/>
    <ao:prefix> receptor antagonist. While </ao:prefix>
    <ao:exact>ondansetron's </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 14:51:25 -0400</pav:createdOn>
    <ao:suffix>mechanism of action has not been fully characterized, it is not a dopamine-receptor antagonist. </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9BD634E5-955A-4F3C-8635-B79E4BC1A6E1">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 14:01:57 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:0F6282BB-A6BD-48A3-847F-C776B00D9013"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7D13EBA3-8D8C-4CE2-BC68-03D8C1564643">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:E69B96D6-3155-4D15-B187-4125EB54FF53"/>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2015-06-24 14:45:01 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:34ED20FB-CA26-4D2E-AA1C-409B8D395CB9">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/75177B0E-1BCD-4296-B6BC-BE16B82420B0"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7B8F9645-3FCD-4A37-80A9-776EE9040394"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D2EBEF3C-0579-4C55-B9A4-17541E469BCC">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:0E9DF7F2-AFE9-49C4-B153-B36B01257B3B"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6A6BA103-5110-46CD-9B53-DD183FB0D543">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/747FB15F-0E72-4257-9624-4B06694CEBDB"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/44DB02B7-1F3B-4AC3-BB10-DA71DD7AB2D6"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5057A643-C8F2-47DF-BDD6-F3F926418451">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:35:22 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:904E47B3-531B-456D-9138-357A2F3FB0D8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AE55FAC3-E060-4B9A-862A-496E91503E4C">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:A5FB18E2-E185-4935-B0E4-7A2A91710841"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:30:16 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3C9FC6EC-2A3D-460B-BBD3-B0501F806754">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 14:44:49 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:491145C4-A045-430B-8632-0E99B7060139"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D65449E7-A994-4E7D-AE8E-CE069C6AE64E">
    <pav:createdOn>2015-06-24 14:51:12 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:52DBAE18-F40A-4F85-B837-DF62214B31C1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:082B75C9-42FD-4AEE-B0DD-3266529AEC2C">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-19 11:03:41 -0400</pav:createdOn>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <ao:body rdf:nodeID="Naab389bd904445a492837e408be1ea52"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:04AED4E0-37EA-4FCF-B3A3-B465FA2ACFA2</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:lastSavedOn>2015-06-26 14:52:05 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:50AE2A4D-DE93-4327-83DA-1CE8DA0DE6B0"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:61A977E5-A1A0-4D6B-ACF8-89AA4A6B6D67">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:ABBBB1E6-F3E6-415D-912F-310F984B5361"/>
    <pav:createdOn>2015-06-24 14:45:18 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:902CE86B-6323-4EAB-9552-9BFBFF2F9199">
    <ao:prefix>with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:29:51 -0400</pav:createdOn>
    <ao:exact>digoxin</ao:exact>
    <ao:suffix> may increase the concentration of digoxin. Therapeutic concentration monitoring of digoxin is recommended when coadministered with HARVONI.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:902CE86B-6323-4EAB-9552-9BFBFF2F9199"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:872F18C8-D0AF-44B7-A6E2-9D12FD618A39">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:47446137-0611-4F86-B7CA-8FB252835300"/>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 14:05:20 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FA1A4382-FD7A-47B4-9FCA-44A5E1809C8D">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:42:30 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:B224EE88-5B44-4C33-935A-ED47191A441C"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:36FE7C2F-46D1-40AD-BFC9-44ABF32E537C">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:createdOn>2015-06-24 14:45:09 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:EFFC915D-19FC-4BE0-991B-1A63021209C6"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7C11BFDC-87F6-41F5-96F3-B0D89DA591EB">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/3EF7E40C-8233-41C5-BCCC-904C620CD4F0"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/68F0ED1B-E47B-4912-B892-E58EB12E61DC"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BD66ED97-4E22-4011-8972-D1E38A7DE1FE">
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:8B620C0B-4B37-45AB-AA03-5F25386CD688"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:72C61C7F-6C03-476B-98FE-E82B9C59A121">
    <ao:exact>ondansetron </ao:exact>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:72C61C7F-6C03-476B-98FE-E82B9C59A121"/>
    <domeo:uuid>72C61C7F-6C03-476B-98FE-E82B9C59A121</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>is a substrate for multiple human hepatic cytochrome P-450 enzymes, including CYP1A2, CYP2D6, and CYP3A4. In terms of overall </ao:prefix>
    <pav:createdOn>2015-06-24 14:54:04 -0400</pav:createdOn>
    <ao:suffix>turnover, CYP3A4 plays a predominant role while formation of the major in vivo metabolites is apparently mediated by CYP1A2. The role of CYP2D6 in ondansetron in vivo metabolism is relatively minor. </ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:16B39690-B40C-40A7-8FB0-3593FD490671">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:32:15 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:59896E95-617B-4A6C-9EDE-407A0D3D71F9"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7CE6CB8C-CA5F-4917-9556-C8C508345887">
    <ao:suffix> </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>carbamazepine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7CE6CB8C-CA5F-4917-9556-C8C508345887"/>
    <pav:createdOn>2015-06-24 13:30:01 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>is recommended when coadministered with HARVONI.    Anticonvulsants :  </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:62F37051-6F0A-47E6-9E62-BBAFD5D1E4B6">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:42649520-3D6A-4C47-A029-6E77363D8B83"/>
    <pav:createdOn>2015-06-24 13:29:20 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:76F0646B-C8BA-4437-8B3F-931B01C0B560">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2015-06-24 14:51:16 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:6831B321-B7D8-4FD8-BC45-50EF2D7C558D"/>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BFAC1FB6-3FF4-4227-B759-92D5B86F82B1">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2285BD92-3B23-4FE5-8938-8019F6DC68FB"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0017B9A0-A3F5-42F2-B563-1426F9669D9C"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/C9833625-0889-45EC-B4C7-31C60A04365D">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>rabeprazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:55379DA0-98D9-4F93-B6CD-36F967DF0107">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-18 16:01:00 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotation:CB1B8764-F767-49D1-8812-BB69F1196B49</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:78311B59-EEDC-4B8C-924C-A722E8EB1F7E"/>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/502D56E9-00C9-4713-AE9C-AA98AE07122D">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>theophylline</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/10438</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8832B53B-67B5-4528-8ADE-E4B3215A6C39">
    <pav:createdOn>2015-06-24 13:30:35 -0400</pav:createdOn>
    <ao:prefix> or </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>rifapentine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8832B53B-67B5-4528-8ADE-E4B3215A6C39"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9876EF6E-0576-4F83-86E4-057D7EA677EA">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:32:20 -0400</pav:createdOn>
    <ao:exact>darunavir</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>/ritonavir + emtricitabine/tenofovir DF</ao:suffix>
    <ao:prefix>emtricitabine / tenofovir DF ‡   </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9876EF6E-0576-4F83-86E4-057D7EA677EA"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5167B743-CB16-42C5-8D5A-B5DF4B34F33A">
    <pav:createdOn>2015-06-24 14:05:08 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>, and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5167B743-CB16-42C5-8D5A-B5DF4B34F33A"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>GS-331007</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:suffix> was observed with the combination of </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:66CC1BA2-2CE7-4DE3-A256-30CB4D1B6E98">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:66CC1BA2-2CE7-4DE3-A256-30CB4D1B6E98"/>
    <ao:prefix>oxcarbazepine  ↓ ledipasvir ↓ sofosbuvir ↓ </ao:prefix>
    <ao:exact>GS-331007</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:30:09 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D257DA17-D0FB-4233-8104-FBACAC0A0C11">
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:32:26 -0400</pav:createdOn>
    <ao:exact>tenofovir DF</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D257DA17-D0FB-4233-8104-FBACAC0A0C11"/>
    <ao:prefix>darunavir / ritonavir + emtricitabine /</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B55F4B0E-9FE1-4AD3-90C2-B9641F3D979E">
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:958B4D9F-3D88-4981-B552-B38331011C1E"/>
    <pav:previousVersion>urn:domeoclient:uuid:7e333e71-de31-4d19-9e13-65096f431517</pav:previousVersion>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-19 10:55:03 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:861d7355-bd05-4520-a9bc-7cbebbde07d6</pav:lineageUri>
    <ao:body rdf:nodeID="N7f612467a976422b87cabdc25bfc3bdd"/>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:createdOn>2015-06-19 10:54:04 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0017B9A0-A3F5-42F2-B563-1426F9669D9C">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>phenytoin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8FE4CE20-53DF-4EB7-A588-F2A4BA003CFB">
    <ao:context rdf:resource="urn:domeoclient:uuid:54D54E55-63DC-4D98-B3F4-72030A66E9F3"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:31:13 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:56EA7F48-3179-452B-BB6A-F74C96533A0D">
    <sio:SIO_000563>poc:MonitoringRecommendation</sio:SIO_000563>
    <dct:description>A required monitoring recommendation is related to the pharmacogenomic biomarker.</dct:description>
    <rdfs:label>Required</rdfs:label>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
    <poc:MonitoringRecommendation>http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#required</poc:MonitoringRecommendation>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1177FD1D-7161-46FA-BEAB-3C134CC80E41">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:651CDE74-8C4C-4728-B528-64420A01F53B"/>
    <pav:createdOn>2015-06-24 13:33:44 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2266C4AF-AC87-4B18-8A9C-67EAAC8C0856">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:8E19D51E-2EA3-4E48-988D-0448052B2201"/>
    <pav:createdOn>2015-06-24 13:32:01 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BADB6CA6-59E1-4D0B-9033-7F41FCE21402">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <ao:prefix>    </ao:prefix>
    <ao:exact>7.8 Clopidogrel\nConcomitant administration of rabeprazole and clopidogrel in healthy subjects had no clinically meaningful effect on exposure to the active metabolite of clopidogrel [see Clinical Pharmacology (12.3)]. No dose adjustment of clopidogrel is necessary when administered with an approved dose of ACIPHEX</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-18 16:05:33 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BADB6CA6-59E1-4D0B-9033-7F41FCE21402"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:761B7445-EC65-4123-AE80-12D835EEB212">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:32:14 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>atazanavir</ao:exact>
    <ao:suffix>/ritonavir + emtricitabine/tenofovir DF</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:761B7445-EC65-4123-AE80-12D835EEB212"/>
    <ao:prefix>HIV protease inhibitor / ritonavir   </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4457E9A8-D9EA-47EC-AA1C-3AD9C77BFCC5">
    <pav:createdOn>2015-06-24 14:45:11 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:20429E4F-8E28-48E0-BC41-B2F25BCF6BD6"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8737A8AA-3C3D-4143-8FEE-54CF3A7E0DF3">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 13:34:40 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:3FC2EE0A-F56F-4C08-848D-9D77FA4529F3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:38CB78BF-DC15-48C6-A716-48D1CD385058">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:28:59 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:E3A1E355-6379-422A-8750-D66F734250F8"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8FCA2599-BD79-40F4-8F97-F64C92FA23F1">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> are not inhibitors or inducers of CYP or UGT1A1 enzymes.</ao:suffix>
    <ao:exact>GS-331007</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>, and </ao:prefix>
    <pav:createdOn>2015-06-24 14:05:23 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8FCA2599-BD79-40F4-8F97-F64C92FA23F1"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3A1B602D-D416-4C4F-8F16-84F1EF4EFBD4">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:FB0AF36D-DB3F-4654-8449-2B0F0BF58348"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DBF1748F-4743-43A5-802F-7F6A5BAA2817">
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:1967A102-179C-4E95-AFB2-07C7F77F9AB0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:30:48 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0F1220E5-7287-4DFB-9D3B-63657827D948">
    <ao:body rdf:nodeID="N5a32af61902b44d6b4541247835fdaa5"/>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <ao:context rdf:resource="urn:domeoclient:uuid:72AED27D-3AC6-4665-8190-9DF45F455F74"/>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoclient:uuid:7e333e71-de31-4d19-9e13-65096f431517</pav:previousVersion>
    <pav:createdOn>2015-06-19 10:53:45 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-19 10:55:03 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:861d7355-bd05-4520-a9bc-7cbebbde07d6</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:20613D2E-4479-4E63-9CF4-13340FDAAFA7">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:DE6D312C-F6A9-4C6B-968E-C217B1E67A32"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:2DCBAB84-202D-41C3-B8EB-9CD9D668C3DF">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
    <dct:description>none</dct:description>
    <sio:SIO_000563>poc:PharmacokineticImpact</sio:SIO_000563>
    <rdfs:label>None</rdfs:label>
    <poc:PharmacokineticImpact>http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#none</poc:PharmacokineticImpact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F2AA53CF-62A0-4AC1-A905-90234DD019B3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F2AA53CF-62A0-4AC1-A905-90234DD019B3"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>, emtricitabine, tenofovir DF</ao:suffix>
    <ao:exact>cobicistat</ao:exact>
    <ao:prefix>prescribing information for recommendations on renal monitoring.    elvitegravir , </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:33:18 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/923C852E-9E60-45D1-B269-C7C882139095">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>phenytoin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9E55F473-6B03-4CBF-BA38-99ACBB369F36">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <pav:createdOn>2015-06-19 11:07:23 -0400</pav:createdOn>
    <ao:prefix>rifampin with esomeprazole sodium .   </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9E55F473-6B03-4CBF-BA38-99ACBB369F36"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:exact>Coadministration of oral contraceptives, diazepam, phenytoin, or quinidine did not seem to change the pharmacokinetic profile of esomeprazole</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:643DBABA-8C4A-43E8-93E6-2320F0D96797">
    <ao:context rdf:resource="urn:domeoclient:uuid:3E79B94A-C1D1-42A0-9BE4-E700237B5197"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2015-06-24 14:51:37 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4F608AE8-73E3-45A3-91FF-C711F5986F79">
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <pav:createdOn>2015-06-26 14:49:36 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <ao:body rdf:nodeID="Nbcb160cca789440d90940d7edf7d5a0a"/>
    <pav:lastSavedOn>2015-06-26 14:52:05 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:374263A0-89AD-4319-AFD7-9BB878C3A63D"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:DE1282D2-0CE4-41FD-B2D4-F234641CE120</pav:lineageUri>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1DC72C25-E026-40E5-AB15-7CB214A5F36F">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 14:06:14 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:8BB81D03-111D-46E8-89AC-A3029079CBBB"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:979A2048-B848-4C06-B910-9ED52FDE4CEA">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:7903C81D-5A98-4BDB-9DCF-0DB798FF5898"/>
    <pav:lastSavedOn>2015-06-26 14:32:43 -0400</pav:lastSavedOn>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotation:50B227FA-E7FC-4980-A526-E9A572C7DCD5</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:createdOn>2015-06-18 16:01:56 -0400</pav:createdOn>
    <ao:body rdf:nodeID="Nc5680043a69447c19a99ef3d23f460be"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FA91C7E9-2B6A-4A0C-9FCB-2F69AEBD76AD">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:21558B94-8A86-4139-B3BD-4F57FB4C76A6"/>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 14:54:07 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/ED5E9AE9-DAAF-4160-BAD0-00136C7381C4">
    <dikbD2R:dose>0.02</dikbD2R:dose>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>digoxin</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3407</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4027E3E0-E55D-4A0D-B3AA-3FA3115F7671">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9B81E126-FBB0-41AB-9685-DF52FE773F0D"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N22fc3e8b79134219bad4f1e679e5554a">
    <domeo:sets rdf:resource="urn:pddi:uuid:4528B99F-3151-4F9E-BF26-4F9318E8B1A2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5B185B3E-4902-4438-85F1-43A683ADE7AD">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix> </ao:suffix>
    <ao:exact>GS-331007</ao:exact>
    <ao:prefix>were 18% and 9% higher, respectively. Population pharmacokinetics analysis in HCV-infected subjects indicated that cirrhosis had no clinically relevant effect on the exposure of sofosbuvir  and </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5B185B3E-4902-4438-85F1-43A683ADE7AD"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:50:54 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2E9B5294-578E-49DB-9868-9FF3A8F509B0">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/90DCD95F-3E59-4340-8C27-DD75DD24089E"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/86651D12-A534-403C-9392-73B8DD0A7979"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/AE2722CE-DF8F-437A-A4B0-E889E3B874C5">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>rabeprazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B60B4D20-6D08-4BFF-A854-44D21AE1B689">
    <ao:prefix>xsd:String</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B60B4D20-6D08-4BFF-A854-44D21AE1B689"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> </ao:suffix>
    <ao:exact>7.4 Compounds Dependent on Gastric pH for Absorption\nDue to its effects on gastric acid secretion, rabeprazole can reduce the absorption of drugs where gastric pH is an important determinant of their bioavailability. Like with other drugs that decrease the intragastric acidity, the absorption of drugs such as ketoconazole, atazanavir, iron salts, erlotinib, and mycophenolate mofetil (MMF) can decrease, while the absorption of drugs such as digoxin can increase during treatment with ACIPHEX.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <domeo:uuid>B60B4D20-6D08-4BFF-A854-44D21AE1B689</domeo:uuid>
    <pav:createdOn>2015-06-26 14:05:44 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C37C664C-2740-4C3F-90C2-2343DA0C4901">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/845A128E-FD6A-44D2-9961-7E5BBB01CD15"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C9833625-0889-45EC-B4C7-31C60A04365D"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/22460253-6B38-4836-9B75-A5D0884CC9B9">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>rabeprazole</rdfs:label>
    <dikbD2R:dose>0.02</dikbD2R:dose>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9897BDAC-2F1A-4DA5-A01F-C2A99F2B368F">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/942F6894-2A7C-41BD-8C67-92964FA36266"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0CB4E5E7-F725-4D85-868C-79CF71B4DEA8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:838E04C1-789B-4C6A-BD3C-15C2DCA662F2">
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A70E203A-CE36-4AEA-AF8A-60C1DC7BE942"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A9DF38FE-4E34-4990-9A79-C1B7044B92FC">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 14:06:26 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:4D1CAE97-5AE6-470B-B5CB-AD33D4969966"/>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5127D1F2-886B-4124-96C2-EEB595CD3FA6">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:302ED0D4-6A0C-4919-AAA6-9119B0A2555F"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:32:24 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3826C72E-AC80-447B-B666-54C904FF490A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> which is associated with increased risk of myopathy, including rhabdomyolysis. Coadministration of HARVONI with rosuvastatin is not recommended.</ao:suffix>
    <ao:prefix> may significantly increase the concentration of </ao:prefix>
    <pav:createdOn>2015-06-24 13:35:25 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3826C72E-AC80-447B-B666-54C904FF490A"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>rosuvastatin </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:988C1C39-10DA-4277-BE55-59F08BF4A209">
    <pav:createdOn>2015-06-24 14:01:40 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>(0.53, 0.69)  1.04 (0.90, 1.20)  NA    </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:988C1C39-10DA-4277-BE55-59F08BF4A209"/>
    <ao:exact>Darunavir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>/ ritonavir</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BA7CEFC5-C16D-45AB-90AE-2F8C30FC9D3B">
    <rdfs:label>ddi Annotation</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:2284e984-435c-475d-8023-97355b70469b</pav:lineageUri>
    <pav:createdOn>2015-06-18 15:53:26 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-26 14:10:58 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:D645D2F4-4D34-4A9F-B51F-F0E2A0F9826D</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <ao:context rdf:resource="urn:domeoclient:uuid:7B4971BC-781B-47AB-8490-5EBDE1B7FB12"/>
    <ao:body rdf:nodeID="Nbd92d633624b4761b4e4e53835069d5d"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AA6BF2C5-504B-46F6-96A1-FBBB5D7C5F0C">
    <ao:context rdf:resource="urn:domeoclient:uuid:988C1C39-10DA-4277-BE55-59F08BF4A209"/>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 14:01:40 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/37342EBC-ED7A-4968-97EB-3B77732F1910">
    <rdfs:label>oral contraceptives</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-group"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8CADFD93-246B-4A98-91B0-A17EC4624EF5">
    <ao:prefix> 20 mg or lower can be administered simultaneously with </ao:prefix>
    <ao:suffix> under fasted conditions.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8CADFD93-246B-4A98-91B0-A17EC4624EF5"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:29:26 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:exact>HARVONI </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:14E27C56-973F-4122-97E2-0DEB66E2B193">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:14E27C56-973F-4122-97E2-0DEB66E2B193"/>
    <pav:createdOn>2015-06-24 14:45:04 -0400</pav:createdOn>
    <ao:suffix>was significantly increased and ondansetron blood concentrations were decreased. However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs </ao:suffix>
    <ao:exact>ondansetron </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:prefix>), the clearance of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>14E27C56-973F-4122-97E2-0DEB66E2B193</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0921F6A0-7C95-46CE-A167-964D87440BED">
    <rdfs:label>Esomeprazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dikbD2R:dose>0.02</dikbD2R:dose>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AB52480B-A3C7-4EB8-B73F-037304C55455">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:40:43 -0400</pav:createdOn>
    <ao:suffix> (N=1542), and GS-331007 (N=2113) were 7290, 1320, and 12,000 ng∙hr/mL, respectively. Steady-state C</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sofosbuvir</ao:exact>
    <ao:prefix> (N=2113), </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AB52480B-A3C7-4EB8-B73F-037304C55455"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:85B7FC8D-6847-450F-87A2-A8DBB01431DE">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:comment>decreased plasma concentrations of clopidogrel
</dikbD2R:comment>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:A033FB49-DA40-4AF7-B1A7-9794F12537F3"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A033FB49-DA40-4AF7-B1A7-9794F12537F3">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8A460368-E52E-454E-80C8-AAEBEB805956"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/669D7ACD-B189-4B8A-9EEB-A3C19BCC5FA8"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:82CA4A6F-BCFF-40AC-8125-A7CB049FCC68">
    <pav:createdOn>2015-06-24 14:03:11 -0400</pav:createdOn>
    <ao:suffix>        150 once daily        </ao:suffix>
    <ao:exact>Simeprevir</ao:exact>
    <ao:prefix>(0.56, 0.76)  0.41 (0.36, 0.48)  NA    </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:82CA4A6F-BCFF-40AC-8125-A7CB049FCC68"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D55C8880-190E-42D0-8546-27C63EC5BE1D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 14:45:03 -0400</pav:createdOn>
    <ao:exact>rifampin</ao:exact>
    <ao:suffix>), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased. However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D55C8880-190E-42D0-8546-27C63EC5BE1D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:prefix>, and </ao:prefix>
    <domeo:uuid>D55C8880-190E-42D0-8546-27C63EC5BE1D</domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1D3D992D-A6FC-49F3-8570-E367501F67A7">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:29:26 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:8CADFD93-246B-4A98-91B0-A17EC4624EF5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3FC2EE0A-F56F-4C08-848D-9D77FA4529F3">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.    H CV Products :  </ao:prefix>
    <pav:createdOn>2015-06-24 13:34:40 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3FC2EE0A-F56F-4C08-848D-9D77FA4529F3"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>simeprevir</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FCFF4854-36D6-46AA-B637-5C0211E1AFD6">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> </ao:suffix>
    <pav:createdOn>2015-06-24 14:45:43 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>FCFF4854-36D6-46AA-B637-5C0211E1AFD6</domeo:uuid>
    <ao:prefix> and </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FCFF4854-36D6-46AA-B637-5C0211E1AFD6"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:exact>serotonin and noradrenaline reuptake inhibitors (SNRIs)</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:78A43EB9-2F9F-4AD1-919A-96196AACBCDC">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:78A43EB9-2F9F-4AD1-919A-96196AACBCDC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>/ritonavir + emtricitabine/tenofovir DF</ao:suffix>
    <ao:prefix>emtricitabine / tenofovir DF ‡   </ao:prefix>
    <pav:createdOn>2015-06-24 13:32:28 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>lopinavir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/E6AF9E8F-6C4D-44B4-AC2B-394622D64DF4">
    <rdfs:label>esomeprazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:20429E4F-8E28-48E0-BC41-B2F25BCF6BD6">
    <ao:exact>Tramadol</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 14:45:11 -0400</pav:createdOn>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:20429E4F-8E28-48E0-BC41-B2F25BCF6BD6"/>
    <domeo:uuid>20429E4F-8E28-48E0-BC41-B2F25BCF6BD6</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>      Although there are no dat</ao:suffix>
    <ao:prefix>   7.4 </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B9A9B58E-E7D3-4A0E-B34C-D1B901EA610D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdOn>2015-06-24 13:33:20 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:FE7E64CB-2E0C-43D0-9AFA-5EE8A9AD3FC4"/>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BDBF440D-6632-4AFB-B15C-575526524672">
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-19 11:05:41 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:34EEF21E-8262-4DAD-8E73-AAC8376E2E64</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:2672E918-5322-4FD6-AA25-69FB201435DD"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-19 11:13:42 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:929B1C40-721A-407F-8A09-CD90300E71A2">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 13:35:05 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:455671EF-A282-4814-96C5-826043846A2F"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:87EF0115-C8CB-4EEA-8E06-EC31B768F498">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:31:05 -0400</pav:createdOn>
    <ao:suffix>. Coadministration is not recommended.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:87EF0115-C8CB-4EEA-8E06-EC31B768F498"/>
    <ao:exact>HARVONI</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix> is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4E05A927-F710-4834-81AA-9BD904D8879B">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:48BDA0FE-0C55-4945-98E7-358610650E2D"/>
    <pav:createdOn>2015-06-24 13:29:32 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:03930415-4E35-4388-9115-172DE3D97ED4">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:03930415-4E35-4388-9115-172DE3D97ED4"/>
    <ao:exact>Anticonvulsants</ao:exact>
    <ao:suffix>:</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>is recommended when coadministered with HARVONI.    </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 13:29:56 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C02B0785-064D-41D8-B5C1-A51F4BC80C3E">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 14:51:06 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:404C8183-3E9F-4FE4-ABAA-0C6D4A41C8E1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8DD4AC30-CA18-47FC-B406-B6AB138A8391">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>tenofovir</ao:exact>
    <ao:prefix>Monitor for </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8DD4AC30-CA18-47FC-B406-B6AB138A8391"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>-associated adverse reactions in patients receiving HARVONI concomitantly with the combination of efavirenz, emtricitabine and tenofovir DF. Refer to VIREAD, TRUVADA, or ATRIPLA prescribing information for recommendations on renal monitoring.</ao:suffix>
    <pav:createdOn>2015-06-24 13:31:48 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E311870E-9D37-4C98-A213-27DD0EFE6E65">
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:31:31 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:4D74B658-A9ED-40C0-8306-F72545868C5C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6550BB9A-B58D-4EFE-9290-8325F58F3970">
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdOn>2015-06-24 13:31:34 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:DCC00389-BD30-4E81-8333-8687C61E4E08"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:811D3C21-D390-48BA-9A80-33FBEF495DB1">
    <ao:suffix>, no clinically significant drug interactions have been either observed or are expected when HARVONI is used with the following drugs individually </ao:suffix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:811D3C21-D390-48BA-9A80-33FBEF495DB1"/>
    <pav:createdOn>2015-06-24 13:35:37 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>HARVONI</ao:exact>
    <ao:prefix>) or </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:02DD69E3-5EAA-493C-915F-E0671CEC31DB">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:35:37 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:811D3C21-D390-48BA-9A80-33FBEF495DB1"/>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:163E445A-9B45-4FEB-8FAA-8BEC5E8EB605">
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:163E445A-9B45-4FEB-8FAA-8BEC5E8EB605"/>
    <ao:exact>amiodarone</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>under fasted conditions.    Antiarrhythmics:  </ao:prefix>
    <pav:createdOn>2015-06-24 13:29:29 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nac12e3de40b2499698a501eab97baf26">
    <domeo:sets rdf:resource="urn:pddi:uuid:E6B970A0-A5AC-46A9-B86C-69DFD8FDF319"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1B3DD780-4249-46E6-8BF2-E7194584147C">
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>7.1 Drugs Metabolized by CYP450\nRabeprazole is metabolized by the cytochrome P450 (CYP450) drug metabolizing enzyme system. Studies in healthy subjects have shown that rabeprazole does not have clinically significant interactions with other drugs metabolized by the CYP450 system, such as warfarin and theophylline given as single oral doses, diazepam as a single intravenous dose, and phenytoin given as a single intravenous dose (with supplemental oral dosing). Steady state interactions of rabeprazole and other drugs metabolized by this enzyme system have not been studied in patients.</ao:exact>
    <pav:createdOn>2015-06-18 15:51:34 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>   </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1B3DD780-4249-46E6-8BF2-E7194584147C"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:700E5CED-610C-4858-966A-85628552F3DC">
    <ao:context rdf:resource="urn:domeoclient:uuid:9EA27DBC-5210-464D-A02B-CEA5DABB9772"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 14:51:13 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N9e51d194c96c4e0aae038833f624c5ba">
    <domeo:sets rdf:resource="urn:pddi:uuid:EB325F9F-A70B-4EA8-BAEE-BBA7E15CB734"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0E7045CB-CAF9-4933-83D9-8169B0CE03D8">
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:prefix> </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 14:58:34 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>0E7045CB-CAF9-4933-83D9-8169B0CE03D8</domeo:uuid>
    <ao:exact>Although there are no data on pharmacokinetic drug interactions between ondansetron and tramadol, data from two small studies indicate that concomitant use of ondansetron may result in reduced analgesic activity of tramadol. Patients on concomitant ondansetron self administered tramadol more frequently in these studies, leading to an increased cumulative dose in patient controlled administration (PCA) of tramadol.</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0E7045CB-CAF9-4933-83D9-8169B0CE03D8"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1C55D3E5-CA87-444E-8BCD-38AB5E9E584F">
    <ao:prefix>HARVONI administration by 4 hours.    </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 13:29:09 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:1C55D3E5-CA87-444E-8BCD-38AB5E9E584F"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>H2-receptor antagonists</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F6711DFF-CFA2-4B07-A265-C2C5AC30B690">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-18 16:00:55 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:361A1B67-1CCB-4343-B92D-15A1469B6FF4"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:24EEABF4-98F9-433A-AE87-6AADE13CC7AD</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F87AA69C-7D44-4450-833F-57AAA0D8BCD9">
    <ao:suffix> (</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Based on drug interaction studies conducted with the components of </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F87AA69C-7D44-4450-833F-57AAA0D8BCD9"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>HARVONI</ao:exact>
    <pav:createdOn>2015-06-24 13:35:36 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/60827E1F-0EDD-4A0B-9161-923256C51C60">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>cilostazol</rdfs:label>
    <dikbD2R:dose>0.04</dikbD2R:dose>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB82BD1C-02C8-40B6-B140-530A078C78F5">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 14:01:48 -0400</pav:createdOn>
    <ao:exact>GS-331007</ao:exact>
    <ao:prefix>(1.10, 1.92)  1.34 (1.12, 1.59)  NA    </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>        0.97(0.90, 1.05)      </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EB82BD1C-02C8-40B6-B140-530A078C78F5"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/303A5B53-27D6-4380-96F8-B22BF5A83D3F">
    <rdfs:label>Clopidogrel</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/32968</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A8519DB7-B58A-4167-AEFC-5BECE945A96B">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:7941C001-E123-4BD3-9E52-626E56FA2E67"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:14481787-9288-4199-8F75-34841FB9BB99">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:8141D30A-E77B-4E2A-9686-B3EC33620E7B"/>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:33:45 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8733187C-8E2D-4009-BE51-FA10C6D34EE6">
    <ao:prefix>ritonavir  ↓ ledipasvir ↓ sofosbuvir ↓ </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8733187C-8E2D-4009-BE51-FA10C6D34EE6"/>
    <ao:exact>GS-331007</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:33:42 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>       Coadministration of HAR</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:0768CA5A-42B5-4AEE-898D-336AADC10B13">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
    <poc:Comment>what an awesome annotation!</poc:Comment>
    <rdfs:label>Comment</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BBD78CA8-0F23-4160-8980-2FBAF1FBC9A3">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/8183</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>phenytoin</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9B81E126-FBB0-41AB-9685-DF52FE773F0D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D0897E0D-B76C-4AA1-9B30-0156A7C79883"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/ED5E9AE9-DAAF-4160-BAD0-00136C7381C4"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <dikbD2R:auc>19%</dikbD2R:auc>
    <dikbD2R:numOfParticipants>Unk</dikbD2R:numOfParticipants>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B465E423-580F-444F-9FFF-69B9F7775DA0">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:30:46 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:2365A102-D21A-464A-A29B-BE8AB76393A3"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A15EB1EC-2E30-4C76-8394-8AF897717FD4">
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:31:45 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:exact>tenofovir disoproxil fumarate (DF)</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A15EB1EC-2E30-4C76-8394-8AF897717FD4"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>   efavirenz , emtricitabine , </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:42649520-3D6A-4C47-A029-6E77363D8B83">
    <ao:exact>Proton-pump inhibitors</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:29:20 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:42649520-3D6A-4C47-A029-6E77363D8B83"/>
    <ao:prefix>at a dose that does not exceed doses comparable to famotidine 40 mg twice daily.    </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:032C5193-FA11-4ED7-B116-DFBA6D3BAF56">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 13:41:23 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:A39F9042-ECE2-4FAE-A41A-055CDB59BB81"/>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EDC97344-95CC-41C6-9D02-B413ECCEF2DA">
    <pav:lineageUri>urn:domeoserver:annotation:6E6668C1-676B-43B4-B540-45B4641348B1</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <ao:body rdf:nodeID="N531acc6d94314cc58fc2244a2674e801"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <pav:createdOn>2015-06-19 11:58:06 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:A98985CB-522B-46BC-98AC-239D454225E9"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2015-06-19 12:02:00 -0400</pav:lastSavedOn>
    <rdfs:label>ddi Annotation</rdfs:label>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B84BA1A0-F1CB-4E17-A5BB-11BFB9A5551F">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B84BA1A0-F1CB-4E17-A5BB-11BFB9A5551F"/>
    <ao:exact>GS-331007</ao:exact>
    <ao:suffix>.</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>Population pharmacokinetics analysis in HCV-infected subjects indicated that race had no clinically relevant effect on the exposure of ledipasvir , sofosbuvir , and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:42:49 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:43E026DA-1EEF-46B0-B29F-35C3E6F4276C">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 13:40:43 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:AB52480B-A3C7-4EB8-B73F-037304C55455"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7109E30A-AFD9-4F6E-9F03-147408458FA5">
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2015-06-19 10:53:30 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7109E30A-AFD9-4F6E-9F03-147408458FA5"/>
    <ao:prefix>is extensively metabolized in the liver by CYP2C19 and CYP3A4.   </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <ao:exact>In vitro and in vivo studies have shown that esomeprazole is not likely to inhibit CYPs 1A2, 2A6, 2C9, 2D6, 2E1 and 3A4. No clinically relevant interactions with drugs metabolized by these CYP enzymes would be expected. Drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin, warfarin, quinidine, clarithromycin or amoxicillin. Postmarketing reports of changes in prothrombin measures have been received among patients on concomitant warfarin and esomeprazole therapy. Increases in INR and prothrombin time may lead to abnormal bleeding and even death. Patients treated with proton pump inhibitors and warfarin concomitantly may need to be monitored for increases in INR and prothrombin time</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/ADA3C8B6-0EB7-45B5-8AC5-CE7FCE24E69B">
    <rdfs:label>esomeprazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0D376767-0310-471A-9277-1AB7DEDD4F16">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:createdOn>2015-06-24 14:54:31 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:AD50317C-F9EF-46BC-827B-B24D2D22C267"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:445F16EB-3F7F-4228-86FA-3BD5D2FEE5DE">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:1D4428CF-B747-41FC-AC59-E66228792F0A"/>
    <pav:createdOn>2015-06-18 15:55:17 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <rdfs:label>ddi Annotation</rdfs:label>
    <ao:body rdf:nodeID="N7bf2a9af89cd418596ca00add50b9dc5"/>
    <pav:lineageUri>urn:domeoserver:annotation:3962CB00-E14E-4783-973E-B25643323A54</pav:lineageUri>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3A195713-ED3B-400E-A099-6915D973B78E">
    <ao:exact>sofosbuvir</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3A195713-ED3B-400E-A099-6915D973B78E"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <pav:createdOn>2015-06-24 13:34:43 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix> is expected to decrease the concentration of ledipasvir and </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:828E63F7-E817-4FAF-B199-C1D9B5E70427">
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-18 16:05:36 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-18 16:00:06 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotation:418580C1-5C84-4AD2-BA86-366B22C992C5</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:AB71E1D5-CBAD-47DD-8283-198B63B85A9D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:30A56BFA-B511-451F-8A9C-CF11FEA38C24">
    <domeo:uuid>30A56BFA-B511-451F-8A9C-CF11FEA38C24</domeo:uuid>
    <ao:prefix>   7.8 Alfentanil and </ao:prefix>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <pav:createdOn>2015-06-24 14:51:13 -0400</pav:createdOn>
    <ao:suffix>      Ondansetron does not alte</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Atracurium</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:30A56BFA-B511-451F-8A9C-CF11FEA38C24"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F228A337-0C25-4598-A6D7-3972632751E8">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F228A337-0C25-4598-A6D7-3972632751E8"/>
    <ao:exact>P-gp inducers</ao:exact>
    <ao:suffix> (e.g., rifampin or St. John's wort) may decrease ledipasvir and sofosbuvir plasma concentrations, leading to reduced therapeutic effect of HARVONI, and the use with P-gp inducers is not recommended with HARVONI </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:57:19 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>Ledipasvir and sofosbuvir are substrates of drug transporters P-gp and BCRP while GS-331007 is not. </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CC4F35B7-329F-4B55-BFE4-481AA1B64A04">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>ledipasvir</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:CC4F35B7-329F-4B55-BFE4-481AA1B64A04"/>
    <ao:prefix>90 once daily  400 once daily  29  </ao:prefix>
    <ao:suffix>        1.63 (1.51, 1.75)     </ao:suffix>
    <pav:createdOn>2015-06-24 14:01:58 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6FCFDA02-3B40-49EA-9B7D-6FDF08A81FFB">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 13:33:10 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:20035265-59C4-491F-97B3-DD8040080FCF"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3D946309-429B-4A19-9ECC-1176BCCF3CE8">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1217BA33-631E-4D50-9C28-E7BAB104F41C"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/28A0F9A6-B477-426F-91B8-7EA455F1AD8B"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N3114b77eb06f407a8488e5f296114654">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:59896E95-617B-4A6C-9EDE-407A0D3D71F9">
    <ao:suffix> + emtricitabine/tenofovir DF</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>ritonavir</ao:exact>
    <pav:createdOn>2015-06-24 13:32:15 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>HIV protease inhibitor / ritonavir   atazanavir /</ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:59896E95-617B-4A6C-9EDE-407A0D3D71F9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:70FDCA3E-43B7-4C99-AD31-002FA0ED3E8A">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:F0726269-B103-4C7D-8B6D-5CF480516C0F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5277F21C-DBA3-4147-8BAC-6BC4ADF34904">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:578AFC15-167F-49CE-80DA-29BC4B5BD6B8"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdOn>2015-06-24 13:34:52 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2401D819-850F-400F-B6F5-DC895B0EDDED">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sofosbuvir</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>        1.15 (0.88, 1.50)     </ao:suffix>
    <ao:prefix>(0.69, 0.93)  0.89 (0.76, 1.06)  NA    </ao:prefix>
    <pav:createdOn>2015-06-24 14:02:25 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2401D819-850F-400F-B6F5-DC895B0EDDED"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:17768823-D380-40C1-87DF-2762B3B34989">
    <pav:createdOn>2015-06-24 14:05:30 -0400</pav:createdOn>
    <ao:suffix> 300 once daily</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>       Atazanavir / ritonavir  </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <ao:exact>atazanavir</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:17768823-D380-40C1-87DF-2762B3B34989"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E6197088-A79F-4571-B7CB-60F5FE717210">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E6197088-A79F-4571-B7CB-60F5FE717210"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>amiodarone</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, ledipasvir, and sofosbuvir concentrations unknown</ao:suffix>
    <pav:createdOn>2015-06-24 13:29:31 -0400</pav:createdOn>
    <ao:prefix>Effect on </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B4D9860A-18AF-4A67-ACAD-EC1D46218518">
    <ao:suffix>, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <pav:createdOn>2015-06-24 13:30:17 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:B4D9860A-18AF-4A67-ACAD-EC1D46218518"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sofosbuvir</ao:exact>
    <ao:prefix> and </ao:prefix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EFEEAF21-EECF-46EA-AA1F-EC8F6180E8C2">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F478CD2C-6BBA-465F-9947-A371C80B4218"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/10CF045C-6E22-4275-9107-769531063098"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CB3EA0D4-97D9-43CD-BBBD-999525A30044">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdOn>2015-06-24 13:35:04 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:2B1C1004-DA2D-415A-AE15-37A6F60A0614"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:690341A1-629C-4B14-8A55-7723055B4F58">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotation:EC17085E-0364-4E3C-9272-265489C6DB7A</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:38789AE9-C5B4-4066-9B3C-6FF0EE6D6A3D"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdOn>2015-06-24 13:59:26 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:59:36 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4AFA497F-59E5-4CA5-AAEE-C41F341E31D4">
    <ao:context rdf:resource="urn:domeoclient:uuid:F496E396-6A4F-467A-B135-656E9DD2E072"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 14:45:32 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:43EAE9AD-E5D9-4929-A88B-FD6EFBB155D7">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:43EAE9AD-E5D9-4929-A88B-FD6EFBB155D7"/>
    <ao:prefix>(0.88, 1.42)  1.00 (0.80, 1.25)  NA    </ao:prefix>
    <ao:exact>GS-331007</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>        1.14 (1.01, 1.29)     </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 14:02:52 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:88F1252C-6A02-4C61-827E-329EB2783241">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:536B960A-09DE-4A54-933D-07A62985E494"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EC715926-FDC1-4250-8100-CB32DAA261A2">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>MMF</ao:exact>
    <pav:createdOn>2015-06-18 16:01:04 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>exposure on organ rejection has not been established in transplant patients receiving PPIs and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>. Use </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EC715926-FDC1-4250-8100-CB32DAA261A2"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:932C7A99-78B6-423A-A3D3-67B955F4C7FD">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8F3F06D9-6619-4593-92A6-3C4ED3DEC76B"/>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 14:05:51 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB09A44A-6C89-4F1F-AA4D-B63D2123D037">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:EB09A44A-6C89-4F1F-AA4D-B63D2123D037"/>
    <ao:prefix> and the combination of </ao:prefix>
    <ao:exact>elvitegravir</ao:exact>
    <ao:suffix>, cobicistat, emtricitabine and tenofovir DF has not been established. Coadministration is not recommended.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:33:29 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A1858A61-864E-4FDE-8460-041D4D2FDF8D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 14:02:54 -0400</pav:createdOn>
    <ao:prefix>20 once daily 2 hours prior to ledipasvir  30 single dose  ND  17  </ao:prefix>
    <ao:exact>ledipasvir</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A1858A61-864E-4FDE-8460-041D4D2FDF8D"/>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:81FC4FFB-555E-4BF4-B0D9-BC2A42D39E71">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-24 14:45:06 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <ao:context rdf:resource="urn:domeoclient:uuid:8ED694C0-1E0F-4D71-873D-D442F08A0001"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B101920A-211E-46C5-AEF4-647FEF133794">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:A2067AB5-ED8F-4CDA-8AAD-1EB9B6BF9D03"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdOn>2015-06-24 14:45:16 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:842BEDF4-89A6-4BDC-9ECF-4B8F06EF0857">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:842BEDF4-89A6-4BDC-9ECF-4B8F06EF0857"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>TRUVADA</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix> or </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:33:15 -0400</pav:createdOn>
    <ao:suffix> prescribing information for recommendations on renal monitoring.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/A8303D27-0105-4BB0-B130-485B30A16D3D">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/3322</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>diazepam</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:461052D9-3BF8-462B-AABD-FA1AF2B48E62">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sofosbuvir</ao:exact>
    <ao:prefix>(0.59, 0.75)  0.66 (0.57, 0.76)    </ao:prefix>
    <ao:suffix>        1.03 (0.87, 1.23)     </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:461052D9-3BF8-462B-AABD-FA1AF2B48E62"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 14:01:52 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:887A63A6-BF10-4C0E-A8EF-00E85489CE86">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdOn>2015-06-24 13:35:09 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:DEC633A4-9532-4B17-B849-118DCD1C19D0"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:EB325F9F-A70B-4EA8-BAEE-BBA7E15CB734">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D6B22657-DA20-408B-9AD8-2DF835B2782E"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D47EC487-1A51-4EE1-BA01-FA2A373AF48F">
    <ao:suffix> is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <ao:prefix>, or </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:exact>oxcarbazepine </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D47EC487-1A51-4EE1-BA01-FA2A373AF48F"/>
    <pav:createdOn>2015-06-24 13:30:14 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6F08DE9F-3541-4E03-8D30-0133E039919D">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 13:31:23 -0400</pav:createdOn>
    <ao:prefix> is expected to decrease the concentration of ledipasvir and </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>sofosbuvir</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6F08DE9F-3541-4E03-8D30-0133E039919D"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:93A919B3-139D-437F-85D9-F478A8F945A5">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8A05AE3A-9675-4D6A-84E4-83488C0E40D1"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/354847BF-F3AF-4F2E-88BF-514BAB0C8329"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:01C92373-EA9B-42D5-B735-F626BA94BFEC">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>Coadministration of HARVONI with rifampin , a</ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:31:18 -0400</pav:createdOn>
    <ao:suffix>, is not recommended </ao:suffix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact> P-gp inducer</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:01C92373-EA9B-42D5-B735-F626BA94BFEC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2A4594E0-CEA6-4598-A1C5-6BAFA46A0B1F">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix>        150 once daily        </ao:suffix>
    <ao:prefix>(0.59, 0.91)  0.95 (0.81, 1.12)    </ao:prefix>
    <ao:exact>Simeprevir</ao:exact>
    <pav:createdOn>2015-06-24 14:06:09 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2A4594E0-CEA6-4598-A1C5-6BAFA46A0B1F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:55022387-B655-48CF-99B9-ED8A36941A09">
    <ao:prefix>rifampin ‡   rifapentine  ↓ ledipasvir ↓ </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2015-06-24 13:30:29 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sofosbuvir</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:55022387-B655-48CF-99B9-ED8A36941A09"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/1217BA33-631E-4D50-9C28-E7BAB104F41C">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>rofecoxib</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/752D768A-A123-4AEC-894F-A0345EF71DCA">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>iron salts</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N31882d61fc0d44d499622d4548f6c5a5">
    <domeo:sets rdf:resource="urn:pddi:uuid:1B56138D-6FEE-4D1E-9B56-E1A1CBFFCCBF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9AE8B2D3-50AF-402B-B7FD-66B6981C8CF2">
    <ao:context rdf:resource="urn:domeoclient:uuid:7268B6C0-4F0B-49F7-BC4F-C7C7D5A332F2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 14:01:43 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B04C7015-A7E6-45CA-89A9-AFD8230CDB5F">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>naproxen</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:9A8CD8A8-7A92-455C-81E9-02924A3D6EDC">
    <ao:exact>Tacrolimus</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>(1.69, 2.94)  1.92 (1.77, 2.07)  NA    </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:9A8CD8A8-7A92-455C-81E9-02924A3D6EDC"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 14:03:09 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>        5 single dose        N</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:204E82BC-F9BF-47E7-98D0-C9B42DA42B82">
    <ao:suffix>is extensively metabolized in humans, with approximately 5% of a radiolabeled dose recovered as the parent compound from the urine. The primary metabolic pathway is hydroxylation on the indole ring followed by subsequent glucuronide or sulfate conjugatio</ao:suffix>
    <pav:createdOn>2015-06-24 14:52:23 -0400</pav:createdOn>
    <domeo:uuid>204E82BC-F9BF-47E7-98D0-C9B42DA42B82</domeo:uuid>
    <ao:prefix> </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Ondansetron </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:204E82BC-F9BF-47E7-98D0-C9B42DA42B82"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:CDF75166-895C-4707-A0EB-313BA1C31796">
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdOn>2015-06-24 13:40:46 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:18BE6837-88C8-4534-A4B5-C66D6354DFBC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:45BD7451-7DA5-47CA-B1E4-883417062A80">
    <domeo:uuid></domeo:uuid>
    <ao:suffix>F</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:45BD7451-7DA5-47CA-B1E4-883417062A80"/>
    <ao:prefix>(0.90, 1.05)  1.24 (1.18, 1.30)  NA    Efavirenz/ emtricitabine/ </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 14:03:31 -0400</pav:createdOn>
    <ao:exact>tenofovir D</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C683D19D-1255-4D18-97FC-F5859222DD17">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>HARVONI </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C683D19D-1255-4D18-97FC-F5859222DD17"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>-associated adverse reactions in patients receiving </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:suffix> concomitantly with the combination of efavirenz, emtricitabine and tenofovir DF. Refer to VIREAD, TRUVADA, or ATRIPLA prescribing information for recommendations on renal monitoring.</ao:suffix>
    <pav:createdOn>2015-06-24 13:31:50 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:1C327AE5-BB57-458A-BBDD-B13906E86B7B">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:61048C6C-BCA5-4E14-80F1-8C49CC2E17D9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:57B82720-EBC0-42F5-B9CD-4816839A1915">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:57B82720-EBC0-42F5-B9CD-4816839A1915"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>(0.83, 0.97)  1.07 (1.02, 1.13)    Elvitegravir/ </ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 14:03:26 -0400</pav:createdOn>
    <ao:exact>cobicistat</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:361A1B67-1CCB-4343-B92D-15A1469B6FF4">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:361A1B67-1CCB-4343-B92D-15A1469B6FF4"/>
    <ao:suffix>has been reported to reduce the exposure to the active metabolite, mycophenolic acid (MPA), possibly due to a decrease in MMF solubility at an increased gastric pH. The clinical relevance of reduced MPA exposure on organ rejection has not been establishe</ao:suffix>
    <ao:exact>MMF </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-18 16:00:55 -0400</pav:createdOn>
    <ao:prefix>in healthy subjects and in transplant patients receiving </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B4BA4022-38B6-42CE-939D-05E4D5C150BA">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>ACIPHEX</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-product"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E73D6B7D-A3A8-4817-A2C4-32DE510299C5">
    <pav:createdOn>2014-02-19 12:38:23 -0500</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid>E73D6B7D-A3A8-4817-A2C4-32DE510299C5</domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E73D6B7D-A3A8-4817-A2C4-32DE510299C5"/>
    <ao:prefix>xsd:String</ao:prefix>
    <ao:suffix>(</ao:suffix>
    <ao:exact>Consider alternative treatment or treatment strategies in patients identified as CYP2C19 poor metabolizers. </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:2020/SPL-annotation/Clopidogrel-1086a7b4-b89b-4bee-8120-5f752626c046.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4B61F64B-1C15-4E99-80D9-A5A7949357CB">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0B69C0B4-361F-4137-815C-32F438BE267E"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B2B5BB89-7E1A-42BF-893A-66324AE663FB"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:104B7FF8-A012-4E11-A279-807735473525">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-19 11:58:46 -0400</pav:createdOn>
    <ao:exact>Esomeprazole inhibits gastric acid secretion. Therefore, esomeprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability. Like with other drugs that decrease the intragastric acidity, the absorption of drugs such as ketoconazole, atazanavir, iron salts, and erlotinib can decrease, while the absorption of drugs such as digoxin can increase during treatment with esomeprazole. Concomitant treatment with omeprazole (20 mg daily) and digoxin in healthy subjects increased the bioavailability of digoxin by 10% (30% in two subjects). Esomeprazole is an enantiomer of omeprazole. Coadministration of digoxin with esomeprazole is expected to increase the systemic exposure of digoxin. Therefore, patients may need to be monitored when digoxin is taken concomitantly with esomeprazole</ao:exact>
    <ao:prefix>esomeprazole or these NSAIDs .  </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:104B7FF8-A012-4E11-A279-807735473525"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:A4C00902-5DB8-4077-88A1-F7B4CC2EBEDC">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:23935A4D-B0D7-4232-A4D7-0167C734A4E3"/>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:59B1E035-6A8C-4BF9-8F1D-2742EFDDA4FA">
    <ao:suffix>        0.89 (0.61, 1.30)     </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:59B1E035-6A8C-4BF9-8F1D-2742EFDDA4FA"/>
    <pav:createdOn>2015-06-24 14:02:46 -0400</pav:createdOn>
    <ao:exact>ledipasvir</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>90 single dose  400 single dose  16  </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8E19D51E-2EA3-4E48-988D-0448052B2201">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:32:01 -0400</pav:createdOn>
    <ao:prefix>, or </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8E19D51E-2EA3-4E48-988D-0448052B2201"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>ATRIPLA</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix> prescribing information for recommendations on renal monitoring.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B4D1AEB6-8792-4EA0-8BC4-87E834A0C675">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:F899E8A3-98A6-438A-AFD4-9A8B21F4B3B7"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 14:01:49 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D01558B5-53CE-4A1A-8C99-228B68DBDC5A">
    <ao:context rdf:resource="urn:domeoclient:uuid:ADEDE14D-56E2-47B4-9304-3812A20B3C8D"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:28:43 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:previousVersion>urn:domeoclient:uuid:b8f2cc8a-d0ef-4f41-b982-9f169e468ba8</pav:previousVersion>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">3</pav:versionNumber>
    <pav:lastSavedOn>2015-06-24 13:28:47 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D4582CD5-9B22-4B2E-9020-9F4EF253FB14">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:35:29 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:3F3D1271-3762-4DA0-95AD-BF61C81EC16F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:90235EBE-A4E7-450D-AB7E-F2CC75A71763">
    <rdfs:label>Highlight</rdfs:label>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:30:53 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:2B94B81B-FC46-481A-989A-76F7B49B6A77"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:47C4A7F7-5DCE-47D9-A794-A20CD0E2E20B">
    <ao:suffix>/ritonavir</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:47C4A7F7-5DCE-47D9-A794-A20CD0E2E20B"/>
    <ao:prefix>has not been established. Coadministration is not recommended.    </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>tipranavir</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 13:33:36 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3B68D5B8-B7B3-4BCB-808F-FC1E13D6D1A5">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:0C6BD587-9087-4AD2-B848-2D0DE3BD872D"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:41:14 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8700ABFA-812B-4DB1-82DF-BF728BC57F9A">
    <pav:createdOn>2015-06-24 14:51:09 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:3F781073-CE54-47DB-9B1F-44AFDAF561D7"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0DC3EB1B-A0BA-4869-AA2B-BEB0A45B1127">
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:8E50581F-BECF-43A4-843D-DDE76ACB85F3"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 14:45:13 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7B4971BC-781B-47AB-8490-5EBDE1B7FB12">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:prefix> </ao:prefix>
    <domeo:uuid>7B4971BC-781B-47AB-8490-5EBDE1B7FB12</domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7B4971BC-781B-47AB-8490-5EBDE1B7FB12"/>
    <ao:exact>7.2 Warfarin\nThere have been reports of increased INR and prothrombin time in patients receiving proton pump inhibitors, including rabeprazole, and warfarin concomitantly. Increases in INR and prothrombin time may lead to abnormal bleeding and even death [see Warnings and Precautions (5.2)].</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-26 13:50:55 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7242AC02-960A-4EE7-89A3-77DCD1C96663">
    <ao:context rdf:resource="urn:domeoclient:uuid:B8A8356B-72A0-4CE0-9ADD-A8069FB45E7D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 14:01:05 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6E9D94E2-E221-47BE-91E9-50195D6774EB">
    <pav:lastSavedOn>2015-06-26 14:52:05 -0400</pav:lastSavedOn>
    <rdfs:label>ddi Annotation</rdfs:label>
    <ao:body rdf:nodeID="N6d04411ff0cb4933aa5dda94c5018158"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:ABBEC517-E5C1-4888-A497-EB1B76018514"/>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <pav:createdOn>2015-06-19 11:05:16 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:lineageUri>urn:domeoserver:annotation:A7C38261-B98F-445E-98C9-6526CC2C71CF</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B42A7D30-E3E7-4E9F-BD94-C056EC00AC4F">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:35A1B681-2EBE-45D7-A28D-EBB2B0C08AB5"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 13:34:54 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:9B9B313F-F668-40F9-9CFD-A322393CBF20">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:9897BDAC-2F1A-4DA5-A01F-C2A99F2B368F"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ndb790365576f485d930905e5ac6e1425">
    <domeo:sets rdf:resource="urn:pddi:uuid:D47865D2-09FA-4C16-A057-DDD0F8569AC9"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:422409A3-4CF4-48DF-89AC-8EB0DB45F077">
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lastSavedOn>2015-06-26 14:52:05 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-19 10:56:21 -0400</pav:createdOn>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <ao:body rdf:nodeID="N313d47cf12d045179df9c2fccfe37954"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <rdfs:label>ddi Annotation</rdfs:label>
    <ao:context rdf:resource="urn:domeoclient:uuid:7AF29A89-7F66-4B47-BA97-56F06C2BA4E0"/>
    <pav:lineageUri>urn:domeoserver:annotationset:861d7355-bd05-4520-a9bc-7cbebbde07d6</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
    <pav:previousVersion>urn:domeoserver:annotationset:C2921BBA-EB65-46BC-96AD-7D521C66EF16</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D80D5542-0075-4893-AA55-E4B43A7A1D36">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdOn>2015-06-24 14:06:06 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:442D0921-16D4-47CD-A51F-62713F2C30D2"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:60473C32-18E4-4261-BA70-0C982FB8F146">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1E4BFD4B-5E4C-4F29-B6E9-6D0736D12537"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DAEFE458-98DE-4894-8048-A533DF02D0C2"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ADB5A04D-32D0-402A-87A2-E4C2C656B227">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix> exposures. If coadministration is necessary, monitor for tenofovir-associated adverse reactions. Refer to VIREAD or TRUVADA prescribing information for recommendations on renal monitoring.</ao:suffix>
    <ao:prefix> therapy to avoid increases in </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:33:11 -0400</pav:createdOn>
    <ao:exact>tenofovir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:ADB5A04D-32D0-402A-87A2-E4C2C656B227"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:536B960A-09DE-4A54-933D-07A62985E494">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/09536245-2892-4889-BEB4-BB9A3CB25145"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/7D571B13-7F6C-4804-BDDB-64675ECF49FF"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:20BB7686-88A0-4E91-BD4D-B473C525AD83">
    <domeo:belongsToSet>urn:domeoserver:annotationset:4656B862-DEAC-4925-801A-71E7A76EDFAB</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:488967DC-0C5B-48AA-96B2-305C27A92FA9"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdfs:label>ddi Annotation</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:D645D2F4-4D34-4A9F-B51F-F0E2A0F9826D</pav:previousVersion>
    <ao:body rdf:nodeID="N5114ec2ebab74207b4b2e353436f2141"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <dikbD2R:assertionType>drug-drug-interaction</dikbD2R:assertionType>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#ddiAnnotation"/>
    <pav:lineageUri>urn:domeoserver:annotationset:2284e984-435c-475d-8023-97355b70469b</pav:lineageUri>
    <pav:lastSavedOn>2015-06-26 14:10:58 -0400</pav:lastSavedOn>
    <pav:createdOn>2015-06-18 15:54:59 -0400</pav:createdOn>
    <dikbD2R:evidenceType>evidence-supports</dikbD2R:evidenceType>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nbb54013c0dec4f8cb020b0e61188aa22">
    <domeo:sets rdf:resource="urn:pddi:uuid:1C327AE5-BB57-458A-BBDD-B13906E86B7B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:115725FD-18A3-4BCE-A414-AA229DAA8A5E">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>rifampin with esomeprazole sodium . </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:115725FD-18A3-4BCE-A414-AA229DAA8A5E"/>
    <ao:exact> Coadministration of oral contraceptives, diazepam, phenytoin, or quinidine did not seem to change the pharmacokinetic profile of esomeprazole.</ao:exact>
    <pav:createdOn>2015-06-19 11:06:02 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B71C7900-E3D5-4F7D-894C-4F09C688C933">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/33F7F627-DA10-4C65-A133-59CC402FB66B"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D0F03E37-C848-4BC2-BF36-5753658B7A0F"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0A70190C-DBEB-4A2B-87D8-7B5B7678460B">
    <pav:createdOn>2015-06-24 14:04:07 -0400</pav:createdOn>
    <ao:prefix> plasma concentrations without increasing </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0A70190C-DBEB-4A2B-87D8-7B5B7678460B"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>GS-331007</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:suffix> plasma concentration; HARVONI may be coadministered with P-gp and/or BCRP inhibitors. Neither </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8E07AED9-E09F-4EBE-B0E7-527787B7E452">
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:41F591AC-C2DC-4399-BF35-8DA276BE377F"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 14:02:41 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A39F9042-ECE2-4FAE-A41A-055CDB59BB81">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix> is approximately 61–65% bound to human plasma proteins and the binding is independent of drug concentration over the range of 1 µg/mL to 20 µg/mL. Protein binding of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:41:23 -0400</pav:createdOn>
    <ao:exact>GS-331007</ao:exact>
    <ao:suffix> was minimal in human plasma. After a single 400 mg dose of [</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A39F9042-ECE2-4FAE-A41A-055CDB59BB81"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:136B390C-8C34-4141-BBA6-5DFAFCED6DF2">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/A547A908-91EA-4679-AAC9-A0288F769F21"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B08FFDA2-AC9C-4AAD-8D25-4097D3ED00B9"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:5A454442-22BF-444D-8B34-E6B173A6006A">
    <pav:createdOn>2015-06-26 14:04:38 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid>5A454442-22BF-444D-8B34-E6B173A6006A</domeo:uuid>
    <ao:exact>7.4 Compounds Dependent on Gastric pH for Absorption\nDue to its effects on gastric acid secretion, rabeprazole can reduce the absorption of drugs where gastric pH is an important determinant of their bioavailability. Like with other drugs that decrease the intragastric acidity, the absorption of drugs such as ketoconazole, atazanavir, iron salts, erlotinib, and mycophenolate mofetil (MMF) can decrease, while the absorption of drugs such as digoxin can increase during treatment with ACIPHEX.</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:5A454442-22BF-444D-8B34-E6B173A6006A"/>
    <ao:prefix>   </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:731B388B-A97C-478E-8E32-2776BCD6B5BF">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 14:54:11 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:6DA5CB15-5144-4ACC-976F-D2A68AE4A1F1"/>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/4AC1B194-FEE1-4356-9627-E08AA5544AA6">
    <rdfs:label>clarithromycin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/21212</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C42BCBEC-7A53-435C-A8B6-A25482272F15">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>PPIs </ao:exact>
    <ao:prefix>exposure on organ rejection has not been established in transplant patients receiving </ao:prefix>
    <ao:suffix>and MMF. Use </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-18 16:01:03 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C42BCBEC-7A53-435C-A8B6-A25482272F15"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F9739C64-1B7F-440E-835B-AE64A8E649E6">
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:35:11 -0400</pav:createdOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:241A8D99-D4BA-4C88-AE30-093EF0184882"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:342424E7-8453-4746-BF8B-BD4F0051DE01">
    <ao:exact>HARVONI</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:32:36 -0400</pav:createdOn>
    <ao:prefix>concentrations in the setting of </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:suffix> and a HIV protease inhibitor/ritonavir has not been established.</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:342424E7-8453-4746-BF8B-BD4F0051DE01"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:30E100DC-0850-4108-A883-8C57C00E30D1">
    <pav:createdOn>2015-06-24 14:59:49 -0400</pav:createdOn>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid>30E100DC-0850-4108-A883-8C57C00E30D1</domeo:uuid>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>   7.5 Serotonergic Drugs    </ao:prefix>
    <ao:exact>Serotonin syndrome (including altered mental status, autonomic instability, and neuromuscular symptoms) has been described following the concomitant use of 5-HT3 receptor antagonists and other serotonergic drugs, including selective serotonin reuptake inhibitors (SSRIs) and serotonin and noradrenaline reuptake inhibitors (SNRIs)</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:30E100DC-0850-4108-A883-8C57C00E30D1"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:person:uuid:080e1430434f70e501434f711b6e0000">
    <foafx:title></foafx:title>
    <foafx:firstname>Richard</foafx:firstname>
    <foafx:picture>http://www.hcklab.org/images/me/paolo%20ciccarese-boston.jpg</foafx:picture>
    <foafx:lastname>Boyce</foafx:lastname>
    <foafx:middlename></foafx:middlename>
    <foafx:email>rdb20@pitt.edu</foafx:email>
    <foafx:name>boycer</foafx:name>
    <rdfs:label>boycer</rdfs:label>
    <foafx:homepage></foafx:homepage>
    <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Person"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D9042A2D-981F-4997-948A-20F4BE1530DC">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:D9A81B88-900A-4A81-AD11-A05AF559B11B"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdOn>2015-06-24 13:34:59 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DEDD7F05-B206-4D64-B6F0-5A91C8A8EEC4">
    <ao:suffix>, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <ao:prefix> is expected to decrease the concentration of ledipasvir and </ao:prefix>
    <pav:createdOn>2015-06-24 13:30:56 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:DEDD7F05-B206-4D64-B6F0-5A91C8A8EEC4"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sofosbuvir</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2812183B-C211-4A2F-8C39-913F6559C7AE">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2812183B-C211-4A2F-8C39-913F6559C7AE"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>1.04 (0.90, 1.20)  NA    Darunavir / </ao:prefix>
    <ao:exact>ritonavir</ao:exact>
    <ao:suffix>        800/100 once daily    </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 14:01:42 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6405CD3F-30AB-48B1-A167-9D2E4BD8D10D">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6405CD3F-30AB-48B1-A167-9D2E4BD8D10D"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>90 once daily  400 once daily  30  </ao:prefix>
    <pav:createdOn>2015-06-24 14:01:11 -0400</pav:createdOn>
    <ao:exact>ledipasvir</ao:exact>
    <ao:suffix>        1.98(1.78, 2.20)      </ao:suffix>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:1432258A-6DD0-4204-87CF-66BCD8D2CDF9">
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:C8FF165F-E319-4B0C-ABD3-2D3DC899DD18"/>
    <pav:createdOn>2015-06-24 13:35:14 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:442D0921-16D4-47CD-A51F-62713F2C30D2">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:442D0921-16D4-47CD-A51F-62713F2C30D2"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 14:06:06 -0400</pav:createdOn>
    <ao:suffix>        400 twice daily       </ao:suffix>
    <ao:exact>Raltegravir</ao:exact>
    <ao:prefix>(0.94, 1.26)  0.99 (0.80, 1.23)    </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:251C6435-7AAA-4167-BD78-2438E725B90A">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>40 single dose 12 hours prior to HARVONI  12  </ao:prefix>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:exact>ledipasvir</ao:exact>
    <pav:createdOn>2015-06-24 14:02:30 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:251C6435-7AAA-4167-BD78-2438E725B90A"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:141F8C41-36D9-4117-ABFB-E7837CC4D51F">
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>should be considered from the safety perspective for individual patients. There are also some antiretroviral drugs of which unchanged serum levels have been reported when given with omeprazole .  </ao:prefix>
    <domeo:uuid>141F8C41-36D9-4117-ABFB-E7837CC4D51F</domeo:uuid>
    <ao:exact>Studies evaluating concomitant administration of esomeprazole and either naproxen (non-selective NSAID) or rofecoxib (COX-2 selective NSAID) did not identify any clinically relevant changes in the pharmacokinetic profiles of esomeprazole or these NSAIDs</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:141F8C41-36D9-4117-ABFB-E7837CC4D51F"/>
    <pav:createdOn>2015-06-26 14:49:51 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DC22E1FE-4EA4-45F8-B276-DFAB69DD8ED7">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:61119CD0-5DFD-4743-8BA2-379DAED4B42E"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D9A81B88-900A-4A81-AD11-A05AF559B11B">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>is not recommended.    Herbal Supplements :  </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D9A81B88-900A-4A81-AD11-A05AF559B11B"/>
    <ao:suffix> </ao:suffix>
    <pav:createdOn>2015-06-24 13:34:59 -0400</pav:createdOn>
    <ao:exact>St. John's wort</ao:exact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6DD3BADF-D580-4C1F-AB70-0A72CE43EDFB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6DD3BADF-D580-4C1F-AB70-0A72CE43EDFB"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:35:21 -0400</pav:createdOn>
    <ao:exact>rosuvastatin</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>HMG-CoA Reductase Inhibitors :  rosuvastatin  ↑ </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A5D03263-5B70-4D1E-B36D-EBEDBBF48CB4">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A5D03263-5B70-4D1E-B36D-EBEDBBF48CB4"/>
    <ao:prefix>(0.95, 1.09)  1.36 (1.23, 1.49)    </ao:prefix>
    <ao:suffix> 150 once daily</ao:suffix>
    <pav:createdOn>2015-06-24 14:05:44 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>cobicistat </ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E9DA2D16-D099-4E8B-B615-BDA0DDB0F4EB">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> In normal volunteers, single intravenous doses of 0.15 mg/kg of </ao:prefix>
    <domeo:uuid>E9DA2D16-D099-4E8B-B615-BDA0DDB0F4EB</domeo:uuid>
    <ao:exact>ondansetron </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E9DA2D16-D099-4E8B-B615-BDA0DDB0F4EB"/>
    <ao:suffix>had no effect on esophageal motility, gastric motility, lower esophageal sphincter pressure, or small intestinal transit time. In another study in six normal male volunteers, a 16-mg dose infused over 5 minutes showed no effect of the drug on cardiac out</ao:suffix>
    <pav:createdOn>2015-06-24 14:51:47 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E07FEA60-B14C-45B7-AA7F-263F095175D8">
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:B6AA9417-B605-403B-8D84-F6601DB47883"/>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:000AFEA1-6BB6-45ED-8045-525C802EAE91">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>Ledipasvir and sofosbuvir are substrates of drug transporters P-gp and BCRP while GS-331007 is not. P-gp inducers (e.g., rifampin or St. John's wort) may decrease ledipasvir and sofosbuvir plasma concentrations, leading to reduced therapeutic effect of </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:exact>HARVONI</ao:exact>
    <pav:createdOn>2015-06-24 14:04:01 -0400</pav:createdOn>
    <ao:suffix>, and the use with P-gp inducers is not recommended with HARVONI </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:000AFEA1-6BB6-45ED-8045-525C802EAE91"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:95C09FC9-FB7F-430B-B5D4-5E406DA01647">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:6A6828BF-433F-4CD1-B30B-E289117002A2</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:000AFEA1-6BB6-45ED-8045-525C802EAE91"/>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdOn>2015-06-24 14:04:01 -0400</pav:createdOn>
    <pav:lastSavedOn>2015-06-24 14:23:05 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">8</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:508F38A7-D0DF-47C2-9B5E-42A2DC1E5367">
    <domeo:uuid></domeo:uuid>
    <ao:exact>HARVONI</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:508F38A7-D0DF-47C2-9B5E-42A2DC1E5367"/>
    <ao:suffix>. Coadministration is not recommended.</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix> is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 13:30:39 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/BD83F901-9197-47AC-A42D-9878E7EF86AD">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>carmustine</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/65F6B9BE-71BA-4E9B-8D7A-C5546E665CDB">
    <rdfs:label>serotonergic drugs</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/drug-group"/>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N97fde83a367f48f49826abd9686eaaad">
    <domeo:sets rdf:resource="urn:pddi:uuid:4D4C1776-9F2A-4B73-8821-F04F41554819"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AFD9AC8E-AD6D-4AB3-A56E-18DE5E2B01BC">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>(0.41, 0.66)  0.58 (0.48, 0.71)  NA    </ao:prefix>
    <pav:createdOn>2015-06-24 14:03:13 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Rifampin</ao:exact>
    <ao:suffix>‡        600 once daily       </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AFD9AC8E-AD6D-4AB3-A56E-18DE5E2B01BC"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:652D1F96-E16B-46A9-BBD0-FEE114478B79">
    <ao:suffix>        1.00 (0.76, 1.32)     </ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:652D1F96-E16B-46A9-BBD0-FEE114478B79"/>
    <pav:createdOn>2015-06-24 14:02:34 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>sofosbuvir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>(0.69, 1.00)  0.98 (0.80, 1.20)  NA    </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:89F41DCF-C3C4-439E-97EC-ACF92D0BE31F">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:89F41DCF-C3C4-439E-97EC-ACF92D0BE31F"/>
    <pav:createdOn>2015-06-24 13:33:28 -0400</pav:createdOn>
    <ao:exact>HARVONI</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:suffix> and the combination of elvitegravir, cobicistat, emtricitabine and tenofovir DF has not been established. Coadministration is not recommended.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>concentrations in the setting of </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7941C001-E123-4BD3-9E52-626E56FA2E67">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/303A5B53-27D6-4380-96F8-B22BF5A83D3F"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E3A0F170-A7B9-4E6A-BCBA-401A56CAE5D5"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:0F1D1060-98DF-4840-B7DB-AB4C63A9F1A9">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix> </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>The coadministration of ondansetron had no effect on the pharmacokinetics and pharmacodynamics of temazepam</ao:exact>
    <domeo:uuid>0F1D1060-98DF-4840-B7DB-AB4C63A9F1A9</domeo:uuid>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:0F1D1060-98DF-4840-B7DB-AB4C63A9F1A9"/>
    <ao:suffix>xsd:String</ao:suffix>
    <pav:createdOn>2015-06-24 15:01:48 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:DA07967E-A7A2-42C4-83D2-9D077D96A8F3">
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotation:9D179B99-8125-41BF-8084-243B57678F01</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 13:59:36 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:59:30 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:37C14F63-F027-44F6-9356-AD6C13333122"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:4091FF72-B4BE-457A-9263-AB2E085C3B10">
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:8958E28C-CC62-4CE8-85B2-3F91309EE7D7"/>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 14:51:08 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <rdfs:label>Highlight</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:7227C100-BBF1-415F-AC67-74E78FC1D161">
    <domeo:uuid></domeo:uuid>
    <ao:exact>HARVONI</ao:exact>
    <pav:createdOn>2015-06-24 13:28:28 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:7227C100-BBF1-415F-AC67-74E78FC1D161"/>
    <ao:prefix>, and the use with P-gp inducers is not recommended with </ao:prefix>
    <ao:suffix> </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:BF13ABBA-974C-4D13-B3D9-09EF5A6BB2FA">
    <rdfs:label>Alleles</rdfs:label>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
    <ns1:Alleles>ta</ns1:Alleles>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:EB2C9B82-E225-474E-80E2-C58CA140779B">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:B95DB431-068F-49FD-98D2-E14757BE4F1F"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:33:24 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:03DC413E-C1B2-4446-A628-D54A0E14FEF4">
    <ao:exact>St. John's wort</ao:exact>
    <ao:suffix>) may decrease ledipasvir and sofosbuvir plasma concentrations, leading to reduced therapeutic effect of HARVONI, and the use with P-gp inducers is not recommended with HARVONI </ao:suffix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 14:00:47 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>Ledipasvir and sofosbuvir are substrates of drug transporters P-gp and BCRP while GS-331007 is not. P-gp inducers (e.g., rifampin or </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:03DC413E-C1B2-4446-A628-D54A0E14FEF4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D3B52782-ED05-4DF4-9B04-3D8052C961A4">
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdOn>2015-06-24 13:32:00 -0400</pav:createdOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <ao:context rdf:resource="urn:domeoclient:uuid:AEEB7E17-5EEE-4AE1-946C-DEFA401806CF"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:333D5DF9-CAE8-4AAC-A75B-7C07C526D13B">
    <ao:suffix>in Phase 3 trials, 37 subjects (29 with genotype 1a and 8 with genotype 1b) qualified for resistance analysis due to virologic failure (35 with virologic relapse, 2 with breakthrough on-treatment due to documented non-adherence). Post-baseline NS5A and N</ao:suffix>
    <ao:exact>HARVONI </ao:exact>
    <ao:prefix>In a pooled analysis of subjects who received </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 14:06:35 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:333D5DF9-CAE8-4AAC-A75B-7C07C526D13B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:B089813C-4903-460C-BDC1-78023B87AE0D">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/437D7C7A-92E0-462C-8348-6497FA63211F"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C0F4B61B-0C95-4C6B-BC2E-0DC5D987C6EB"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2672E918-5322-4FD6-AA25-69FB201435DD">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>rifampin with esomeprazole sodium .  Coadministration of </ao:prefix>
    <ao:suffix>, </ao:suffix>
    <domeo:uuid></domeo:uuid>
    <ao:exact>oral contraceptives</ao:exact>
    <pav:createdOn>2015-06-19 11:05:41 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2672E918-5322-4FD6-AA25-69FB201435DD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AE080DAC-07A7-407D-8DE8-3B723EE6AC78">
    <ao:context rdf:resource="urn:domeoclient:uuid:1CEE84E7-EE74-47C6-A2FB-414E306D92F4"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotation:DBCB63DE-2AC7-4A1F-9B0F-06A33BF9B672</pav:lineageUri>
    <pav:createdOn>2015-06-19 11:04:15 -0400</pav:createdOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:6950146E-637C-4402-B4DA-DC9EF3440DBA</domeo:belongsToSet>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lastSavedOn>2015-06-19 11:13:42 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/28A0F9A6-B477-426F-91B8-7EA455F1AD8B">
    <rdfs:label>esomeprazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:B68CB993-FF06-42DC-9683-F32CB86AA560">
    <ao:context rdf:resource="urn:domeoclient:uuid:606EE405-D693-4099-9B68-EEBAF0989AD8"/>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:33:17 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F2138CBF-3156-4994-9973-B0FE596799DD">
    <pav:createdOn>2015-06-24 13:29:46 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F2138CBF-3156-4994-9973-B0FE596799DD"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix>       Coadministration of HAR</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>digoxin</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>Adverse Reactions (6.2) ]     digoxin  ↑ </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FCD85EC4-04DD-4DF3-9155-E01E66AFFFA4">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:createdOn>2015-06-24 13:29:04 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <ao:context rdf:resource="urn:domeoclient:uuid:54709A02-DE7C-4CE2-9C5D-7AA7A2C15C51"/>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/F0DF205F-F4F6-447A-8D96-652B0BAD0709">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>mycophenolate mofetil</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:ED252933-988E-4648-8406-1C148CD2E7F6">
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:previousVersion>xsd:String</pav:previousVersion>
    <ao:context rdf:resource="urn:domeoclient:uuid:B13439A7-2217-4393-820A-4C2ED080B5C5"/>
    <pav:createdOn>2015-06-24 14:55:34 -0400</pav:createdOn>
    <rdfs:label>Highlight</rdfs:label>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:958B4D9F-3D88-4981-B552-B38331011C1E">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <ao:prefix>is extensively metabolized in the liver by CYP2C19 and CYP3A4.   </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:958B4D9F-3D88-4981-B552-B38331011C1E"/>
    <ao:exact>In vitro and in vivo studies have shown that esomeprazole is not likely to inhibit CYPs 1A2, 2A6, 2C9, 2D6, 2E1 and 3A4. No clinically relevant interactions with drugs metabolized by these CYP enzymes would be expected. Drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin, warfarin, quinidine, clarithromycin or amoxicillin. Postmarketing reports of changes in prothrombin measures have been received among patients on concomitant warfarin and esomeprazole therapy. Increases in INR and prothrombin time may lead to abnormal bleeding and even death. Patients treated with proton pump inhibitors and warfarin concomitantly may need to be monitored for increases in INR and prothrombin time</ao:exact>
    <pav:createdOn>2015-06-19 10:54:04 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/B08FFDA2-AC9C-4AAD-8D25-4097D3ED00B9">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>warfarin</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/11289</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0F337F95-4751-4C6D-A90B-F434AE7F84BA">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/371E5ECF-93A3-4876-886A-9E45EAA51509"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/37342EBC-ED7A-4968-97EB-3B77732F1910"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:AB5FCEF5-653A-41F7-9D37-1D1D5FEE4915">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>Table 3 provides a listing of established or potentially clinically significant drug interactions. The drug interactions described are based on studies conducted with either </ao:prefix>
    <pav:createdOn>2015-06-24 13:28:40 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:AB5FCEF5-653A-41F7-9D37-1D1D5FEE4915"/>
    <ao:exact>HARVONI</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>, the components of HARVONI (ledipasvir and sofosbuvir) as individual agents, or are predicted drug interactions that may occur with HARVONI </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nbd92d633624b4761b4e4e53835069d5d">
    <domeo:sets rdf:resource="urn:pddi:uuid:BD66ED97-4E22-4011-8972-D1E38A7DE1FE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:2615D048-46FA-4557-B691-24297A4787D9">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
    <poc:MedicalCondition>tmc</poc:MedicalCondition>
    <rdfs:label>MedicalCondition</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Naa5e0bf72cce44f3a3f8197a5323f3a8">
    <domeo:sets rdf:resource="urn:pddi:uuid:FB7A62C6-4E6E-4406-9717-458E36BF511D"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/102BA6E5-B06A-41F3-B840-424D1230569E">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>rabeprazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:2365A102-D21A-464A-A29B-BE8AB76393A3">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:30:46 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:2365A102-D21A-464A-A29B-BE8AB76393A3"/>
    <ao:prefix> is expected to decrease the concentration of </ao:prefix>
    <ao:suffix> and sofosbuvir, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <ao:exact>ledipasvir</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/32941B14-099C-454A-AE54-9C3CD71A33B2">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>ondansetron</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:48FCA91B-3EAD-4029-A1C9-B2768BA5CD0E">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact>digoxin</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>, Adverse Reactions (6.2) ]     </ao:prefix>
    <pav:createdOn>2015-06-24 13:29:45 -0400</pav:createdOn>
    <ao:suffix>       ↑ digoxin       Coadmin</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:48FCA91B-3EAD-4029-A1C9-B2768BA5CD0E"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8D09FC70-23D9-438F-8C23-CD68634F22E6">
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdOn>2015-06-24 13:41:38 -0400</pav:createdOn>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <rdfs:label>Highlight</rdfs:label>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <ao:context rdf:resource="urn:domeoclient:uuid:D83BA006-6847-4773-AF79-65DC01F2DCDB"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/0B69C0B4-361F-4137-815C-32F438BE267E">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>esomeprazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne9c56b5ba8474a9a9187322af8d4fde3">
    <domeo:sets rdf:resource="urn:pddi:uuid:24A8491C-58D3-465E-9751-C3866F42BE74"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:80427841-8733-4D31-B75E-C7B5AC762B29">
    <poc:PharmacokineticImpact>http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#none</poc:PharmacokineticImpact>
    <sio:SIO_000563>poc:PharmacokineticImpact</sio:SIO_000563>
    <rdfs:label>None</rdfs:label>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
    <dct:description>none</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3318F312-0989-4238-ADDF-0ACDE57D79BD">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3318F312-0989-4238-ADDF-0ACDE57D79BD"/>
    <ao:exact>sofosbuvir</ao:exact>
    <pav:createdOn>2015-06-24 14:02:02 -0400</pav:createdOn>
    <ao:suffix>        1.33 (1.14, 1.56)     </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:prefix>(1.64, 1.94)  1.91 (1.76, 2.08)    </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/7D571B13-7F6C-4804-BDDB-64675ECF49FF">
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>esomeprazole</rdfs:label>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3F3D1271-3762-4DA0-95AD-BF61C81EC16F">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>which is associated with increased risk of myopathy, including rhabdomyolysis. Coadministration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 13:35:29 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix> with rosuvastatin is not recommended.</ao:suffix>
    <ao:exact>HARVONI </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:3F3D1271-3762-4DA0-95AD-BF61C81EC16F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:54FE181A-5351-4C93-84BE-B2AFA6411C35">
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:suffix>is contraindicated </ao:suffix>
    <domeo:uuid>54FE181A-5351-4C93-84BE-B2AFA6411C35</domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 14:44:56 -0400</pav:createdOn>
    <ao:exact>ondansetron </ao:exact>
    <ao:prefix>, concomitant use of apomorphine with </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:54FE181A-5351-4C93-84BE-B2AFA6411C35"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/354847BF-F3AF-4F2E-88BF-514BAB0C8329">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>esomeprazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A2DE8B85-AD53-46D3-8EC0-315550708632">
    <domeo:uuid>A2DE8B85-AD53-46D3-8EC0-315550708632</domeo:uuid>
    <pav:createdOn>2015-06-26 14:47:37 -0400</pav:createdOn>
    <ao:exact>Omeprazole has been reported to interact with some antiretroviral drugs. The clinical importance and the mechanisms behind these interactions are not always known. Increased gastric pH during omeprazole treatment may change the absorption of the antiretroviral drug. Other possible interaction mechanisms are via CYP2C19. For some antiretroviral drugs, such as atazanavir and nelfinavir, decreased serum levels have been reported when given together with omeprazole. Following multiple doses of nelfinavir (1250 mg, twice daily) and omeprazole (40 mg daily), AUC was decreased by 36% and 92%, Cmax by 37% and 89% and Cmin by 39% and 75%, respectively, for nelfinavir and M8. Following multiple doses of atazanavir (400 mg daily) and omeprazole (40 mg daily, 2 hr before atazanavir), AUC was decreased by 94%, Cmax by 96%, and Cmin by 95%. Concomitant administration with omeprazole and drugs such as atazanavir and nelfinavir is therefore not recommended. For other antiretroviral drugs, such as saquinavir, elevated serum levels have been reported with an increase in AUC by 82%, in Cmax by 75% and in Cmin by 106% following multiple dosing of saquinavir/ritonavir (1,000 mg/100 mg) twice daily for 15 days with omeprazole 40 mg daily coadministered days 11 to 15. Dose reduction of saquinavir should be considered from the safety perspective for individual patients. There are also some antiretroviral drugs of which unchanged serum levels have been reported when given with omeprazole.</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/069d7015-a2e4-4dbb-8255-2172e22a6300.html</ao:hasSource>
    <ao:prefix>plasma concentrations and thereby reduce its therapeutic effect.  </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix>xsd:String</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A2DE8B85-AD53-46D3-8EC0-315550708632"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0F6E43FF-F96D-4E81-8097-B80CC7151AF2">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/12BCBC47-19C9-4E77-86C9-396A81D17AE2"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/880B6869-AE91-4174-979A-3393AD1D4AEA"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:BFC0CDB7-F6B6-46D4-9C3D-50F1FBE6F9A1">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:BFC0CDB7-F6B6-46D4-9C3D-50F1FBE6F9A1"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>ritonavir</ao:exact>
    <ao:prefix>HARVONI and a HIV protease inhibito r /</ao:prefix>
    <pav:createdOn>2015-06-24 13:32:56 -0400</pav:createdOn>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix> has not been established.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:E270A93B-A228-44D8-98DD-415E4A6D1405">
    <ao:prefix> (primarily at high dose; see methotrexate prescribing information) may elevate and prolong serum levels of </ao:prefix>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/5d103551-978f-472a-9c62-51e6e4dea068.html</ao:hasSource>
    <ao:exact>methotrexate </ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> and/or its metabolite hydroxymethotrexate. However, no formal drug interaction studies of </ao:suffix>
    <pav:createdOn>2015-06-18 16:04:11 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:E270A93B-A228-44D8-98DD-415E4A6D1405"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb3b1aed679e642a891d2c69dff4e4e0a">
    <domeo:sets rdf:resource="urn:pddi:uuid:88F1252C-6A02-4C61-827E-329EB2783241"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N697827ff8fa846b78c1b9161f830168d">
    <domeo:sets rdf:resource="urn:pddi:uuid:4320BBEC-6B55-4B9E-BCB8-E615576F99D3"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/35EAB02B-C746-4C61-926F-DF758E04038E">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>atracurium</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8958E28C-CC62-4CE8-85B2-3F91309EE7D7">
    <pav:createdOn>2015-06-24 14:51:08 -0400</pav:createdOn>
    <domeo:uuid>8958E28C-CC62-4CE8-85B2-3F91309EE7D7</domeo:uuid>
    <ao:suffix>. </ao:suffix>
    <ao:hasSource>	http://dbmi-icode-01.dbmi.pitt.edu/DDI-labels/d89017aa-b8c3-4fd2-8e68-44e2cfd6f290.html</ao:hasSource>
    <ao:exact>methotrexate</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>did not increase blood levels of high-dose </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:8958E28C-CC62-4CE8-85B2-3F91309EE7D7"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:75A84D48-D6B8-434E-86C6-DE82AD308CAB">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <ao:context rdf:resource="urn:domeoclient:uuid:1C55D3E5-CA87-444E-8BCD-38AB5E9E584F"/>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdOn>2015-06-24 13:29:09 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:458FDCF9-BC4F-4EEC-9AB7-FB00991C94E3">
    <ao:prefix> solubility decreases as pH increases. Drugs that increase gastric pH are expected to decrease concentration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 13:28:55 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <ao:exact>ledipasvir</ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:458FDCF9-BC4F-4EEC-9AB7-FB00991C94E3"/>
    <ao:suffix>.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:8B620C0B-4B37-45AB-AA03-5F25386CD688">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AD7B8ABD-B06E-40E2-B1BF-4DBAA0C2F3D8"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8D79383B-2A3E-4E36-9C5F-92DB228F0374"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8036C253-34D4-4A2C-AE41-06A567DB009F">
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/21212</dailymed:activeMoietyRxCUI>
    <rdfs:label>clarithromycin</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:94611C47-47D7-4D38-8EEF-17379EF5BB78">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
    <sio:SIO_000563>poc:DrugSelectionRecommendation</sio:SIO_000563>
    <poc:DrugSelectionRecommendation>http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#alternative-recommended</poc:DrugSelectionRecommendation>
    <dct:description>The pharmacogenomic biomarker is related to a recommendation to use an alternative drug.</dct:description>
    <rdfs:label>Alternative Recommended</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne1f3f4a6200942eb81cdc748c0fc2f9a">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:878B20AD-EEB7-41E0-9875-74CA796015C4">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/328A9BFC-C9D1-4F27-A323-9988E3DE16D0"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/D143698A-7E6F-46CA-8F23-071A8337E3E5"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3580DAFC-9D65-45D8-A93C-CECDA56A1F4E">
    <ao:context rdf:resource="urn:domeoclient:uuid:78A43EB9-2F9F-4AD1-919A-96196AACBCDC"/>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <rdfs:label>Highlight</rdfs:label>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <pav:createdOn>2015-06-24 13:32:28 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6EA9EBAE-DDEF-4493-A525-C7EBD19B43A0">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6EA9EBAE-DDEF-4493-A525-C7EBD19B43A0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:exact>Herbal Supplements</ao:exact>
    <pav:createdOn>2015-06-24 13:34:57 -0400</pav:createdOn>
    <ao:suffix>:</ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>simeprevir is not recommended.    </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:91425A2B-743A-42D7-953D-A9B4896A6A96">
    <ao:prefix>The safety of increased </ao:prefix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:91425A2B-743A-42D7-953D-A9B4896A6A96"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:exact>tenofovir </ao:exact>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:33:25 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:suffix> concentrations in the setting of HARVONI and the combination of elvitegravir, cobicistat, emtricitabine and tenofovir DF has not been established. Coadministration is not recommended.</ao:suffix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:3E8B1646-11E2-415C-80B5-9F81F9937554">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/2B6DE5B1-07D2-474A-80A6-363307A7D6D9"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/836125FD-9114-4165-B3B7-6D009B850F81"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nb9b3c01db8d245459fd2a995ee0bcfc4">
    <domeo:sets rdf:resource="urn:pddi:uuid:6F1DB130-30FB-448D-A104-ADD824A0E9B5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A8F3B4FF-7B64-4E32-B95C-C91881D911EC">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A8F3B4FF-7B64-4E32-B95C-C91881D911EC"/>
    <ao:prefix> have been evaluated in healthy adult subjects and in subjects with chronic hepatitis C. Following oral administration of </ao:prefix>
    <ao:exact>HARVONI</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix>, </ao:suffix>
    <pav:createdOn>2015-06-24 13:40:11 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D7EE8318-ED9C-4ED7-9F37-C173E6FECBC0">
    <ao:suffix> is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>ritonavir</ao:exact>
    <pav:createdOn>2015-06-24 13:33:46 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:D7EE8318-ED9C-4ED7-9F37-C173E6FECBC0"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>/</ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:D0CBB383-05F9-40BD-8EB7-190662945E36">
    <ao:context rdf:resource="urn:domeoclient:uuid:7BE2C8F5-F7F5-4EA5-8A63-74744B527237"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <domeo:belongsToSet>urn:domeoserver:annotationset:3AEAFE61-E492-43A4-B095-43FB51348586</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 14:56:39 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:E2CEFBC4-1D69-40CB-A382-84AA5B9684E2</pav:lineageUri>
    <pav:createdOn>2015-06-24 14:55:22 -0400</pav:createdOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">1</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>xsd:String</pav:previousVersion>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:6C783FB5-B1DF-4953-A17C-D3351874DA5F">
    <pav:createdOn>2015-06-24 14:05:53 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:prefix>0.180/0.215/0.25/</ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix> 0.025 once daily</ao:suffix>
    <ao:exact>ethinyl estradiol </ao:exact>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:6C783FB5-B1DF-4953-A17C-D3351874DA5F"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:4A52E415-9BEF-4919-9BE3-D47ADF169D55">
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:D1896C4A-04E1-4FF4-946F-BA52781461AC"/>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/790F7DD9-B082-43CE-85AF-0A3C94CCEAD9">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>Omeprazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7646</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N30de5a9469fb49feb850732c755f9cd3">
    <domeo:sets rdf:resource="urn:pddi:uuid:B7AF6CD1-531B-4E74-9EE3-7175F1CC3A1B"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ne38325e993d54b91b31032438f348794">
    <domeo:sets rdf:resource="urn:pddi:uuid:B5F1AF2F-264E-4FD5-87DF-6A0D282D56DD"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:A0F0B55C-92C3-42AC-BA8B-D25B34B24813">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
    <sio:SIO_000563>poc:PharmacokineticImpact</sio:SIO_000563>
    <poc:PharmacokineticImpact>http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#metabolism-decrease</poc:PharmacokineticImpact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:91C1CFA2-4D8A-4251-B376-95CE972C903B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/6D0E5332-9579-42E1-9D35-67887E5B604E"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/1317357D-54DA-4F8F-91DE-1604061BC8FD"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:BE46D5BB-4558-4167-AF51-2B679838F53F">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/E66ECD58-5893-4E7B-A359-CEDE3E62DF19"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F2F330FF-BB9F-4A83-9839-13942A2BED74"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ndf1e8dd34684436baeb991b69807a9b0">
    <domeo:sets rdf:resource="urn:pddi:uuid:A8519DB7-B58A-4167-AEFC-5BECE945A96B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:241A8D99-D4BA-4C88-AE30-093EF0184882">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>St. John's wort</ao:exact>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 13:35:11 -0400</pav:createdOn>
    <ao:prefix>with </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:241A8D99-D4BA-4C88-AE30-093EF0184882"/>
    <ao:suffix>, a P-gp inducer is not recommended </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:FCF24CB4-A151-42ED-A71D-5C251DD4ED3F">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:FCF24CB4-A151-42ED-A71D-5C251DD4ED3F"/>
    <ao:exact>carbamazepine</ao:exact>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>with </ao:prefix>
    <ao:suffix>, phenytoin, phenobarbital, or oxcarbazepine is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of HARVONI. Coadministration is not recommended.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <pav:createdOn>2015-06-24 13:30:12 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:2FD5B82E-A631-4EEE-AA57-F2AA5ACAB779">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/87A24CD3-F883-4C83-A060-9363A257B9CF"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/C15D4D58-873C-479E-9A2B-264652E742A2"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:AA18BF65-3F61-4179-8A1D-B73034A9E587">
    <rdfs:label>poor-metabolizer</rdfs:label>
    <sio:SIO_000628>poc:Variant</sio:SIO_000628>
    <poc:Variant>http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#poor-metabolizer</poc:Variant>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
    <dct:description>A specific variant of a gene, including the wild-type allele, or a patient phenotype</dct:description>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:F19A3603-072E-4A60-80CD-CB7B769C3112">
    <ao:prefix> may result in serious symptomatic bradycardia. The mechanism of this effect is unknown. Coadministration of amiodarone with </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:F19A3603-072E-4A60-80CD-CB7B769C3112"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix> is not recommended; if coadministration is required, cardiac monitoring is recommended </ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <pav:createdOn>2015-06-24 13:29:41 -0400</pav:createdOn>
    <ao:exact>HARVONI</ao:exact>
    <domeo:uuid></domeo:uuid>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:D1896C4A-04E1-4FF4-946F-BA52781461AC">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/091B1535-5762-4976-86BA-97D3F802A0CA"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AA78478C-E9A0-4224-98EE-C218B099E493"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/68F0ED1B-E47B-4912-B892-E58EB12E61DC">
    <rdfs:label>omeprazole</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7646</dailymed:activeMoietyRxCUI>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A428BCC0-4A63-443B-BB0D-4B09FAB918E8">
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:suffix>        5 single dose        N</ao:suffix>
    <pav:createdOn>2015-06-24 14:06:12 -0400</pav:createdOn>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A428BCC0-4A63-443B-BB0D-4B09FAB918E8"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>Tacrolimus</ao:exact>
    <ao:prefix>(2.39, 2.86)  2.69 (2.44, 2.96)  NA    </ao:prefix>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:3B42C83D-8558-408E-B626-5FE2649E0072">
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:E280279C-D0B7-4CF4-9EB1-9552A37B93DE</pav:previousVersion>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <ao:context rdf:resource="urn:domeoclient:uuid:BCF38BE6-95B6-4AB2-B90A-D9BE13FB20BF"/>
    <pav:lastSavedOn>2015-06-24 13:30:58 -0400</pav:lastSavedOn>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">4</pav:versionNumber>
    <pav:createdOn>2015-06-24 13:30:02 -0400</pav:createdOn>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:213CED45-C627-4F20-82C8-D940623C4FA6">
    <ao:prefix>(1.42, 1.71)    Elvitegravir / cobicistat  </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:213CED45-C627-4F20-82C8-D940623C4FA6"/>
    <pav:createdOn>2015-06-24 14:05:43 -0400</pav:createdOn>
    <ao:exact>elvitegravir</ao:exact>
    <ao:suffix> 150 once daily</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/669D7ACD-B189-4B8A-9EEB-A3C19BCC5FA8">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>esomeprazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:844425B4-210F-4F94-96EC-2C9EDC2D5EF8">
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:prefix>(1.87, 3.45)  4.53 (3.26, 6.30)  NA    </ao:prefix>
    <ao:suffix>        0.60 (0.53, 0.69)     </ao:suffix>
    <pav:createdOn>2015-06-24 14:01:39 -0400</pav:createdOn>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:exact>GS-331007</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:844425B4-210F-4F94-96EC-2C9EDC2D5EF8"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/87A24CD3-F883-4C83-A060-9363A257B9CF">
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>omeprazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/7646</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:C8FF165F-E319-4B0C-ABD3-2D3DC899DD18">
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:prefix>Coadministration of HARVONI with St. John's wort , a </ao:prefix>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:C8FF165F-E319-4B0C-ABD3-2D3DC899DD18"/>
    <ao:exact>P-gp inducer</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <pav:createdOn>2015-06-24 13:35:14 -0400</pav:createdOn>
    <ao:suffix> is not recommended </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E69C97F3-DD42-4274-BD9F-553DE3648279">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4AC1B194-FEE1-4356-9627-E08AA5544AA6"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/9083FC28-34C3-43F1-ABFD-E19F7094B4A9"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na0b61b3337e74e67bc811e9d9babc295">
    <domeo:sets rdf:resource="urn:pddi:uuid:8E50503E-3FD9-479D-8F85-3CA3446466F4"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:40B75ED6-1906-4335-8A56-0406C85B9976">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BD83F901-9197-47AC-A42D-9878E7EF86AD"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/DEC759BC-5FA0-46B2-A7E1-2F0C417EE7F2"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:979CD2A9-4928-41B1-91F1-0CD2BEEE3158">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:979CD2A9-4928-41B1-91F1-0CD2BEEE3158"/>
    <ao:exact>digoxin</ao:exact>
    <domeo:uuid></domeo:uuid>
    <ao:prefix> may increase the concentration of </ao:prefix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:suffix>. Therapeutic concentration monitoring of digoxin is recommended when coadministered with HARVONI.</ao:suffix>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 13:29:52 -0400</pav:createdOn>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:08F7591C-8D26-49D1-ADED-73CBF6D8583E">
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <dikbD2R:statement>ncit:Qualitative</dikbD2R:statement>
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:C293AFBD-A438-49D6-A16F-C782A2CD92FA"/>
    <dikbD2R:modality>ncit:negative</dikbD2R:modality>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:E63287DF-F8A7-4604-9C55-697F2AD673D0">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/FB32D318-794D-4C21-98A3-C8C4F2989310"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/923C852E-9E60-45D1-B269-C7C882139095"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:6F1DB130-30FB-448D-A104-ADD824A0E9B5">
    <sio:SIO_000563>dikbD2R:modality</sio:SIO_000563>
    <dikbD2R:modality>ncit:positive</dikbD2R:modality>
    <dikbD2R:statement>ncit:quantitative</dikbD2R:statement>
    <sio:SIO_000205>dikbD2R:statement</sio:SIO_000205>
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#DrugDrugInteractionStatement"/>
    <sio:SIO_000628 rdf:resource="urn:pddi:uuid:05814CF8-0DC0-4445-8375-38A95B98775D"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4185661995254120894c47b64a642bfb">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:87720AF2-FAB3-4F5A-8DD9-455898EF2F42">
    <ao:suffix> that cannot be efficiently rephosphorylated and lacks anti-HCV activity in vitro. After a single 400 mg oral dose of [</ao:suffix>
    <ao:prefix> nucleotide biosynthesis pathway. Dephosphorylation results in the formation of nucleoside metabolite</ao:prefix>
    <pav:createdOn>2015-06-24 13:41:50 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <ao:exact> GS-331007</ao:exact>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <domeo:uuid></domeo:uuid>
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:87720AF2-FAB3-4F5A-8DD9-455898EF2F42"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N38cf1b61155a450390c5a07bde12e53e">
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
    <permissions:isLocked>false</permissions:isLocked>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:15CCD238-A976-4247-92FE-21E992A68365">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/4AFA1DB8-57A9-46BF-9D4E-4AD1937D9C5F"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/CF31EF34-410C-4FEB-8776-DC4E017716E0"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/14E1D563-86A2-4C9C-AAFC-2A0C221E712B">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdfs:label>esomeprazole</rdfs:label>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:A9978477-7492-492E-9AD9-0709A5751B0E">
    <ao:hasSelector rdf:resource="urn:domeoclient:uuid:A9978477-7492-492E-9AD9-0709A5751B0E"/>
    <ao:exact> oral contraceptives</ao:exact>
    <ao:prefix>,</ao:prefix>
    <ao:suffix>, </ao:suffix>
    <ao:hasSource>http://dbmi-icode-01.dbmi.pitt.edu:80/DDI-labels/f4ec77e4-bae8-4db0-b3d5-bde09c5fa075.html</ao:hasSource>
    <domeo:uuid></domeo:uuid>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#SpecificResource"/>
    <pav:createdOn>2015-06-24 13:35:42 -0400</pav:createdOn>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#PrefixSuffixTextSelector"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N531acc6d94314cc58fc2244a2674e801">
    <domeo:sets rdf:resource="urn:pddi:uuid:689F1ACF-7F51-4D73-9C1B-A1E74F0035AE"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7bf2a9af89cd418596ca00add50b9dc5">
    <domeo:sets rdf:resource="urn:pddi:uuid:B5B14349-CBE2-4104-8D33-8D1547C5E602"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nc5680043a69447c19a99ef3d23f460be">
    <domeo:sets rdf:resource="urn:pddi:uuid:E07FEA60-B14C-45B7-AA7F-263F095175D8"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N313d47cf12d045179df9c2fccfe37954">
    <domeo:sets rdf:resource="urn:pddi:uuid:4421F6B6-683E-4D48-ADB1-4230ACF03ADB"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf970759d097448d1b3ae1f328a6ae01c">
    <domeo:sets rdf:resource="urn:pddi:uuid:E872450C-D5BC-488E-982F-1E045C60EE53"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/D143698A-7E6F-46CA-8F23-071A8337E3E5">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdfs:label>esomeprazole</rdfs:label>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6d04411ff0cb4933aa5dda94c5018158">
    <domeo:sets rdf:resource="urn:pddi:uuid:D4C6944D-2B65-47FC-A9A5-FFC53D3C0D3B"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Na00921bbbeaf41409ad6144a274966ac">
    <domeo:sets rdf:resource="urn:pddi:uuid:5663414D-5202-44A3-8C33-DBBFB72B34C5"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:linkedspls:uuid:1ED20ED1-FB0C-422E-8105-1ED7D0D52049">
    <rdf:type rdf:resource="http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#PharmacogenomicsStatement"/>
    <dct:description>none</dct:description>
    <sio:SIO_000563>poc:PharmacokineticImpact</sio:SIO_000563>
    <rdfs:label>None</rdfs:label>
    <poc:PharmacokineticImpact>http://purl.org/net/nlprepository/spl-pharmgx-annotation-poc#none</poc:PharmacokineticImpact>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:DE6D312C-F6A9-4C6B-968E-C217B1E67A32">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <dikbD2R:numOfParticipants>Unk</dikbD2R:numOfParticipants>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/F9DC5F39-5E01-4813-9D0A-15DD2D3F918B"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/0921F6A0-7C95-46CE-A167-964D87440BED"/>
    <dikbD2R:auc>10%</dikbD2R:auc>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:C293AFBD-A438-49D6-A16F-C782A2CD92FA">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/ADA3C8B6-0EB7-45B5-8AC5-CE7FCE24E69B"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/BBD78CA8-0F23-4160-8980-2FBAF1FBC9A3"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N506dcfd1e6da4b629b2e2dafd846ad9f">
    <domeo:sets rdf:resource="urn:pddi:uuid:F49FA73C-A632-40A2-A984-8CEE9D40615B"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:domeoclient:uuid:8E0338DD-3BE9-4C9D-9ED2-6B382BB74502">
    <domeo:belongsToSet>urn:domeoserver:annotationset:9E51C3D1-39A2-4652-A15E-F8DF4AA6EE70</domeo:belongsToSet>
    <pav:lastSavedOn>2015-06-24 13:48:04 -0400</pav:lastSavedOn>
    <pav:lineageUri>urn:domeoserver:annotationset:d164de39-dbb0-479a-8c42-eb1525a1eab9</pav:lineageUri>
    <ao:context rdf:resource="urn:domeoclient:uuid:368BC474-49D4-43C7-8063-96E85874F3FA"/>
    <pav:createdOn>2015-06-24 13:42:29 -0400</pav:createdOn>
    <pav:createdBy>urn:person:uuid:080e143043ef9cf90143f8ea240c0005</pav:createdBy>
    <pav:createdWith>urn:domeo:software:id:Domeo-2.0alpha-040</pav:createdWith>
    <rdfs:label>Highlight</rdfs:label>
    <pav:previousVersion>urn:domeoserver:annotationset:C358DE34-DB54-4AEA-8539-B919836090D4</pav:previousVersion>
    <pav:versionNumber rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">5</pav:versionNumber>
    <rdf:type rdf:resource="http://www.w3.org/ns/oa#Highlight"/>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/8A05AE3A-9675-4D6A-84E4-83488C0E40D1">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <rdfs:label>ketoconazole</rdfs:label>
    <sio:SIO_000228>dikbD2R:precipitant-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/6135</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N61aee1e0c3f04be5a27e597a895e1dc0">
    <domeo:sets rdf:resource="urn:pddi:uuid:89CB96C7-C2FE-4074-8ED8-CFAC554F7323"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nf70afcce49bd4131a643ef83a37477da">
    <domeo:sets rdf:resource="urn:pddi:uuid:FA0D7B15-46CE-44A2-B9DB-888B18129207"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N927d1c04f9284410959f2300ca2f719e">
    <domeo:sets rdf:resource="urn:pddi:uuid:A4C00902-5DB8-4077-88A1-F7B4CC2EBEDC"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N39780304147d47a1b3a9a45b43df7d3f">
    <domeo:sets rdf:resource="urn:pddi:uuid:D98C450A-3F5C-4BA5-B5CC-67EE9AAB44E5"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N578a84f95d88403eaab8dec1f0c5170b">
    <permissions:isLocked>false</permissions:isLocked>
    <permissions:accessType>urn:domeo:access:public</permissions:accessType>
  </rdf:Description>
  <rdf:Description rdf:about="file:///home/yin2/python-SPL-connector/97FE176E-F74A-4C89-8D9E-0D61BB262B54">
    <dct:description>Referred to the drug in the interaction.</dct:description>
    <sio:SIO_000228>dikbD2R:object-drug-of-interaction</sio:SIO_000228>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/active-ingredient"/>
    <rdfs:label>ondansetron</rdfs:label>
    <dailymed:activeMoietyRxCUI>http://purl.bioontology.org/ontology/RXNORM/</dailymed:activeMoietyRxCUI>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Naab389bd904445a492837e408be1ea52">
    <domeo:sets rdf:resource="urn:pddi:uuid:F88B4270-3108-4EC5-90F7-AC5AE63F34C1"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nae7a93d397884f7299b4943404c70c03">
    <domeo:sets rdf:resource="urn:pddi:uuid:9978323E-6250-41F4-A8A5-53444DDEFFDC"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N8eea819de9d943d893d6a431c29a2c88">
    <domeo:sets rdf:resource="urn:pddi:uuid:33E27E30-70E8-4B23-A205-68964E913421"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nbcb160cca789440d90940d7edf7d5a0a">
    <domeo:sets rdf:resource="urn:pddi:uuid:D2EBEF3C-0579-4C55-B9A4-17541E469BCC"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N1ad4492e28ff43b69fda229d122263bd">
    <domeo:sets rdf:resource="urn:pddi:uuid:032F234F-9670-4104-81F1-5B1E0045E1AA"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5a32af61902b44d6b4541247835fdaa5">
    <domeo:sets rdf:resource="urn:pddi:uuid:883B4A5D-B0CD-4F31-A00B-1D0931A05171"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:0E9DF7F2-AFE9-49C4-B153-B36B01257B3B">
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/14E1D563-86A2-4C9C-AAFC-2A0C221E712B"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/B04C7015-A7E6-45CA-89A9-AFD8230CDB5F"/>
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6255314984e24015b5482e1701f69c4b">
    <domeo:sets rdf:resource="urn:pddi:uuid:4A52E415-9BEF-4919-9BE3-D47ADF169D55"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N10d0d32cdec74608a170db85d454db7a">
    <domeo:sets rdf:resource="urn:pddi:uuid:F4C99D39-C95C-49D8-9702-01E37B79229C"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N40a1b92c0b8b415fb87e36a0388951ca">
    <domeo:sets rdf:resource="urn:pddi:uuid:76214DD5-F739-4F31-B3BE-FE0AADBFD1AE"/>
  </rdf:Description>
  <rdf:Description rdf:about="urn:pddi:uuid:7AA0718E-EF1F-4DCA-B4A9-1EA6CAC03112">
    <rdf:type rdf:resource="http://dbmi-icode-01.dbmi.pitt.edu:2020/vocab/resource/PK_DDI"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/8134FD05-7D3D-4B7E-84B5-1C353893691D"/>
    <sio:SIO_000132 rdf:resource="file:///home/yin2/python-SPL-connector/AE2722CE-DF8F-437A-A4B0-E889E3B874C5"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7f612467a976422b87cabdc25bfc3bdd">
    <domeo:sets rdf:resource="urn:pddi:uuid:46A5402B-3A8E-4C2B-93DB-5583213BD0D1"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N291820426f55420393d6f9759707134c">
    <domeo:sets rdf:resource="urn:pddi:uuid:6A523E71-53C3-4CC6-8839-C9706F1A7B5A"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Nae898502a0894d49b32a4ea3fd95d8a6">
    <domeo:sets rdf:resource="urn:pddi:uuid:4027E3E0-E55D-4A0D-B3AA-3FA3115F7671"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Ncdb3ef91d86c4c55a4a746f3661b0727">
    <domeo:sets rdf:resource="urn:pddi:uuid:838E04C1-789B-4C6A-BD3C-15C2DCA662F2"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N7188691895a347388a725e864dfda9ff">
    <domeo:sets rdf:resource="urn:pddi:uuid:9B9B313F-F668-40F9-9CFD-A322393CBF20"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N16b475a12c0e4f24b49b0657a1f316ae">
    <domeo:sets rdf:resource="urn:pddi:uuid:2F067E6D-130F-46E7-99E7-C36EB735262A"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N6bdc0f784b5843609a0786b69cadc84b">
    <domeo:sets rdf:resource="urn:pddi:uuid:C207EF3B-85CF-42E7-8A7C-58F0E6A11DC8"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N2c773e08fe7546c7aa2fbc30cc9a3a7a">
    <domeo:sets rdf:resource="urn:pddi:uuid:DA9F9ECD-BD26-442E-B926-8282B005FB81"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N4ab0dff5ec51472995ea68a1fb2be3e6">
    <domeo:sets rdf:resource="urn:pddi:uuid:DC22E1FE-4EA4-45F8-B276-DFAB69DD8ED7"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N16eb050157e1445b9199eb9dad8f1549">
    <domeo:sets rdf:resource="urn:pddi:uuid:08F7591C-8D26-49D1-ADED-73CBF6D8583E"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="Neec5e0b24e964414a38397d2ea5bede3">
    <domeo:sets rdf:resource="urn:pddi:uuid:DC0955C1-EFC0-4995-A434-15EABB66AE36"/>
  </rdf:Description>
  <rdf:Description rdf:nodeID="N5114ec2ebab74207b4b2e353436f2141">
    <domeo:sets rdf:resource="urn:pddi:uuid:B6C0AC51-BD1D-425B-A355-337B17F99721"/>
  </rdf:Description>
</rdf:RDF>
